Sentence,class,file
"7, Issue 3      http://www.thno .org 627  Mass cytometry   0.5 x 106 MDAMB231 X4 and 0.5 x 106  MDAMB231 cells were aliquoted per sample, to  which 1 mL of 1:500 diluted 500 µM 103Rh DN A  intercalator (Fluidigm) with Staining Buffer  (Fluidigm) was added for 15 minutes at RT to stain  dead cells as the dye only enters cells when cell membranes are compromised.",Non-OADS,/arxiv_data1/oa_pdf/d4/b9/thnov07p0624.PMC5327638.pdf
"7, Issue 3      http://www.thno .org 628  Biodistribution Studies   Mice were sacrificed at twenty -four hours after  intravenous injection of 50 μ g of  (111In)hybrid -Cy5-Ac-TZ14011,  (165Ho)hybrid -Cy5-Ac-  TZ14011  or 111In(165Ho)hybrid -Cy5-Ac-TZ14011 (10  MBq, n=3 -5 for each group), and tissues were excised  and weighed individually.",Non-OADS,/arxiv_data1/oa_pdf/d4/b9/thnov07p0624.PMC5327638.pdf
"7, Issue 3      http://www.thno .org 629  performed using basal CXCR4 expressing  MDAMB 231 cells and CXCR4 overexpressing  MDAMB231 X4 cells.",Non-OADS,/arxiv_data1/oa_pdf/d4/b9/thnov07p0624.PMC5327638.pdf
"7, Issue 3      http://www.thno .org 630  In vivo  biodistribution patterns   In vivo  radioactivity- based imaging was  performed in mice using SPECT after intravenous  injection of 111In-hybrid -Cy5-Ac-TZ14011  (tracer- labeling: 10 MBq/mouse, 3.5*1011 111In atoms;  Figure 2A).",Non-OADS,/arxiv_data1/oa_pdf/d4/b9/thnov07p0624.PMC5327638.pdf
"7, Issue 3      http://www.thno .org 631    Figure 3.",Non-OADS,/arxiv_data1/oa_pdf/d4/b9/thnov07p0624.PMC5327638.pdf
"7, Issue 3      http://www.thno .org 632  targeting moiety and the size of the label.",Non-OADS,/arxiv_data1/oa_pdf/d4/b9/thnov07p0624.PMC5327638.pdf
"7, Issue 3      http://www.thno .org 633  8.",Non-OADS,/arxiv_data1/oa_pdf/d4/b9/thnov07p0624.PMC5327638.pdf
This is an open access article distributed under the terms of the Creative Commons  Attribution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/36/0f/thnov07p0634.PMC5327639.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/36/0f/thnov07p0634.PMC5327639.pdf
This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/7f/eb/thnov07p0647.PMC5327640.pdf
See http://ivyspring.com/terms for ful l terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/7f/eb/thnov07p0647.PMC5327640.pdf
This is an open access article distributed under the terms of the Creative Commons Attri bution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ae/1a/thnov07p0664.PMC5327641.pdf
This  is an open  access  article  distributed  under  the terms  of the Creative  Commons  Attribution  (CC BY-NC)  license   (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/27/9e/thnov07p0677.PMC5327642.pdf
See  http://ivyspring.com/terms  for full terms  and  conditions.,Non-OADS,/arxiv_data1/oa_pdf/27/9e/thnov07p0677.PMC5327642.pdf
This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ed/e9/thnov07p0694.PMC5327643.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/ed/e9/thnov07p0694.PMC5327643.pdf
2008;27(4):611-632.  http://www.jultrasoundmed.org/content/27/4/611.abstract.,Non-OADS,/arxiv_data1/oa_pdf/ed/e9/thnov07p0694.PMC5327643.pdf
This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/6d/26/thnov07p0703.PMC5327644.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/6d/26/thnov07p0703.PMC5327644.pdf
This is an open access article distributed under the terms of the Creative Commons  Attribution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/8e/3b/thnov07p0717.PMC5327645.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/8e/3b/thnov07p0717.PMC5327645.pdf
According to the TCGA guidelines (http://cancergenome.nih.gov/publications/publica tionguidelines ).,Non-OADS,/arxiv_data1/oa_pdf/8e/3b/thnov07p0717.PMC5327645.pdf
"According to the Cancer Cell Lines Project Database (COSMI C -  http://cancer.sanger.ac.uk/cell_lines), there are no genetic mutations  of RTKs on HeLa, SiHa, Caski and  C-33A cervical cancer cell lines.",Non-OADS,/arxiv_data1/oa_pdf/8e/3b/thnov07p0717.PMC5327645.pdf
This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/54/0b/thnov07p0733.PMC5327646.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/54/0b/thnov07p0733.PMC5327646.pdf
This is an open access article distributed under the terms of the Creative Commons Attribu tion (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/75/80/thnov07p0751.PMC5327647.pdf
See http://ivyspring.com/terms for full terms and condi tions.,Non-OADS,/arxiv_data1/oa_pdf/75/80/thnov07p0751.PMC5327647.pdf
This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2e/28/thnov07p0764.PMC5327648.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/2e/28/thnov07p0764.PMC5327648.pdf
This  is an open  access  article  distributed  under  the terms  of the Creative  Commons  Attribution  (CC BY-NC)  license   (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/df/d3/thnov07p0775.PMC5327649.pdf
See  http://ivyspring.com/terms  for full terms  and  conditions.,Non-OADS,/arxiv_data1/oa_pdf/df/d3/thnov07p0775.PMC5327649.pdf
This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license  (https://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/50/62/thnov07p0789.PMC5327650.pdf
See http://ivyspring.com/terms for full terms and conditions.,Non-OADS,/arxiv_data1/oa_pdf/50/62/thnov07p0789.PMC5327650.pdf
[Internet] https://www.thermofisher.com/order/catalog/product/10606D   71.,Non-OADS,/arxiv_data1/oa_pdf/50/62/thnov07p0789.PMC5327650.pdf
https://www.systembio.com/microrna- research/exoquick -exosomes/overvi ew.,OADS,/arxiv_data1/oa_pdf/50/62/thnov07p0789.PMC5327650.pdf
https://www.thermofisher.com/sg/en/home/life -science/cell-analysis/exo somes.html.,Non-OADS,/arxiv_data1/oa_pdf/50/62/thnov07p0789.PMC5327650.pdf
Available from: http://www.who.int/mediacentre/factsheets/fs286/en/.,Non-OADS,/arxiv_data1/oa_pdf/1d/46/IJHS-11-4.PMC5327669.pdf
Available from: http://www.pndajk.gov.pk/glance.asp.,Non-OADS,/arxiv_data1/oa_pdf/1d/46/IJHS-11-4.PMC5327669.pdf
Available from: http://www.apps.who.int/iris/ bitstream/10665/204871/1/9789241565257_eng.,OADS,/arxiv_data1/oa_pdf/9b/84/IJHS-11-3.PMC5327670.pdf
Available  from: http://www.theglobalfund.org/documents/core/infonotes/Core_ TB-HIV_Infonote_en/.,Non-OADS,/arxiv_data1/oa_pdf/bc/4d/IJHS-11-10.PMC5327674.pdf
Available from: http://www.ephi.gov.et/images/ pictures/Final_National_TB-HIV_Sentinel_Surveillance__OCT_20_ FE2015_(1)%20(1).pdf.,Non-OADS,/arxiv_data1/oa_pdf/bc/4d/IJHS-11-10.PMC5327674.pdf
Available  from: http://www.stoptb.org/assets/2012/02/21/global/TB/HIV  Collaborative Activities.,Non-OADS,/arxiv_data1/oa_pdf/bc/4d/IJHS-11-10.PMC5327674.pdf
Available from: http://www.apps.who.int/iris/ bitstream/10665/44728/1/9789241564380_eng.pdf.,Non-OADS,/arxiv_data1/oa_pdf/bc/4d/IJHS-11-10.PMC5327674.pdf
Available from: http://www.afro.,Non-OADS,/arxiv_data1/oa_pdf/bc/4d/IJHS-11-10.PMC5327674.pdf
Available from:  http://www.who.int/hiv/pub/meetingreports/WHO_3Is_meeting_ report.pdf.,OADS,/arxiv_data1/oa_pdf/bc/4d/IJHS-11-10.PMC5327674.pdf
"Journal of  Preventive Medicine  & Public Health 38 Copyright © 2017  The Korean Society for Preventive MedicineJ Prev Med Public Health 2017;50:38-59      https://doi.org/10.3961/jpmph.16.081 Development and Validation of a Novel Generic Health- related Quality of Life Instrument With 20 Items (HINT-20) Min-Woo Jo1*, Hyeon-Jeong Lee1*, Soo Young Kim2, Seon-Ha Kim3, Hyejung Chang4, Jeonghoon Ahn5, Minsu Ock1 1Department of Preventive Medicine, University of Ulsan College of Medicine, Seoul; 2Department of Family Medicine, Kangdong Sacred Heart  Hospital, Hallym University College of Medicine, Seoul; 3Department of Nursing, Dankook University College of Nursing, Cheonan; 4Department of  Management, Kyung Hee University School of Management, Seoul; 5Department of Health Convergence, Ewha Womans University, Seoul, KoreaOriginal Article Objectives: Few attempts have been made to develop a generic health-related quality of life (HRQoL) instrument and to examine its  validity and reliability in Korea.",Non-OADS,/arxiv_data1/oa_pdf/d9/eb/jpmph-50-1-38.PMC5327678.pdf
"This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/4.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.pISSN 1975-8375 eISSN 2233-4521  INTRODUCTION Measuring health-related quality of life (HRQoL) is impor - tant in both clinical practice and public health.",Non-OADS,/arxiv_data1/oa_pdf/d9/eb/jpmph-50-1-38.PMC5327678.pdf
ORCID Min-Woo Jo   http://orcid.org/0000-0002-4574-1318 Hyeon-Jeong Lee   http://orcid.org/0000-0002-0822-2420 Soo Young Kim   http://orcid.org/0000-0002-3205-9408 Seon-Ha Kim   http://orcid.org/0000-0002-9417-396X Hyejung Chang   http://orcid.org/0000-0002-5666-1305 Jeonghoon Ahn   http://orcid.org/0000-0002-0177-0192 Minsu Ock   http://orcid.org/0000-0001-9949-9224 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/d9/eb/jpmph-50-1-38.PMC5327678.pdf
Available from:  https://www.england.nhs.uk/wp-content/uploads/2013/   12/5yr-strat-plann-guid-wa.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d9/eb/jpmph-50-1-38.PMC5327678.pdf
Avail - able from: https://eprovide.mapi-trust.org/search?form[searc hText]=&form[ezxform_token] =HnJDBAkSIG8hPTmob348O 1cLy0jyub9fShuWYaVyeXY .,OADS,/arxiv_data1/oa_pdf/d9/eb/jpmph-50-1-38.PMC5327678.pdf
Available from: https://www.oecd.org/gender/data/OECD_   1564_TUSupdatePortal.xls .,OADS,/arxiv_data1/oa_pdf/d9/eb/jpmph-50-1-38.PMC5327678.pdf
"Journal of  Preventive Medicine  & Public Health 18 Copyright © 2017  The Korean Society for Preventive MedicineJ Prev Med Public Health 2017;50:18-28    •  https://doi.org/10.3961/jpmph.16.087 Distribution and Determinants of Low Birth Weight in   Developing Countries Rashidul Alam Mahumud1, Marufa Sultana1, Abdur Razzaque Sarker1,2  1Health Economics and Financing Research, Health Systems and Population Studies Division, International Centre for Diarrhoeal Disease Research,  Bangladesh (icddr,b), Dhaka, Bangladesh; 2Department of Management Science, University of Strathclyde, Glasgow, United KingdomOriginal Article Objectives: Low birth weight (LBW) is a major public health concern, especially in developing countries, and is frequently related to  child morbidity and mortality.",Non-OADS,/arxiv_data1/oa_pdf/f1/16/jpmph-50-1-18.PMC5327679.pdf
"Key words:  Developing countries, Global health, Low birth weight, Odds ratio  Received:  September 19, 2016, Accepted:  December 19, 2016 Corresponding author:  Rashidul Alam Mahumud, MSc 68 Shaheed Tajuddin Ahmed Sarani, Mohakhali, Dhaka, Bangladesh Tel: +880-2-9827001-10, Fax:  +880-2-8811568   E-mail:  rashidul.alam@icddrb.org This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/4.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION Infant birth weight is a significant predictor of the immedi - ate and future health status of a newborn.",Non-OADS,/arxiv_data1/oa_pdf/f1/16/jpmph-50-1-18.PMC5327679.pdf
ORCID  Rashidul Alam Mahumud   http://orcid.org/0000-0001-9788- 1868 Marufa Sultana   h ttp://orcid.org/0000-0002-4481-0748   Abdur Razzaque Sarker   http://orcid.org/0000-0002-2022- 7590 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/f1/16/jpmph-50-1-18.PMC5327679.pdf
Avail - able from: http://dhsprogram.com/pubs/pdf/DHSM10/ DHS6_Survey_Org_Manual_7Dec2012_DHSM10.pdf.,OADS,/arxiv_data1/oa_pdf/f1/16/jpmph-50-1-18.PMC5327679.pdf
Available from: http://www.dhsprogram.com/pubs/pdf/ DHSG1/Guide_to_DHS_Statistics_29Oct2012_DHSG1.pdf.,OADS,/arxiv_data1/oa_pdf/f1/16/jpmph-50-1-18.PMC5327679.pdf
"Journal of  Preventive Medicine  & Public Health 29 Copyright © 2017  The Korean Society for Preventive MedicineJournal of  Preventive Medicine  & Public Health PB Copyright © 2017  The Korean Society for Preventive MedicineJ Prev Med Public Health 2017;50:29-37    •  https://doi.org/10.3961/jpmph.16.099 Evaluation of Geographic Indices Describing Health Care  Utilization Agnus M. Kim1, Jong Heon Park2, Sungchan Kang3, Yoon Kim1,3 1Department of Health Policy and Management, Seoul National University College of Medicine, Seoul; 2Big Data Steering Department, National  Health Insurance Service, Wonju; 3Institute of Health Policy and Management, Seoul National University Medical Research Center, Seoul, Korea Original Article Objectives: The accurate measurement of geographic patterns of health care utilization is a prerequisite for the study of geographic  variations in health care utilization.",Non-OADS,/arxiv_data1/oa_pdf/25/34/jpmph-50-1-29.PMC5327680.pdf
"Key words:  Small-area analysis, Health care, Utilization, Variation, Insurance, Korea Received:  October 14, 2016, Accepted:  December 19, 2016 Corresponding author:  Yoon Kim, MD, PhD 103 Daehak-ro, Jongno-gu, Seoul 03080, Korea Tel: +82-2-740-8363, Fax:  +82-2-743-2009   E-mail:  yoonkim@snu.ac.kr This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/4.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION Geographic variation in health care utilization has been a  major issue in health care policy and research for decades.",Non-OADS,/arxiv_data1/oa_pdf/25/34/jpmph-50-1-29.PMC5327680.pdf
ORCID Angus M. Kim   http://orcid.org/0000-0002-6616-2534 Sungchan Kang   http://orcid.org/0000-0002-4876-3205 Yoon Kim   http://orcid.org/0000-0001-7257-1679 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/25/34/jpmph-50-1-29.PMC5327680.pdf
Available from: https://www.oecd.org/ els/health-systems/FOCUS-on-Geographic-Variations-in- Health-Care.pdf.,Non-OADS,/arxiv_data1/oa_pdf/25/34/jpmph-50-1-29.PMC5327680.pdf
Available from: http://www.dartmouthat - las.org/downloads/reports/Decision_making_report_022411.,Non-OADS,/arxiv_data1/oa_pdf/25/34/jpmph-50-1-29.PMC5327680.pdf
Available from: http://www.oecd.org/health/health-systems/ health-at-a-glance-19991312.htm.,Non-OADS,/arxiv_data1/oa_pdf/25/34/jpmph-50-1-29.PMC5327680.pdf
"Journal of  Preventive Medicine  & Public Health 10 Copyright © 2017  The Korean Society for Preventive MedicineJ Prev Med Public Health 2017;50:10-17    •  https://doi.org/10.3961/jpmph.16.080 Meeting Recommended Levels of Physical Activity in   Relation to Preventive Health Behavior and Health Status  Among Adults Peter D. Hart1,2, Gabriel Benavidez1,2, James Erickson1 1Health Promotion Program, Montana State University-Northern, Havre, MT; 2Kinesmetrics Lab, Montana State University-Northern, Havre, MT, USAOriginal Article Objectives: The purpose of this study was to examine the relationship of meeting the recommended levels of physical activity (PA)  with health status and preventive health behavior in adults.",Non-OADS,/arxiv_data1/oa_pdf/00/3f/jpmph-50-1-10.PMC5327681.pdf
"Box 7751 Havre, MT 59501-7751, USA Tel: +1-406-265-3719, Fax:  +1-406-265-4129 E-mail:  peter.hart@msun.edu This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/4.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.pISSN 1975-8375 eISSN 2233-4521  INTRODUCTION As of 2014, seven of the 10 leading causes of death in the US  were chronic diseases (heart disease, cancers, chronic lower  respiratory diseases, cerebrovascular diseases, Alzheimer dis - ease, diabetes mellitus, and influenza and pneumonia) [1].",Non-OADS,/arxiv_data1/oa_pdf/00/3f/jpmph-50-1-10.PMC5327681.pdf
ORCID Peter D. Hart   https://orcid.org/0000-0002-4947-9310 Gabriel Benavidez   https://orcid.org/0000-0003-2268-6229 James Erickson   https://orcid.org/0000-0002-4745-0610 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/00/3f/jpmph-50-1-10.PMC5327681.pdf
Available from: https://www.cdc.gov/ nchs/data/hus/hus15.pdf.,OADS,/arxiv_data1/oa_pdf/00/3f/jpmph-50-1-10.PMC5327681.pdf
Available from: https://www.cdc.gov/ chronicdisease/overview/index.htm.,OADS,/arxiv_data1/oa_pdf/00/3f/jpmph-50-1-10.PMC5327681.pdf
Available from: https://www.cdc.gov/physicalactivi - ty/downloads/pa_fact_sheet_adults.pdf.,Non-OADS,/arxiv_data1/oa_pdf/00/3f/jpmph-50-1-10.PMC5327681.pdf
Available from:  http://www.healthypeople.gov/2010/hp2020/Comments/ default.asp.,Non-OADS,/arxiv_data1/oa_pdf/00/3f/jpmph-50-1-10.PMC5327681.pdf
Available  from: https://www.cdc.gov/brfss/data_tools.htm.,OADS,/arxiv_data1/oa_pdf/00/3f/jpmph-50-1-10.PMC5327681.pdf
Available from: https://www.cdc.gov/brfss/annu - al_data/2013/pdf/overview_2013.pdf.,OADS,/arxiv_data1/oa_pdf/00/3f/jpmph-50-1-10.PMC5327681.pdf
Available from: http://www.cdc.gov/brfss/pdf/PA%20 RotatingCore_BRFSSGuide_508Comp_07252013FINAL.pdf.,OADS,/arxiv_data1/oa_pdf/00/3f/jpmph-50-1-10.PMC5327681.pdf
Available from:  https://www.cdc.gov/brfss/annual_data/2013/pdf/2013_cal - culated_variables_version15.pdf.,OADS,/arxiv_data1/oa_pdf/00/3f/jpmph-50-1-10.PMC5327681.pdf
Available from: http://apps.who.int/bmi/index.jsp?,OADS,/arxiv_data1/oa_pdf/00/3f/jpmph-50-1-10.PMC5327681.pdf
Available from:  https://www.cdc.gov/brfss/annual_data/2013/pdf/code - book13_llcp.pdf.,OADS,/arxiv_data1/oa_pdf/00/3f/jpmph-50-1-10.PMC5327681.pdf
Available  from: http://www-01.ibm.com/common/ssi/cgi-bin/ssialias?h tmlfid =YTD03116USEN&appname =skmwww.,OADS,/arxiv_data1/oa_pdf/00/3f/jpmph-50-1-10.PMC5327681.pdf
"Journal of  Preventive Medicine  & Public Health 60 Copyright © 2017  The Korean Society for Preventive MedicineJ Prev Med Public Health 2017;50:60-65    •  https://doi.org/10.3961/jpmph.16.079 Tobacco Use Among Students Aged 13-15 Years in South  Korea: The 2013 Global Youth Tobacco Survey Sunhye Choi1, Yoonjung Kim1, Jihye Lee1, Mina Kashiwabara2, Kyungwon Oh1 1Division of Health and Nutrition Survey, Centers for Disease Control and Prevention, Cheongju, Korea;  2Tobacco Free Initiative, World Health   Organization Regional Office for the Western Pacific, Manila, Philippines Original Article Objectives: We examined the prevalence of tobacco use and exposure to secondhand smoke among middle-school students in Korea  using the Global Youth Tobacco Survey (GYTS) in 2013.",Non-OADS,/arxiv_data1/oa_pdf/c6/08/jpmph-50-1-60.PMC5327682.pdf
"Key words:  Global Youth Tobacco Survey, Republic of Korea, Tobacco use Received:  August 24, 2016, Accepted:  December 29, 2016 Corresponding author:  Kyungwon Oh, PhD 187 Osongsaengmyeong 2-ro, Heungdeok-gu, Cheongju 28159, Korea Tel: +82-43-719-7460, Fax:  +82-43-719-7527   E-mail:  kwoh27@korea.kr This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/4.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.pISSN 1975-8375 eISSN 2233-4521  INTRODUCTION Tobacco use is a major preventable risk factor for premature  death and disease worldwide [1].",Non-OADS,/arxiv_data1/oa_pdf/c6/08/jpmph-50-1-60.PMC5327682.pdf
ORCID Sunhye Choi   https://orcid.org/0000-0002-2942-0290 Kyungwon Oh   https://orcid.org/0000-0001-8097-6078 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/c6/08/jpmph-50-1-60.PMC5327682.pdf
Avail - able from: http://apps.who.int/iris/bitstream/10665/43818/   1/9789241596282_eng.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c6/08/jpmph-50-1-60.PMC5327682.pdf
Available from: http://www.who.int/nmh/events/un_ncd_ summit2011/political_declaration_en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c6/08/jpmph-50-1-60.PMC5327682.pdf
Available from: https://www.cdc.gov/mmwr/pdf/rr/rr4304.pdf.,OADS,/arxiv_data1/oa_pdf/c6/08/jpmph-50-1-60.PMC5327682.pdf
Avail - able from: https://www.cdc.gov/tobacco/global/gtss/gtssda - ta/index.html.,Non-OADS,/arxiv_data1/oa_pdf/c6/08/jpmph-50-1-60.PMC5327682.pdf
Available from:  https://yhs.cdc.go.kr/new/pages/pds3.asp (Korean).,Non-OADS,/arxiv_data1/oa_pdf/c6/08/jpmph-50-1-60.PMC5327682.pdf
"Journal of  Preventive Medicine  & Public Health 1 Copyright © 2017  The Korean Society for Preventive MedicineJournal of  Preventive Medicine  & Public Health PB Copyright © 2017  The Korean Society for Preventive MedicineJ Prev Med Public Health 2017;50:1-9    •  https://doi.org/10.3961/jpmph.16.101 The Impact of the Financial Crisis on Lifestyle Health   Determinants Among Older Adults Living in the   Mediterranean Region: The Multinational MEDIS Study  (2005-2015) Alexandra Foscolou1, Stefanos Tyrovolas1,2, George Soulis1, Anargiros Mariolis3, Suzanne Piscopo4, Giuseppe Valacchi5,6,  Foteini Anastasiou7, Christos Lionis7, Akis Zeimbekis8, Josep-Antoni Tur9, Vassiliki Bountziouka1, Dimitra Tyrovola1,   Efthimios Gotsis1, George Metallinos1, Antonia-Leda Matalas1, Evangelos Polychronopoulos1, Labros Sidossis1,10,   Demosthenes B. Panagiotakos1  1Department of Nutrition and Dietetics, School of Health Science and Education, Harokopio University, Athens, Greece; 2Parc Sanitari Sant Joan de  Déu, Fundació Sant Joan de Déu, CIBERSAM, Universitat de Barcelona, Barcelona, Spain; 3Health Center of Areopolis, General Hospital of Sparta,   Areopolis, Greece; 4University of Malta, Nutrition, Family and Consumer Studies Office, Msida, Republic of Malta; 5Department of Life Sciences and  Biotechnology, University of Ferrara, Ferrara, Italy; 6Department of Animal Science, Plants for Human Health Institute, North Carolina State   University, Kannapolis, NC, USA; 7Clinic of Social and Family Medicine, School of Medicine, University of Crete, Heraklion; 8Health Center of Kalloni,  General Hospital of Mitilini, Mitilini, Greece; 9Research Group on Community Nutrition and Oxidative Stress, Universitat de les Illes Balears &   CIBEROBN, Guillem Colom Bldg, Campus, Palma de Mallorca, Spain; 10Department of Kinesiology and Health, School of Arts and Sciences, Rutgers  University, Newark, NJ, USA Original Article Objectives: By the end of the 2000s, the economic situation in many European countries started to deteriorate, generating financial  uncertainty, social insecurity and worse health status.",Non-OADS,/arxiv_data1/oa_pdf/58/68/jpmph-50-1-1.PMC5327683.pdf
"Key words:  Financial crisis, Lifestyle health determinant index, Socioeconomic status, Health status, Older adults, Mediterranean islands Received:  October 23, 2016 Accepted:  November 23, 2016 Corresponding author:  Demosthenes B. Panagiotakos, PhD 46 Paleon Polemiston St., Glyfada, Attica 166 74, Greece Tel: +30-210-9603116, Fax:  +30-210-9600719 E-mail:  d.b.Panagiotakos@usa.net  This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/4.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.pISSN 1975-8375 eISSN 2233-4521  INTRODUCTION According to the World Health Organization (WHO), the de - terminants of good health can be divided into three major  categories: the socioeconomic environment, the physical envi - ronment, and lifestyle and behaviours [1].",Non-OADS,/arxiv_data1/oa_pdf/58/68/jpmph-50-1-1.PMC5327683.pdf
ORCID Alexandra Foscolou   http://orcid.org/0000-0002-8068-577X Stefanos Tyrovolas   http://orcid.org/0000-0003-1498-0997 Giuseppe Valacchi   http://orcid.org/0000-0002-8792-0947 Christos Lionis   http://orcid.org/0000-0002-9324-2839 Vassiliki Bountziouka   http://orcid.org/0000-0003-2522-1582  Evangelos Polychronopoulos   http://orcid.org/0000-0001- 7061-4081 Labros Sidossis   http://orcid.org/0000-0003-0887-2156  Demosthenes B. Panagiotakos   http://orcid.org/0000-0001- 8583-153X REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/58/68/jpmph-50-1-1.PMC5327683.pdf
Available from: http://www.who.int/hia/ evidence/doh/en/.,OADS,/arxiv_data1/oa_pdf/58/68/jpmph-50-1-1.PMC5327683.pdf
Available from: http://www.who.int/sub - stance_abuse/en/.,Non-OADS,/arxiv_data1/oa_pdf/58/68/jpmph-50-1-1.PMC5327683.pdf
Available from: http://www.euro.who.int/en/publications/ab - stracts/gaining-health.-the-european-strategy-for-the-pre - vention-and-control-of-noncommunicable-diseases .,Non-OADS,/arxiv_data1/oa_pdf/58/68/jpmph-50-1-1.PMC5327683.pdf
Aging Ment Health 2016. doi: https://doi.org/10.10 80/13607863.2016.1191060.,Non-OADS,/arxiv_data1/oa_pdf/58/68/jpmph-50-1-1.PMC5327683.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/b4/a1/ccid-10-051.PMC5327846.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/b4/a1/ccid-10-051.PMC5327846.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical, Cosmetic and Investigational Dermatology 2017:10 51–56Clinical, Cosmetic and Investigational Dermatology Dovepress submit your manuscript | www.dovepress.com Dovepress 51 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CCID.S130013 Microbiome in atopic dermatitis Uwe Wollina Department of Dermatology and  Allergology, Academic T eaching Hospital Dresden-Friedrichstadt,  Dresden, GermanyAbstract:  Atopic dermatitis (AD) is a common chronic inflammatory skin disease affecting  ~10–20% of the general population.",Non-OADS,/arxiv_data1/oa_pdf/b4/a1/ccid-10-051.PMC5327846.pdf
"Correspondence: Uwe Wollina   Department of Dermatology and  Allergology, Academic Teaching Hospital Dresden-Friedrichstadt, Friedrichstrasse 41, 01067 Dresden, GermanyTel +49 451 480 1685   Fax +49 351 480 1219   Email wollina-uw@khdf.deJournal name: Clinical, Cosmetic and Investigational Dermatology Article Designation: REVIEWY ear: 2017V olume: 10Running head verso: WollinaRunning head recto: Atopic dermatitisDOI: http://dx.doi.org/10.2147/CCID.S130013",Non-OADS,/arxiv_data1/oa_pdf/b4/a1/ccid-10-051.PMC5327846.pdf
"Clinical, Cosmetic and Investigational Dermatology 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journal Clinical, Cosmetic and Investigational Dermatology is an interna- tional, peer-reviewed, open access, online journal that focuses on   the latest clinical and experimental research in all aspects of skin   disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/b4/a1/ccid-10-051.PMC5327846.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authorsDovepress 56 Wollina 39.,Non-OADS,/arxiv_data1/oa_pdf/b4/a1/ccid-10-051.PMC5327846.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/69/b0/ccid-10-067.PMC5327847.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/69/b0/ccid-10-067.PMC5327847.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical, Cosmetic and Investigational Dermatology 2017:10 67–69Clinical, Cosmetic and Investigational Dermatology Dovepress submit your manuscript | www.dovepress.com Dovepress 67 CASE REPORT open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CCID.S127040 Superficial basal cell carcinoma treated with 70%  trichloroacetic acid applied topically: a case study Anca Chiriac1–3 Piotr Brzezinski4 Cosmin Moldovan5 Cristian Podoleanu6 Marius Florin Coros7 Simona Stolnicu8 1Department of Dermatology,   Nicolina Medical Center, Iasi,   2Department of Dermatology,   Apollonia University, Iasi,   3Department of Dermatology, P .",Non-OADS,/arxiv_data1/oa_pdf/69/b0/ccid-10-067.PMC5327847.pdf
"Correspondence: Marius Florin Coros  Department of Surgery, University of Medicine and Pharmacy of Tirgu Mures38 Gheorghe Marinescu Street, Targu‑Mures 540139, RomaniaTel +40 265 215 551Email corosmarius1@gmail.comJournal name: Clinical, Cosmetic and Investigational Dermatology Article Designation: CASE REPORTY ear: 2017V olume: 10Running head verso: Chiriac et alRunning head recto: Basal cell carcinoma treated with 70% TCADOI: http://dx.doi.org/10.2147/CCID.S127040",Non-OADS,/arxiv_data1/oa_pdf/69/b0/ccid-10-067.PMC5327847.pdf
"Clinical, Cosmetic and Investigational Dermatology 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journal Clinical, Cosmetic and Investigational Dermatology is an interna- tional, peer-reviewed, open access, online journal that focuses on   the latest clinical and experimental research in all aspects of skin   disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/69/b0/ccid-10-067.PMC5327847.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authorsDovepress 69 Basal cell carcinoma treated with 70% TCA Conclusion The 70% TCA could be an effective and safe non-invasive  choice of therapy for low-risk BCCs; easy to perform, inex-pensive, with good cosmetic results, especially for patients who are not likely to undergo invasive or expensive treatments.",Non-OADS,/arxiv_data1/oa_pdf/69/b0/ccid-10-067.PMC5327847.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/af/a3/cia-12-431.PMC5327848.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2017:12 431–436Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  431OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S11324 0 Bone cement distribution in the vertebral  body affects chances of recompression after  percutaneous vertebroplasty treatment in  elderly patients with osteoporotic vertebral  compression fractures liang Zhang Qiang Wang lin Wang Jian shen Qiwei Zhang Changtai sun Department of Orthopedics,   Beijing hospital, national  Center of gerontology, People’s  republic of ChinaObjective:  Percutaneous vertebroplasty (PVP) is a surgical procedure that has been widely  used to treat patients suffering from osteoporotic vertebral compression fractures (OVCFs).",Non-OADS,/arxiv_data1/oa_pdf/af/a3/cia-12-431.PMC5327848.pdf
"1 Dahua road, Dong  Dan, Beijing 100730, People’s republic  of China Tel +86 10 8513 6172 email sunchangtai151005@163.co mJournal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Zhang et al Running head recto: PVP treatment for elderly patients with OVCF DOI: http://dx.doi.org/10.2147/CIA.S113240",Non-OADS,/arxiv_data1/oa_pdf/af/a3/cia-12-431.PMC5327848.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/af/a3/cia-12-431.PMC5327848.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/af/a3/cia-12-431.PMC5327848.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/d4/2a/amep-8-171.PMC5327849.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/d4/2a/amep-8-171.PMC5327849.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Advances in Medical Education and Practice 2017:8 171–178Advances in Medical Education and Practice Dovepress submit your manuscript | www.dovepress.com Dovepress 171 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S119611 Searching for a written patient feedback  instrument for patient–medical student  consultations Nicola Hogan1  Henry Li1  Carmel Pezaro2  Noel Roberts2  Erica Schmidt3  Jenepher Martin2 1Monash School of Medicine, Monash  University, 2Medical Student Programs,   Eastern Health Clinical School,   Monash University and Deakin University,  3Student Academic Support  Unit, Faculty of Medicine, Nursing and Health Sciences, Monash University,  Melbourne, VIC, AustraliaObjective: The Patient Teaching Associate (PTA) program at Eastern Health Clinical School  uses volunteer patients with chronic illnesses in consultation-based medical student education.",Non-OADS,/arxiv_data1/oa_pdf/d4/2a/amep-8-171.PMC5327849.pdf
"Correspondence:  Noel Roberts   Medical Student Programs, Eastern  Health Clinical School, Monash University, 5 Arnold Street, Box Hill, Melbourne, VIC 3128, Australia   Tel +61 3 9091 8890   Email noel.roberts@monash.eduJournal name: Advances in Medical Education and Practice Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 8Running head verso: Hogan et alRunning head recto: Searching for a patient feedback instrument student consultationsDOI: http://dx.doi.org/10.2147/AMEP .S119611",Non-OADS,/arxiv_data1/oa_pdf/d4/2a/amep-8-171.PMC5327849.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/advances-in-medical-education-and-practice-journalAdvances in Medical Education and Practice is an international, peer-  reviewed, open access journal that aims to present and publish research on Medical Education covering medical, dental, nursing and allied   health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/d4/2a/amep-8-171.PMC5327849.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Advances in Medical Education and Practice 2017:8submit your manuscript | www.dovepress.com Dovepress Dovepress Dovepress 178 Hogan et al  18. International Alliance of Patients’ Organisation (UK).,Non-OADS,/arxiv_data1/oa_pdf/d4/2a/amep-8-171.PMC5327849.pdf
Available from: http://iapo.org.uk/sites/default/files/files/IAPO_declaration_English.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d4/2a/amep-8-171.PMC5327849.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/6e/b6/cmar-9-041.PMC5327850.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/6e/b6/cmar-9-041.PMC5327850.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Cancer Management and Research 2017:9 41–50Cancer Management and Research Dovepress submit your manuscript | www.dovepress.com Dovepress  41 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CMAR.S97543Differential pharmacology and clinical utility of  rolapitant in chemotherapy-induced nausea and  vomiting Bernardo Leon Rapoport The Medical Oncology Centre of  Rosebank, Johannesburg, South AfricaAbstract:  Chemotherapy-induced nausea and vomiting (CINV) is a debilitating side effect of  many cytotoxic chemotherapy regimens.",Non-OADS,/arxiv_data1/oa_pdf/6e/b6/cmar-9-041.PMC5327850.pdf
"Acute CINV is therefore particularly sensitive to 5-HT 3 receptor antagonists;9 however, these  agents have little impact on delayed CINV ,9 suggesting that the pathophysiologic Correspondence: Bernardo Leon  RapoportThe Medical Oncology Centre of Rosebank, 129 Oxford Road, Corner Northwold, Saxonwold, Johannesburg 2196, South Africa Tel +27 11 880 4169   Email brapoport@rosebankoncology.co.zaJournal name: Cancer Management and Research Article Designation: REVIEWY ear: 2017V olume: 9Running head verso: RapoportRunning head recto: Rolapitant pharmacology and clinical utility in CINVDOI: http://dx.doi.org/10.2147/CMAR.S97543",Non-OADS,/arxiv_data1/oa_pdf/6e/b6/cmar-9-041.PMC5327850.pdf
"Cancer Management and Research 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Cancer Management and Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/cancer-management-and-research-journalCancer Management and Research is an international, peer-reviewed  open access journal focusing on cancer research and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/6e/b6/cmar-9-041.PMC5327850.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 50 Rapoport,Non-OADS,/arxiv_data1/oa_pdf/6e/b6/cmar-9-041.PMC5327850.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/ca/9e/ccid-10-057.PMC5327851.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/ca/9e/ccid-10-057.PMC5327851.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical, Cosmetic and Investigational Dermatology 2017:10 57–66Clinical, Cosmetic and Investigational Dermatology Dovepress submit your manuscript | www.dovepress.com Dovepress 57 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CCID.S125580 The role of inflammation in adipocytolytic  nonsurgical esthetic procedures for body  contouring Jonathas Xavier Pereira1 Yuri Cavalcante2 Riane Wanzeler de Oliveira3 1Department of Pathology, Faculty  of Medicine, 2Faculty of Dentistry,   3Faculty of Medicine, Federal  University of Rio de Janeiro, Rio de  Janeiro, BrazilBackground: The adipocytolytic non-surgical esthetic procedures are indicated for the reduction  of localized fat and are effective in reducing local adiposity through the ablation of adipocytes  with fast and lasting results, besides causing local inflammation.",Non-OADS,/arxiv_data1/oa_pdf/ca/9e/ccid-10-057.PMC5327851.pdf
"Carlos Chagas Filho, 393 Bloco F, CEP 21941-902, Cidade Universitária, Ilha do Fundão, Rio de Janeiro, BrazilTel +55 021 3938 6483Email jonathasxp@gmail.comJournal name: Clinical, Cosmetic and Investigational Dermatology Article Designation: REVIEWY ear: 2017V olume: 10Running head verso: Pereira et alRunning head recto: Inflammation in adipocytolytic esthetic proceduresDOI: http://dx.doi.org/10.2147/CCID.S125580",Non-OADS,/arxiv_data1/oa_pdf/ca/9e/ccid-10-057.PMC5327851.pdf
"Clinical, Cosmetic and Investigational Dermatology 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journal Clinical, Cosmetic and Investigational Dermatology is an interna- tional, peer-reviewed, open access, online journal that focuses on   the latest clinical and experimental research in all aspects of skin   disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/ca/9e/ccid-10-057.PMC5327851.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authorsDovepress 66 Pereira et al 52.,Non-OADS,/arxiv_data1/oa_pdf/ca/9e/ccid-10-057.PMC5327851.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/20/4c/clep-9-113.PMC5327852.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/20/4c/clep-9-113.PMC5327852.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical Epidemiology 2017:9 113–125Clinical Epidemiology Dovepress submit your manuscript | www.dovepress.com Dovepress 113 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CLEP .S106257 The clinical impact of serrated colorectal polyps Brendon M O’Connell1 Seth D Crockett2 1Department of Medicine, 2Division  of Gastroenterology and Hepatology,   University of North Carolina School of Medicine, Chapel Hill, NC, USAAbstract: Serrated polyps (SPs) of the colorectum pose a novel challenge to practicing gas- troenterologists.",Non-OADS,/arxiv_data1/oa_pdf/20/4c/clep-9-113.PMC5327852.pdf
"However, a series Correspondence: Seth D Crockett Division of Gastroenterology and Hepatology, University of North Carolina School of Medicine, CB 7080, Chapel Hill, NC 27599, USATel +1 919 962 2608Fax +1 919 966 8929Email sethc@med.unc.eduJournal name: Clinical Epidemiology Article Designation: REVIEWY ear: 2017V olume: 9Running head verso: O’Connell and CrockettRunning head recto: Impact of serrated polypsDOI: http://dx.doi.org/10.2147/CLEP .S106257",Non-OADS,/arxiv_data1/oa_pdf/20/4c/clep-9-113.PMC5327852.pdf
"Clinical Epidemiology 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical Epidemiology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinical-epidemiology-journalClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica-tion of risk factors and screening procedures to develop optimal pre-ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/20/4c/clep-9-113.PMC5327852.pdf
Available at: http://www.drugs.com/pro/ singulair.html.,Non-OADS,/arxiv_data1/oa_pdf/f4/6d/prs-139-379e.PMC5327859.pdf
Available at: http://www.drugs.com/pro/ accolate.html.,Non-OADS,/arxiv_data1/oa_pdf/f4/6d/prs-139-379e.PMC5327859.pdf
"This is an Open Access article distributed under the terms of the Crea- tive Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, andreproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ea/3c/uajb-17-025.PMC5327872.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/14/48/copd-12-691.PMC5327901.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 691–696International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  691OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S12774 2 The immediate effect of soft tissue manual  therapy intervention on lung function in severe  chronic obstructive pulmonary disease Carlos Cruz-Montecinos1–3 Diego godoy-Olave4 Felipe a Contreras-Briceño5 Paulina gutiérrez4 rodrigo T orres-Castro2 leandro Miret-Venegas3 roger M engel6 1laboratory of Biomechanics and  Kinesiology, san José hospital,   santiago, Chile; 2Department of  Physical Therapy, Faculty of Medicine,   University of Chile, santiago, Chile;   3Unit of Kinesiology and Physical  Therapy, san José hospital, santiago,   Chile; 4Departamento de Kinesiología,   Universidad Metropolitana de  Ciencias de la educación, santiago,   Chile; 5Facultad de Medicina, Pontificia  Universidad Católica de Chile,   santiago, Chile; 6Department of  Chiropractic, Macquarie University,   sydney, australiaBackground and objective:  In chronic obstructive pulmonary disease (COPD), accessory  respiratory muscles are recruited as a compensatory adaptation to changes in respiratory  mechanics.",Non-OADS,/arxiv_data1/oa_pdf/14/48/copd-12-691.PMC5327901.pdf
"The increase in EEV limits tidal  and inspiratory reserve volumes resulting in a negative impact on inspiratory capacity  (IC).4 The changes alter the position of the ribs causing a state similar to sustained Correspondence: roger M engel Department of Chiropractic, Macquarie  University, sydney, nsW 2109, australia Tel +61 2 9850 6387 Fax +61 2 9850 9389 email roger.engel@mq.edu.a u Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Cruz-Montecinos et al Running head recto: Effect of soft tissue manual therapy intervention on lung function in COPD DOI: http://dx.doi.org/10.2147/COPD.S127742",Non-OADS,/arxiv_data1/oa_pdf/14/48/copd-12-691.PMC5327901.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/14/48/copd-12-691.PMC5327901.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/14/48/copd-12-691.PMC5327901.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/be/a2/copd-12-705.PMC5327902.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 705–715International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  705OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S12803 1 repression of T oll-like receptor-4 by microrna- 149-3p is associated with smoking-related COPD Wen shen1,* Jia liu2,* guohou Zhao1 Minjuan Fan1 gao song3 Yang Zhang1 Zhiying Weng3 Y ou Zhang4 1Department of respiratory Medicine,   2Department of experimental  Zoology, The second affiliated  hospital of Kunming Medical  University, 3school of Pharmaceutical  science, Kunming Medical University,   4Department of hematology, The  second affiliated hospital of Kunming  Medical University, Kunming, Yunnan  Province, People’s republic of China *These authors contributed equally  to this workBackground:  Smoking is the leading cause of COPD.",Non-OADS,/arxiv_data1/oa_pdf/be/a2/copd-12-705.PMC5327902.pdf
"It is  also associated with systemic inflammation, which may contribute to or worsen several  comorbidities and may be derived from the “spill-over” of inflammatory mediators from  the peripheral lungs.3 The development of COPD is multifactorial, and the risk factors are  both genetic and environmental.4 Even though traffic and other outdoor pollution, sec - ondhand smoke (SHS), biomass smoke and dietary factors are all associated with COPD,  cigarette smoking is regarded as one of the most important contributors to COPD.5 Increasing evidence showing that smoking is a cause of COPD has been growing  for 40 years and has been extensively reviewed in three US Surgeon General’s Correspondence: You Zhang Department of hematology, The second  Affiliated Hospital of Kunming Medical  University, no 374 Dianmian road,  Kunming 650101, Yunnan Province,  People’s republic of China Tel +86 138 8801 0118 email you_zhang2016@163.co m  Zhiying Weng school of Pharmaceutical science,  Kunming Medical University, no 1168,  Chenggong District, Kunming 650500,  Yunnan Province, People’s republic of  China Tel +86 138 8832 0577 email 2428663043@qq.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Shen et al Running head recto: Repression of TLR-4 by microRNA-149-3p in COPD DOI: http://dx.doi.org/10.2147/COPD.S128031",Non-OADS,/arxiv_data1/oa_pdf/be/a2/copd-12-705.PMC5327902.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/be/a2/copd-12-705.PMC5327902.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/be/a2/copd-12-705.PMC5327902.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/64/e5/copd-12-581.PMC5327903.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 581–587International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  581OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S10924 3 reduced nuclear translocation of serum response  factor is associated with skeletal muscle atrophy  in a cigarette smoke-induced mouse model  of COPD ran Ma Xuefang gong hua Jiang Chunyi lin Yuqin Chen Xiaoming Xu Chenting Zhang Jian Wang Wenju lu nanshan Zhong guangzhou Institute of respiratory  Disease, state Key laboratory  of respiratory Diseases, The 1st  affiliated hospital, guangzhou Medical  University, guangzhou, guangdong,   People’s republic of ChinaAbstract:  Skeletal muscle atrophy and dysfunction are common complications in the chronic  obstructive pulmonary disease (COPD).",Non-OADS,/arxiv_data1/oa_pdf/64/e5/copd-12-581.PMC5327903.pdf
"Tamoxifen-inducible SRF knockout mice showed significant  signs of muscle atrophy.7 Age or physical activity-related changes in the expression and Correspondence: nanshan Zhong;   Wenju lu guangzhou Institute of respiratory  Disease, state Key laboratory  of respiratory Diseases, The 1st  Affiliated Hospital, Guangzhou  Medical University, 151 Yanjiang road,  guangzhou, guangdong 510120, People’s  republic of China Tel +86 20 8306 2888 Fax +86 20 8306 2729 email nanshan@vip.163.co m;   wlu92@yahoo.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Ma et al Running head recto: SRF and cigarette smoke DOI: http://dx.doi.org/10.2147/COPD.S109243",Non-OADS,/arxiv_data1/oa_pdf/64/e5/copd-12-581.PMC5327903.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/64/e5/copd-12-581.PMC5327903.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/64/e5/copd-12-581.PMC5327903.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f1/48/copd-12-677.PMC5327905.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 677–689International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  677OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S12389 6 COPD symptom burden: impact on health  care resource utilization, and work and activity  impairment Bo Ding1 Mark small2 gina Bergström3 Ulf holmgren3 1Medical evidence and Observational  research, astraZeneca gothenburg,   Mölndal, sweden; 2real World  research ( respiratory), adelphi real  World, Bollington, UK; 3global Payer  evidence and Pricing, astraZeneca  gothenburg, Mölndal, swedenBackground:  Chronic obstructive pulmonary disease (COPD) can greatly impact the quality  of life by limiting patients’ activities.",Non-OADS,/arxiv_data1/oa_pdf/f1/48/copd-12-677.PMC5327905.pdf
"Data derived from the Behavioral Risk Factor Surveillance Correspondence: Bo Ding Medical evidence and Observational  research, global Medical affairs,  astraZeneca gothenburg,  Pepparedsleden 1, se-431 83 Mölndal,  sweden Tel +46 31 776 2406 email b o.ding@astrazeneca.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Ding et al Running head recto: COPD symptom burden, health care utilization and work impairment DOI: http://dx.doi.org/10.2147/COPD.S123896",OADS,/arxiv_data1/oa_pdf/f1/48/copd-12-677.PMC5327905.pdf
Available from: http://www.who.int/whosis/whostat/EN_WHS08_Full.,OADS,/arxiv_data1/oa_pdf/f1/48/copd-12-677.PMC5327905.pdf
Available  from: http://www.goldcopd.org /.,Non-OADS,/arxiv_data1/oa_pdf/f1/48/copd-12-677.PMC5327905.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/f1/48/copd-12-677.PMC5327905.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f1/48/copd-12-677.PMC5327905.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/6c/af/dddt-11-483.PMC5327906.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2017:11 483–496Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  483Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S12850 3 Polyphosphoester nanoparticles as biodegradable  platform for delivery of multiple drugs and sirna hadeel elzeny1,* Fuwu Zhang2,* esraa n ali1 heba a Fathi1 shiyi Zhang3 richen li2 Mohamed a el-Mokhtar4 Mostafa a hamad5 Karen l Wooley2,6 Mahmoud elsabahy1,6–8 1assiut international center of  nanomedicine, al-rajhy liver  hospital, assiut University, assiut,   egypt; 2Departments of chemistry,   chemical engineering and Materials  science and engineering, Texas  a&M University, college station,   TX, Usa; 3school of Biomedical  engineering, shanghai Jiao Tong  University, shanghai, People’s  republic of china; 4Department  of Microbiology and immunology,   Faculty of Medicine, 5Department of  surgery, Faculty of Medicine, assiut  University, assiut, egypt; 6laboratory  for synthetic-Biologic interactions,   Department of chemistry, Texas  a&M University, college station, TX,   Usa; 7Department of Pharmaceutics,   Faculty of Pharmacy, assiut University,   assiut, 8Misr University for science  and Technology, 6th of October  city, egypt *These authors contributed equally  to this workAbstract:  Delivery of multiple therapeutics and/or diagnostic agents to diseased tissues is  challenging and necessitates the development of multifunctional platforms.",Non-OADS,/arxiv_data1/oa_pdf/6c/af/dddt-11-483.PMC5327906.pdf
"edu; wooley@chem.tamu.ed u Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Elzeny et al Running head recto: Polyphosphoester nanoparticles as biodegradable platform DOI: http://dx.doi.org/10.2147/DDDT.S128503",Non-OADS,/arxiv_data1/oa_pdf/6c/af/dddt-11-483.PMC5327906.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/6c/af/dddt-11-483.PMC5327906.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/6c/af/dddt-11-483.PMC5327906.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/79/0b/ijn-12-1431.PMC5327907.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 1431–1439International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1431OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12899 6 gold nanoparticles and electroporation impose  both separate and synergistic radiosensitizing  effects in hT -29 tumor cells: an in vitro study Zohre rezaee1,2 ali Yadollahpour1,2 Vahid Bayati1 Fereshteh Negad Dehbashi1 1cellular and Molecular research  center, ahvaz Jundishapur  University of Medical sciences,   avhaz, Iran; 2Department of Medical  Physics, school of Medicine, ahvaz  Jundishapur University of Medical  sciences, ahvaz,  IranBackground and objective:  Radiation therapy (RT) is the gold standard treatment for more  than half of known tumors.",Non-OADS,/arxiv_data1/oa_pdf/79/0b/ijn-12-1431.PMC5327907.pdf
"IR induces  DNA damage by direct or indirect action through the generation of reactive oxygen  species (ROS).2 Unfortunately, there is no discrimination between normal and malig - nant tissues in absorption of IRs, and thus doses of radiation must be limited to spare  healthy surrounding tissue.3 One approach to increase discrimination between tumors  and healthy tissues and thereby increasing the efficiency of radiation therapy is the use  of radiosensitizer to preferably enhance dose at the site of tumor.4–6 In recent years, correspondence: ali Yadollahpour Department of Medical Physics, school of  Medicine, ahvaz Jundishapur University of  Medical sciences, golestan Blvd., ahvaz  61357-33118, Iran Fax +98 613 312 028 email yadollahpour.a@gmail.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Rezaee et al Running head recto: Radiosensitizing effect of GNPs and EP in HT-29 cells DOI: http://dx.doi.org/10.2147/IJN.S128996",Non-OADS,/arxiv_data1/oa_pdf/79/0b/ijn-12-1431.PMC5327907.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/79/0b/ijn-12-1431.PMC5327907.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/79/0b/ijn-12-1431.PMC5327907.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/03/46/copd-12-717.PMC5327908.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 717–724International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  717OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S11052 0 effect of simvastatin on MMPs and TIMPs in  cigarette smoke-induced rat COPD model Jiawei sun1,* Jie Bao2,* Yanan shi3 Bin Zhang4 lindong Yuan5 Junhong li1 lihai Zhang1 Mo sun6 ling Zhang2 Wuzhuang sun1 1Department of respiratory  Medicine, First hospital of hebei  Medical University, 2Department  of respiratory Medicine, Chest  hospital of hebei Province, 3Maternal  and Child health Care Center of  hebei Province, 4Department of  emergency, First hospital of hebei  Medical University, shijiazhuang,   5Department of respiratory Medicine,   People’s hospital of liaocheng,   liaocheng, 6hebei Medical University,   shijiazhuang, People’s republic of  China *These authors contributed equally  to this workBackground:  Proteases may play an important role in the development of chronic obstructive  pulmonary disease and emphysema in response to cigarette smoke exposure (CSE).",Non-OADS,/arxiv_data1/oa_pdf/03/46/copd-12-717.PMC5327908.pdf
"Keywords:  tissue injury, tissue repair, smokingCorrespondence: Wuzhuang sun Department of respiratory Medicine,  First hospital of hebei Medical  University, 89 Donggang road,  shijiazhuang 050031, People’s   republic of China Tel +86 186 3388 9856 email swzhg@126.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Sun et al Running head recto: Effect of simvastatin on MMPs and TIMPs in a COPD rat model DOI: http://dx.doi.org/10.2147/COPD.S110520",Non-OADS,/arxiv_data1/oa_pdf/03/46/copd-12-717.PMC5327908.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/03/46/copd-12-717.PMC5327908.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/03/46/copd-12-717.PMC5327908.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/26/7e/copd-12-735.PMC5327909.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 735–744International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  735OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S11225 6 Impact of comorbid conditions in COPD patients  on health care resource utilization and costs in a  predominantly Medicare population Phil schwab1 amol D Dhamane2 sari D hopson1 Chad Moretz1 srinivas annavarapu1 Kate Burslem2 andrew renda3 shuchita Kaila2 1Comprehensive health Insights Inc.,   louisville, KY, 2health economics  and Outcomes research, Boehringer  Ingelheim Pharmaceuticals Inc.,   ridgefield, CT, 3humana Inc.,   louisville, KY, UsaBackground:  Patients with chronic obstructive pulmonary disease (COPD) often have multiple  underlying comorbidities, which may lead to increased health care resource utilization (HCRU)  and costs.",Non-OADS,/arxiv_data1/oa_pdf/26/7e/copd-12-735.PMC5327909.pdf
"Keywords:  COPD, comorbidities, utilization, cost, database, Medicare Background Chronic lower respiratory diseases are the third leading cause of death in the US.1 One  of the most prevalent diseases in this category is chronic obstructive pulmonary disease  (COPD), which affects ~24 million US adults.2 COPD poses a substantial economic  burden in the US; COPD-related medical costs were estimated to be $32.1 billion Correspondence: Phil schwab Comprehensive health Insights Inc.,  515 West Market street, louisville,  KY 40202, Usa Tel +1 502 476 5610 Fax +1 502 206 0208 email pschwab@humana.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Schwab et al Running head recto: COPD and comorbid conditions: impact on utilization and cost DOI: http://dx.doi.org/10.2147/COPD.S112256",Non-OADS,/arxiv_data1/oa_pdf/26/7e/copd-12-735.PMC5327909.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/26/7e/copd-12-735.PMC5327909.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/26/7e/copd-12-735.PMC5327909.pdf
"Available from: http://www.goldcopd.org/uploads/users/files/ GOLD_Report_2015_Feb18.pd f. Accessed October 27, 2015.",OADS,/arxiv_data1/oa_pdf/26/7e/copd-12-735.PMC5327909.pdf
Available  from: http://www.hcup-us.ahrq.gov/toolssoftware/ccs/ccs.js p. Accessed  August 2013.,OADS,/arxiv_data1/oa_pdf/26/7e/copd-12-735.PMC5327909.pdf
Available from:  https://www.bls.gov/data /.,OADS,/arxiv_data1/oa_pdf/26/7e/copd-12-735.PMC5327909.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ad/dd/copd-12-725.PMC5327910.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 725–734International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  725RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/COPD.S12598 0 Occupational COPD and job exposure matrices:  a systematic review and meta-analysis Steven Sadhra1 Om P Kurmi2 Sandeep S Sadhra1 Kin Bong Hubert Lam2 Jon G Ayres1 1Institute of Occupational and  environmental Medicine, University   of Birmingham, edgbaston,   Birmingham, 2Nuffield Department  of Population Health, Clinical Trial  Service Unit and epidemiological  Studies Unit, University of Oxford,   Oxford, UKBackground:  The association between occupational exposure and COPD reported previously  has mostly been derived from studies relying on self-reported exposure to vapors, gases, dust,  or fumes (VGDF), which could be subjective and prone to biases.",Non-OADS,/arxiv_data1/oa_pdf/ad/dd/copd-12-725.PMC5327910.pdf
"Keywords:  COPD, occupation, airborne substances, job exposure matrices Introduction The importance of occupational exposure as a cause of COPD has been recognized for  decades.1–3 A recent systematic review concluded that there is strong and consistent  evidence to support a causal association between occupational exposure(s) and COPD.4  Recent reviews have identified associations between a few specific occupational pollut - ants, mainly dusts (silica, wood, coal, cotton, and grain) and fumes (rubber, welding,  and cadmium), and the development of COPD.4,5 However, there is still an ongoing  debate on the relative importance of the different occupational pollutants forms (vapors,  gases, dusts, fumes, fibers, and mists) to which individuals may be exposed at work;  this information would be valuable when identifying suitable workplace interventions  and when planning adjustments at work for individuals either at risk of developing  work-related COPD or when improving work ability in individuals with COPD.Correspondence: Om P Kurmi Nuffield Department of Population  Health, Clinical Trial Service Unit and  epidemiological Studies Unit, University  of Oxford, Richard Doll Building, Old  Road Campus, Roosevelt Drive, Oxford,  OX3 7LF, UK Tel +44 1865 743 927 email om.kurmi@ndph.ox.ac.u k Journal name: International Journal of COPD Article Designation: Review Y ear: 2017 Volume: 12 Running head verso: Sadhra et al Running head recto: Systematic review and meta-analysis DOI: http://dx.doi.org/10.2147/COPD.S125980",Non-OADS,/arxiv_data1/oa_pdf/ad/dd/copd-12-725.PMC5327910.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/ad/dd/copd-12-725.PMC5327910.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ad/dd/copd-12-725.PMC5327910.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/d6/f9/cpaa-9-019.PMC5327911.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/d6/f9/cpaa-9-019.PMC5327911.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical Pharmacology: Advances and Applications 2017:9 19–28Clinical Pharmacology: Advances and Applications Dovepress submit your manuscript | www.dovepress.com Dovepress  19 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CPAA.S115687The effect of apixaban on the pharmacokinetics of  digoxin and atenolol in healthy subjects Charles Frost1 Yan Song1 Zhigang Yu2 Jessie Wang3 Lois S Lee4 Alan Schuster5 Allyson Pollack1 Frank LaCreta1 1Exploratory Clinical and Translational  Research, Bristol-Myers Squibb,   Princeton, NJ, USA; 2Medical Sciences,   Amgen Asia R&D Center, Shanghai,  People’s Republic of China;  3Global  Biometric Sciences, Bristol-Myers Squibb, Princeton, NJ,  4Clinical  Research, Intercept Pharmaceuticals,  San Diego, CA,  5Bioanalytical Sciences,   Bristol-Myers Squibb, Princeton,  NJ, USAPurpose: Apixaban is often coadministered with treatments for cardiovascular comorbidi- ties, which may lead to unintended drug−drug interactions (DDIs).",Non-OADS,/arxiv_data1/oa_pdf/d6/f9/cpaa-9-019.PMC5327911.pdf
"Therefore, it is important to assess the potential for pharmacokinetic interac-tions between apixaban and possible concomitant cardiovascular treatments.Correspondence: Yan Song Exploratory Clinical and Translational Research, 8A1.18, Bristol-Myers Squibb, 311 Pennington Rocky Hill Road, Pennington, NJ 08534-2130, USATel +1 609 818 3561Fax +1 609 818 3220Email Yan.Song@bms.comJournal name: Clinical Pharmacology: Advances and Applications Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 9Running head verso: Frost et alRunning head recto: Apixaban effect on pharmacokinetics of digoxin and atenolol in healthy subjectsDOI: http://dx.doi.org/10.2147/CPAA.S115687",Non-OADS,/arxiv_data1/oa_pdf/d6/f9/cpaa-9-019.PMC5327911.pdf
Available from: http://packageinserts.bms.com/pi/pi_eliquis.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d6/f9/cpaa-9-019.PMC5327911.pdf
Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020405s004lbl.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d6/f9/cpaa-9-019.PMC5327911.pdf
Available from: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm292362.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d6/f9/cpaa-9-019.PMC5327911.pdf
"Clinical Pharmacology: Advances and Applications 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical Pharmacology: Advances and Applications Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinical-pharmacology-advances-and-applications-journalClinical Pharmacology: Advances and Applications is an international,  peer-reviewed, open access journal publishing original research, reports, reviews and commentaries on all areas of drug experience in humans.",Non-OADS,/arxiv_data1/oa_pdf/d6/f9/cpaa-9-019.PMC5327911.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 28 Frost et al  21.,Non-OADS,/arxiv_data1/oa_pdf/d6/f9/cpaa-9-019.PMC5327911.pdf
Available from: http://www1.astrazeneca-us.com/pi/tenormin.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d6/f9/cpaa-9-019.PMC5327911.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/95/0c/cpaa-9-029.PMC5327912.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/95/0c/cpaa-9-029.PMC5327912.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical Pharmacology: Advances and Applications 2017:9 29–38Clinical Pharmacology: Advances and Applications Dovepress submit your manuscript | www.dovepress.com Dovepress  29 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CPAA.S119875Pharmaceutical characterization of novel tenofovir  liposomal formulations for enhanced oral drug  delivery: in vitro pharmaceutics and Caco-2  permeability investigations Crystal B Spinks1 Ahmed S Zidan2,3 Mansoor A Khan4 Muhammad J Habib1 Patrick J Faustino2 1Department of Pharmaceutical  Sciences, School of Pharmacy, Howard  University, Washington, DC, 2Division  of Product Quality Research, Office of Pharmaceutical Quality, Food and Drug Administration, Silver Spring,  MD, USA;  3Faculty of Pharmacy,   Zagazig University, Zagazig, Egypt;   4Irma Lerma Rangel College of  Pharmacy, T exas A&M Health Science Center, College Station, TX, USAAbstract: Tenofovir, currently marketed as the prodrug tenofovir disoproxil fumarate, is used  clinically to treat patients with HIV/AIDS.",Non-OADS,/arxiv_data1/oa_pdf/95/0c/cpaa-9-029.PMC5327912.pdf
"1 TDF therapy has been  associated Correspondence: Patrick J Faustino Division of Product Quality Research, Office of Pharmaceutical Quality, Food and Drug Administration, Life Science Building 64, 10903 New Hampshire Avenue, Silver Spring, MD 20993, USATel +1 301 796 0021Fax +1 301 796 9816Email patrick.faustino@fda.hhs.govJournal name: Clinical Pharmacology: Advances and Applications Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 9Running head verso: Spinks et alRunning head recto: Pharmaceutical characterization of novel tenofovir liposomal formulationsDOI: http://dx.doi.org/10.2147/CPAA.S119875",Non-OADS,/arxiv_data1/oa_pdf/95/0c/cpaa-9-029.PMC5327912.pdf
Available from: http://www.gilead.com/~/media/files/pdfs/medicines/liver-disease/viread/viread_pi.pdf.,Non-OADS,/arxiv_data1/oa_pdf/95/0c/cpaa-9-029.PMC5327912.pdf
Available from: http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm070570.pdf.,Non-OADS,/arxiv_data1/oa_pdf/95/0c/cpaa-9-029.PMC5327912.pdf
Available from: http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q2_R1/Step4/Q2_R1__Guideline.pdf.,OADS,/arxiv_data1/oa_pdf/95/0c/cpaa-9-029.PMC5327912.pdf
Available at: http://www.sciencedirect.com/science/article/pii/S1878535214001695.,Non-OADS,/arxiv_data1/oa_pdf/95/0c/cpaa-9-029.PMC5327912.pdf
Available at: http://www.sciencedirect.com/science/article/pii/S1878535213001883.,Non-OADS,/arxiv_data1/oa_pdf/95/0c/cpaa-9-029.PMC5327912.pdf
Available from: http://www.fda.gov/ downloads/Drugs/Guidances/UCM134409.pdf.,Non-OADS,/arxiv_data1/oa_pdf/95/0c/cpaa-9-029.PMC5327912.pdf
"Clinical Pharmacology: Advances and Applications 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical Pharmacology: Advances and Applications Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinical-pharmacology-advances-and-applications-journalClinical Pharmacology: Advances and Applications is an international,  peer-reviewed, open access journal publishing original research, reports, reviews and commentaries on all areas of drug experience in humans.",Non-OADS,/arxiv_data1/oa_pdf/95/0c/cpaa-9-029.PMC5327912.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 38 Spinks et al,Non-OADS,/arxiv_data1/oa_pdf/95/0c/cpaa-9-029.PMC5327912.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/6f/10/copd-12-697.PMC5327913.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 697–703International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  697OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S13094 3 heterogeneity of asthma–COPD overlap  syndrome hyonsoo Joo1 Deokjae han1 Jae ha lee2 Chin Kook rhee1 1Division of Pulmonary, allergy and  Critical Care Medicine, Department  of Internal Medicine, seoul st Mary’s  hospital, College of Medicine, The  Catholic University of Korea, seoul,   2Division of Pulmonology, Department  of Internal Medicine, Inje University  College of Medicine, haeundae Paik  hospital, Busan, republic of KoreaAbstract:  Many patients suffering from asthma or COPD have overlapping features of both dis - eases.",Non-OADS,/arxiv_data1/oa_pdf/6f/10/copd-12-697.PMC5327913.pdf
"Different diagnostic criteria (broad and narrow) for ACOS have  been proposed by various groups.1–6 Depending on the various definitions, the prevalence  of ACOS also varies.7 One broad definition of ACOS has been proposed by Gibson and  Simpson.3 Patients with fixed airflow obstruction with bronchodilator reversibility (BDR)  or bronchial hyperresponsiveness (BHR) can be considered to have ACOS.Correspondence: Chin Kook rhee Division of Pulmonary, allergy and  Critical Care Medicine, Department  of Internal Medicine, seoul st Mary’s  hospital, College of Medicine,  The Catholic University of Korea, 222  Banpo-daero, seocho-gu, seoul 06591,  republic of Korea Tel +82 2 2258 6067 Fax +82 2 599 3589 email chinkook@catholic.ac.k r Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Joo et al Running head recto: Heterogeneity of ACOS DOI: http://dx.doi.org/10.2147/COPD.S130943",Non-OADS,/arxiv_data1/oa_pdf/6f/10/copd-12-697.PMC5327913.pdf
"Available from: http://ginasthma.org/wp- content/uploads/2016/01/GINA_Report_2015_Aug11-1.pd f. Accessed  October 15, 2016.",OADS,/arxiv_data1/oa_pdf/6f/10/copd-12-697.PMC5327913.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/6f/10/copd-12-697.PMC5327913.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/6f/10/copd-12-697.PMC5327913.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/8b/7b/ijn-12-1441.PMC5327914.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 1441–1452International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1441OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12540 9 Preparation of a nano- and micro-fibrous  decellularized scaffold seeded with autologous  mesenchymal stem cells for inguinal hernia repair Yinlong Zhang1,* Yuanyuan Zhou1,* Xu Zhou2,* Bin Zhao1,* Jie chai1 hongyi liu1 Yifei Zheng1 Jinling Wang3 Yaozong Wang4 Yilin Zhao2 1Medical college, Xiamen University,   2Department of Oncology and  Vascular Intervention radiology,   3Department of emergency,   4Department of Orthopaedics,   Zhongshan hospital, Xiamen  University, Xiamen, People’s Republic  of china *These authors contributed equally   to this workAbstract:  Prosthetic meshes used for hernioplasty are usually complicated with chronic pain  due to avascular fibrotic scar or mesh shrinkage.",Non-OADS,/arxiv_data1/oa_pdf/8b/7b/ijn-12-1441.PMC5327914.pdf
"As a result, prosthetic grafts correspondence: Yilin Zhao Department of Oncology and Vascular  Intervention radiology, Zhongshan  hospital, Xiamen University, No 201-209,  Hubin South Road, 361004 Xiamen,  People’s Republic of China email zyllbz@gmail.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Zhang et al Running head recto: Study on decellularized, MSCs-seeded scaffold for hernia repair  DOI: http://dx.doi.org/10.2147/IJN.S125409",Non-OADS,/arxiv_data1/oa_pdf/8b/7b/ijn-12-1441.PMC5327914.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/8b/7b/ijn-12-1441.PMC5327914.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/8b/7b/ijn-12-1441.PMC5327914.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b6/18/dddt-11-469.PMC5327915.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2017:11 469–481Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  469Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S12410 2 antiproliferation effect of imatinib mesylate  on McF7, T -47D tumorigenic and McF 10a  nontumorigenic breast cell lines via PDgFr- β,  PDgF-BB, c-Kit and scF genes ali Kadivar1 Behnam Kamalidehghan1 hamid akbari Javar2 Benyamin Karimi3 reihaneh sedghi4 Mohamed ibrahim noordin1 1Department of Pharmacy, Faculty of  Medicine, University of Malaya, Kuala  lumpur, Malaysia; 2Department of  Pharmaceutics, Faculty of Pharmacy,   T ehran University of Medical sciences  (TUM s), T ehran, iran; 3Department of  Pharmacology, Faculty of Medicine,   University of Malaya, Kuala lumpur,   Malaysia; 4Faculty of Medicine, shiraz  University of Medical sciences  (sUM s), shiraz, iranAbstract:  Recent cancer molecular therapies are targeting main functional molecules to control  applicable process of cancer cells.",Non-OADS,/arxiv_data1/oa_pdf/b6/18/dddt-11-469.PMC5327915.pdf
"The RTK  family comprises growth factor receptors, such as the receptor of stem cell factor  (SCF), c-Kit, platelet-derived growth factor receptor (PDGFR), the insulin growth  factor receptor and epidermal growth factor receptor.1–4correspondence: ali Kadivar Department of Pharmacy, Faculty of  Medicine, University of Malaya, Jalan  Pantai Baru, 50603, Kuala lumpur,  Malaysia email alikadivar@gmail.co m  hamid akbari Javar Department of Pharmaceutics, Faculty of  Pharmacy, Tehran University of Medical  sciences (TUMs), 1416753955, Tehran,  iran email akbarijo@tums.ac.i r Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Kadivar et al Running head recto: Antiproliferation and cytostatic activity of imatini DOI: http://dx.doi.org/10.2147/DDDT.S124102",Non-OADS,/arxiv_data1/oa_pdf/b6/18/dddt-11-469.PMC5327915.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/b6/18/dddt-11-469.PMC5327915.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b6/18/dddt-11-469.PMC5327915.pdf
"This is an Open Access article distributed under the terms of th e Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, dist ribution, and reproduction in any medium, pro- vided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/68/63/ijda-6-001.PMC5327916.pdf
"1, 1 –5 http://dx.doi.org/10.1080/21556660.2016.1278545 Article 0009.R1/1278545 All rights reserved: reproduction in whole or part not permitted",Non-OADS,/arxiv_data1/oa_pdf/68/63/ijda-6-001.PMC5327916.pdf
Available from: http://www.cms.gov/Medicare/Provider-Enrollment-and-Certification/SurveyCertificationGenInfo/Downloads/Survey-and-Cert-Letter-13-35.pdf .,OADS,/arxiv_data1/oa_pdf/68/63/ijda-6-001.PMC5327916.pdf
Available from: http://www.youngliving.com/en_US/products/essential-oils/singles/lavender-essential-oil .,Non-OADS,/arxiv_data1/oa_pdf/68/63/ijda-6-001.PMC5327916.pdf
Available from: http://www.youngliving.com/en_US/products/essential-oils/ singles/lavender-essential-oil .,Non-OADS,/arxiv_data1/oa_pdf/68/63/ijda-6-001.PMC5327916.pdf
"This is an Open Access article distributed under the terms of th e Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, dist ribution, and reproduction in any medium, pro- vided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/42/5a/ijda-6-006.PMC5327917.pdf
"1, 6 –9 http://dx.doi.org/10.1080/21556660.2016.1278546 Article 0010.R1/1278546 All rights reserved: reproduction in whole or part not permitted",Non-OADS,/arxiv_data1/oa_pdf/42/5a/ijda-6-006.PMC5327917.pdf
"Production and hosting by ElsevierJournal of Advanced Research (2016) 7, 719–726 Cairo University Journal of Advanced Research http://dx.doi.org/10.1016/j.jare.2016.04.001 2090-1232 /C2112016 Production and hosting by Elsevier B.V. on behalf of Cairo University.",Non-OADS,/arxiv_data1/oa_pdf/dc/1b/main.PMC5328027.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dc/1b/main.PMC5328027.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/dc/1b/main.PMC5328027.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d7/28/tcrm-13-273.PMC5328124.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2017:13 273–278Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  273ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S12314 8 Helicobacter pylori  infection is not associated with  failure to thrive: a case control study nan-Chang Chiu1,2,* Chien-Yu lin3,* hsin Chi1 Chun-Yan Yeung1,2 Wei-hsin Ting1 Wai-Tao Chan1 Chuen-Bin Jiang1 sung-Tse li3,4 Chao-hsu lin3 hung-Chang lee1,2 1Department of Pediatrics, MacKay  Children’s hospital, 2Department of  Medicine, MacKay Junior College of  Medicine, nursing and Management,   Taipei, 3Department of Pediatrics,   hsinchu MacKay Memorial hospital,   hsinchu City, 4Department of  statistics and information science,   Fu Jen Catholic University,   new Taipei,  Taiwan *These authors contributed equally  to this workPurpose:  The long-term impact of Helicobacter pylori  infection is complex, and concerns  about the need for eradication exist.",Non-OADS,/arxiv_data1/oa_pdf/d7/28/tcrm-13-273.PMC5328124.pdf
"2, Zhongshan n. Rd, Taipei City  10449, Taiwan email ped2435@mmh.org.t w Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Chiu et al Running head recto: Helicobacter pylori  infection is not associated with failure to thrive DOI: http://dx.doi.org/10.2147/TCRM.S123148",Non-OADS,/arxiv_data1/oa_pdf/d7/28/tcrm-13-273.PMC5328124.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/d7/28/tcrm-13-273.PMC5328124.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d7/28/tcrm-13-273.PMC5328124.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/cf/9c/rru-9-027.PMC5328125.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/cf/9c/rru-9-027.PMC5328125.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Research and Reports in Urology 2017:9 27–35Research and Reports in Urology Dovepress submit your manuscript | www.dovepress.com Dovepress  27 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/RRU.S125791Effect of triptorelin on lower urinary tract  symptoms in Australian prostate cancer patients Henry H Woo1  Declan G Murphy2,3  Gerard M T esta4  Jeremy P Grummet5  Michael Chong6  Andrew P Stork7 1Sydney Adventist Hospital Clinical  School, University of Sydney,   Wahroonga, NSW, 2Division of Cancer  Surgery, Peter MacCallum Cancer Centre, Melbourne, VIC,  3Australian  Prostate Cancer Research Centre,  Epworth Healthcare, Richmond,  VIC,  4Shire Urology, Miranda, NSW,   5Australian Urology Associates,   Malvern, VIC, 6Department of Urology,   Repatriation General Hospital,  Daw Park, SA,  7Ipsen Pty Ltd, Glen  Waverley, VIC, Australia Purpose: Prostate cancer is often comorbidly associated with lower urinary tract symptoms  (LUTS), but few studies have assessed the effects of androgen deprivation therapy on LUTS  in this patient group.",Non-OADS,/arxiv_data1/oa_pdf/cf/9c/rru-9-027.PMC5328125.pdf
"4,9–12 It causes Correspondence: Henry H Woo San Clinic, Sydney Adventist Hospital, 185 Fox Valley Road, NSW 2076, AustraliaTel +61 2 9473 8765Fax +61 2 9473 8969Email henry.woo@sydney.edu.auJournal name: Research and Reports in Urology Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 9Running head verso: Woo et alRunning head recto: Triptorelin and LUTS in prostate cancer patientsDOI: http://dx.doi.org/10.2147/RRU.S125791",Non-OADS,/arxiv_data1/oa_pdf/cf/9c/rru-9-027.PMC5328125.pdf
"Research and Reports in Urology 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Research and Reports in Urology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/research-and-reports-in-urology-journalResearch and Reports in Urology is an international, peer-reviewed,  open access journal publishing original research, reports, editorials, reviews and commentaries on all aspects of adult and pediatric urology in the clinic and laboratory including the following topics: Pathology, pathophysiology of urological disease; Investigation and treatment of urological disease; Pharmacology of drugs used for the treatment of urological disease.",Non-OADS,/arxiv_data1/oa_pdf/cf/9c/rru-9-027.PMC5328125.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 35 Triptorelin and LUTS in prostate cancer patients Table S1 Participating sites, investigators, and approving ethics committees Approving local human research ethics committee (HREC) Site name Site lead investigator Bellberry Limited HREC Australian Urology Associates Brisbane Private HospitalMacarthur UrologyShire UrologyA/Prof J GrummetDr J YaxleyDr K HaghighiDr G Testa Epworth HealthCare HREC Epworth Richmond A/Prof D Murphy Mount Hospital HREC Mount Urology Dr A Tan Riverina Cancer Care Centre HREC Riverina Cancer Care Centre Dr S Sowter Southern Adelaide Health Service/Flinders University HREC Repatriation General Hospital Dr M Chong Sydney Adventist Hospital HREC San Clinic A/Prof H WooSupplementary material",Non-OADS,/arxiv_data1/oa_pdf/cf/9c/rru-9-027.PMC5328125.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/81/43/tcrm-13-263.PMC5328126.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2017:13 263–272Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  263ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S12755 5 Music therapy-induced changes in salivary cortisol  level are predictive of cardiovascular mortality  in patients under maintenance hemodialysis Yi-Chou hou1 Yen-Ju lin2 Kuo-Cheng lu1 han-sun Chiang3 Chia-Chi Chang4 li-King Yang1 1Department of internal Medicine,   Cardinal Tien hospital, school of  Medicine, Fu-Jen Catholic University,   2Department of nursing, Taipei  Medical University, 3graduate  institute of Basic Medicine, College  of Medicine, Fu Jen Catholic  University, new Taipei City, 4school  of gerontology health Management,   College of nursing, Taipei Medical  University, Taipei, Taiwan, Republic  of ChinaBackground:  Music therapy has been applied in hemodialysis (HD) patients for relieving  mental stress.",Non-OADS,/arxiv_data1/oa_pdf/81/43/tcrm-13-263.PMC5328126.pdf
"In addition, HD can result in adverse reactions,  such as hypotension, muscle cramping, nausea, vomiting, headache, and chest pain.2  Elderly patients with ESRD often have comorbidities such as cardiovascular disease and  autonomic dysfunction, which limit their ability to cope with physiological stressors and Correspondence: Chia-Chi Chang school of gerontology health  Management, College of nursing, Taipei  Medical University, 250 Wu-Xing street,  Taipei 110, Taiwan, Republic of China Tel/fax +886 2 2736 1661 6336 email cchang@tmu.edu.t w li-King Yang Department of internal Medicine,  Cardinal Tien hospital, school of  Medicine, Fu-Jen Catholic University,  362 Chung-Cheng Road, hsin-Tien  District, new Taipei City 23148, Taiwan,  Republic of China Tel +886 2 2219 3391 65343 Fax +886 2 2218 5579 email margaretlaiking@yahoo.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Hou et al Running head recto: Salivary cortisol changes by music therapy in HD patients DOI: http://dx.doi.org/10.2147/TCRM.S127555",Non-OADS,/arxiv_data1/oa_pdf/81/43/tcrm-13-263.PMC5328126.pdf
"Available  from: https://www.usrds.org/adr.asp x. Accessed January 24, 2017.",OADS,/arxiv_data1/oa_pdf/81/43/tcrm-13-263.PMC5328126.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/81/43/tcrm-13-263.PMC5328126.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/81/43/tcrm-13-263.PMC5328126.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/7e/4e/ijwh-9-101.PMC5328127.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Women’s Health 2017:9 101–103International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  101Letteropen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/IJWH.S12916 8 therapeutic dilemma in patients with short  cervices during pregnancy after conization Shunji Suzuki Department of Obstetrics and  Gynecology, Japanese red Cross  Katsushika Maternity Hospital,   tokyo, JapanDear editor We read the recent review article entitled “Prevention of preterm delivery: current  challenges and future prospects” by van Zijl et al.1 However, they did not adequately  discuss the prevention of preterm delivery in cases with a history of conization, or a  cone biopsy of the uterine cervix.2,3 Performing a cervical cerclage has been common  in the treatment of pregnant women with cervical insufficiency to prevent preterm  delivery, as reported by van Zijl et al.1 However, the effect of prophylactic cerclage in  women with a history of conization is little understood, because there are no prospec - tive randomized controlled trials concerning the efficiency and risk of prophylactic  cerclage in this subgroup of pregnant women.3–15 Table 1 summarizes the previous  examinations concerning the effect of prophylactic cerclage in pregnancy after coniza - tion, including four English language articles searched using PubMed (Bethesda,  MD, USA) and eight Japanese language articles searched using Igaku Chuo Zasshi®  (NPO Japan Medical Abstracts society, Tokyo, Japan), with the key search terms  of “cerclage” and “conization”.4–15 In these studies, statistical significances of the  categorical variables were tested by χ2 test (with Y ates’s correction) or Fisher’s exact  test.",Non-OADS,/arxiv_data1/oa_pdf/7e/4e/ijwh-9-101.PMC5328127.pdf
"A therapeutic dilemma exists among patients with short cervix in pregnancy  after conization.Correspondence: Shunji Suzuki  Department of Obstetrics and  Gynecology, Japanese red Cross  Katsushika Maternity Hospital,  5-11-12 tateishi, Katsushika-ku,  tokyo 124-0012, Japan tel +81 3 3693 5211 Fax +81 3 3694 8725 email czg83542@mopera.ne.j p Journal name: International Journal of Women’s Health Article Designation: Letter Y ear: 2017 Volume: 9 Running head verso: Suzuki Running head recto: Cerclage for pregnancy after conization DOI: http://dx.doi.org/10.2147/IJWH.S129168",Non-OADS,/arxiv_data1/oa_pdf/7e/4e/ijwh-9-101.PMC5328127.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/7e/4e/ijwh-9-101.PMC5328127.pdf
"Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.Dove pres s International Journal of Women’s Health 2017:9submit your manuscript | www.dovepress.co m Dove press Dove press 103Cerclage for pregnancy after conization Authors’ reply Maud D van Zijl1 Bouchra Koullali1 Ben WJ Mol2 eva Pajkrt1 Martijn A Oudijk1 1Department of Obstetrics and Gynecology, Academic Medical  Center (AMC), Amsterdam, the Netherlands; 2robinson Institute  School for reproductive Health and Pediatrics, University of  Adelaide, Adelaide, SA, Australia Correspondence: Martijn A Oudijk Department of Obstetrics and Gynecology, Academic Medical Center,  Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands tel +31 20 566 7204 email m.a.oudijk@amc.n l  Dear editor We have read the response by Dr Suzuki with interest, and we  agree with Dr Suzuki that our paper does not discuss preven - tive measures in cases with a history of conization.",Non-OADS,/arxiv_data1/oa_pdf/7e/4e/ijwh-9-101.PMC5328127.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/4b/e2/tcrm-13-139.PMC5328128.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2017:13 139–149Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  139ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S12462 1 effect of orlistat on periostin, adiponectin,  inflammatory markers and ultrasound grades  of fatty liver in obese NAFLD patients Rashid ali Khan1 Prem Kapur2 Abhinav Jain3 Farrukh Farah4 Uma Bhandari1 1Department of Pharmacology,   Faculty of Pharmacy, 2Department of  Medicine, 3Department of Radiology,   4Department of Paramedical Sciences,   hamdard institute of Medical sciences  & Research, Jamia Hamdard, New  Delhi, IndiaAbstract:  Orlistat is recommended in the treatment of obesity, which is an independent  risk factor for nonalcoholic fatty liver disease (NAFLD).",Non-OADS,/arxiv_data1/oa_pdf/4b/e2/tcrm-13-139.PMC5328128.pdf
"Keywords:  NAFLD, orlistat, obesity, periostin, ultrasound grades of fatty liver Introduction Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease  encircling a histological scale progressing from simple steatosis to steatohepatitis, and  fibrosis.1 The global prevalence of NAFLD is 25.24% with a prevalence in the Indian  population ranging from 9% to 32%.2,3 The precise etiology of NAFLD is unknown;  however, there are strong associations with obesity, metabolic/insulin resistance (IR)  syndrome and dyslipidemia.4 IR is the key factor in the pathogenesis of NAFLD and  is deeply entangled with the progression of fatty liver to advanced stages of fibrosis  and cirrhosis.5,6 A meta-analysis concluded that obesity is a universal, well-reported  and independent risk factor for NAFLD.7 Current treatment strategies for NAFLD emphasize on the amelioration of risk  factors (ie, obesity and IR) with the aim of averting the progression of the disease, or Correspondence: Uma Bhandari Department of Pharmacology, Faculty  of Pharmacy, Jamia Hamdard, Hamdard  Nagar, New Delhi 110062, India email uma_bora@hotmail.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Ali Khan et al Running head recto: Effect of orlistat in obese NAFLD patients DOI: http://dx.doi.org/10.2147/TCRM.S124621",Non-OADS,/arxiv_data1/oa_pdf/4b/e2/tcrm-13-139.PMC5328128.pdf
"Information on the STROBE Initiative is  available at http://www.strobe-statement.or g. Permission to reproduce this table was provided by Cochrane Switzerland.1 Freely available on the Web sites of PLoS Medicine  at http://www.plosmedicine.org /, annals of internal Medicine at http://www.annals.org /, and Epidemiology at http://www.epidem.com /.",OADS,/arxiv_data1/oa_pdf/4b/e2/tcrm-13-139.PMC5328128.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/4b/e2/tcrm-13-139.PMC5328128.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/4b/e2/tcrm-13-139.PMC5328128.pdf
Available from: http://www.strobe-statement.org/ index.php?id=available-checklists.,OADS,/arxiv_data1/oa_pdf/4b/e2/tcrm-13-139.PMC5328128.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/3f/7d/jaa-10-017.PMC5328129.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/3f/7d/jaa-10-017.PMC5328129.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Asthma and Allergy 2017:10 17–21Journal of Asthma and Allergy Dovepress submit your manuscript | www.dovepress.com Dovepress 17 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JAA.S127580Peak inspiratory flow rate measurement by using  In-Check DIAL for the different inhaler devices   in elderly with obstructive airway diseases Theerasuk Kawamatawong   Supattra Khiawwan   Prapaporn Pornsuriyasak Division of Pulmonary and Critical  Care Medicine, Department of Medicine, Ramathibodi Hospital,  Mahidol University, Bangkok, ThailandBackground: Inhaler device technique is a common cause of treatment failure in patients  with asthma and chronic obstructive pulmonary disease.",Non-OADS,/arxiv_data1/oa_pdf/3f/7d/jaa-10-017.PMC5328129.pdf
"2 Patient inhaler techniques and Correspondence: Theerasuk  Kawamatawong   Division of Pulmonary and Critical Care Medicine, Department of Medicine, Ramathibodi Hospital, Mahidol University, Rama 6 Road, Bangkok 10400, Thailand   Tel +66 2 201 1619   Fax +66 2 201 1629   Email ktheerasuk@hotmail.comJournal name: Journal of Asthma and Allergy Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Kawamatawong et alRunning head recto: PIFR measurement for elderly patients using In-Check DIALDOI: http://dx.doi.org/10.2147/JAA.S127580",Non-OADS,/arxiv_data1/oa_pdf/3f/7d/jaa-10-017.PMC5328129.pdf
"Journal of Asthma and Allergy 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Asthma and Allergy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-asthma-and-allergy-journalThe Journal of Asthma and Allergy is an international, peer-reviewed  open access journal publishing original research, reports, editorials and commentaries on the following topics: Asthma; Pulmonary physi-ology; Asthma related clinical health; Clinical immunology and the immunological basis of disease; Pharmacological interventions and new therapies.",Non-OADS,/arxiv_data1/oa_pdf/3f/7d/jaa-10-017.PMC5328129.pdf
Avail-able from: http://www.who.int/healthinfo/survey/ageingdefnolder/en/.,Non-OADS,/arxiv_data1/oa_pdf/3f/7d/jaa-10-017.PMC5328129.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/08/b8/tcrm-13-237.PMC5328130.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2017:13 237–244Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  237ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S12786 8 Psychological factors as risk factors for poor hip  function after total hip arthroplasty achim Benditz1 Petra Jansen2 Jan schaible1 Christina Roll1 Joachim grifka1 Jürgen götz1 1Department of Orthopedics,   University Medical Center  Regensburg, asklepios Klinikum  Bad abbach, Bad abbach, 2Department  of sport science, University of  Regensburg, Regensburg, germanyAbstract:  Recovery after total hip arthroplasty (THA) is influenced by several psychological  aspects, such as depression, anxiety, resilience, and personality traits.",Non-OADS,/arxiv_data1/oa_pdf/08/b8/tcrm-13-237.PMC5328130.pdf
"We focused on psychological factors such as major depression, state and Correspondence: achim Benditz Department of Orthopedics,  Orthopädische Klinik für die Universität  Regensburg, asklepios Klinikum  Bad abbach, Kaiser-Karl-V-allee 3,  93077 Bad abbach, germany Tel +49 17 2833 0955 email achim.benditz@ukr.d e Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Benditz et al Running head recto: Psychological factors influence the outcome after THA DOI: http://dx.doi.org/10.2147/TCRM.S127868",Non-OADS,/arxiv_data1/oa_pdf/08/b8/tcrm-13-237.PMC5328130.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/08/b8/tcrm-13-237.PMC5328130.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/08/b8/tcrm-13-237.PMC5328130.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/b3/e3/ijnrd-10-061.PMC5328132.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/b3/e3/ijnrd-10-061.PMC5328132.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Journal of Nephrology and Renovascular Disease 2017:10 61–76International Journal of Nephrology and Renovascular Disease Dovepress submit your manuscript | www.dovepress.com Dovepress 61 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJNRD.S121473 Ultrastructural changes and nestin expression  accompanying compensatory renal growth after  unilateral nephrectomy in adult rats Mohamed Ahmed Eladl1,2 Wael M Elsaed2,3 Hoda Atef4 Mohamed El-Sherbiny2 1Department of Basic Medical  Sciences, University of Sharjah,   Sharjah, United Arab Emirates;   2Anatomy and Embryology  Department, Faculty of Medicine,  Mansoura University, Mansoura,  Egypt;  3Anatomy and Embryology  Department, Faculty of Medicine,  Taibah University, Madinah, Saudi Arabia;  4Department of Histology,   University of Mansoura, Mansoura,  EgyptBackground: Several renal disorders affect the glomerular podocytes.",Non-OADS,/arxiv_data1/oa_pdf/b3/e3/ijnrd-10-061.PMC5328132.pdf
"Keywords: glomerular proliferation, podocytes, basement membrane, subpodocytic space,  TEM, nestin, nephrectomy, compensatory Correspondence: Mohamed Ahmed Eladl Department of Basic Medical Sciences, University of Sharjah, PO Box 27272, Sharjah, United Arab EmiratesEmail meladl@sharjah.ac.aeJournal name: International Journal of Nephrology and Renovascular Disease Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Eladl et alRunning head recto: Unilateral nephrectomy in adult ratsDOI: http://dx.doi.org/10.2147/IJNRD.S121473",Non-OADS,/arxiv_data1/oa_pdf/b3/e3/ijnrd-10-061.PMC5328132.pdf
"International Journal of Nephrology and Renovascular Disease 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress International Journal of Nephrology and Renovascular Disease Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/international-journal-of-nephrology-and-renovascular-disease-journalThe International Journal of Nephrology and Renovascular Disease is   an international, peer-reviewed open access journal focusing on the  pathophysiology of the kidney and vascular supply.",Non-OADS,/arxiv_data1/oa_pdf/b3/e3/ijnrd-10-061.PMC5328132.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published   authors.Dovepress 76 Eladl et al  65.,Non-OADS,/arxiv_data1/oa_pdf/b3/e3/ijnrd-10-061.PMC5328132.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/71/89/tcrm-13-223.PMC5328134.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2017:13 223–236Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  223Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S10434 3 Update on targeted therapies for advanced  non-small cell lung cancer: nivolumab in context Alexander D Le1,* Saeed K Alzghari2,* Gary w Jean2 Ninh M La-Beck1 1Department of immunotherapeutics  and Biotechnology, School of  Pharmacy, Texas Tech University  Health Sciences Center, Abilene,   2Department of Pharmacy Practice,   School of Pharmacy, Texas Tech  University Health Sciences Center,   Dallas, TX, USA *These authors contributed equally  to this workAbstract:  While the initial treatment of non-small cell lung cancer (NSCLC) usually relies on  surgical resection followed by systemic cytotoxic chemotherapy and/or radiation therapy, recent  advances in understanding of NSCLC biology and immunology have spurred the development  of numerous targeted therapies.",Non-OADS,/arxiv_data1/oa_pdf/71/89/tcrm-13-223.PMC5328134.pdf
"Epidermal growth factor receptor (EGFR)-targeted  therapies One of the first therapeutic targets in NSCLC is the EGFR, a tyrosine kinase receptor,  which typically plays a role in promoting epidermal growth, organogenesis, and Correspondence: Ninh M La-Beck Department of immunotherapeutics  and Biotechnology, School of Pharmacy,  Texas Tech University Health Sciences  Center, 1718 Pine Street, Abilene,  TX 79601, USA Tel +1 325 696 0433 email irene.la-beck@ttuhsc.ed u Journal name: Therapeutics and Clinical Risk Management Article Designation: Review Y ear: 2017 Volume: 13 Running head verso: Le et al Running head recto: Nivolumab for NSCLC DOI: http://dx.doi.org/10.2147/TCRM.S104343",Non-OADS,/arxiv_data1/oa_pdf/71/89/tcrm-13-223.PMC5328134.pdf
"Available from: https://www.nccn.org/professionals/ physician_gls/pdf/nscl.pd f. Accessed February 14, 2017.",Non-OADS,/arxiv_data1/oa_pdf/71/89/tcrm-13-223.PMC5328134.pdf
"Bristol-Myers Squibb Announces Top- Line Results from CheckMate -026, a Phase 3 Study of Opdivo  (nivolumab) in Treatment-Naïve Patients with Advanced Non-Small  Cell Lung Cance r. Available from: http://investor.bms.com/investors/ news-and-events/press-releases/press-release-details/2016/Bristol- Myers-Squibb-Announces-Top-Line-Results-from-CheckMate--026- a-Phase-3-Study-of-Opdivo-nivolumab-in-Treatment-Nave-Patients- with-Advanced-Non-Small-Cell-Lung-Cancer/default.aspx.",Non-OADS,/arxiv_data1/oa_pdf/71/89/tcrm-13-223.PMC5328134.pdf
"Available at: http://www.esmo.org/Conferences/ ESMO-2016-Congress/Press-Media/Significant-Survival-Gains- with-Atezolizumab-vs-Docetaxel-for-Non-Small-Cell-Lung-Cance r.  Accessed February 14, 2017.",Non-OADS,/arxiv_data1/oa_pdf/71/89/tcrm-13-223.PMC5328134.pdf
Available  from: https://clinicaltrials.gov/ct2/show/NCT0259594 4.,Non-OADS,/arxiv_data1/oa_pdf/71/89/tcrm-13-223.PMC5328134.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/71/89/tcrm-13-223.PMC5328134.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/71/89/tcrm-13-223.PMC5328134.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b1/c5/tcrm-13-255.PMC5328135.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2017:13 255–262Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  255ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S12913 3 association of uremic pruritus in hemodialysis  patients with the number of days of high mean 24- hour particulate matter with a diameter of ,2.5 μm Ming-hui liu1,* Ming-Jen Chan2,* Ching-Wei hsu2,3 Cheng-hao Weng2,3 Tzung-hai Yen2,3 Wen-hung huang2,3 1Department of Pediatric Dentistry,   2Department of n ephrology and  Division of Clinical Toxicology and  T oxicology laboratory, Chang gung  Memorial hospital, linkou Medical  Center, 3Chang gung University  College of Medicine, Taoyuan, Taiwan,   Republic of China *These authors contributed equally  to this workAbstract:  Uremic pruritus (UP) is a common and incapacitating symptom in patients undergoing  hemodialysis (HD).",Non-OADS,/arxiv_data1/oa_pdf/b1/c5/tcrm-13-255.PMC5328135.pdf
"Written informed consent was obtained from all patients for Correspondence: Wen-hung huang Department of nephrology and Division  of Clinical Toxicology and Toxicology  laboratory, Chang gung Memorial  hospital, linkou Medical Center, 5,  Fu-shing street, gueishan, Taoyuan 333,  Taiwan, Republic of China email williammedia@gmail.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Liu et al Running head recto: PM2.5 and uremic pruritus DOI: http://dx.doi.org/10.2147/TCRM.S129133",Non-OADS,/arxiv_data1/oa_pdf/b1/c5/tcrm-13-255.PMC5328135.pdf
"Available from: http://taqm.epa.gov.tw/taqm/ zh-tw/default.asp x. Accessed September 6, 2016.",OADS,/arxiv_data1/oa_pdf/b1/c5/tcrm-13-255.PMC5328135.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/b1/c5/tcrm-13-255.PMC5328135.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/c5/tcrm-13-255.PMC5328135.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/05/28/vhrm-13-055.PMC5328136.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/05/28/vhrm-13-055.PMC5328136.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Vascular Health and Risk Management 2017:13 55–60Vascular Health and Risk Management Dovepress submit your manuscript | www.dovepress.com Dovepress  55 ORiginal ReseaRcH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/VHRM.S121086Prevalence of mild cognitive impairment in  employable patients after acute coronary   event in cardiac rehabilitation annett salzwedel1 Maria-Dorothea Heidler1,2 Kathrin Haubold1 Martin schikora2 Rona Reibis3 Karl Wegscheider4 Michael Jöbges2 Heinz Völler1,5 1center for Rehabilitation Research,   University of Potsdam, Potsdam,   2Brandenburg Klinik, Bernau,   3cardiological Outpatient clinic, am  Park sanssouci, Potsdam, 4institute for  Medical Biometry and epidemiology,   University Medical center Hamburg- eppendorf, Hamburg, 5Klinik am see,   Rüdersdorf, germanyIntroduction: Adequate cognitive function in patients is a prerequisite for successful imple- mentation of patient education and lifestyle coping in comprehensive cardiac rehabilitation (CR)  programs.",Non-OADS,/arxiv_data1/oa_pdf/05/28/vhrm-13-055.PMC5328136.pdf
"1 For a suc-correspondence: annett salzwedel center for Rehabilitation Research, University of Potsdam, am neuen   Palais 10, 14469 Potsdam, germanyTel +49 331 977 4061Fax +49 331 977 4081email annett.salzwedel@uni-potsdam.deJournal name: Vascular Health and Risk Management Article Designation: Original ResearchY ear: 2017V olume: 13Running head verso: Salzwedel et alRunning head recto: Mild cognitive impairment in cardiac rehabilitationDOI: http://dx.doi.org/10.2147/VHRM.S121086",Non-OADS,/arxiv_data1/oa_pdf/05/28/vhrm-13-055.PMC5328136.pdf
"Vascular Health and Risk Management 2017:13submit your manuscript | www.dovepress.com Dovepress Dovepress Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/vascular-health-and-risk-management-journal Vascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on concise rapid reporting of clinical studies on the processes involved in the maintenance of vascular health; the monitoring, prevention and treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/05/28/vhrm-13-055.PMC5328136.pdf
Visit http://www.dovepress.com/   testimonials.php to read real quotes from published authors.Dovepress 60 salzwedel et al  10.,Non-OADS,/arxiv_data1/oa_pdf/05/28/vhrm-13-055.PMC5328136.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e6/57/ijwh-9-089.PMC5328137.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Women’s Health 2017:9 89–99International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  89OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S12080 9 a randomized crossover trial on the effect of  compression stockings on nausea and vomiting  in early pregnancy erika Mendoza1 Felix amsler2 1Venenpraxis, Wunstorf, germany;   2amsler consulting, Basel, switzerlandIntroduction:  This study aimed to assess the impact of wearing compression stockings on  women’s quality of life (QoL) associated with nausea and vomiting in early pregnancy (NVP).",Non-OADS,/arxiv_data1/oa_pdf/e6/57/ijwh-9-089.PMC5328137.pdf
"In pregnancy, physical examination  and routine laboratory investigations should be performed to rule out known and  treatable reasons for the condition.3 NVP is diagnosed only after other causes have  been ruled out; furthermore, as it is limited to early pregnancy, it is often diagnosed  retrospectively.3correspondence: erika Mendoza Venenpraxis, speckenstraße 10,  31515 Wunstorf, germany Tel +49 5031 912781 Fax +49 5031 912782 email erika.mendoza@t-online.d e Journal name: International Journal of Women’s Health Article Designation: Original Research Y ear: 2017 Volume: 9 Running head verso: Mendoza and Amsler Running head recto: Compression stockings alleviate nausea in early pregnancy DOI: http://dx.doi.org/10.2147/IJWH.S120809",Non-OADS,/arxiv_data1/oa_pdf/e6/57/ijwh-9-089.PMC5328137.pdf
Available from: https://www.nice.,Non-OADS,/arxiv_data1/oa_pdf/e6/57/ijwh-9-089.PMC5328137.pdf
"Available from: https://www.clinicalguidelines.gov.au/portal/2349/ venous-thromboembolism-vte-prophylaxis-pregnancy-and-puerperiu m.  Accessed February 2, 2017.",Non-OADS,/arxiv_data1/oa_pdf/e6/57/ijwh-9-089.PMC5328137.pdf
Available from: https://www.rcog.org.uk/en/guidelines-research- services/guidelines/gtg37a /.,Non-OADS,/arxiv_data1/oa_pdf/e6/57/ijwh-9-089.PMC5328137.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/e6/57/ijwh-9-089.PMC5328137.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e6/57/ijwh-9-089.PMC5328137.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/63/6f/ppa-11-297.PMC5328138.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2017:11 297–303Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  297Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S12703 9 Adherence in ulcerative colitis: an overview Anna T esta1 Fabiana Castiglione1 Olga Maria Nardone1 Giorgio L Colombo2 1Gastroenterology, University  of Naples Federico ii, Naples,   2Department of Drug Sciences,   University of Pavia, Pavia, italyAbstract:  Medication adherence is an important challenge while treating chronic illnesses,  such as ulcerative colitis (UC), that require a long-term management to induce and maintain  clinical remission.",Non-OADS,/arxiv_data1/oa_pdf/63/6f/ppa-11-297.PMC5328138.pdf
"Non-adherence may  impact the effectiveness of a cure and determine the worsening of health conditions,  the need of examinations or implementation of drugs, and the increase in morbidity  and mortality.4–6 According to the WHO definition, the term “adherence” is the extent to which  a person’s behavior – taking medication, following a diet and/or executing lifestyle  changes – corresponds to agreed recommendations from a health care provider.7,8 In routine clinical practice, therapeutic adherence plays a critical role in the man - agement of UC; therefore, the decision-making process should also include a thorough Correspondence: Anna Testa Gastroenterology, University of Naples  Federico ii, via Sergio Pansini, 5, 80131  Naples, italy email annatesta82@virgilio.i t Journal name: Patient Preference and Adherence Article Designation: Review Y ear: 2017 Volume: 11 Running head verso: Testa et al Running head recto: Adherence in ulcerative colitis: an overview DOI: http://dx.doi.org/10.2147/PPA.S127039",Non-OADS,/arxiv_data1/oa_pdf/63/6f/ppa-11-297.PMC5328138.pdf
Available  from:  http://www.who.int/chp/knowledge/publications/adherence_ report/en /.,Non-OADS,/arxiv_data1/oa_pdf/63/6f/ppa-11-297.PMC5328138.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/63/6f/ppa-11-297.PMC5328138.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/5e/af/rmhp-10-017.PMC5328139.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/5e/af/rmhp-10-017.PMC5328139.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Risk Management and Healthcare Policy 2017:10 17–28Risk Management and Healthcare Policy Dovepress submit your manuscript | www.dovepress.com Dovepress 17 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/RMHP .S75918 Salt reduction in China: a state-of-the-art review Shuai Shao1,2 Yechu Hua3 Ying Yang4 Xiaojuan Liu5 Jingruo Fan6 An Zhang7 Jingling Xiang8 Mingjing Li9 Lijing L Yan1,2 1Global Health Research Center,   Duke Kunshan University, Kunshan,   Jiangsu, China; 2Duke Global Health  Institute, 3School of Economics,   Duke University, Durham, NC,  USA;  4Department of Public Health,   Wuhan University, Wuhan, Hubei,   5Department of Biostatistics, School  of Public Health, Shandong University,  Jinan, Shandong, China;  6Department  of Accounting, School of Business and Management, The Hong Kong University of Science and T echnology,  Kowloon, Hong Kong;  7Department  of Statistics and Applied Probability,  National University of Singapore,  Singapore;  8School of Business,   Sichuan University, Chengdu, Sichuan,   9Department of Public Health, School  of Public Health and Management,  Chongqing Medical University,  Chongqing, ChinaObjective: This study aimed to reveal the latest evidence on salt reduction initiatives in China  in order to identify the contextual cost-effective interventions, as well as the barriers encountered  during China’ s long march to reach its population salt reduction goal.",Non-OADS,/arxiv_data1/oa_pdf/5e/af/rmhp-10-017.PMC5328139.pdf
"Correspondence: Lijing L Yan Global Heath Research Center, Duke Kunshan University, 8 Duke Avenue, Kunshan, Jiangsu Province 215316, ChinaTel +86 512 3665 7057Fax +86 512 5772 8899Email Lijing.yan@duke.eduJournal name: Risk Management and Healthcare Policy Article Designation: REVIEWY ear: 2017V olume: 10Running head verso: Shao et alRunning head recto: Salt reduction in ChinaDOI: http://dx.doi.org/10.2147/RMHP .S75918",Non-OADS,/arxiv_data1/oa_pdf/5e/af/rmhp-10-017.PMC5328139.pdf
Avail-able from: http://ghdx.healthdata.org/global-burden-disease-study-   2013-gbd-2013-data-downloads.,Non-OADS,/arxiv_data1/oa_pdf/5e/af/rmhp-10-017.PMC5328139.pdf
Available from: http://www.worldactiononsalt.com/news/salt-news/2016/177218.html.,Non-OADS,/arxiv_data1/oa_pdf/5e/af/rmhp-10-017.PMC5328139.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT02092090.,Non-OADS,/arxiv_data1/oa_pdf/5e/af/rmhp-10-017.PMC5328139.pdf
Avail- able from: http://www.actiononsalt.org.uk/about/aims/31934.html.,Non-OADS,/arxiv_data1/oa_pdf/5e/af/rmhp-10-017.PMC5328139.pdf
Available from: http://www.who.int/nmh/global_monitoring_   framework/en/.,OADS,/arxiv_data1/oa_pdf/5e/af/rmhp-10-017.PMC5328139.pdf
Available from: http://www.tsinfo.js.cn/inquiry/gbtdetails.aspx?A100=NY/T%201040-2012.,OADS,/arxiv_data1/oa_pdf/5e/af/rmhp-10-017.PMC5328139.pdf
Available from: http://www.docin.com/p-977861860.html.,Non-OADS,/arxiv_data1/oa_pdf/5e/af/rmhp-10-017.PMC5328139.pdf
Available from: http://www.wsjsw.gov.cn/wsj/n422/n424/u1ai139715.html.,Non-OADS,/arxiv_data1/oa_pdf/5e/af/rmhp-10-017.PMC5328139.pdf
"Risk Management and Healthcare Policy 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Risk Management and Healthcare Policy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/risk-management-and-healthcare-policy-journalRisk Management and Healthcare Policy is an international, peer-reviewed,  open access journal focusing on all aspects of public health, policy, and preventative measures to promote good health and improve morbidity and mortality in the population.",Non-OADS,/arxiv_data1/oa_pdf/5e/af/rmhp-10-017.PMC5328139.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 28 Shao et al  71.,Non-OADS,/arxiv_data1/oa_pdf/5e/af/rmhp-10-017.PMC5328139.pdf
Available from: http://www.cdc.gov/globalhealth/stories/reducing_sodium_2015.html.,Non-OADS,/arxiv_data1/oa_pdf/5e/af/rmhp-10-017.PMC5328139.pdf
Available from: http://www.georgeinstitute.org.cn/media-releases/study-identifies-a-new-community-based-strategy-to-reduce-popula-tion-sodium-intake-in?utm_source= George+ Institute+ External+ Email +List&utm_campaign= 0783bfc986-TGI_eNewsletter_RADAC&utm_   medium= email&utm_term= 0_0972953fbb-0783bfc986-95170073.,Non-OADS,/arxiv_data1/oa_pdf/5e/af/rmhp-10-017.PMC5328139.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/44/9a/tcrm-13-245.PMC5328140.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2017:13 245–253Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  245ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S12370 2 increased risk of endotracheal intubation and  heart failure following acute myocardial infarction  in patients with urolithiasis: a nationwide  population-based study shun-Ku lin,1,2,* Jui-Ming  liu,3,* Ying-hsu Chang,4  Yuan-Tien Ting,5 see-T ong  Pang,4 Ren-Jun hsu,6–8  Po-hung lin4,9 1institute of Traditional Medicine,   school of Medicine, national Yang- Ming University, 2Department  of Chinese Medicine, Taipei City  hospital, Ren-ai Branch, Taipei,   3Division of Urology, Department of  surgery, Taoyuan general hospital,   Ministry of health and Welfare,   4Division of Urology, Department  of surgery, Chang gung Memorial  hospital at linkou, Taoyuan, 5Division  of Urology, Department of surgery,   Chang Bing show Chwan Memorial  hospital, Changhua, 6Biobank  Management Center of the Tri- service  general hospital, 7Department of  Pathology and graduate institute of  Pathology and Parasitology, the Tri- service general hospital, 8graduate  institute of life sciences, national  Defense Medical Center, Taipei,   9graduate institute of Clinical Medical  science, College of Medicine, Chang  gung University, Taoyuan, Taiwan,   Republic of China *These authors contributed equally  to this workBackground:  Urolithiasis is a common urinary tract disease worldwide.",Non-OADS,/arxiv_data1/oa_pdf/44/9a/tcrm-13-245.PMC5328140.pdf
"In several studies, urolithiasis has been  connected to systemic diseases, including hypertension,6 diabetes mellitus,7 metabolic Correspondence: Po-hung lin Division of Urology, Department of  surgery, Chang gung Memorial hospital  at linkou, no 5, Fuxing street, guishan  District, Taoyuan 333, Taiwan, Republic  of China Tel +886 3 328 1200 2103 email m7587@adm.cgmh.org.t w Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Lin et al Running head recto: Urolithiasis and complications of AMI DOI: http://dx.doi.org/10.2147/TCRM.S123702",Non-OADS,/arxiv_data1/oa_pdf/44/9a/tcrm-13-245.PMC5328140.pdf
Available from: http://nhird.nhri.,Non-OADS,/arxiv_data1/oa_pdf/44/9a/tcrm-13-245.PMC5328140.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/44/9a/tcrm-13-245.PMC5328140.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/44/9a/tcrm-13-245.PMC5328140.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/8e/a9/ijn-12-1499.PMC5328141.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 1499–1514International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1499OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12484 3 Biodegradable polymeric micelles coencapsulating  paclitaxel and honokiol: a strategy for breast  cancer therapy in vitro and in vivo Ning Wang Zhihan Wang* shihong Nie* linjiang song Tao he suleixin Yang Xi Yang cheng Yi Qinjie Wu changyang gong state Key laboratory of Biotherapy  and cancer center, collaborative  Innovation center for Biotherapy,   West china hospital, sichuan  University, chengdu, People’s  republic of china *These authors contributed equally  to this workAbstract:  The combination of chemotherapy drugs attracts more attention in clinical cancer  trials.",Non-OADS,/arxiv_data1/oa_pdf/8e/a9/ijn-12-1499.PMC5328141.pdf
"Unfortunately, Cremophor EL releases histamine after degradation in the body, caus - ing serious side effects, such as hypersensitivity.6 It is imperative to develop novel correspondence: Qinjie Wu state Key laboratory of Biotherapy and  cancer center, West china hospital,  sichuan University, People’s south road,  Wuhou District, chengdu 610041,  People’s republic of china Tel +86 134 0282 3774 email cellwqj@163.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Wang et al Running head recto: Biodegradable polymeric micelles coencapsulating PTX and HK DOI: http://dx.doi.org/10.2147/IJN.S124843",Non-OADS,/arxiv_data1/oa_pdf/8e/a9/ijn-12-1499.PMC5328141.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/8e/a9/ijn-12-1499.PMC5328141.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/8e/a9/ijn-12-1499.PMC5328141.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c9/13/ijn-12-1515.PMC5328142.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 1515International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/c9/13/ijn-12-1515.PMC5328142.pdf
"Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s 1515CorrIgeNdumopen access to scientific and medical research open Access Full T ext Article http: //dx.doi.org/10.2147/IJN.S13322 9 Long-term intravenous administration of carboxylated single-walled  carbon nanotubes induces persistent accumulation in the lungs and  pulmonary fibrosis via the nuclear factor-kappa B pathway [Corrigendum] Yue Qin, Suning Li, Gan Zhao, et al.",Non-OADS,/arxiv_data1/oa_pdf/c9/13/ijn-12-1515.PMC5328142.pdf
In Figure 2 Notes “1 mL per rat” should be “1 mL/kg  body weight”.Journal name: International Journal of Nanomedicine Article Designation: Corrigendum Y ear: 2017 Volume: 12 Running head verso: Qin et al Running head recto: Long-term intravenous administration of carboxylated single-walled carbon DOI: http://dx.doi.org/10.2147/IJN.S133229,Non-OADS,/arxiv_data1/oa_pdf/c9/13/ijn-12-1515.PMC5328142.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/1c/7b/ppa-11-305.PMC5328144.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2017:11 305–322Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  305Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S12665 1 Barriers and facilitators of adjuvant hormone  therapy adherence and persistence in women  with breast cancer: a systematic review Zoe Moon Rona Moss-Morris Myra S Hunter Sophie Carlisle Lyndsay D Hughes Health Psychology Section,   Department of Psychology,   institute of Psychiatry, Psychology &   Neuroscience, King’s College  London, London, UKPurpose:  Nonadherence to hormone therapy in breast cancer survivors is common and associated  with increased risk of mortality.",Non-OADS,/arxiv_data1/oa_pdf/1c/7b/ppa-11-305.PMC5328144.pdf
"Five to ten years of  HT significantly reduces rates of cancer recurrence and mortality in women with ER +  early breast cancer.2,3 Despite significant clinical benefits, many women do not take HT as  prescribed, which leads to a significantly increased risk of mortality and recurrence.4–6Correspondence: Lyndsay D Hughes Health Psychology Section, Department  of Psychology, institute of Psychiatry,  Psychology & Neuroscience,  King’s College London, 5th Floor  Bermondsey wing, Guy’s Hospital,  London Se1 9RT, UK email lyndsay.hughes@kcl.ac.u k Journal name: Patient Preference and Adherence Article Designation: Review Y ear: 2017 Volume: 11 Running head verso: Moon et al Running head recto: Barriers and facilitators of HT adherence DOI: http://dx.doi.org/10.2147/PPA.S126651",Non-OADS,/arxiv_data1/oa_pdf/1c/7b/ppa-11-305.PMC5328144.pdf
Available from: http://www.cancerresearchuk.,Non-OADS,/arxiv_data1/oa_pdf/1c/7b/ppa-11-305.PMC5328144.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/1c/7b/ppa-11-305.PMC5328144.pdf
"2, 266 –270 http://dx.doi.org/10.1080/21645515.2017.1264755",Non-OADS,/arxiv_data1/oa_pdf/1f/41/khvi-13-02-1264755.PMC5328205.pdf
"Arch Virol 1998; 143:1449-60; PMID:9742051; http://dx.doi.org/10.1007/s007050050389 [2] Brainard J, Pond K, Hooper L, Edmunds K, Hunter P. Presence and persistence of ebola or Marburg virus in patients and survivors: a rapid systematic review.",Non-OADS,/arxiv_data1/oa_pdf/1f/41/khvi-13-02-1264755.PMC5328205.pdf
PLoS Negl Trop Dis 2016; 10:e0004475; PMID:26927697; http://dx.doi.org/10.1371/journal.pntd.0004475 [3] Centres for Disease Control and Prevention.,Non-OADS,/arxiv_data1/oa_pdf/1f/41/khvi-13-02-1264755.PMC5328205.pdf
http://www.cdc.gov/vhf/ ebola/about.html .,Non-OADS,/arxiv_data1/oa_pdf/1f/41/khvi-13-02-1264755.PMC5328205.pdf
https://www.cdc.gov/vhf/ebola/outbreaks/ 2014-west-africa/ .,Non-OADS,/arxiv_data1/oa_pdf/1f/41/khvi-13-02-1264755.PMC5328205.pdf
Epidemiol Infect 2016; 144:1652-60; PMID:26808232; http://dx.doi.org/ 10.1017/S0950268816000054 [6] Fallah M for the Prevail III Research Team.,Non-OADS,/arxiv_data1/oa_pdf/1f/41/khvi-13-02-1264755.PMC5328205.pdf
http://www.who.int/csr/disease/ebola/one- year-report/virus-origin/en .,Non-OADS,/arxiv_data1/oa_pdf/1f/41/khvi-13-02-1264755.PMC5328205.pdf
EMBO Mol Med 2015; 7:17-23; http://dx.doi.org/10.15252/emmm.201404792 [9] World Health Organization.,Non-OADS,/arxiv_data1/oa_pdf/1f/41/khvi-13-02-1264755.PMC5328205.pdf
Third World Quarterly 2016; 37:401-8; http://dx.doi.org/10.1080/01436597.2015.1112232 [11] World Health Organization.,Non-OADS,/arxiv_data1/oa_pdf/1f/41/khvi-13-02-1264755.PMC5328205.pdf
http://apps.who.int/ebola/current-situation/ebola-situation- report-3-february-2016 .,Non-OADS,/arxiv_data1/oa_pdf/1f/41/khvi-13-02-1264755.PMC5328205.pdf
http://www.who.int/csr/disease/ebola/guinea- ﬂareup-update/en/ .,Non-OADS,/arxiv_data1/oa_pdf/1f/41/khvi-13-02-1264755.PMC5328205.pdf
Sci Adv 2016; 2:e1600378; PMID:27386513; http://dx.doi.org/10.1126/sciadv.1600378[16] Ayukekbong JA.,OADS,/arxiv_data1/oa_pdf/1f/41/khvi-13-02-1264755.PMC5328205.pdf
"J Epidemiol Community Health 2016; 70(1):1-2; PMID:26372790; http://dx.doi.org/10.1136/jech-2015-206138 [17] Ledgerwood JE, DeZure AD, Stanley DA, Novik L, Enama ME, Ber- kowitz NM, Hu Z, Joshi G, Ploquin A, Sitar S, et al.",Non-OADS,/arxiv_data1/oa_pdf/1f/41/khvi-13-02-1264755.PMC5328205.pdf
"Lancet 2015; 386:857-86; PMID:26248676; http://dx.doi.org/10.1016/S0140-6736(15)61117-5 [19] Agnandji S, Huttner A, Zinser ME, Njuguna P, Dahlke C, Fernandes JF, Yerly S, Dayer JA, Kraehling V, Kasonta R, et al.",OADS,/arxiv_data1/oa_pdf/1f/41/khvi-13-02-1264755.PMC5328205.pdf
"N Engl J Med 2016; 374:1647-60;PMID:25830326; http://dx.doi.org/10.1056/NEJMoa1502924 [20] Milligan ID, Gibani MM, Sewell R, Clutterbuck EA, Campbell D, Plested E, Nuthall E, Voysey M, Silva-Reyes L, McElrath MJ, et al.Safety and immunogenicity of novel adenovirus type 26- and modi-ﬁed vaccinia ankara-vectored ebola vaccines: A randomized clinical trial.",Non-OADS,/arxiv_data1/oa_pdf/1f/41/khvi-13-02-1264755.PMC5328205.pdf
JAMA 2016; 315(15):1610-23; PMID:27092831; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1f/41/khvi-13-02-1264755.PMC5328205.pdf
"BMC Med 2015; 13:271; PMID:26482396; http://dx.doi.org/10.1186/s12916-015-0477-2 [22] Kucharski AJ, Eggo RM, Watson CH, Camacho A, Funk S, Edmunds WJ.",OADS,/arxiv_data1/oa_pdf/1f/41/khvi-13-02-1264755.PMC5328205.pdf
Emerg Infect Dis 2016; 22:105-8; PMID:26691346;http://dx.doi.org/10.3201/eid2201.151410 [23] CIDRAP & Wellcome Trust.,Non-OADS,/arxiv_data1/oa_pdf/1f/41/khvi-13-02-1264755.PMC5328205.pdf
"Curr Opin Immunol 2009; 21:346-51; PMID:19500964; http://dx.doi.org/10.1016/j.coi.2009.05.016 [26] Moorthy BM, Fast P, Greenwood B. Heterologous prime-boost immunisation in Ebola vaccine development, testing and licensure.",Non-OADS,/arxiv_data1/oa_pdf/1f/41/khvi-13-02-1264755.PMC5328205.pdf
http://www.who.int/immunization/research/meetings_ workshops/WHO_primeboost_Ebola_21nov14_meeting_report.pdf .,Non-OADS,/arxiv_data1/oa_pdf/1f/41/khvi-13-02-1264755.PMC5328205.pdf
Available at: http://www.ebovac.org/the-trials/the-trials-phase-3/ .,Non-OADS,/arxiv_data1/oa_pdf/1f/41/khvi-13-02-1264755.PMC5328205.pdf
Making a difference: The global Ebola response out- look 2015. https://ebolaresponse.un.org/sites/default/ ﬁles/ebolaout look_full.pdf .,Non-OADS,/arxiv_data1/oa_pdf/1f/41/khvi-13-02-1264755.PMC5328205.pdf
BiolLett 2016; 12:20151079; PMID:27277951; http://dx.doi.org/10.1098/rsbl.2015.1079 [30] World Health Organization.,Non-OADS,/arxiv_data1/oa_pdf/1f/41/khvi-13-02-1264755.PMC5328205.pdf
http://www.who.int/immu nization/research/tar get-product-pro ﬁle/ebolavaccine/en/ .,Non-OADS,/arxiv_data1/oa_pdf/1f/41/khvi-13-02-1264755.PMC5328205.pdf
"JHosp Infect 2016; 94(2):113-115; PMID:27499080; http://dx.doi.org/10.1016/j.jhin.2016.07.004 [32] Osterholm M, Moore K, Ostrowsky J, Kimball-Baker K, Farrar J, Wellcome Trust-CIDRAP Ebola Vaccine Team B.",Non-OADS,/arxiv_data1/oa_pdf/1f/41/khvi-13-02-1264755.PMC5328205.pdf
Lancet Infect Dis 2016; 16:e1-9; PMID:26526664; http://dx.doi.org/10.1016/ S1473-3099(15)00416-8270 G. SHUKAREV ET AL.,OADS,/arxiv_data1/oa_pdf/1f/41/khvi-13-02-1264755.PMC5328205.pdf
"2, 428 –434 http://dx.doi.org/10.1080/21645515.2017.1264796",Non-OADS,/arxiv_data1/oa_pdf/e6/8b/khvi-13-02-1264796.PMC5328206.pdf
"ORCID Sara Boccalini http://orcid.org/0000-0002-9695-7549 Paolo Bonanni http://orcid.org/0000-0003-2875-3744 References [1] File TM Jr., Marrie TJ.",Non-OADS,/arxiv_data1/oa_pdf/e6/8b/khvi-13-02-1264796.PMC5328206.pdf
Postgrad Med 2010; 122:130-4; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e6/8b/khvi-13-02-1264796.PMC5328206.pdf
Hum Vac- cin 2010; 6:91821; http://dx.doi.org/10.4161/hv.6.11.13352 [4] Centers for Disease Control and Prevention (CDC).,Non-OADS,/arxiv_data1/oa_pdf/e6/8b/khvi-13-02-1264796.PMC5328206.pdf
BMC Infect Dis 2012; 12:207; PMID:22954038; http://dx.doi.org/10.1186/1471-2334-12-207 [6] Centers for Disease Control and Prevention (CDC).,Non-OADS,/arxiv_data1/oa_pdf/e6/8b/khvi-13-02-1264796.PMC5328206.pdf
"JClin Microbiol 2013; 51:8207; http://dx.doi.org/10.1128/JCM.01917-12 [8] Alfonsi V, D ’Ancona F, Giambi C, Nacca G, Rota MC.",OADS,/arxiv_data1/oa_pdf/e6/8b/khvi-13-02-1264796.PMC5328206.pdf
Health Policy 2011; 103:176-83; PMID:22030308; http://dx.doi.org/10.1016/j.healthpol.2011.10.002 [9] Ministero della Salute.,Non-OADS,/arxiv_data1/oa_pdf/e6/8b/khvi-13-02-1264796.PMC5328206.pdf
Available from: http://www.salute.,Non-OADS,/arxiv_data1/oa_pdf/e6/8b/khvi-13-02-1264796.PMC5328206.pdf
Vaccine 2012; 30:4717-8; PMID:22621828; http://dx.doi.org/10.1016/j.vaccine.2012.04.093 [12] Tuscany Region.,Non-OADS,/arxiv_data1/oa_pdf/e6/8b/khvi-13-02-1264796.PMC5328206.pdf
[Italian] Available from: http://www301.regione.toscana.it/bancadati/atti/Contenuto.,Non-OADS,/arxiv_data1/oa_pdf/e6/8b/khvi-13-02-1264796.PMC5328206.pdf
"Thorax 2012; 67:71-9; PMID:20729232; http://dx.doi.org/10.1136/thx.2009.129502 [14] Martinelli D, Pedalino B, Cappelli MG, Caputi G, Sallustio A, Fortu- nato F, Tafuri S, Cozza V, Germinario C, Chironna M, et al.",Non-OADS,/arxiv_data1/oa_pdf/e6/8b/khvi-13-02-1264796.PMC5328206.pdf
"Hum Vaccin Immunother 2014; 10(1):33-9; PMID:24096297; http://dx.doi.org/10.4161/hv.26650 [15] Bechini A, Taddei C, Barchielli A, Levi M, Tiscione E, Santini MG, Niccolini F, Mechi MT, Panatto D, Amicizia D, et al.",Non-OADS,/arxiv_data1/oa_pdf/e6/8b/khvi-13-02-1264796.PMC5328206.pdf
"Hum Vaccin Immunother 2015; 11(1):156-65; PMID:25483529; http://dx.doi.org/10.4161/hv.34418 [16] Fortunato F, Martinelli D, Cappelli MG, Cozza V, Prato R. Impact of pneumococcal conjugate universal routine vaccination on pneumo-coccal disease in Italian children.",Non-OADS,/arxiv_data1/oa_pdf/e6/8b/khvi-13-02-1264796.PMC5328206.pdf
"J Immunol Res 2015; 2015:206757;PMID:26351644; http://dx.doi.org/10.1155/2015/206757 [17] Amodio E, Costantino C, Boccalini S, Tramuto F, Maida CM, Vitale F. Estimating the burden of hospitalization for pneumococcal pneu-monia in a general population aged 50 years or older and implica- tions for vaccination strategies.",Non-OADS,/arxiv_data1/oa_pdf/e6/8b/khvi-13-02-1264796.PMC5328206.pdf
"Hum Vaccin Immunother 2014; 10 (5):1337-42; PMID:24577505; http://dx.doi.org/10.4161/hv.27947 [18] Durando P, Faust SN, Fletcher M, Krizova P, Torres A, Welte T. Experience with pneumococcal polysaccharide conjugate vaccine (conjugated to CRM197 carrier protein) in children and adults.",Non-OADS,/arxiv_data1/oa_pdf/e6/8b/khvi-13-02-1264796.PMC5328206.pdf
"Clin Microbiol Infect 2013; 19(Suppl 1):1-9; PMID:24083785; http://dx.doi.org/10.1111/1469-0691.12320 [19] Durando P, Crovari P, Ansaldi F, Sticchi L, Sticchi C, Turello V, Marensi L, Giacchino R, Timitilli A, Carloni R, et al.",Non-OADS,/arxiv_data1/oa_pdf/e6/8b/khvi-13-02-1264796.PMC5328206.pdf
"Vaccine 2009; 27:3459-62; PMID:19200823; http://dx.doi.org/10.1016/j.vaccine.2009.01.052 [20] Miller E, Andrews NJ, Waight PA, Slack MP, George RC.",Non-OADS,/arxiv_data1/oa_pdf/e6/8b/khvi-13-02-1264796.PMC5328206.pdf
"Lancet Infect Dis 2011 Oct; 11(10):760-8;PMID:21621466; http://dx.doi.org/10.1016/S1473-3099(11)70090-1 [21] Waight PA, Andrews NJ, Ladhani SN, Sheppard CL, Slack MP, Miller E. Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after itsintroduction: an observational cohort study.",Non-OADS,/arxiv_data1/oa_pdf/e6/8b/khvi-13-02-1264796.PMC5328206.pdf
"Lancet Infect Dis 2015May; 15(5):535-43; PMID:25801458; http://dx.doi.org/10.1016/ S1473-3099(15)70044-7 [22] Pasinato A, Indol ﬁG, Marchisio P, Valleriani C, Cortimiglia M, Spa- nevello V, Chiamenti G, Buzzetti R, Resti M, Azzari C. Italian groupHUMAN VACCINES & IMMUNOTHERAPEUTICS 433",Non-OADS,/arxiv_data1/oa_pdf/e6/8b/khvi-13-02-1264796.PMC5328206.pdf
"Pneu- mococcal serotype distribution in 1315 nasopharyngeal swabs from ahighly vaccinated cohort of Italian children as detected by RT-PCR.Vaccine 2014; 32:1375-81; PMID:24486364; http://dx.doi.org/ 10.1016/j.vaccine.2014.01.023 [23] Azzari C, Cortimiglia M, Nieddu F, Moriondo M, Indol ﬁG, Mattei R, Zuliani M, Adriani B, Degl ’Innocenti R, Consales G, et al.",Non-OADS,/arxiv_data1/oa_pdf/e6/8b/khvi-13-02-1264796.PMC5328206.pdf
Arch Pediatr Ado-lesc Med 2007; 161:1162-8; PMID:18056561; http://dx.doi.org/ 10.1001/archpedi.161.12.1162434 S. BOCCALINI ET AL.,Non-OADS,/arxiv_data1/oa_pdf/e6/8b/khvi-13-02-1264796.PMC5328206.pdf
"2, 255 –265 http://dx.doi.org/10.1080/21645515.2017.1264750",Non-OADS,/arxiv_data1/oa_pdf/2c/80/khvi-13-02-1264750.PMC5328210.pdf
"Infect Dis Clin North Am 2001; 15(1):155-169; PMID:11301813;http://dx.doi.org/10.1016/S0891-5520(05)70273-7 [2] Cohn AC, MacNeil JR, Clark TA, Ortega-Sanchez IR, Briere EZ, Meissner HC, Baker CJ, Messonnier NE, Centers for Disease Controland Prevention.",OADS,/arxiv_data1/oa_pdf/2c/80/khvi-13-02-1264750.PMC5328210.pdf
Available at: http://www.cdc.gov/ meningococcal/clinical-info.html .,Non-OADS,/arxiv_data1/oa_pdf/2c/80/khvi-13-02-1264750.PMC5328210.pdf
Emerg Infect Dis 2013; 19:566-573; PMID:23628376; http://dx.doi.org/10.3201/ eid1904.111799 [6] Centers for Disease Control and Prevention.,Non-OADS,/arxiv_data1/oa_pdf/2c/80/khvi-13-02-1264750.PMC5328210.pdf
Available at: https://surv.esr.cri.nz/PDF_surveil lance/MeningococcalDisease/2013/2013AnnualRpt.pdf .,Non-OADS,/arxiv_data1/oa_pdf/2c/80/khvi-13-02-1264750.PMC5328210.pdf
MMWR Morb Mortal WklyRep 2015; 64:1171-1176; http://dx.doi.org/10.15585/mmwr.,Non-OADS,/arxiv_data1/oa_pdf/2c/80/khvi-13-02-1264750.PMC5328210.pdf
"Clin Microbiol Infect 2006; 12:1024-1026;PMID:16961641; http://dx.doi.org/10.1111/j.1469-0691.2006.01521.x [14] Stewart A, Coetzee N, Knapper E, Rajanaidu S, Iqbal Z, Duggal H. Public health action and mass chemoprophylaxis in response to asmall meningococcal infection outbreak at a nursery in the West Midlands, England.",Non-OADS,/arxiv_data1/oa_pdf/2c/80/khvi-13-02-1264750.PMC5328210.pdf
"Perspect Public Health 2013; 133:104-109; PMID:23467531; http://dx.doi.org/10.1177/1757913912439928 [15] Chatt C, Gajraj R, Hawker J, Neal K, Tahir M, Lawrence M, Gray SJ, Lucidarme J, Carr AD, Clark SA, et al.",Non-OADS,/arxiv_data1/oa_pdf/2c/80/khvi-13-02-1264750.PMC5328210.pdf
"Arch Dis Child 2012; 97:248-249; PMID:22247241; http://dx.doi.org/10.1136/arch dischild-2011-301074 [17] Stephens DS, Greenwood B, Brandtzaeg P. Epidemic meningitis, meningococcaemia, and Neisseria meningitidis.",Non-OADS,/arxiv_data1/oa_pdf/2c/80/khvi-13-02-1264750.PMC5328210.pdf
"Lancet 2007;369:2196-2210; PMID:17604802; http://dx.doi.org/10.1016/S0140-6736(07)61016-2 [18] Dastouri F, Hosseini AM, Haworth E, Khandaker G, Rashid H, Booy R. Complications of serogroup B meningococcal disease in survivors:a review.",Non-OADS,/arxiv_data1/oa_pdf/2c/80/khvi-13-02-1264750.PMC5328210.pdf
"Infect Disord Drug Targets 2015; 14:205-212; http://dx.doi.org/10.2174/1871526515999150320155614 [19] Viner RM, Booy R, Johnson H, Edmunds WJ, Hudson L, Bedford H, Kaczmarski E, Rajput K, Ramsay M, Christie D. Outcomes of inva-sive meningococcal serogroup B disease in children and adolescents(MOSAIC): a case-control study.",Non-OADS,/arxiv_data1/oa_pdf/2c/80/khvi-13-02-1264750.PMC5328210.pdf
"Lancet Neurol 2012; 11:774-783; PMID:22863608; http://dx.doi.org/10.1016/S1474-4422(12)70180-1 [20] Finne J, Leinonen M, Makela PH.",OADS,/arxiv_data1/oa_pdf/2c/80/khvi-13-02-1264750.PMC5328210.pdf
"J Am CollSurg 2007; 205:205-216; PMID:17660066; http://dx.doi.org/10.1016/j.jamcollsurg.2007.03.027 [22] Lennon D, Reid S, Stewart J, Jackson C, Crengle S, Percival T. Reducing inequalities with vaccines: New Zealand ’s MeNZB vaccine initiative tocontrol an epidemic.",Non-OADS,/arxiv_data1/oa_pdf/2c/80/khvi-13-02-1264750.PMC5328210.pdf
"J Paediatr Child Health 2012; 48:193-201; PMID:21996021; http://dx.doi.org/10.1111/j.1440-1754.2010.01969.x [23] Tappero JW, Lagos R, Ballesteros AM, Plikaytis B, Williams D, Dykes J, Gheesling LL, Carlone GM, Hoiby EA, Holst J, et al.",Non-OADS,/arxiv_data1/oa_pdf/2c/80/khvi-13-02-1264750.PMC5328210.pdf
"JAMA 1999; 281:1520-1527;PMID:10227322; http://dx.doi.org/10.1001/jama.281.16.1520 [24] Holst J, Feiring B, Naess LM, Norheim G, Kristiansen P, Hoiby EA, Bryn K, Oster P, Costantino P, Taha MK, et al.",OADS,/arxiv_data1/oa_pdf/2c/80/khvi-13-02-1264750.PMC5328210.pdf
"Vaccine 2005; 23:2202-2205; PMID:15755595; http://dx.doi.org/10.1016/j.vaccine.2005.01.058 [25] Martin DR, Ruijne N, McCallum L, O ’Hallahan J, Oster P. The VR2 epitope on the PorA P1.7-2,4 protein is the major target for theimmune response elicited by the strain-speci ﬁc group B meningococ- cal vaccine MeNZB.",Non-OADS,/arxiv_data1/oa_pdf/2c/80/khvi-13-02-1264750.PMC5328210.pdf
"Clin Vaccine Immunol 2006; 13:486-491; PMID:16603616; http://dx.doi.org/10.1128/CVI.13.4.486-491.2006 [26] Bjune G, Hoiby EA, Gronnesby JK, Arnesen O, Fredriksen JH, Hal- stensen A, Holten E, Lindbak AK, Nokleby H, Rosenqvist E, et al.",OADS,/arxiv_data1/oa_pdf/2c/80/khvi-13-02-1264750.PMC5328210.pdf
"Lancet 1991; 338:1093-1096;PMID:1682541; http://dx.doi.org/10.1016/0140-6736(91)91961-S [27] Zlotnick GW, Jones TR, Liberator P, Hao L, Harris S, McNeil LK, Zhu D, Perez J, Eiden J, Jansen KU, et al.",OADS,/arxiv_data1/oa_pdf/2c/80/khvi-13-02-1264750.PMC5328210.pdf
"Hum Vaccin Immunother 2015; 11:5-13; PMID:25483509; http://dx.doi.org/10.4161/hv.34293 [28] Green LR, Eiden J, Hao L, Jones T, Perez J, McNeil LK, Jansen KU, Anderson AS.",OADS,/arxiv_data1/oa_pdf/2c/80/khvi-13-02-1264750.PMC5328210.pdf
"Methods Mol Biol 2016; 1403:445-469; PMID:27076147; http://dx.doi.org/ 10.1007/978-1-4939-3387-7_25 [29] Fletcher LD, Bern ﬁe l dL ,B a r n i a kV ,F a r l e yJ E ,H o w e l lA ,K n a u fM ,O o iP , Smith RP, Weise P, Wetherell M, et al.",OADS,/arxiv_data1/oa_pdf/2c/80/khvi-13-02-1264750.PMC5328210.pdf
"Infect Immun 2004; 72:2088-2100; PMID:15039331; http://dx.doi.org/10.1128/IAI.72.4.2088-2100.2004 [30] Murphy E, Andrew L, Lee KL, Dilts DA, Nunez L, Fink PS, Ambrose K, Borrow R, Findlow J, Taha MK, et al.",Non-OADS,/arxiv_data1/oa_pdf/2c/80/khvi-13-02-1264750.PMC5328210.pdf
"J Infect Dis 2009; 200:379-389; PMID:19534597; http://dx.doi.org/10.1086/600141 [31] Jiang HQ, Hoiseth SK, Harris SL, McNeil LK, Zhu D, Tan C, Scott AA, Alexander K, Mason K, Miller L, et al.",OADS,/arxiv_data1/oa_pdf/2c/80/khvi-13-02-1264750.PMC5328210.pdf
"Vaccine 2010; 28:6086-6093; PMID:20619376; http://dx.doi.org/10.1016/j.vaccine.2010.06.083 [32] Folaranmi T, Rubin L, Martin SW, Patel M, MacNeil JR. Use of serogroup B meningococcal vaccines in persons aged /C2110 years at increased risk for serogroup B meningococcal disease: recommenda- tions of the Advisory Committee on Immunization Practices, 2015.MMWR Morb Mortal Wkly Rep 2015; 64:608-612.",Non-OADS,/arxiv_data1/oa_pdf/2c/80/khvi-13-02-1264750.PMC5328210.pdf
Available at: http://www.fda.gov/downloads/ AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesa ndOtherBiologics/VaccinesandRelatedBiologicalProductsAdvisoryCommittee/UCM248586.pdf .,Non-OADS,/arxiv_data1/oa_pdf/2c/80/khvi-13-02-1264750.PMC5328210.pdf
"Popul Health Metr 2013; 11:17;PMID:24016339; http://dx.doi.org/10.1186/1478-7954-11-17 [36] Borrow R, Balmer P, Miller E. Meningococcal surrogates of protection – serum bactericidal antibody act ivity.",Non-OADS,/arxiv_data1/oa_pdf/2c/80/khvi-13-02-1264750.PMC5328210.pdf
Vaccine 2005; 23:2222-2227; PMID:15755600; http://dx.doi.org/10.1016/j.vaccine.2005.01.051HUMAN VACCINES & IMMUNOTHERAPEUTICS 263,Non-OADS,/arxiv_data1/oa_pdf/2c/80/khvi-13-02-1264750.PMC5328210.pdf
"Vaccine 2001; 20Suppl 1: S58-67; PMID:11587814; http://dx.doi.org/10.1016/S0264- 410X(01)00299-7 [40] Frasch CE, Borrow R, Donnelly J. Bactericidal antibody is the immu- nologic surrogate of protection against meningococcal disease.",Non-OADS,/arxiv_data1/oa_pdf/2c/80/khvi-13-02-1264750.PMC5328210.pdf
"Vac-cine 2009; 27(suppl 2):B112-116; PMID:19464093; http://dx.doi.org/ 10.1016/j.vaccine.2009.04.065 [41] Ramsay ME, Andrews N, Kaczmarski EB, Miller E. Ef ﬁcacy of meningococcal serogroup C conjugate vaccine in teenagers and tod-dlers in England.",Non-OADS,/arxiv_data1/oa_pdf/2c/80/khvi-13-02-1264750.PMC5328210.pdf
"J Exp Med1969; 129:1367-1384; PMID:4977283; http://dx.doi.org/10.1084/ jem.129.6.1367 [45] Vipond C, Care R, Feavers IM.",Non-OADS,/arxiv_data1/oa_pdf/2c/80/khvi-13-02-1264750.PMC5328210.pdf
"Vaccine 2012; 30 Suppl 2: B10- 17; PMID:22607894; http://dx.doi.org/10.1016/j.vaccine.2011.12.060 [46] Gill CJ, Ram S, Welsch JA, Detora L, Anemona A.",Non-OADS,/arxiv_data1/oa_pdf/2c/80/khvi-13-02-1264750.PMC5328210.pdf
"Vaccine 2011; 30:29-34; PMID:22075087; http://dx.doi.org/10.1016/j.vaccine.2011.10.068 [47] Borrow R, Miller E. Surrogates of protection.",Non-OADS,/arxiv_data1/oa_pdf/2c/80/khvi-13-02-1264750.PMC5328210.pdf
"Eur J Immunol 1991; 21:11- 16; PMID:1703960; http://dx.doi.org/10.1002/eji.1830210103 [50] Harris SL, Donald RGK, Hawkins JC, Tan C, O ’Neill RE, McNeil LK, Perez J, Anderson AS, Jansen KU, Jones TR.",Non-OADS,/arxiv_data1/oa_pdf/2c/80/khvi-13-02-1264750.PMC5328210.pdf
"Vaccine 2013; 31:1569-1575; PMID:23352429; http://dx.doi.org/10.1016/j.vaccine.2013.01.021 [52] Nissen MD, Marshall HS, Richmond PC, Jiang Q, Harris SL, Jones TR, J a n s e nK U ,P e r e zJ L .Ar a n d o m i z e d ,c o n t r o l l e d ,p h a s e1 / 2t r i a lo fa Neisseria meningitidis serogroup B bivalent rLP2086 vaccine in healthy children and adolescents.",Non-OADS,/arxiv_data1/oa_pdf/2c/80/khvi-13-02-1264750.PMC5328210.pdf
"Pediatr Infect Dis J 2013; 32:364-371;PMID:23114369; http://dx.doi.org/10.1097/INF.0b013e31827b0d24 [53] Richmond PC, Marshall HS, Nissen MD, Jiang Q, Jansen KU, Gar- ces-Sanchez M, Martinon-Torres F, Beeslaar J, Szenborn L, Wysocki J, et al.",OADS,/arxiv_data1/oa_pdf/2c/80/khvi-13-02-1264750.PMC5328210.pdf
"Lancet Infect Dis 2012; 12:597-607; PMID:22569484;http://dx.doi.org/10.1016/S1473-3099(12)70087-7 [54] Richmond PC, Nissen MD, Marshall HS, Lambert SB, Roberton D, Gruber WC, Jones TR, Arora A.",Non-OADS,/arxiv_data1/oa_pdf/2c/80/khvi-13-02-1264750.PMC5328210.pdf
Vaccine 2012; 30:6163-6174; PMID:22871351; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2c/80/khvi-13-02-1264750.PMC5328210.pdf
"J Pediatric Infect Dis Soc 2016; 5:180-187; PMID:26803328; http://dx.doi.org/10.1093/jpids/piv064 [56] Senders S, Bhuyan P, Jiang Q, Absalon J, Eiden JJ, Jones TR, York LJ, Jansen KU, O ’Neill RE, Harris SL, et al.",Non-OADS,/arxiv_data1/oa_pdf/2c/80/khvi-13-02-1264750.PMC5328210.pdf
"Pediatr Infect Dis J 2016; 35:548-554;PMID:26835974; http://dx.doi.org/10.1097/INF.0000000000001072 [57] Reiner DM, Bhuyan P, Eiden JJ, Ginis J, Harris S, Jansen KU, J i a n gQ ,J o n e sT R ,O ’Neill RE, York LJ, et al.",OADS,/arxiv_data1/oa_pdf/2c/80/khvi-13-02-1264750.PMC5328210.pdf
Vaccine 2016; 34:809-813; PMID:26707218; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/2c/80/khvi-13-02-1264750.PMC5328210.pdf
"J Pediatric InfectDis Soc 2016; 5:152-160; PMID:26407272; http://dx.doi.org/10.1093/ jpids/piv039 [59] Vesikari V, Senders S, Absalon J, Eiden JJ, Jansen KU, Beeslaar J, York LJ, Jones TR, Maansson R, Harris SL, et al.",Non-OADS,/arxiv_data1/oa_pdf/2c/80/khvi-13-02-1264750.PMC5328210.pdf
"Pharmacotherapy 2016; 36:880-892; PMID:27332671; http://dx.doi.org/10.1002/phar.1790 [65] Diermayer M, Hedberg K, Hoesly F, Fischer M, Perkins B, Reeves M, Fleming D. Epidemic serogroup B meningococcal disease in Oregon:264 R. G. K. DONALD ET AL.",OADS,/arxiv_data1/oa_pdf/2c/80/khvi-13-02-1264750.PMC5328210.pdf
"JAMA 1999; 281:1493- 1497; PMID:10227318; http://dx.doi.org/10.1001/jama.281.16.1493 [66] Clark SA, Lekshmi A, Lucidarme J, Hao L, Tsao H, Lee-Jones L, Jan- sen KU, Newbold LS, Anderson AS, Borrow R. Differences between culture & non-culture con ﬁrmed invasive meningococci with a focus on factor H-binding protein distribution.",OADS,/arxiv_data1/oa_pdf/2c/80/khvi-13-02-1264750.PMC5328210.pdf
"J Infect 2016; 73:63-70;PMID:27025206; http://dx.doi.org/10.1016/j.jinf.2016.03.012 [67] Hoiseth SK, Murphy E, Andrew L, Vogel U, Frosch M, Hellenbrand W, Abad R, Vazquez JA, Borrow R, Findlow J, et al.",OADS,/arxiv_data1/oa_pdf/2c/80/khvi-13-02-1264750.PMC5328210.pdf
"Pediatr Infect Dis J 2013; 32:1096-1101; PMID:23694830; http://dx.doi.org/10.1097/INF.0b013e31829aa63b [68] Domnich A, Gasparini R, Amicizia D, Boccadifuoco G, Giuliani MM, Panatto D. Meningococcal antigen ty ping system development and appli- cation to the evaluation of effectiveness of meningococcal B vaccine and possible use for other purposes.",Non-OADS,/arxiv_data1/oa_pdf/2c/80/khvi-13-02-1264750.PMC5328210.pdf
"J Immunol Res 2015; 2015:353461;PMID:26351645; http://dx.doi.org/10.1155/2015/353461 [69] Manigart O, Trotter C, Findlow H, Assefa A, Mihret W, Moti Demisse T, Yeshitela B, Osei I, Hodgson A, Quaye SL, et al.",Non-OADS,/arxiv_data1/oa_pdf/2c/80/khvi-13-02-1264750.PMC5328210.pdf
PLoS ONE 2016; 11:e0147928; PMID:26872255; http://dx.doi.org/10.1371/journal.pone.0147928 [70] Adis Insight (Springer).,OADS,/arxiv_data1/oa_pdf/2c/80/khvi-13-02-1264750.PMC5328210.pdf
"Clin Vaccine Immunol 2015; 22:1227-1234; PMID:26424832; http://dx.doi.org/10.1128/CVI.00474-15 [72] Medini D, Stella M, Wassil J. MATS: Global coverage estimates for 4CMenB, a novel multicomponent meningococcal B vaccine.",Non-OADS,/arxiv_data1/oa_pdf/2c/80/khvi-13-02-1264750.PMC5328210.pdf
"Vac- cine 2015; 33:2629-2636; PMID:25882169; http://dx.doi.org/10.1016/ j.vaccine.2015.04.015 [73] Donnelly J, Medini D, Boccadifuoco G, Biolchi A, Ward J, Frasch C, Moxon ER, Stella M, Comanducci M, Bambini S, et al.",Non-OADS,/arxiv_data1/oa_pdf/2c/80/khvi-13-02-1264750.PMC5328210.pdf
"N Engl J Med 2016; 375:220-228; PMID:27468058; http://dx.doi.org/10.1056/NEJMoa1514866 [75] McNeil LK, Murphy E, Zhao XJ, Guttmann S, Harris SL, Scott AA, Tan C, Mack M, DaSilva I, Alexander K, et al.",OADS,/arxiv_data1/oa_pdf/2c/80/khvi-13-02-1264750.PMC5328210.pdf
"Vaccine 2009; 27:3417-3421; PMID:19200847; http://dx.doi.org/10.1016/j.vaccine.2009.01.075 [76] McNeil LK, Zlotnick GW, Camposano E, Logan SM, Novikova EG, Zhao XJ, Anderson AS, Pride MW, Jansen KU.",Non-OADS,/arxiv_data1/oa_pdf/2c/80/khvi-13-02-1264750.PMC5328210.pdf
"N Engl J Med 1977; 297:686-691; PMID:408682; http://dx.doi.org/10.1056/ NEJM197709292971302 [79] Sikkema DJ, Friedman KE, Corsaro B, Kimura A, Hildreth SW, Madore DV, Quataert SA.",OADS,/arxiv_data1/oa_pdf/2c/80/khvi-13-02-1264750.PMC5328210.pdf
"J Pediatr 1996; 128:196-202; PMID:8636811; http://dx.doi.org/10.1016/S0022-3476(96) 70389-X [81] Vesikari T, Forsten A, Bianco V, Van der Wielen M, Miller JM.",OADS,/arxiv_data1/oa_pdf/2c/80/khvi-13-02-1264750.PMC5328210.pdf
"Hum Vaccin Immunother 2016; 12:132-139; PMID:26575983; http://dx.doi.org/10.1080/ 21645515.2015.1058457 [82] Gandhi A, Balmer P, York LJ.",Non-OADS,/arxiv_data1/oa_pdf/2c/80/khvi-13-02-1264750.PMC5328210.pdf
"Published with license by Taylor & Francis.This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered , transformed, or built upon in any way.HUMAN VACCINES & IMMUNOTHERAPEUTICS 2017, VOL.",Non-OADS,/arxiv_data1/oa_pdf/f6/79/khvi-13-02-1264788.PMC5328216.pdf
"2, 440 –444 http://dx.doi.org/10.1080/21645515.2017.1264788",Non-OADS,/arxiv_data1/oa_pdf/f6/79/khvi-13-02-1264788.PMC5328216.pdf
ORCID Ilaria Barberis http://orcid.org/0000-0003-1179-7206 Chiara Paganino http://orcid.org/0000-0002-7782-8039 References [1] Zanetti AR.,Non-OADS,/arxiv_data1/oa_pdf/f6/79/khvi-13-02-1264788.PMC5328216.pdf
"Vaccine 2001 Mar 21; 19(17 –19):2380-3; PMID:11257364; http://dx.doi.org/10.1016/S0264-410X(00)00458-8 [2] Stroffolini T, Mele A, Tosti ME, Gallo G, Balocchini E, Ragni P, San- tonastasi F, Marzolini A, Ciccozzi M, Moiraghi A.",Non-OADS,/arxiv_data1/oa_pdf/f6/79/khvi-13-02-1264788.PMC5328216.pdf
"J Hepatol 2000; 33(6):980-5;PMID:11131462; http://dx.doi.org/10.1016/S0168-8278(00)80132-4 [3] Floreani A, Baldo V, Cristofoletti M, Renzulli G, Valeri A, Zanetti C, Trivello R. Long-term persistence of anti-HBs after vaccinationagainst HBV: an 18 year experience in health care workers.",Non-OADS,/arxiv_data1/oa_pdf/f6/79/khvi-13-02-1264788.PMC5328216.pdf
"Vaccine2004; 22:607-610; PMID:14741151; http://dx.doi.org/10.1016/j.vac cine.2003.09.001 [4] Italian Law, May 27 1991.",Non-OADS,/arxiv_data1/oa_pdf/f6/79/khvi-13-02-1264788.PMC5328216.pdf
Available from: http://www.iss.it/binary/tras/cont/ 19911004_Circolare%204%20ott%201991.1181036033.pdf (last access on: 18 August 2016).,OADS,/arxiv_data1/oa_pdf/f6/79/khvi-13-02-1264788.PMC5328216.pdf
"Lancet 1988; 2(8620):1132; PMID:2903337; http://dx.doi.org/10.1016/S0140-6736(88)90540-5 [6] Mele A, Stroffolini T, Zanetti AR.",OADS,/arxiv_data1/oa_pdf/f6/79/khvi-13-02-1264788.PMC5328216.pdf
"J Med Virol 2002; 67(3):440-3. Review; PMID:12116041; http://dx.doi.org/ 10.1002/jmv.10092 [7] Heininger U, Gambon M, Gruber V, Margelli D. Successful hepatitis B immunization in non- and low responding health care workers.",OADS,/arxiv_data1/oa_pdf/f6/79/khvi-13-02-1264788.PMC5328216.pdf
"World JHepatol 2015; 7(3):488-97; PMID:25848472; http://dx.doi.org/10.4254/wjh.v7.i3.488 [10] Lamberti M, De Rosa A, Garzillo EM, Corvino AR, Sannolo N, De Pascalis S, Di Fiore E, Westermann C, Arnese A, Gabriella DG, et al.Vaccination against hepatitis b viru s: are Italian medical students suf ﬁ- ciently protected after the public vaccination programme?.",Non-OADS,/arxiv_data1/oa_pdf/f6/79/khvi-13-02-1264788.PMC5328216.pdf
2016;11:3;PMID:26539242; http://dx.doi.org/10.1186/s12995-015-0083-4 [11] Italian Law decree n. 81 of 9h April 2008.,Non-OADS,/arxiv_data1/oa_pdf/f6/79/khvi-13-02-1264788.PMC5328216.pdf
Vaccine 2001; 19(17 –19):2389-94; PMID:11257366; http://dx.doi.org/10.1016/S0264-410X(00)00460-6[13] Italian Ministry of Health.,Non-OADS,/arxiv_data1/oa_pdf/f6/79/khvi-13-02-1264788.PMC5328216.pdf
Available from: http://www.salute.gov.it/imgs/c_17_pub blicazioni_1721_allegato.pdf (last access on 18 August 2016).,Non-OADS,/arxiv_data1/oa_pdf/f6/79/khvi-13-02-1264788.PMC5328216.pdf
Vaccine 2014; 32 (51):6902-10; PMID:25444815; http://dx.doi.org/10.1016/j.vaccine.,Non-OADS,/arxiv_data1/oa_pdf/f6/79/khvi-13-02-1264788.PMC5328216.pdf
Vaccine 2009; 27:3459-3462;PMID:19200823; http://dx.doi.org/10.1016/j.vaccine.2009.01.052 [16] Zanetti AR.,Non-OADS,/arxiv_data1/oa_pdf/f6/79/khvi-13-02-1264788.PMC5328216.pdf
"Lancet InfectDis 2010; 10(11):755-6 ; PMID:20884297; http://dx.doi.org/10.1016/S1473-3099(10)70195-X [17] Gabutti A, Roman /C18o L, Blanc P, Meacci F, Amendola A, Mele A, Mazzotta F, Zanetti AR.",Non-OADS,/arxiv_data1/oa_pdf/f6/79/khvi-13-02-1264788.PMC5328216.pdf
Vaccine 2007; 25:3129-32; PMID:17291637; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/f6/79/khvi-13-02-1264788.PMC5328216.pdf
"Lancet 2005; 366(9494):1379-84; PMID:16226616; http://dx.doi.org/10.1016/S0140-6736(05)67568-X [19] Chiara F, Bartolucci GB, Cattai M, Piazza A, Nicolli A, Buja A, Trevisan A.",Non-OADS,/arxiv_data1/oa_pdf/f6/79/khvi-13-02-1264788.PMC5328216.pdf
"Vaccine 2013; 32(1):62-8); PMID:24188755; http://dx.doi.org/10.1016/j.vaccine.2013.10.074 [20] Coppola N, Corvino AR, De Pascalis S, Signoriello G, Di Fiore E, Nienhaus A, Sagnelli E, Lamberti M. The long-term immunoge-nicity of recombinant hepatitis B virus (HBV) vaccine: contribu- tion of universal HBV vaccination in Italy.",Non-OADS,/arxiv_data1/oa_pdf/f6/79/khvi-13-02-1264788.PMC5328216.pdf
"BMC Infect Dis 2015; 15:149; PMID:25884719; http://dx.doi.org/10.1186/s12879-015-0874-3 [21] Chiara F, Bartolucci GB, Mongillo M, Ferretto L, Nicolli A, Trevisan A.",Non-OADS,/arxiv_data1/oa_pdf/f6/79/khvi-13-02-1264788.PMC5328216.pdf
"Infection 2012; 40(3):299-302; PMID:22173948; http://dx.doi.org/10.1007/s15010-011- 0233-2 [23] Spada E, Roman /C18o L, Tosti ME, Zuccaro O, Paladini S, Chironna M, Coppola RC, Cuccia M, Mangione R, Marrone F, et al.",Non-OADS,/arxiv_data1/oa_pdf/f6/79/khvi-13-02-1264788.PMC5328216.pdf
"Clin Microbiol Infect 2014; 20(10):O680-6; PMID:24528380; http://dx.doi.org/10.1111/1469-0691.12591 [24] Poorolajal J, Hooshmand E. Booster dose vaccination for preventing hepatitis B. Cochrane Database Syst Rev 2016; 7(6):CD008256.",Non-OADS,/arxiv_data1/oa_pdf/f6/79/khvi-13-02-1264788.PMC5328216.pdf
Hum Vaccin Immunother 2013; 9(7):1466-76;PMID:23571167; http://dx.doi.org/10.4161/hv.24480 [26] Advisory Committee on Immunization Practices; Centers for Disease Control and Prevention (CDC).,Non-OADS,/arxiv_data1/oa_pdf/f6/79/khvi-13-02-1264788.PMC5328216.pdf
Available from: http://www.camera.it/parlam/leggi/deleghe/03196dl.htm (last access on 18 August 2016).444 G. DINI ET AL.,Non-OADS,/arxiv_data1/oa_pdf/f6/79/khvi-13-02-1264788.PMC5328216.pdf
"Published with license by Taylor & Francis.This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial NoDerivatives License ( http://creativecommons.org/licenses/by-nc-nd/4.0/.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered , transformed, or built upon in any way.HUMAN VACCINES & IMMUNOTHERAPEUTICS 2017, VOL.",Non-OADS,/arxiv_data1/oa_pdf/af/4e/khvi-13-02-1264834.PMC5328218.pdf
"2, 399 –404 http://dx.doi.org/10.1080/21645515.2017.1264834",Non-OADS,/arxiv_data1/oa_pdf/af/4e/khvi-13-02-1264834.PMC5328218.pdf
ORCID Cristiano Alicino http://orcid.org/0000-0002-6473-9870 Cecilia Trucchi http://orcid.org/0000-0003-4633-202X Chiara Paganino http://orcid.org/0000-0002-7782-8039 Ilaria Barberis http://orcid.org/0000-0003-1179-7206 Sara Boccalini http://orcid.org/0000-0002-9695-7549 Domenico Martinelli http://orcid.org/0000-0001-8028-3167 Barbara Pellizzari http://orcid.org/0000-0001-5504-3444 Angela Bechini http://orcid.org/0000-0002-6013-8779 Andrea Orsi http://orcid.org/0000-0002-2433-9610 Paolo Bonanni http://orcid.org/0000-0003-2875-3744 Rosa Prato http://orcid.org/0000-0001-8138-5835 Giancarlo Icardi http://orcid.org/0000-0002-8463-8487 References [1] Johnson RW.,Non-OADS,/arxiv_data1/oa_pdf/af/4e/khvi-13-02-1264834.PMC5328218.pdf
Expert Rev Vaccines 2010; 9(3 Suppl):21-6; PMID:20192714; http://dx.doi.org/ 10.1586/erv.10.30 [2] Cohen JI.,Non-OADS,/arxiv_data1/oa_pdf/af/4e/khvi-13-02-1264834.PMC5328218.pdf
"N Engl J Med 2013; 369(3):255-63; PMID:23863052; http://dx.doi.org/10.1056/NEJMcp1302674 [3] Kawai K, Gebremeskel BG, Acosta CJ.",OADS,/arxiv_data1/oa_pdf/af/4e/khvi-13-02-1264834.PMC5328218.pdf
Rev Med Microbiol 1993; 4:222-30;http://dx.doi.org/10.1097/00013542-199310000-00006 [5] Schmader K. Herpes zoster in older adults.,Non-OADS,/arxiv_data1/oa_pdf/af/4e/khvi-13-02-1264834.PMC5328218.pdf
"Clin Infect Dis 2001; 32:1481-6; PMID:11317250; http://dx.doi.org/10.1086/320169 [6] Schmader K, Gnann JW Jr, Watson CP.",OADS,/arxiv_data1/oa_pdf/af/4e/khvi-13-02-1264834.PMC5328218.pdf
J Infect Dis 2008; 197:S207-15; PMID:18419399; http://dx.doi.org/10.1086/ 522152HUMAN VACCINES & IMMUNOTHERAPEUTICS 403,Non-OADS,/arxiv_data1/oa_pdf/af/4e/khvi-13-02-1264834.PMC5328218.pdf
"BMC Med 2010; 8:37; PMID:20565946; http://dx.doi.org/10.1186/1741-7015-8-37 [8] Whitley RJ, Shukla S, Crooks RJ.",Non-OADS,/arxiv_data1/oa_pdf/af/4e/khvi-13-02-1264834.PMC5328218.pdf
"J Infect Dis 1998; 178:S71-5; PMID:9852979; http://dx.doi.org/ 10.1086/514274 [9] Jung BF, Johnson RW, Grif ﬁn DR, Dworkin RH.",OADS,/arxiv_data1/oa_pdf/af/4e/khvi-13-02-1264834.PMC5328218.pdf
Neurology2004; 62:1545-51; PMID:15136679; http://dx.doi.org/10.1212/01.,Non-OADS,/arxiv_data1/oa_pdf/af/4e/khvi-13-02-1264834.PMC5328218.pdf
"J Infect 1999; 38:116- 119; PMID:10342652; http://dx.doi.org/10.1016/S0163-4453(99) 90079-8 [13] Di Legami V, Gianino MM, Atti MCD, Massari M, Migliardi A, Tomba GS, Zotti C, Zoster Study Group.",OADS,/arxiv_data1/oa_pdf/af/4e/khvi-13-02-1264834.PMC5328218.pdf
"Epidemiology and costs of herpes zoster: background data to estimate the impact of vaccination.Vaccine 2007; 25:7598-7604; PMID:17889410; http://dx.doi.org/10.1016/j.vaccine.2007.07.049 [14] Gialloreti LE, Merito M, Pezzotti P, Naldi L, Gatti A, Beillat M, Serra- dell L, di Marzo R, Volpi A.",Non-OADS,/arxiv_data1/oa_pdf/af/4e/khvi-13-02-1264834.PMC5328218.pdf
"BMC Infect Dis 2010; 10:230; PMID:20682044; http://dx.doi.org/10.1186/1471-2334-10-230 [15] Takao Y, Miyazaki Y, Okeda M, Onishi F, Yano S, Gomi Y, Ishikawa T, Okuno Y, Mori Y, Asada H, et al.",OADS,/arxiv_data1/oa_pdf/af/4e/khvi-13-02-1264834.PMC5328218.pdf
"Incidences of Herpes Zoster andPostherpetic Neuralgia in Japanese adults aged 50 years and older from a community-based prospective cohort study: The SHEZ study.J Epidemiol 2015; 25:617-25; PMID:26399445; http://dx.doi.org/10.2188/jea.JE20140210 [16] Fleming DM, Cross KW, Cobb WA, Chapman RS.",Non-OADS,/arxiv_data1/oa_pdf/af/4e/khvi-13-02-1264834.PMC5328218.pdf
"Epidemiol Infect2004; 132:1-5; PMID:14979582; http://dx.doi.org/10.1017/ S0950268803001523 [17] Johnson BH, Palmer L, Gatwood J, Lenhart G, Kawai K, Acosta CJ.",OADS,/arxiv_data1/oa_pdf/af/4e/khvi-13-02-1264834.PMC5328218.pdf
"BMC Infect Dis 2015; 15:502; PMID:26546419; http://dx.doi.org/10.1186/s12879-015-1262-8 [18] Kawai K, Rampakakis E, Tsai TF, Cheong HJ, Dhitavat J, Covarru- bias AO, Yang L, Cashat-Cruz M, Monsanto H, Johnson K, et al.",OADS,/arxiv_data1/oa_pdf/af/4e/khvi-13-02-1264834.PMC5328218.pdf
"Int J Infect Dis 2015; 34:126-31; PMID:25841633;http://dx.doi.org/10.1016/j.ijid.2015.03.022 [19] Tran KD, Falcone MM, Choi DS, Goldhardt R, Karp CL, Davis JL, Galor A.",OADS,/arxiv_data1/oa_pdf/af/4e/khvi-13-02-1264834.PMC5328218.pdf
"Ophthalmology 2016; 123:1469-75; PMID:27067924;http://dx.doi.org/10.1016/j.ophtha.2016.03.005 [20] Yawn BP, Wollan PC, Kurland MJ, St Sauver JL, Saddier P. Herpes zoster recurrences more frequent than previously reported.",Non-OADS,/arxiv_data1/oa_pdf/af/4e/khvi-13-02-1264834.PMC5328218.pdf
"MayoClin Proc 2011; 86:88-93; PMID:21220354; http://dx.doi.org/10.4065/mcp.2010.0618 [21] Paganino C, Alicino C, Trucchi C, Albanese E, Sticchi L, Icardi G. Herpes Zoster: the rationale for the introduction of vaccination inItaly.",Non-OADS,/arxiv_data1/oa_pdf/af/4e/khvi-13-02-1264834.PMC5328218.pdf
Adv Ther 2016; 33:1094-104;PMID:27262452; http://dx.doi.org/10.1007/s12325-016-0355-0404 C. ALICINO ET AL.,OADS,/arxiv_data1/oa_pdf/af/4e/khvi-13-02-1264834.PMC5328218.pdf
"2, 359 –368 http://dx.doi.org/10.1080/21645515.2017.1264797",Non-OADS,/arxiv_data1/oa_pdf/dd/8e/khvi-13-02-1264797.PMC5328222.pdf
"Acknowledgments The authors would like to thank Prof. Paolo Castiglia, University of Sassari and Prof. Chiara Azzari, University of Florence, for their contribution to the revision of the ﬁnal document.ORCID Paolo Bonanni http://orcid.org/0000-0003-2875-3744 Sara Boccalini http://orcid.org/0000-0002-9695-7549 References [1] Waghorn DJ.",Non-OADS,/arxiv_data1/oa_pdf/dd/8e/khvi-13-02-1264797.PMC5328222.pdf
"J Clin Pathol 2001; 54:214-8; PMID:11253134; http://dx.doi.org/10.1136/ jcp.54.3.214 [2] Castagnola E, Fioredda F. Prevention of life-threatening infections due to encapsulated bacteria in children with hyposplenia or asple- nia: a brief review of current recommendations for practical pur- poses.",Non-OADS,/arxiv_data1/oa_pdf/dd/8e/khvi-13-02-1264797.PMC5328222.pdf
"Eur J Haematol 2003; 71:319-26; PMID:14667194; http://dx.doi.org/10.1034/j.1600-0609.2003.00158.x [3] White BP, Aanning HL.",Non-OADS,/arxiv_data1/oa_pdf/dd/8e/khvi-13-02-1264797.PMC5328222.pdf
"Infect Dis Clin North Am 2001 Jun; 15(2):551-65, x; PMID:11447709; http://dx.doi.org/10.1016/S0891-5520(05)70159-8 [6] Di Cataldo A, Puleo S, Li Destri G, Racalbuto A, Trombatore G, Lat- teri F, Rodolico G. Splenic trauma and overwhelming postsplenec- tomy infection.",Non-OADS,/arxiv_data1/oa_pdf/dd/8e/khvi-13-02-1264797.PMC5328222.pdf
"Arch Intern Med 1977; 137:1526-30; PMID:921438; http://dx.doi.org/10.1001/archinte.1977.03630230022009 [8] Bisharat N, Omari H, Lavi I, Raz R. Risk of infection and death among postsplenectomy patients.",OADS,/arxiv_data1/oa_pdf/dd/8e/khvi-13-02-1264797.PMC5328222.pdf
J Infect 2001; 43:182-6; PMID:11798256; http://dx.doi.org/10.1053/jinf.2001.0904 [9] Singer DB.,Non-OADS,/arxiv_data1/oa_pdf/dd/8e/khvi-13-02-1264797.PMC5328222.pdf
"Clin Infect Dis 2008 Apr 1; 46(7):1015-23; PMID:18444818;http://dx.doi.org/10.1086/529142 [11] Meerveld-Eggink A, de Weerdt O, van Velzen-Blad H, Biesma DH.",OADS,/arxiv_data1/oa_pdf/dd/8e/khvi-13-02-1264797.PMC5328222.pdf
"Vaccine 2011 Jan 17; 29(4):675-80; PMID:21115060; http://dx.doi.org/10.1016/j.vaccine.2010.11.034 [12] Musher DM, Ceasar H, Kojic EM, Musher BL, Gathe JC Jr, Romero- Steiner S, White AC Jr. Administration of protein-conjugate pneu- mococcal vaccine to patients who have invasive disease after splenec-tomy despite their having received 23-valent pneumococcal polysaccharide vaccine.",Non-OADS,/arxiv_data1/oa_pdf/dd/8e/khvi-13-02-1264797.PMC5328222.pdf
"J Infect Dis 2005 Apr 1; 191(7):1063-7; PMID:15747240; http://dx.doi.org/10.1086/428135 [13] Nived P, Jørgensen CS, Settergren B. Vaccination status and immune response to 13-valent pneumococcal conjugate vaccine in asplenic individuals.",OADS,/arxiv_data1/oa_pdf/dd/8e/khvi-13-02-1264797.PMC5328222.pdf
"Vaccine 2015; 33(14):1688-1694; http://dx.doi.org/ 10.1016/j.vaccine.2015.02.026 [14] Rosado MM, Gesualdo F, Marcellini V, Di Sabatino A, Corazza GR, Smacchia MP, Nobili B, Baronci C, Russo L, Rossi F, et al.",Non-OADS,/arxiv_data1/oa_pdf/dd/8e/khvi-13-02-1264797.PMC5328222.pdf
"Preserved antibody levels and loss of memory B cells against pneumococcus and tetanus after splenectomy: tailoring better vaccination strategies.Eur J Immunology 2013 OCT; 43 (10):2659-70; http://dx.doi.org/10.1002/eji.201343577 [15] Clutterbuck EA, Lazarus R, Yu LM, Bowman J, Bateman EA, Diggle L, Angus B, Peto TE, Beverley PC, Mant D, et al.",Non-OADS,/arxiv_data1/oa_pdf/dd/8e/khvi-13-02-1264797.PMC5328222.pdf
J Infect Dis 2012 May 1; 205(9):1408-16; PMID:22457293; http://dx.doi.org/10.1093/infdis/jis212HUMAN VACCINES & IMMUNOTHERAPEUTICS 365,Non-OADS,/arxiv_data1/oa_pdf/dd/8e/khvi-13-02-1264797.PMC5328222.pdf
"Br J Surg 2008 Mar; 95(3):273-80;PMID:18278784; http://dx.doi.org/10.1002/bjs.6106 [18] Forstner C1, Plefka S, Tobudic S, Winkler HM, Burgmann K, Burg- mann H. Effectiveness and immunogenicity of pneumococcal vacci-nation in splenectomized and functionally asplenic patients.",OADS,/arxiv_data1/oa_pdf/dd/8e/khvi-13-02-1264797.PMC5328222.pdf
"Vaccine2012 Aug 10; 30(37):5449-52; PMID:22749594; http://dx.doi.org/ 10.1016/j.vaccine.2012.06.048 [19] Papadatou I, Piperi C, Alexandraki K, Kattamis A, Theodoridou M, Spoulou V. Antigen-speci ﬁc B-cell response to 13-valent pneumo- coccal conjugate vaccine in asplenic individuals with b-thalassemia previously immunized with 23-valent pneumococcal polysaccharide vaccine.",Non-OADS,/arxiv_data1/oa_pdf/dd/8e/khvi-13-02-1264797.PMC5328222.pdf
"Clin Infect Dis 2014 Sep 15; 59(6):862-5; PMID:24879786;http://dx.doi.org/10.1093/cid/ciu409 [20] Lazarus R, Clutterbuck E, Yu LM, Bowman J, Bateman EA, Diggle L, Angus B, Peto TE, Beverley PC, Mant D, et al.",OADS,/arxiv_data1/oa_pdf/dd/8e/khvi-13-02-1264797.PMC5328222.pdf
"Clin Infect Dis 2011 Mar 15; 52 (6):736-42; PMID:21367726; http://dx.doi.org/10.1093/cid/cir003 [21] Musher DM, Rueda AM, Nahm MH, Graviss EA, Rodriguez-Barra- das MC.",Non-OADS,/arxiv_data1/oa_pdf/dd/8e/khvi-13-02-1264797.PMC5328222.pdf
J Infect Dis 2008 Oct 1; 198(7):1019-27; PMID:18710324; http://dx.doi.org/10.1086/591629 [22] Centers for Disease Control and Prevention.,Non-OADS,/arxiv_data1/oa_pdf/dd/8e/khvi-13-02-1264797.PMC5328222.pdf
"United States, 2016 ( http://www.cdc.gov/ vaccines/schedules/downloads/adult/adult-combined-schedule.pdf ) [23] Public Health England.",Non-OADS,/arxiv_data1/oa_pdf/dd/8e/khvi-13-02-1264797.PMC5328222.pdf
"Available at: https://www.gov.uk/gov ernment/uploads/system/ uploads/attachment_data/ ﬁle/263318/Green-Book-C hapter-25-v5_2.pdf [24] SItI, SIP, FIMP ^a€“FIMMG.",OADS,/arxiv_data1/oa_pdf/dd/8e/khvi-13-02-1264797.PMC5328222.pdf
Avail- able from: http://www.apel-pediatri.org/attachments/794_Calendar io_vaccini_16.pdf ) [25] Tuscany Region.,Non-OADS,/arxiv_data1/oa_pdf/dd/8e/khvi-13-02-1264797.PMC5328222.pdf
"[Italian] Available from : http://www301.regione.toscana.it/ bancadati/atti/Contenuto.xml?id D5099142&nomeFile DDelibera_n.571 _del_27-04-2015-Allegato-1 [26] Rubin LG, Levin MJ, Ljungman P, Davies EG, Avery R, Tomblyn M, Bousvaros A, Dhanireddy S, Sung L, Keyserling H, et al.",Non-OADS,/arxiv_data1/oa_pdf/dd/8e/khvi-13-02-1264797.PMC5328222.pdf
Ther Adv Vaccines 2015 Jan; 3(1):13-23; PMID:25553243; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/dd/8e/khvi-13-02-1264797.PMC5328222.pdf
Available from: https://farmaci.agenziafar maco.gov.it/bancadatifarmaci/[33] Centers for Disease Control and Prevention.,Non-OADS,/arxiv_data1/oa_pdf/dd/8e/khvi-13-02-1264797.PMC5328222.pdf
"Infect Immun 2004; 72(1):332-7 ; PMID:14688112; http://dx.doi.org/ 10.1128/IAI.72.1.332-337.2004 [36] Spoulou V, Tzanakaki G, Lekka S, Chouliaras G, Ladis V, Theodori- dou M. Natural and vaccine-induced immunity to Neisseria Menin- gitidis serogroup C in asplenic patients with beta-thalassemia.",Non-OADS,/arxiv_data1/oa_pdf/dd/8e/khvi-13-02-1264797.PMC5328222.pdf
"Vaccine 2011 15; 29(27):4435-8; PMID:21497638; http://dx.doi.org/10.1016/j.vaccine.2011.03.080 [37] Meerveld-Eggink A, de Weerdt O, de Voer RM, Berbers GA, van Velzen-Blad H, Vlaminckx BJ, Biesma DH, Rijkers GT.",Non-OADS,/arxiv_data1/oa_pdf/dd/8e/khvi-13-02-1264797.PMC5328222.pdf
Eur JClin Microbiol Infect Dis 2011; 30:611-618; http://dx.doi.org/10.1007/s10096-010-1129-2 [38] Committee on Infectious Diseases.,Non-OADS,/arxiv_data1/oa_pdf/dd/8e/khvi-13-02-1264797.PMC5328222.pdf
"Pediatrics 2011Dec; 128(6):1213-8; PMID:22123893; http://dx.doi.org/10.1542/ peds.2011-2380 [39] Rubin LG, Schaffner W. Care of the Asplenic Patient.",Non-OADS,/arxiv_data1/oa_pdf/dd/8e/khvi-13-02-1264797.PMC5328222.pdf
"N Engl J Med 2014; 371:349-356; PMID:25054718; http://dx.doi.org/10.1056/NEJMe1412744 [40] Harji DP, Jaunoo SS, Mistry P, Nesargikar PN.",OADS,/arxiv_data1/oa_pdf/dd/8e/khvi-13-02-1264797.PMC5328222.pdf
"Int J Surg 2009 Oct; 7(5):421-3;PMID:19607947; http://dx.doi.org/10.1016/j.ijsu.2009.07.003 [41] Salvadori MI, Price VE.",OADS,/arxiv_data1/oa_pdf/dd/8e/khvi-13-02-1264797.PMC5328222.pdf
"Clin Microbiol Rev 2010 Oct; 23(4):740-80; PMID:20930072; http://dx.doi.org/10.1128/CMR.00048-09 [43] Davies JM, Lewis MP, Wimperis J, Ra ﬁI, Ladhani S, Bolton-Maggs PH; British Committee for Standards in Haematology.",Non-OADS,/arxiv_data1/oa_pdf/dd/8e/khvi-13-02-1264797.PMC5328222.pdf
Br J Haematol 2011 Nov; 155(3):308-17; PMID:21988145; http://dx.doi.org/10.1111/j.1365-2141.2011.08843.x [44] Centers for Disease Control and Prevention.,Non-OADS,/arxiv_data1/oa_pdf/dd/8e/khvi-13-02-1264797.PMC5328222.pdf
"J Infect Dis 2001 Jun 15; 183(12):1819-21; PMID:11372038; http://dx.doi.org/10.1086/320727 [47] Briere EC, Rubin L, Moro PL, et al.",OADS,/arxiv_data1/oa_pdf/dd/8e/khvi-13-02-1264797.PMC5328222.pdf
"Hib Chapter 16. https://www.gov.uk/government/publications/haemophilus-in ﬂuen zae-type-hib-the-green-book-chapter16 [51] Christopoulou I, Roose K, Iba ~nez LI, Saelens X.",Non-OADS,/arxiv_data1/oa_pdf/dd/8e/khvi-13-02-1264797.PMC5328222.pdf
"Expert Rev Vaccines 2015 Jan; 14(1):55-67; PMID:25209381; http://dx.doi.org/10.1586/14760584.2015.957191 [52] Langley JM, Dodds L, Fell D, Langley GR.",Non-OADS,/arxiv_data1/oa_pdf/dd/8e/khvi-13-02-1264797.PMC5328222.pdf
BMC Infect Dis 2010 Jul 22; 10:219;PMID:20649965; http://dx.doi.org/10.1186/1471-2334-10-219 [53] Public Health England.,Non-OADS,/arxiv_data1/oa_pdf/dd/8e/khvi-13-02-1264797.PMC5328222.pdf
In ﬂuenza Chapter 19 https://www.gov.uk/government/publications/in ﬂuenza-the-green- book-chapter-19) [54] Public Health England.,Non-OADS,/arxiv_data1/oa_pdf/dd/8e/khvi-13-02-1264797.PMC5328222.pdf
"Human vaccin Immunother 2012 Jan; 8 (1):67-75;http://dx.doi.org/10.4161/hv.8.1.18419 [56] Manzoli L, Ioannidis JP, Flacco ME, De Vito C, Villari P. Effective- ness and harms of seasonal and pandemic in ﬂuenza vaccines in chil- dren, adults and elderly.",Non-OADS,/arxiv_data1/oa_pdf/dd/8e/khvi-13-02-1264797.PMC5328222.pdf
Vaccin Immunother 2012 July 1; 8 (7):851-62; http://dx.doi.org/10.4161/hv.19917 [57] Centers for Disease Control and Prevention.,Non-OADS,/arxiv_data1/oa_pdf/dd/8e/khvi-13-02-1264797.PMC5328222.pdf
"Washington D.C.: Public Health Foundation, 2015. chapter 21 tetanus ( http://www.cdc.gov/vaccines/pubs/pink book/tetanus.html ) [58] Public Health England.",Non-OADS,/arxiv_data1/oa_pdf/dd/8e/khvi-13-02-1264797.PMC5328222.pdf
"Tetanus Chapter 30 https://www.gov.uk/government/publications/tetanus-the-green-bo ok-chapter-30 [59] Blatter M, Friedland LR, Weston WM, Li P, Howe B. Immunogenic- ity and safety a tetanus toxoid, reduced diphtheria toxoid and three- component acellular pertussis vaccine in adults 19 –64 years of age.",Non-OADS,/arxiv_data1/oa_pdf/dd/8e/khvi-13-02-1264797.PMC5328222.pdf
"Vaccine 2009; 27:765-772; PMID:19041352; http://dx.doi.org/10.1016/j.vaccine.2008.11.028 [60] Hara M, Okada K, Yamaguchi Y. Immunogenicity and Safety after Booster Vaccination of Diphtheria, Tetanus, and Acellular Pertussis in Young Adults: an Open Randomized Controlled Trial in Japan.Clin Vaccine Immunol 2013 Dec; 20(12):1799-1804;PMID:24108779; http://dx.doi.org/10.1128/CVI.00490-13 [61] Wei SC, Tatti K, Cushing K, Rosen J, Brown K, Cassiday P, Clark T, Olans R, Pawloski L, Martin M, et al.",Non-OADS,/arxiv_data1/oa_pdf/dd/8e/khvi-13-02-1264797.PMC5328222.pdf
Clinical Infection Desease 2010; 51 (3):315-21; http://dx.doi.org/10.1086/653938 [62] Centers for Disease Control and Prevention.,Non-OADS,/arxiv_data1/oa_pdf/dd/8e/khvi-13-02-1264797.PMC5328222.pdf
"Hum Vaccin 2009May; 5(5):315-21; PMID:19011374; http://dx.doi.org/10.4161/hv.5.5.6911 [64] Wendelboe AM, Van Rie A, Salmaso S, Englund JA.",OADS,/arxiv_data1/oa_pdf/dd/8e/khvi-13-02-1264797.PMC5328222.pdf
"Pediatr Infect Dis J 2005 May; 24(5 Suppl):S58-61; PMID:15876927;http://dx.doi.org/10.1097/01.inf.0000160914.59160.41[65] Sin MA, Zenke R, R €onckendorf R, Littmann M, Jorgensen P, Hellen- brand W. Pertussis outbreak in primary and secondary schools inludwigslust, Germany demonstrating the role of waning immunity.Pediatr Infect Dis J 2009 Mar; 28(3):242-4; PMID:19209094; http:// dx.doi.org/10.1097/INF.0b013e31818a5d69 [66] WHO.",Non-OADS,/arxiv_data1/oa_pdf/dd/8e/khvi-13-02-1264797.PMC5328222.pdf
"Epidemiol Infect 2008 Nov; 136(11):1576-84; PMID:18198000; http://dx.doi.org/10.1017/ S0950268807000192 [68] Pickering LK, Baker CJ, Freed GL, Gall SA, Grogg SE, Poland GA, Rodewald LE, Schaffner W, Stinch ﬁeld P, Tan L, et al.",OADS,/arxiv_data1/oa_pdf/dd/8e/khvi-13-02-1264797.PMC5328222.pdf
ClinInfect Dis 2009 Sep 15; 49(6):817-40; PMID:19659433; http://dx.doi.org/10.1086/605430 [69] Public Health Agency of Canada.,Non-OADS,/arxiv_data1/oa_pdf/dd/8e/khvi-13-02-1264797.PMC5328222.pdf
(https://www.cdc.gov/mmwr/pr eview/mmwrhtml/rr6204a1.htm ) [72] Centers for Disease Control and Prevention.,Non-OADS,/arxiv_data1/oa_pdf/dd/8e/khvi-13-02-1264797.PMC5328222.pdf
Euro Surveill 2016; 21(24):pii D30257; PMID:27336188; http://dx.doi.org/10.2807/ 1560-7917.ES.2016.21.24.30257 [76] Centers for Disease Control and Prevention.,Non-OADS,/arxiv_data1/oa_pdf/dd/8e/khvi-13-02-1264797.PMC5328222.pdf
"Pediatr Infect Dis J 2013; 32(7):e305-13; PMID:23838789; http://dx.doi.org/10.1097/INF.0b013e31828b7def [78] Australian Government, Department of Health.",Non-OADS,/arxiv_data1/oa_pdf/dd/8e/khvi-13-02-1264797.PMC5328222.pdf
Immunotherapy 2015 Dec; 7(12):1273-92; PMID:26289364; http://dx.doi.org/ 10.2217/IMT.15.74 [83] Ministero della Sanit /C18a.,Non-OADS,/arxiv_data1/oa_pdf/dd/8e/khvi-13-02-1264797.PMC5328222.pdf
Measles: Chapter 21 (https://www.gov.uk/government/publications/measles-the-green-bo ok-chapter-21 ) [85] Public Health England.,Non-OADS,/arxiv_data1/oa_pdf/dd/8e/khvi-13-02-1264797.PMC5328222.pdf
Mumps: Chapter 23 (https://www.gov.uk/government/publications/mumps-the-green-bo ok-chapter-23 ) [86] Public Health England.,Non-OADS,/arxiv_data1/oa_pdf/dd/8e/khvi-13-02-1264797.PMC5328222.pdf
Rubella: Chapter 28 (https://www.gov.uk/government/publications/rubella-the-green-bo ok-chapter-28 ) [87] Public Health England.,Non-OADS,/arxiv_data1/oa_pdf/dd/8e/khvi-13-02-1264797.PMC5328222.pdf
Varicella: Chapter 34 (https://www.gov.uk/government/publications/varicella-the-green-b ook-chapter-34 ) [88] Center for Disease Control and Prevention.,Non-OADS,/arxiv_data1/oa_pdf/dd/8e/khvi-13-02-1264797.PMC5328222.pdf
"N Engl J Med 1986; 314:1593-9; PMID:3086721; http://dx.doi.org/10.1056/NEJM198606193142501 [91] Hirst C, Owusu-Ofori S. Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease.",Non-OADS,/arxiv_data1/oa_pdf/dd/8e/khvi-13-02-1264797.PMC5328222.pdf
"J Infect Dis 2010 Jan 1; 201(1):32-41; PMID:19947881;http://dx.doi.org/10.1086/648593 [93] Salvadori MI, Price VE.",OADS,/arxiv_data1/oa_pdf/dd/8e/khvi-13-02-1264797.PMC5328222.pdf
Lancet 2011 Jul 2; 378(9785):86-97; PMID:21474172;http://dx.doi.org/10.1016/S0140-6736(10)61493-6 [95] Rubin LG.,Non-OADS,/arxiv_data1/oa_pdf/dd/8e/khvi-13-02-1264797.PMC5328222.pdf
"2, 376 –378 http://dx.doi.org/10.1080/21645515.2017.1264799",Non-OADS,/arxiv_data1/oa_pdf/f2/dd/khvi-13-02-1264799.PMC5328223.pdf
"ORCID Daniela Amicizia http://orcid.org/0000-0002-9707-5214 Alexander Domnich http://orcid.org/0000-0001-9608-8892 Lucia Arata http://orcid.org/0000-0002-8708-2955 Daniela Zoli http://orcid.org/0000-0002-8949-9068 Carla Maria Zotti http://orcid.org/0000-0003-3898-1206 Maria Rosaria Gualano http://orcid.org/0000-0001-7357-2892 Roberto Gasparini http://orcid.org/0000-0002-1012-6913 Donatella Panatto http://orcid.org/0000-0002-2677-0551 References [1] Kawai K, Gebremeskel BG, Acosta CJ.",Non-OADS,/arxiv_data1/oa_pdf/f2/dd/khvi-13-02-1264799.PMC5328223.pdf
"BMJ Open 2014; 4:e004833; PMID:24916088; http://dx.doi.org/10.1136/ bmjopen-2014-004833 [2] Johnson RW, Rice AS.",Non-OADS,/arxiv_data1/oa_pdf/f2/dd/khvi-13-02-1264799.PMC5328223.pdf
"Angle Orthod 2013; 83:966-72; PMID:23705940; http://dx.doi.org/10.2319/030113-174.1 [5] Helgason S, Petursson G, Gudmundsson S, Sigurdsson JA.",OADS,/arxiv_data1/oa_pdf/f2/dd/khvi-13-02-1264799.PMC5328223.pdf
"BMCInfect Dis 2010; 10:230; PMID:20682044; http://dx.doi.org/10.1186/ 1471-2334-10-230 [8] di Luzio Paparatti U, Arpinelli F, Vison /C18aG .H e r p e sz o s t e ra n di t s complications in Italy: an obser vational survey .",Non-OADS,/arxiv_data1/oa_pdf/f2/dd/khvi-13-02-1264799.PMC5328223.pdf
"J Infect 1999; 38:116-20; PMID:10342652; http://dx.doi.org/10.1016/S0163-4453 (99)90079-8 [9] Volpi A, Gatti A, Pica F, Bellino S, Marsella LT, Sabato AF.",OADS,/arxiv_data1/oa_pdf/f2/dd/khvi-13-02-1264799.PMC5328223.pdf
J Med Virol 2008; 80:1646-52; PMID:18649332; http://dx.doi.org/10.1002/jmv.21254378 D. AMICIZIA ET AL.,Non-OADS,/arxiv_data1/oa_pdf/f2/dd/khvi-13-02-1264799.PMC5328223.pdf
"Published with license by Taylor & Francis.This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered , transformed, or built upon in any way.HUMAN VACCINES & IMMUNOTHERAPEUTICS 2017, VOL.",Non-OADS,/arxiv_data1/oa_pdf/8e/3f/khvi-13-02-1264748.PMC5328232.pdf
"2, 477 –483 http://dx.doi.org/10.1080/21645515.2017.1264748",Non-OADS,/arxiv_data1/oa_pdf/8e/3f/khvi-13-02-1264748.PMC5328232.pdf
"ORCID Alessio Signori http://orcid.org/0000-0001-6289-9144 References [1] Golden DB, Mof ﬁtt J, Nicklas RA, Freeman T, Graft DF, Reisman RE, Tracy JM, Bernstein D, Blessing-Moore J, Cox L, et al.",OADS,/arxiv_data1/oa_pdf/8e/3f/khvi-13-02-1264748.PMC5328232.pdf
2011; 127(4):852-4.e1-23; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/8e/3f/khvi-13-02-1264748.PMC5328232.pdf
Clin Exp Allergy 2009; 39:1467- 76; http://dx.doi.org/10.1111/j.1365-2222.2009.03324.x [3] Annila I. Bee venom allergy.,OADS,/arxiv_data1/oa_pdf/8e/3f/khvi-13-02-1264748.PMC5328232.pdf
"J Dtsch Dermatol Ges 2010; 8:114-27; PMID:19751222; http://dx.doi.org/10.1111/ j.1610-0387.2009.07125_supp.x [5] Casale TB, Burks AW.",Non-OADS,/arxiv_data1/oa_pdf/8e/3f/khvi-13-02-1264748.PMC5328232.pdf
N Engl J Med 2014; 370:1432-9; PMID:24716682; http://dx.doi.org/10.1056/NEJMcp1302681 [6] Reisman RE.,OADS,/arxiv_data1/oa_pdf/8e/3f/khvi-13-02-1264748.PMC5328232.pdf
"Curr Opin Allergy Clin Immunol 2005; 5:355-8; PMID:15985819; http://dx.doi.org/10.1097/01.all.0000173782.35283.b6 [7] Severino M, Bonadonna P, Passalacqua G. Large local reactions from stinging insects: from epidemiology to management.",Non-OADS,/arxiv_data1/oa_pdf/8e/3f/khvi-13-02-1264748.PMC5328232.pdf
"2009; 9:334-7; PMID:19458526; http://dx.doi.org/10.1097/ACI.0b013e32832d0668 [8] Muraro A, Roberts G, Worm M, Bil /C18o MB, Brockow K, Fern /C19andez Rivas M, Santos AF, Zolkipli ZQ, Bellou A, Beyer K, et al.",OADS,/arxiv_data1/oa_pdf/8e/3f/khvi-13-02-1264748.PMC5328232.pdf
"Allergy 2011; 66(Suppl 95):35-7; http://dx.doi.org/10.1111/j.1398-9995.2011.02630.x [10] Fernandez J, Blanca M, Soriano V, Sanchez J, Juarez C. Epidemiolog- ical study of the prevalence of allergic reactions to Hymenoptera in a rural population in the Mediterranean area.",Non-OADS,/arxiv_data1/oa_pdf/8e/3f/khvi-13-02-1264748.PMC5328232.pdf
"Clin Exp Allergy 1999;29:1069-74; PMID:10457110; http://dx.doi.org/10.1046/j.1365- 2222.1999.00614.x [11] Incorvaia C, Mauro M, Pastorello EA.",Non-OADS,/arxiv_data1/oa_pdf/8e/3f/khvi-13-02-1264748.PMC5328232.pdf
"Allergol Int 2014; 63:21-6; PMID:24270224; http://dx.doi.org/10.2332/ allergolint.13-OA-0556 [13] Kochuyt AM, Van Hoeyveld E, Stevens EA.",OADS,/arxiv_data1/oa_pdf/8e/3f/khvi-13-02-1264748.PMC5328232.pdf
"Clin Exp Allergy 1993; 23:190-5; PMID:8472189;http://dx.doi.org/10.1111/j.1365-2222.1993.tb00881.x [14] Bonadonna P, Schiappoli M, Dama A, Olivieri M, Perbellini L, Senna G, Passalacqua G. Is hymenoptera venom allergy an occupationaldisease?",Non-OADS,/arxiv_data1/oa_pdf/8e/3f/khvi-13-02-1264748.PMC5328232.pdf
Occup Environ Med 2008; 65:217-218; PMID:18283131; http://dx.doi.org/10.1136/oem.2007.036400 [15] Mueller HL.,OADS,/arxiv_data1/oa_pdf/8e/3f/khvi-13-02-1264748.PMC5328232.pdf
"J Asthma Res 1966; 3:331-3; PMID:4380730; http://dx.doi.org/10.3109/02770906609106941 [16] Giannandrea F, Marini Bettolo P, D ’Onofrio A, Riccardi F, Bernardini P. Systemic reactions to hymenoptera stings: epidemio-logic study of 100 forestry department agents.",Non-OADS,/arxiv_data1/oa_pdf/8e/3f/khvi-13-02-1264748.PMC5328232.pdf
"Immunotherapy 2012; 4:1153-66; http://dx.doi.org/10.2217/imt.12.113 [23] Becerril- /C19Angeles M, N /C19u~nez-Vel /C19 azquez M, Mar /C19ın-Mart /C19ınez J; Grupo del Programa Nacional de Control de la Abeja AfricanizadaSAGARPA.",Non-OADS,/arxiv_data1/oa_pdf/8e/3f/khvi-13-02-1264748.PMC5328232.pdf
"BMJ Open 2014; 4(8):e005593; PMID:25099935; http://dx.doi.org/ 10.1136/bmjopen-2014-005593 [25] Boyle RJ, Elremeli M, Hockenhull J, Cherry MG, Bulsara MK, Dan- iels M, Oude Elberink JN.",Non-OADS,/arxiv_data1/oa_pdf/8e/3f/khvi-13-02-1264748.PMC5328232.pdf
Int Arch Allergy Immu- nol 2013; 160:86-92; PMID:22948338; http://dx.doi.org/10.1159/000338942HUMAN VACCINES & IMMUNOTHERAPEUTICS 481,Non-OADS,/arxiv_data1/oa_pdf/8e/3f/khvi-13-02-1264748.PMC5328232.pdf
"Curr Opin Allergy Clin Immunol 2003; 3:287-93;PMID:12865773; http://dx.doi.org/10.1097/00130832-200308000-00009 [28] Moscato G, Pala G, Sastre J. Speci ﬁc immunotherapy and biological treatments for occupational allergy.",OADS,/arxiv_data1/oa_pdf/8e/3f/khvi-13-02-1264748.PMC5328232.pdf
"Curr Opin Allergy Clin Immu-nol 2014; 14:576-81; PMID:25115685; http://dx.doi.org/10.1097/ ACI.0000000000000105 [29] Bil /C19o BM, Rueff F, Mosbech H, Bonifazi F, Oude-Elberink JN; EAACI interest group on insect venom hypersensitivity.",Non-OADS,/arxiv_data1/oa_pdf/8e/3f/khvi-13-02-1264748.PMC5328232.pdf
"Allergy 2005; 60:1339-49; http://dx.doi.org/ 10.1111/j.1398-9995.2005.00963.x [30] Bonifazi F, Jutel M, Bil /C18o BM, Birnbaum J, Muller U; EAACI Interest Group on Insect Venom Hypersensitivity.",OADS,/arxiv_data1/oa_pdf/8e/3f/khvi-13-02-1264748.PMC5328232.pdf
"Allergy 2005; 60:1459-70; PMID:16266376; http://dx.doi.org/ 10.1111/j.1398-9995.2005.00960.x [31] Krishna MT, Ewan PW, Diwakar L, Durham SR, Frew AJ, Leech SC, Nasser SM; British society for allergy and clinical immunology.",Non-OADS,/arxiv_data1/oa_pdf/8e/3f/khvi-13-02-1264748.PMC5328232.pdf
"Clin Exp Allergy2011; 41:1201-20; PMID:21848758; http://dx.doi.org/10.1111/j.1365- 2222.2011.03788.x [32] Moscato G, Pala G, Crivellaro M, Siracusa A. Anaphylaxis as occupa- tional risk.",Non-OADS,/arxiv_data1/oa_pdf/8e/3f/khvi-13-02-1264748.PMC5328232.pdf
"Curr Opin Allergy Clin Immunol 2014; 14:328-33; PMID:24873935; http://dx.doi.org/10.1097/ACI.0000000000000066 [33] Sampson HA, Mu ~noz-Furlong A, Campbell RL, Adkinson NF Jr, Bock SA, Branum A, Brown SG, Camargo CA Jr, Cydulka R, Galli SJ, et al.",Non-OADS,/arxiv_data1/oa_pdf/8e/3f/khvi-13-02-1264748.PMC5328232.pdf
Declaration of Helsinki: ethical princi- ples for medical research involving human subjects 2013. available athttp://www.wma.net/en/30publications/10policies/b3/ .,Non-OADS,/arxiv_data1/oa_pdf/8e/3f/khvi-13-02-1264748.PMC5328232.pdf
available at http://www.agen ziafarmaco.gov.it/sites/default/ ﬁles/111.88758.1186138046156a0be.pdf .,Non-OADS,/arxiv_data1/oa_pdf/8e/3f/khvi-13-02-1264748.PMC5328232.pdf
"Published with license by Taylor & Francis.This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered , transformed, or built upon in any way.HUMAN VACCINES & IMMUNOTHERAPEUTICS 2017, VOL.",Non-OADS,/arxiv_data1/oa_pdf/f0/e4/khvi-13-02-1264779.PMC5328239.pdf
"2, 456 –463 http://dx.doi.org/10.1080/21645515.2017.1264779",Non-OADS,/arxiv_data1/oa_pdf/f0/e4/khvi-13-02-1264779.PMC5328239.pdf
"ORCID Cecilia Trucchi http://orcid.org/0000-0003-4633-202X Cristiano Alicino http://orcid.org/0000-0002-6473-9870 Andrea Orsi http://orcid.org/0000-0002-2433-9610 Chiara Paganino http://orcid.org/0000-0002-7782-8039 Ilaria Barberis http://orcid.org/0000-0003-1179-7206 Emanuela Rappazzo http://orcid.org/0000-0002-7129-366X Bianca Bruzzone http://orcid.org/0000-0002-3456-1899 Laura Sticchi http://orcid.org/0000-0002-0413-9443 Filippo Ansaldi http://orcid.org/0000-0002-0413-9443 References [1] Cromer D, van Hoek AJ, Jit M, Edmunds WJ, Fleming D, Miller E. The burden of in ﬂuenza in England by age and clinical risk group: a statistical analysis to inform vaccine policy.",Non-OADS,/arxiv_data1/oa_pdf/f0/e4/khvi-13-02-1264779.PMC5328239.pdf
"J Infect 2014; 68(4):363- 71; PMID:24291062; http://dx.doi.org/10.1016/j.jinf.2013.11.013 [2] Nair H, Brooks WA, Katz M, Roca A, Berkley JA, Madhi SA, Sim- merman JM, Gordon A, Sato M, Howie S, et al.",OADS,/arxiv_data1/oa_pdf/f0/e4/khvi-13-02-1264779.PMC5328239.pdf
Lancet 2011; 378:1917-30;PMID:22078723; http://dx.doi.org/10.1016/S0140-6736(11)61051-9 [3] World Health Organization.,Non-OADS,/arxiv_data1/oa_pdf/f0/e4/khvi-13-02-1264779.PMC5328239.pdf
"Phar macoeconomics 2008; 26:911-24; PMID:18850761; http://dx.doi.org/10.2165/00019053-200826110-00004 [5] Tafalla M, Buijssen M, Geets R, Vonk Noordegraaf-Schouten M. A comprehensive review of the epidemiology and disease burden ofInﬂuenza B in 9 European countries.",OADS,/arxiv_data1/oa_pdf/f0/e4/khvi-13-02-1264779.PMC5328239.pdf
Hum Vaccin Immunother 2016; 12(4):993-1002; PMID:26890005; http://dx.doi.org/10.1080/ 21645515.2015.1111494HUMAN VACCINES & IMMUNOTHERAPEUTICS 461,Non-OADS,/arxiv_data1/oa_pdf/f0/e4/khvi-13-02-1264779.PMC5328239.pdf
"PLoS ONE 2007; 2:e1296; PMID:18074020; http://dx.doi.org/ 10.1371/journal.pone.0001296 [7] Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Ander- son LJ, Fukuda K. Mortality associated with in ﬂuenza and respira- tory syncytial virus in the United States.",Non-OADS,/arxiv_data1/oa_pdf/f0/e4/khvi-13-02-1264779.PMC5328239.pdf
"JAMA 2003; 289:179-186; PMID:12517228; http://dx.doi.org/10.1001/jama.289.2.179 [8] Thompson WW, Shay DK, Weintraub E, Brammer L, Bridges CB, Cox NJ, Fukuda K. In ﬂuenza-associated hospitalizations in the United States.",Non-OADS,/arxiv_data1/oa_pdf/f0/e4/khvi-13-02-1264779.PMC5328239.pdf
JAMA 2004; 292:1333-1340; http://dx.doi.org/ 10.1001/jama.292.11.1333 [9] Kilbourne ED.,Non-OADS,/arxiv_data1/oa_pdf/f0/e4/khvi-13-02-1264779.PMC5328239.pdf
"Emerg Infect Dis 2006; 12:9-14; PMID:16494710; http://dx.doi.org/10.3201/ eid1201.051254 [10] Paul Glezen W, Schmier JK, Kuehn CM, Ryan KJ, Oxford J.",OADS,/arxiv_data1/oa_pdf/f0/e4/khvi-13-02-1264779.PMC5328239.pdf
"Am J Public Health 2013; 103:e43-e51; PMID:23327249; http://dx.doi.org/10.2105/ AJPH.2012.301137 [11] Camilloni B, Neri M, Lepri E, Basileo M, Sigismondi N, Puzelli S, Donatelli I, Iorio AM.",Non-OADS,/arxiv_data1/oa_pdf/f0/e4/khvi-13-02-1264779.PMC5328239.pdf
"Vaccine 2010; 28(47):7536-41; PMID:20846530;http://dx.doi.org/10.1016/j.vaccine.2010.08.064 [12] Grant KA, Carville K, Fielding JE, Barr IG, Riddell MA, Tran T, Kelly HA.",Non-OADS,/arxiv_data1/oa_pdf/f0/e4/khvi-13-02-1264779.PMC5328239.pdf
"Int J Mol Sci 2016; 17 (4):549; PMID:27089319; http://dx.doi.org/10.3390/ijms17040549 [16] Matsuzaki Y, Sugawara K, Takashita E, Muraki Y, Hongo S, Katsush- ima N, Mizuta K, Nishimura H. Genetic diversity of in ﬂuenza B virus: The frequent reassortment and cocirculation of the genetically distinct reassortant viruses in a community.",OADS,/arxiv_data1/oa_pdf/f0/e4/khvi-13-02-1264779.PMC5328239.pdf
"J Med Virol 2004; 74:132-140; PMID:15258979; http://dx.doi.org/10.1002/jmv.20156 [17] Bedford T, Riley S, Barr IG, Broor S, Chadha M, Cox NJ, Daniels RS, Gunasekaran CP, Hurt AC, Kelso A, et al.",OADS,/arxiv_data1/oa_pdf/f0/e4/khvi-13-02-1264779.PMC5328239.pdf
"Nature 2015; 523 (7559):217-20; PMID:26053121; http://dx.doi.org/10.1038/nature14460 [18] Irving SA, Patel DC, Kieke BA, Donahue JG, Vandermause MF, Shay DK, Belongia EA.",OADS,/arxiv_data1/oa_pdf/f0/e4/khvi-13-02-1264779.PMC5328239.pdf
In ﬂuenza Other Respir Viruses 2012; 6:37-43; PMID:21668663; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f0/e4/khvi-13-02-1264779.PMC5328239.pdf
"J Clin Microbiol2010; 48:1425-1427; PMID:20107085; http://dx.doi.org/10.1128/ JCM.02116-09 [20] Moa AM, Muscatello DJ, Turner RM, MacIntyre CR.",OADS,/arxiv_data1/oa_pdf/f0/e4/khvi-13-02-1264779.PMC5328239.pdf
In ﬂuenza Other Respir Viruses 2016 (in press); PMID:27650482; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f0/e4/khvi-13-02-1264779.PMC5328239.pdf
Vaccine 2010; 28:2149-56; PMID:20003926; http://dx.doi.org/10.1016/j.vaccine.2009.11.068 [22] Belshe RB.,Non-OADS,/arxiv_data1/oa_pdf/f0/e4/khvi-13-02-1264779.PMC5328239.pdf
"J Med Virol 2004; 74:29-40; PMID:15258965; http://dx.doi.org/10.1002/jmv.20225 [24] Skowronski DM, Janjua NZ, Sabaiduc S, de Serres G, Winter AL, Gubbay JB, Dickinson JA, Fonseca K, Charest H, Bastien N, et al.Inﬂuenza A/subtype and B/lineage effectiveness estimates for the 2011 –2012 trivalent vaccine: Cross-season and cross-lineage protec- tion with unchanged vaccine.",Non-OADS,/arxiv_data1/oa_pdf/f0/e4/khvi-13-02-1264779.PMC5328239.pdf
"J Infect Dis 2014; 210:126-137;PMID:24446529; http://dx.doi.org/10.1093/infdis/jiu048 [25] Lo YC, Chuang JH, Kuo HW, Huang WT, Hsu YF, Liu MT, Chen CH, Huang HH, Chang CH, Chou JH, et al.",OADS,/arxiv_data1/oa_pdf/f0/e4/khvi-13-02-1264779.PMC5328239.pdf
"J Med Virol 2003; 70(3):463-9; PMID:12767012; http://dx.doi.org/10.1002/jmv.10418 [30] Kanegae Y, Sugita S, Endo A, Ishida M, Senya S, Osako K, Nerome K, Oya A.",OADS,/arxiv_data1/oa_pdf/f0/e4/khvi-13-02-1264779.PMC5328239.pdf
"J Gen Virol 1992; 73(Pt 10):2737-42; PMID:2309452; http://dx.doi.org/ 10.1016/0042-6822(90)90186-U [32] Lindstrom SE, Hiromoto Y, Nishimura H, Saito T, Nerome R, Ner- ome K. Comparative analysis of evolutionary mechanisms of the hemagglutinin and three internal protein genes of in ﬂuenza B virus: multiple cocirculating lineages and frequent reassortment of the NP,M, and NS genes.",OADS,/arxiv_data1/oa_pdf/f0/e4/khvi-13-02-1264779.PMC5328239.pdf
Virology 2002; 303(1):1-8; PMID:12482653; http://dx.doi.org/10.1006/viro.2002.1719 [34] World Health Organization FluNet website.,Non-OADS,/arxiv_data1/oa_pdf/f0/e4/khvi-13-02-1264779.PMC5328239.pdf
Available at: http://www.salute.gov.it/imgs/C_17_pubbli cazioni_2418_allegato.pdf .,Non-OADS,/arxiv_data1/oa_pdf/f0/e4/khvi-13-02-1264779.PMC5328239.pdf
"Hum Vaccin Immunother 2013; 9(3):561-7; PMID:23292210;http://dx.doi.org/10.4161/hv.23235 [38] Ansaldi F, Orsi A, Altomonte F, Bertone G, Parodi V, Carloni R, Moscatelli P, Pasero E, Oreste P, Icardi G. Emergency departmentsyndromic surveillance system for early detection of 5 syndromes: a462 C. TRUCCHI ET AL.",Non-OADS,/arxiv_data1/oa_pdf/f0/e4/khvi-13-02-1264779.PMC5328239.pdf
"Hum VaccinImmunother 2015; 11(1):166-7; PMID:25483530; http://dx.doi.org/ 10.4161/hv.34419 [40] Ansaldi F, Bacilieri S, Amicizia D, Valle L, Ban ﬁF, Durando P, Sticchi L, Gasparini R, Icardi G, Crovari P. Antigenic characteri-sation of in ﬂuenza B virus with a new microneutralisation assay:comparison to haemagglutination and sequence analysis.",Non-OADS,/arxiv_data1/oa_pdf/f0/e4/khvi-13-02-1264779.PMC5328239.pdf
"J Med Virol 2004; 74(1):141-6; PMID:15258980; http://dx.doi.org/10.1002/jmv.20157 [41] Wiley DC, Skehel JJ.",Non-OADS,/arxiv_data1/oa_pdf/f0/e4/khvi-13-02-1264779.PMC5328239.pdf
"Annu Rev Biochem 1987; 56:365-94; PMID:3304138; http://dx.doi.org/10.1146/annurev.bi.56.070187.002053 [42] Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. MEGA6: molecular evolutionary genetics analysis version 6.0.",OADS,/arxiv_data1/oa_pdf/f0/e4/khvi-13-02-1264779.PMC5328239.pdf
Mol Biol Evol2013; 30(12):2725-9; PMID:24132122; http://dx.doi.org/10.1093/molbev/mst197HUMAN VACCINES & IMMUNOTHERAPEUTICS 463,Non-OADS,/arxiv_data1/oa_pdf/f0/e4/khvi-13-02-1264779.PMC5328239.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Self-careLymphedema symptoms Health IT UsabilityFeasibilityBreast neoplasmsBreast cancer survivorLymphedemaSymptoms 1.,Non-OADS,/arxiv_data1/oa_pdf/9c/32/main.PMC5328240.pdf
http://dx.doi.org/10.1016/j.invent.2016.08.001 2214-7829/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9c/32/main.PMC5328240.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9c/32/main.PMC5328240.pdf
"The homepage of TOLF with an introduction of the system, avatar simulation video of lymphaticsystem and patients' testimonies can be accessed through this link (http://optimallymph.org ).2.3.",Non-OADS,/arxiv_data1/oa_pdf/9c/32/main.PMC5328240.pdf
http://dx.doi.org/10.1089/lrb.2005.2.208 PMID: 20218084.,OADS,/arxiv_data1/oa_pdf/9c/32/main.PMC5328240.pdf
http://dx.doi.org/10.1111/jnu.12117 Epub 2014 Dec 4.,Non-OADS,/arxiv_data1/oa_pdf/9c/32/main.PMC5328240.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/9c/32/main.PMC5328240.pdf
"http://dx.doi.org/10.2147/BCTT.S87854 #1825502, PMID: 26527899.",Non-OADS,/arxiv_data1/oa_pdf/9c/32/main.PMC5328240.pdf
http://dx.doi.org/10.1245/ s10434-014-3761-z Online First.,Non-OADS,/arxiv_data1/oa_pdf/9c/32/main.PMC5328240.pdf
http://dx.doi.org/10.3390/jpm5030326 PMID: 26404383.,OADS,/arxiv_data1/oa_pdf/9c/32/main.PMC5328240.pdf
http://dx.doi.org/10.2196/resprot.,Non-OADS,/arxiv_data1/oa_pdf/9c/32/main.PMC5328240.pdf
"5104 2016, URL: http://www.researchprotocols.org/2017/1/e7/ .",OADS,/arxiv_data1/oa_pdf/9c/32/main.PMC5328240.pdf
http://dx.doi.org/10.1245/s10434- 010-0941-3 .,Non-OADS,/arxiv_data1/oa_pdf/9c/32/main.PMC5328240.pdf
"18 (Supplement),68–79.http://dx.doi.org/10.1188/14.CJON.S3.68-79 PMID: 25427610.",OADS,/arxiv_data1/oa_pdf/9c/32/main.PMC5328240.pdf
http://dx.doi.org/10.1002/pon.3201 Epub 2012 Oct 9.,Non-OADS,/arxiv_data1/oa_pdf/9c/32/main.PMC5328240.pdf
"61 (2), 69 –90.http://dx.doi.org/10.3322/caac.20107 .",Non-OADS,/arxiv_data1/oa_pdf/9c/32/main.PMC5328240.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/9c/32/main.PMC5328240.pdf
http://dx.doi.org/10.1007/s00520-010-0870-5 .,Non-OADS,/arxiv_data1/oa_pdf/9c/32/main.PMC5328240.pdf
http://dx.doi.org/10.1097/NNR.0b013e31824f82b2 .,Non-OADS,/arxiv_data1/oa_pdf/9c/32/main.PMC5328240.pdf
"7 (1), 29 –45.http://dx.doi.org/10.1089/lrb.2008.",Non-OADS,/arxiv_data1/oa_pdf/9c/32/main.PMC5328240.pdf
http://dx.doi.org/10.1245/ s10434-009-0452-2 PMID:19365624.64 M.R.,OADS,/arxiv_data1/oa_pdf/9c/32/main.PMC5328240.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ac/8b/ott-10-1155.PMC5328291.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 1155–1164OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1155Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S12795 5 Update on the role of trabectedin in the  treatment of intractable soft tissue sarcomas Federica Recine Alberto Bongiovanni Nada Riva valentina Fausti Alessandro De vita Laura Mercatali Chiara Liverani Giacomo Miserocchi Dino Amadori T oni ibrahim Osteoncology and Rare T umors  Center, istituto Scientifico Romagnolo  per lo Studio e la Cura dei Tumori  (iRST) iRCCS, Meldola, italyAbstract:  Soft tissue sarcomas (STS) represent a variety of tumors of mesenchymal origin,  accounting for about 1% of all adult cancers.",Non-OADS,/arxiv_data1/oa_pdf/ac/8b/ott-10-1155.PMC5328291.pdf
"Among these, the most common variants are  liposarcoma (LPS) and leiomyosarcoma (LMS), both of which show specific clinical  and biologic features.2,3 Although STS can develop in any mesenchymal site of the body, the extremities  and retroperitoneum represent the most frequent localizations, occurring in 60% and  20% of cases, respectively.4 Optimal management of STS is challenging and requires  a multimodality therapeutic approach involving a multidisciplinary team from STS  reference centers.5 Wide surgery is the cornerstone of treatment for localized disease, whereas the role  of adjuvant and neoadjuvant therapies remains controversial and is only proposed in  selected cases.6 However, a considerable number of patients (30%–50%) will develop  metastatic disease, with an overall survival (OS) of about 12–15 months.7 In the metastatic setting, palliative systemic anthracycline-based chemotherapy  with or without ifosfamide represents the standard first-line treatment.8 Second- or  further-line chemotherapy including gemcitabine, dacarbazine or ifosfamide can also  be used on the basis of the sarcoma histotype, but the optimal sequencing strategy of  therapy has yet to be identified.9,10 Within the group of targeted therapies, pazopanib is  an option for the management of previously treated nonadipocytic sarcomas.11 More - over, another drug, eribulin, was recently approved for use in pretreated patients with Correspondence: Alberto Bongiovanni Osteoncology and Rare Tumors Center,  Istituto Scientifico Romagnolo per lo  Studio e la Cura dei Tumori (iRST)  iRCCS, via Piero Maroncelli 40, 47014  Meldola (FC), italy Tel +39 05 4373 9100 Fax +39 05 4373 9123 email alberto.bongiovanni@irst.emr.i t Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2017 Volume: 10 Running head verso: Recine et al Running head recto: Role of trabectedin in the treatment of intractable soft tissue sarcomas DOI: http://dx.doi.org/10.2147/OTT.S127955",Non-OADS,/arxiv_data1/oa_pdf/ac/8b/ott-10-1155.PMC5328291.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/ac/8b/ott-10-1155.PMC5328291.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ac/8b/ott-10-1155.PMC5328291.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ba/0a/ott-10-1143.PMC5328292.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 1143–1147OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1143Case repO rTopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S12927 5 Long-term survival after a favorable response  to anti-eGFr antibody plus chemotherapy to  treat bone marrow metastasis: a case report of  KRAS-wildtype rectal cancer sho Nakamura Tadahisa Fukui shuhei suzuki Hiroyuki Takeda Kaname Watanabe Takashi Y oshioka Department of Clinical Oncology,   Yamagata University Faculty of  Medicine, Yamagata, JapanAbstract:  Bone marrow metastasis is a rare consequence of colorectal cancer that results in a  poor prognosis; few reports describe a favorable response to doublet chemotherapy combined  with targeted therapy, which is currently the standard treatment.",Non-OADS,/arxiv_data1/oa_pdf/ba/0a/ott-10-1143.PMC5328292.pdf
"Myelofibrosis was sus - pected because of the significant signal change in the spinal body on magnetic resonance Correspondence: Takashi Yoshioka Department of Clinical Oncology,  Yamagata University Faculty of Medicine,  2-2-2 Iida-nishi, Yamagata 990-9585, Japan Tel +81 23 628 5224 Fax +81 23 628 5225 email ytakashi@med.id.yamagata-u.ac.j p Journal name: OncoTargets and Therapy Article Designation: Case report Y ear: 2017 Volume: 10 Running head verso: Nakamura et al Running head recto: Anti-EGFR antibody and bone marrow metastasis DOI: http://dx.doi.org/10.2147/OTT.S129275",Non-OADS,/arxiv_data1/oa_pdf/ba/0a/ott-10-1143.PMC5328292.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/ba/0a/ott-10-1143.PMC5328292.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ba/0a/ott-10-1143.PMC5328292.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/7b/57/ott-10-1071.PMC5328293.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 1071–1079OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1071Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S12533 0 siX1 overexpression predicts poor prognosis and  induces radioresistance through aKT signaling in  esophageal squamous cell carcinoma Zheng he1,2 guang li2 lingrong Tang2 Yaming li1 1Department of n uclear Medicine,   2Department of radiation Oncology,   The First hospital of china Medical  University, china Medical University,   shenyang, chinaAbstract:  The Sineoculis homeobox homolog 1 (SIX1) protein has been found to be  overexpressed in several human cancers.",Non-OADS,/arxiv_data1/oa_pdf/7b/57/ott-10-1071.PMC5328293.pdf
"SIX1  level remains high in the embryo and maintains progenitor cell survival.9–11 Decreased  SIX1 induced apoptosis and loss of organ size.12 SIX1 remains at a low level in adult  tissues, and its overexpression contributes to oncogenesis.13 SIX1 was found to be  overexpressed in cervical, breast, pancreatic, and ovarian carcinomas.14–18 It was reported correspondence: Yaming li Department of nuclear Medicine,  The First hospital of china Medical  University, nanjing north st 155, heping  District, shenyang, liaoning 110001,  china email ymli2001@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: He et al Running head recto: Clinical significance of SIX1 in 119 ESCC tissues DOI: http://dx.doi.org/10.2147/OTT.S125330",Non-OADS,/arxiv_data1/oa_pdf/7b/57/ott-10-1071.PMC5328293.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/7b/57/ott-10-1071.PMC5328293.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/7b/57/ott-10-1071.PMC5328293.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/8f/57/opth-11-429.PMC5328294.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2017:11 429–434Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  429Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S12327 3 Measurement of peripapillary retinal nerve  fiber layer thickness and macular thickness in  anisometropia using spectral domain optical  coherence tomography: a prospective study neha singh Jolly rohatgi Ved Prakash Gupta Vinod Kumar Department of Ophthalmology,   University College of Medical  sciences, Delhi, indiaPurpose:  To study whether there is a difference in central macular thickness (CMT) and  peripapillary retinal nerve fiber layer (RNFL) thickness between the two eyes of individuals having  anisometropia .1 diopter (D) using spectral domain optical coherence tomography (OCT).",Non-OADS,/arxiv_data1/oa_pdf/8f/57/opth-11-429.PMC5328294.pdf
"Anisometropia is therefore of great use in refractive  error research.Correspondence: neha singh 1/252, rasmi Khand, sharda nagar  Yojana, Lucknow, Uttar Pradesh, India Tel +91 99 5855 2139 email nhsngh.89@gmail.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Singh et al Running head recto: Peripapillary RNFL and CMT in anisometropia DOI: http://dx.doi.org/10.2147/OPTH.S123273",Non-OADS,/arxiv_data1/oa_pdf/8f/57/opth-11-429.PMC5328294.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/8f/57/opth-11-429.PMC5328294.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/8f/57/opth-11-429.PMC5328294.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a9/73/opth-11-387.PMC5328295.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2017:11 387–392Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  387Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S12794 3 The role of serum apelin in retinopathy of  prematurity Yasser F ali1 salah el-Morshedy1 abdulbasit abdulhalim  imam2 nasser ismai  a abdelrahman1 riad M elsayed3 Usama M alkholy1 nermin abdalmonem1 Mohammed M shehab1 1Department of Pediatrics, Faculty of  Medicine, Zagazig University, Zagazig,   2Department of Pediatrics, al-azhar  Faculty of Medicine-girls, Cairo,   3Pediatric neurology Unit, Pediatric  Department, Mansoura University,   Mansoura, egyptObjective:  To evaluate the role of serum apelin as a diagnostic tool in retinopathy of prema - turity (ROP) disease.",Non-OADS,/arxiv_data1/oa_pdf/a9/73/opth-11-387.PMC5328295.pdf
"Hypoxia and hyperoxia,  by the high levels of supplemental oxygen the infant may receive in the neonatal  intensive care unit (NICU), inhibit production of growth factors, such as VEGF, which  causes cessation of normal retinal growth, and vessels constriction with a potential for  vaso-obliteration of new immature vessels, resulting in tissue hypoxia that releases Correspondence: riad M elsayed Pediatric neurology Unit, Pediatric  Department, Faculty of Medicine,  Mansoura University, PO 35516,  el gomhoria street, Mansoura City,  35516 Mansoura, egypt Tel +20 50 224 3117 Fax +20 50 226 2024 email shewaka1971@yahoo.co mJournal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Ali et al Running head recto: Serum apelin in ROP DOI: http://dx.doi.org/10.2147/OPTH.S127943",Non-OADS,/arxiv_data1/oa_pdf/a9/73/opth-11-387.PMC5328295.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/a9/73/opth-11-387.PMC5328295.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a9/73/opth-11-387.PMC5328295.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/6a/db/opth-11-409.PMC5328296.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2017:11 409–410Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  409Letteropen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/OPTH.S13210 1 regarding optical coherence tomography grading  of ischemia in central retinal venous occlusion Koushik tripathy Department of Vitreoretina  and Uvea, ICAre eye Hospital &   Postgraduate Institute, Noida,   Uttar Pradesh, IndiaDear editor The author read with interest the article by Browning et al.1 The author humbly wants  to discuss a few facts.",Non-OADS,/arxiv_data1/oa_pdf/6a/db/opth-11-409.PMC5328296.pdf
"1995;102(10):1434–1444.Correspondence: Koushik tripathy ICAre eye Hospital & Postgraduate  Institute, e3A, Sector-26, Noida,  Uttar Pradesh, India, 201301 tel +91 120 255 5969 email drkoushiktripathy@icarehospital.or g Journal name: Clinical Ophthalmology Article Designation: Letter Y ear: 2017 Volume: 11 Running head verso: Tripathy Running head recto: OCT for grading ischemia in CRVO DOI: http://dx.doi.org/10.2147/OPTH.S132101",Non-OADS,/arxiv_data1/oa_pdf/6a/db/opth-11-409.PMC5328296.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/6a/db/opth-11-409.PMC5328296.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/6a/db/opth-11-409.PMC5328296.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/98/44/opth-11-417.PMC5328297.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2017:11 417–427Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  417Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S11341 4 Profound vision loss impairs psychological  well-being in young and middle-aged individuals giancarlo a garcia1,2 Matin Khoshnevis1,3 Jesse gale1,4 starleen e Frousiakis1,5 Tiffany J hwang1,6 lissa Poincenot1 rustum Karanjia1,7–9 David Baron6 alfredo a sadun1,7 1Doheny eye institute, los angeles,   Ca, Usa; 2University of California,   irvine school of Medicine, irvine, C a,   Usa; 3Department of Ophthalmology,   T emple University, Philadelphia, P a,   Usa; 4Wellington school of Medicine  and health sciences, University of  Otago, Wellington, nZ; 5Department  of Ophthalmology, new York  Medical College, Valhalla, nY, Usa;   6Department of Psychiatry & The  Behavioral sciences, Keck school  of Medicine, University of southern  California, los angeles, C a, Usa;   7Doheny eye Centers, Department of  Ophthalmology, David geffen school  of Medicine at UC la, los angeles  California, C a, Usa; 8Department  of Ophthalmology, University of  Ottawa, Ottawa, On , Canada; 9Ottawa  hospital health research institute,   Ottawa, On , CanadaPurpose:  The aim of this study was to evaluate the effects of profound vision loss on  psychological well-being in adolescents, young adults, and middle-aged adults with regard  to mood, interpersonal interactions, and career-related goals.",Non-OADS,/arxiv_data1/oa_pdf/98/44/opth-11-417.PMC5328297.pdf
"In adults aged Correspondence: giancarlo a garcia Doheny eye institute, 800 south  Fairmount avenue, suite 215,  Pasadena, Ca 91105, Usa Tel +1 626 817 4701 Fax +1 626 817 4702 email giancarg@uci.ed u Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Garcia et al Running head recto: Psychological impact of vision loss in younger individuals DOI: http://dx.doi.org/10.2147/OPTH.S113414",Non-OADS,/arxiv_data1/oa_pdf/98/44/opth-11-417.PMC5328297.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/98/44/opth-11-417.PMC5328297.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/98/44/opth-11-417.PMC5328297.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/05/b7/ott-10-1173.PMC5328298.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 1173–1179OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1173Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S12130 1 Aberrant histone modification in CD19+ B cells  of patients with chronic lymphocytic leukemia Keshu Zhou Qing Zhang Yanyan liu Yuanyuan Xiong shengsheng Wu Jingke Yang hu Zhou Xinjian liu Xudong Wei Y ongping song Department of Hematology,   affiliated cancer hospital of  Zhengzhou University, Henan Cancer  Hospital, Zhengzhou, People’s  republic of chinaAbstract:  The aim of this study was to detect the alterations in histone methylation and  acetylation in patients with chronic lymphocytic leukemia (CLL).",Non-OADS,/arxiv_data1/oa_pdf/05/b7/ott-10-1173.PMC5328298.pdf
"The N-terminal tails of these proteins are subjected  to several posttranslational modifications such as acetylation, deacetylation, and  methylation.3 The combination of these covalent modifications gives rise to the  so-called “histone code”.4 Transcription becomes active when histones are acetylated  by histone acetyltransferases (HATs), silenced when histones are deacetylated by correspondence: Yongping song Department of Hematology, Affiliated  Cancer Hospital of Zhengzhou University,  Henan Cancer Hospital, No 127  Dongmin Road, Zhengzhou 450008,  Henan, People’s Republic of China Tel +86 371 6558 7357 email songyongping@medmail.com.c n Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Zhou et al Running head recto: Aberrant histone modification in CLL DOI: http://dx.doi.org/10.2147/OTT.S121301",Non-OADS,/arxiv_data1/oa_pdf/05/b7/ott-10-1173.PMC5328298.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/05/b7/ott-10-1173.PMC5328298.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/05/b7/ott-10-1173.PMC5328298.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/85/6c/ott-10-1149.PMC5328300.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 1149–1154OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1149Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S13101 4 association between TP53 gene arg72Pro  polymorphism and Wilms’ tumor risk in a  chinese population Wen Fu,1,2,* Zhen-Jian  Zhuo,3,* Wei Jia,1,2 Jinhong  Zhu,4 shi-Bo Zhu,1,2  Ze-Feng lin,1,2 Feng-hua  Wang,1,2 huimin Xia,1,2 Jing he,1,2 guo-chang liu1,2 1Department of Pediatric Urology,   guangzhou Women and children’s  Medical center, guangzhou Medical  University, guangzhou, guangdong,   2Department of Pediatric surgery,   guangzhou institute of Pediatrics,   guangzhou Women and children’s  Medical center, guangzhou Medical  University, guangzhou, guangdong,   3Faculty of Medicine, school of  chinese Medicine, The chinese  University of hong Kong, hong Kong,   4Molecular epidemiology laboratory,   Department of laboratory Medicine,   harbin Medical University cancer  hospital, harbin, heilongjiang,   People’s republic of china *These authors contributed equally  to this workAbstract:  Wilms’ tumor is one of the most prevalent pediatric malignancies, ranking fourth  in childhood cancer worldwide.",Non-OADS,/arxiv_data1/oa_pdf/85/6c/ott-10-1149.PMC5328300.pdf
"TP53  gene is one of the most commonly mutated genes in human cancers.8  The TP53  gene is a tumor suppressor gene, playing an important role in the mainte - nance of DNA integrity, cell cycle control, and apoptosis.9–11 According to dbSNP  database ( http://www.ncbi.nlm.nih.gov/projects/SN P), at least 1,462 single-nucleotide correspondence: guo-chang liu Department of Pediatric Urology,  guangzhou institute of Pediatrics,  guangzhou Women and children’s  Medical center, guangzhou Medical  University, 9 Jinsui road, guangzhou  510623, guangdong, People’s republic  of china email starbless2003@126.co m  Jing he Department of Pediatric surgery,  guangzhou institute of Pediatrics,  guangzhou Women and children’s  Medical center, guangzhou Medical  University, 9 Jinsui road, guangzhou  510623, guangdong, People’s republic  of china email hejing198374@gmail.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Fu et al Running head recto: TP53 gene Arg72Pro polymorphism and Wilms’ tumor risk DOI: http://dx.doi.org/10.2147/OTT.S131014",Non-OADS,/arxiv_data1/oa_pdf/85/6c/ott-10-1149.PMC5328300.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/85/6c/ott-10-1149.PMC5328300.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/85/6c/ott-10-1149.PMC5328300.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/74/10/ott-10-1111.PMC5328301.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 1111–1114OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1111LeTTeropen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S13139 6 Internal mammary lymph node management –  further direction D Vrana1,2 J Gatek3,4 1Department of Oncology, 2Institute  of Molecular and Translational  Medicine, Faculty of Medicine  and Dentistry, Palacky University,   Olomouc, 3Department of Surgery,   Atlas Hospital, 4Faculty of Humanities,   T omas Bata University in Zlín, Zlín,   Czech republicDear editor We read the article titled “Internal mammary sentinel lymph node biopsy: abandon  or persist?” by Qiu et al with high interest.",Non-OADS,/arxiv_data1/oa_pdf/74/10/ott-10-1111.PMC5328301.pdf
"Pavlova 6, Olomouc,  Czech republic Tel +420 588 444 295 email davvrana@gmail.co m Journal name: OncoTargets and Therapy Article Designation: Letter Y ear: 2017 Volume: 10 Running head verso: Vrana and Gatek Running head recto: Internal mammary lymph node management DOI: http://dx.doi.org/10.2147/OTT.S131396",Non-OADS,/arxiv_data1/oa_pdf/74/10/ott-10-1111.PMC5328301.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/74/10/ott-10-1111.PMC5328301.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/74/10/ott-10-1111.PMC5328301.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/14/67/opth-11-441.PMC5328302.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2017:11 441–447Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  441Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S12834 1 systemic abnormalities associated with retinal  vein occlusion in young patients suthasinee sinawat1 Chavisa Bunyavee2 Tanapat ratanapakorn1 supat sinawat3 Wipada laovirojjanakul1 Y osanan Y ospaiboon1 1KKU eye Center, Department of  Ophthalmology, Faculty of Medicine,   Khon Kaen University, Khon  Kaen, Thailand; 2Department of  Ophthalmology, Faculty of Medicine,   nawamindaradhiraj University,   Bangkok, Thailand; 3Department of  Physiology, Faculty of Medicine, Khon  Kaen University, Khon Kaen, ThailandObjectives:  To study the systemic abnormalities associated with retinal vein occlusion in  patients aged 50 years with a particular emphasis on atherosclerotic diseases and thrombo - philic disorders.",Non-OADS,/arxiv_data1/oa_pdf/14/67/opth-11-441.PMC5328302.pdf
"Previous studies of these young patients revealed an associa - tion with thrombophilia,11–13 connective tissue diseases,14 antiphospholipid antibody  syndrome,15–16 hyperhomocysteinemia,11,17 and hyperviscosity syndrome.18 Most of  these studies, however, were case reports or small case studies, and there have been Correspondence: Yosanan Yospaiboon KKU eye Center, Department of  Ophthalmology, Faculty of Medicine,  Khon Kaen University, 123 Mitraparb  highway, Khon Kaen 40002, Thailand Tel +66 43 348 383 email yosanan@kku.ac.t h Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Sinawat et al Running head recto: Retinal vein occlusion in young patients DOI: http://dx.doi.org/10.2147/OPTH.S128341",Non-OADS,/arxiv_data1/oa_pdf/14/67/opth-11-441.PMC5328302.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/14/67/opth-11-441.PMC5328302.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/14/67/opth-11-441.PMC5328302.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d7/f4/ott-10-1081.PMC5328303.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 1081–1089OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1081Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S12210 6 Metronomic treatment of advanced non-small-cell  lung cancer with daily oral vinorelbine – a   Phase i trial sylvia guetz1,* amanda T ufman2,* Joachim von Pawel3 achim rittmeyer4 astrid Borgmeier2 Pierre Ferré5 Birgit edlich6 rudolf Maria huber2 1ev.",Non-OADS,/arxiv_data1/oa_pdf/d7/f4/ott-10-1081.PMC5328303.pdf
"Although patients with early-stage disease may be cured by surgical resection, most correspondence: rudolf Maria huber Division of respiratory Medicine  and Thoracic Oncology, University  hospital Munich – campus innenstadt,  Thoracic Oncology centre Munich,  Ziemsenstrasse 1, D-80336 Munich,  germany Tel +49 89 4400 52590 Fax +49 89 4400 54905 email huber@med.uni-muenchen.d e Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Guetz et al Running head recto: Metronomic treatment of advanced non-small-cell lung cancer DOI: http://dx.doi.org/10.2147/OTT.S122106",Non-OADS,/arxiv_data1/oa_pdf/d7/f4/ott-10-1081.PMC5328303.pdf
Available from: http://globocan.iarc.fr .,Non-OADS,/arxiv_data1/oa_pdf/d7/f4/ott-10-1081.PMC5328303.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/d7/f4/ott-10-1081.PMC5328303.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d7/f4/ott-10-1081.PMC5328303.pdf
"Available from: http://ctep.cancer.gov/ protocolDevelopment /electronic_applications/docs/ctcaev3.pd f.  Accessed December 19, 2016.",Non-OADS,/arxiv_data1/oa_pdf/d7/f4/ott-10-1081.PMC5328303.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/33/35/ott-10-1165.PMC5328304.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 1165–1172OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1165Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S12663 7 Prognostic and clinicopathologic significance of  neutrophil-to-lymphocyte ratio in esophageal  squamous cell carcinoma: evidence from a  meta-analysis Yu huang Yue sun Ping Peng sixian Zhu Wei sun Peng Zhang Department of Oncology,   Tongji Hospital, Tongji Medical  College, Huazhong University of  Science and T echnology, Wuhan,   People’s Republic of ChinaPurpose:  Evidence from an increasing number of studies has demonstrated that the  neutrophil-to-lymphocyte ratio (NLR) is a prognostic factor for various cancers.",Non-OADS,/arxiv_data1/oa_pdf/33/35/ott-10-1165.PMC5328304.pdf
"Such biomarkers are easily  assessable and provide important information for clinicians regarding preventive and  therapeutic strategies for ESCC patients.5–7correspondence: Peng Zhang Department of Oncology, Tongji  Hospital, Tongji Medical College,  Huazhong University of Science and  Technology, No 1095 Jie Fang Avenue,  Hankou, Wuhan 430030, People’s  Republic of China Tel +86 27 8366 3405 Fax +86 27 8366 2834 email pengzhang@tjh.tjmu.edu.c n Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Huang et al Running head recto: Neutrophil-to-lymphocyte ratio in esophageal squamous cell carcinoma DOI: http://dx.doi.org/10.2147/OTT.S126637",Non-OADS,/arxiv_data1/oa_pdf/33/35/ott-10-1165.PMC5328304.pdf
"Available from: http://www.ohri.ca/programs/clinical_epi - demiology/oxford.as p. Accessed February 14, 2017.",Non-OADS,/arxiv_data1/oa_pdf/33/35/ott-10-1165.PMC5328304.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/33/35/ott-10-1165.PMC5328304.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/33/35/ott-10-1165.PMC5328304.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/7d/47/ott-10-1181.PMC5328305.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 1181–1189OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1181Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11041 1 Preoperative lymphocyte-to-monocyte ratio  predicts survival in primary hepatitis B virus-positive  hepatocellular carcinoma after curative resection correspondence: hong-Wei Xu First Department of general surgery,  The First Affiliated Hospital of Xin-Xiang  Medical University, 88 Jiankang road,  Weihui, henan 463000, People’s republic  of china Tel +86 373 440 2120 Fax +86 373 440 2120 email xuhongwei880@sina.co m guang-Jun li1 Juan-Juan Ji2 Fang Yang2 hong-Wei Xu1 Yu Bai3 1First Department of general surgery,   2Department of gastroenterology,   3Department of Pathology, The First  affiliated hospital of Xin-Xiang  Medical University, henan, People’s  republic of chinaBackground:  Both inflammation and immunity are associated with the development of  malignancy.",Non-OADS,/arxiv_data1/oa_pdf/7d/47/ott-10-1181.PMC5328305.pdf
"Keywords:  lymphocyte-to-monocyte ratio, survival, HBV, hepatocellular carcinoma Introduction In the People’s Republic of China, recent health statistics data have revealed the increasing  trend of morbidity and mortality of people with liver cancer in a setting of an estimated  100 million carriers of hepatitis B virus (HBV), accounting for the most common cancer  and the second leading cause of cancer-related death.1 Although the development of  comprehensive treatment and advances in surgery have benefited liver cancer patients,  the prognosis remains poor mainly due to high recurrence and metastasis rates after surgi - cal resection, especially for HBV -positive hepatocellular carcinoma.2,3 Classification of  patients facilitates predicting survival, thus helping to provide individualized therapies and  improve clinical survival outcomes; therefore, the importance of prognostic and predictive  biomarkers has been increasingly recognized.4 However, biomarkers definitely associ - ated with prognosis are currently limited to clinicopathological characteristics which can  only be assessed through postoperative histological studies and findings during surgery,  such as histological stage, the pathological type, or TNM stage.5–9 So novel pretreatment  biomarkers characterized by affordability and technical feasibility are required.Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Li et al Running head recto: LMR predicts survival of HBV( +) HCC DOI: http://dx.doi.org/10.2147/OTT.S110411",Non-OADS,/arxiv_data1/oa_pdf/7d/47/ott-10-1181.PMC5328305.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/7d/47/ott-10-1181.PMC5328305.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/7d/47/ott-10-1181.PMC5328305.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b4/69/ott-10-1101.PMC5328306.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 1101–1110OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1101Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11215 8 Impact of gefitinib in early stage treatment on  circulating cytokines and lymphocytes for patients  with advanced non-small cell lung cancer Jin sheng1–3,* Wenfeng Fang1–3,* Xia liu3 shan Xing1,2,4 Jianhua Zhan1,2 Yuxiang Ma1,2 Yan huang1–3 ningning Zhou1–3 hongyun Zhao1–3 li Zhang1–3 1State Key Laboratory of Oncology  in south china, 2Collaborative  innovation center for cancer  Medicine, 3Department of Medical  Oncology, 4Department of clinical  Laboratory, Sun Yat-Sen University  cancer center, guangzhou,   Guangdong, People’s Republic of  china *These authors contributed equally  to this workObjectives:  The impact of epidermal growth factor receptor (EGFR) tyrosine-kinase inhibitors  (TKIs) on the human immune system remains undefined.",Non-OADS,/arxiv_data1/oa_pdf/b4/69/ott-10-1101.PMC5328306.pdf
"Keywords:  non-small cell lung cancer, gefitinib, PD-L1, lymphocyte, cytokine Introduction Recent insights into genetic aberrations and the role of the immune system in  non-small cell lung cancer (NSCLC) have ushered in a new era of rapidly evolv - ing targeted therapy and immune-based treatments.1–3 Tyrosine-kinase inhibitors  (TKIs) targeting epidermal growth factor receptor (EGFR) are efficacious as targeted  therapy for NSCLC.4–7 Although the progression-free survival (PFS) and the overall  survival (OS) have been significantly improved, patients inevitably develop acquired  resistance, and durable responses for advanced NSCLC have only been reported with  immunologic therapy.8,9  Very recent findings include the mechanism of immunoediting and the complexity  of immune escape mechanisms in cancer.10 Programmed cell death protein-1 (PD-1)  and its ligand-1 (PD-L1) are key immunological checkpoints mediating immune escape  of cancer cells and limiting the anticancer immune response.11,12 Blocking PD-1 or  PD-L1 can restore the functions of tumor-specific T cells, which will further be reacti - vated to initiate direct killing of tumor cells, and the secretion of immuno-stimulatory  cytokines such as interferon-gamma (INF- γ), interleukin (IL)-2, and tumor necrosis correspondence: li Zhang Department of Medical Oncology, sun  Yat-Sen University Cancer Center,  651 Dongfeng road east, guangzhou,  guangdong 510060, People’s  Republic of China Tel +86 20 8734 3458 Fax +86 20 8734 3535 email zhangli@sysucc.org.c n Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Sheng et al Running head recto: Immunomodulatory effects of gefitinib DOI: http://dx.doi.org/10.2147/OTT.S112158",Non-OADS,/arxiv_data1/oa_pdf/b4/69/ott-10-1101.PMC5328306.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/b4/69/ott-10-1101.PMC5328306.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b4/69/ott-10-1101.PMC5328306.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/43/3c/opth-11-403.PMC5328307.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2017:11 403–408Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  403Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S12865 1 Prolongation of injection interval after switching  therapy from ranibizumab to aflibercept in  Japanese patients with macular edema secondary  to branch retinal vein occlusion Mizuki Tagami ryuto sai Masahide Fukuda atsushi azumi Ophthalmology Department, eye  Center, Kobe Kaisei hospital, Kobe,   hyogo, JapanPurpose:  This study was conducted to investigate the outcome of switching therapy from  ranibizumab to aflibercept in Japanese patients with macular edema (ME) secondary to branch  retinal vein occlusion (BRVO) in daily practice.",Non-OADS,/arxiv_data1/oa_pdf/43/3c/opth-11-403.PMC5328307.pdf
"Additionally, because BRVO often occurs  in working-age populations, frequent hospital visits for injection or examination may Correspondence: Mizuki Tagami Ophthalmology Department, eye Center,  Kobe Kaisei hospital, 11-15 shinohara- Kitamachi, 3-Chome, nada-ku, Kobe,  hyogo 657 0068, Japan Tel +81 78 871 5201 Fax +81 78 871 5206 email m-tagami@kobe-kaisei.or g Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Tagami et al Running head recto: Aflibercept injection intervals in BRVO-ME DOI: http://dx.doi.org/10.2147/OPTH.S128651",Non-OADS,/arxiv_data1/oa_pdf/43/3c/opth-11-403.PMC5328307.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/43/3c/opth-11-403.PMC5328307.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/43/3c/opth-11-403.PMC5328307.pdf
"9, 1281556 http://dx.doi.org/10.1080/20002297.2017.1281556 © 2017 The Author(s).",Non-OADS,/arxiv_data1/oa_pdf/02/6e/zjom-9-1281556.PMC5328311.pdf
"Published by Informa UK Limited, trading as Taylor & Francis Group This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/02/6e/zjom-9-1281556.PMC5328311.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d9/2f/ott-10-1001.PMC5328316.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 1001OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/d9/2f/ott-10-1001.PMC5328316.pdf
"Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.Dove pres s 1001COrrigendumopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S13286 6 Significance of downregulation of renal organic cation transporter  (SLC47A1) in cisplatin-induced proximal tubular injury [Corrigendum] Mizuno T, Sato W, Ishikawa K, et al.",Non-OADS,/arxiv_data1/oa_pdf/d9/2f/ott-10-1001.PMC5328316.pdf
"“TG2, transglutaminase 2” also  should be removed from the abbreviations list.Journal name: OncoTargets and Therapy Article Designation: Corrigendum Y ear: 2017 Volume: 10 Running head verso: Mizuno et al Running head recto: Significance of downregulation of renal organic cation transporter (SLC47A1) DOI: http://dx.doi.org/10.2147/OTT.S132866",Non-OADS,/arxiv_data1/oa_pdf/d9/2f/ott-10-1001.PMC5328316.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/62/de/opth-11-449.PMC5328317.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2017:11 449–452Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  449Study Pr OtOCO lopen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/OPTH.S12516 0 the uK Paediatric Ocular trauma Study 1  (POtS1): development of a global standardized  protocol for prospective data collection in  pediatric ocular trauma Freda Sii1,2 robert J Barry1 richard J Blanch1 Joseph Abbott3 Caroline J MacEwen4 Peter Shah1,2,5,6 1department of Ophthalmology,   Queen Elizabeth Hospital Birmingham,   2Birmingham Institute for Glaucoma  research, Institute of translational  Medicine, university Hospitals  Birmingham NHS Foundation trust,   3department of Ophthalmology,   Birmingham Children’s Hospital  NHS Foundation trust, Birmingham,   4department of Ophthalmology,   Ninewells Hospital and Medical  School, dundee, 5National Institute of  Health research Biomedical research  Centre, Moorfields Eye Hospital NHS  Foundation trust and uCl Institute of  Ophthalmology, london, 6Centre for  Health and Social Care Improvement,   School of Health and Wellbeing,   university of Wolverhampton,   Wolverhampton, uKBackground:  Ocular trauma is an important cause of visual morbidity in children worldwide.",Non-OADS,/arxiv_data1/oa_pdf/62/de/opth-11-449.PMC5328317.pdf
"Worldwide estimates  suggest that ocular trauma is responsible for up to 280,000 hospital admissions annually  in children aged ,15 years.1 However, ocular trauma cases requiring hospital admission Correspondence: Freda Sii department of Ophthalmology, Queen  Elizabeth Hospital Birmingham, university  Hospital, Birmingham NHS Foundation  trust, Mindelsohn Way, Edgbaston,  Birmingham, B15 2WB, uK Email sii.freda@gmail.co m Journal name: Clinical Ophthalmology Article Designation: Study Protocol Y ear: 2017 Volume: 11 Running head verso: Sii et al Running head recto: The UK Paediatric Ocular Trauma Study 1 DOI: http://dx.doi.org/10.2147/OPTH.S125160",Non-OADS,/arxiv_data1/oa_pdf/62/de/opth-11-449.PMC5328317.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/62/de/opth-11-449.PMC5328317.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/62/de/opth-11-449.PMC5328317.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/61/e4/opth-11-435.PMC5328318.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2017:11 435–440Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  435Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S11934 3 Corneal thickness in dry eyes in an iraqi population noora Mauwafak ali1 Furkaan M hamied1 Qasim K Farhood2 1Department of surgery, College  of Medicine, al-Qadisiya University,   Diwaniyah, 2Department of surgery,   College of Medicine, University of  Babylon, hillah, iraqBackground:  Dry eye disorder is a multifactorial disease of the tears and ocular surface that  results in discomfort and visual disturbance.",Non-OADS,/arxiv_data1/oa_pdf/61/e4/opth-11-435.PMC5328318.pdf
"With maturation, Correspondence: Qasim K Farhood Department of surgery, College of  Medicine, University of Babylon,  PO Box 4 iraq - Babylon - hilla,  Babylon 52001, iraq email qasim_1964@ymail.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Ali et al Running head recto: CCT of dry eyes in an Iraqi population DOI: http://dx.doi.org/10.2147/OPTH.S119343",Non-OADS,/arxiv_data1/oa_pdf/61/e4/opth-11-435.PMC5328318.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/61/e4/opth-11-435.PMC5328318.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/61/e4/opth-11-435.PMC5328318.pdf
"Available from: http://www.aaojournal.org/article/S0161- 6420(13)00020-1/abstrac t. Accessed September 19, 2016.",Non-OADS,/arxiv_data1/oa_pdf/61/e4/opth-11-435.PMC5328318.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f6/93/opth-11-411.PMC5328319.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2017:11 411–416Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  411Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S12536 4 Cytokine biomarkers in tear film for primary  open-angle glaucoma Divakar gupta1,* Joanne C Wen2,* Janet l huebner3 sandra stinnett1 Virginia B Kraus3,4 henry C Tseng1 Molly Walsh1 1Department of Ophthalmology, Duke  University Medical Center, Durham,   nC, 2Department of Ophthalmology,   University of Washington, Seattle,   Wa, 3Duke Molecular Physiology  institute, 4Division of Rheumatology,   Department of Medicine, Duke  University School of Medicine,   Durham, nC, Usa *These authors contributed equally  to this workPurpose:  To determine the utility of tear film cytokines as biomarkers for early primary  open-angle glaucoma (POAG).",Non-OADS,/arxiv_data1/oa_pdf/f6/93/opth-11-411.PMC5328319.pdf
"The tear film is easily accessed Correspondence: Divakar gupta Department of Ophthalmology, Duke  University Medical Center, 2351  erwin rd, Durham, nC 27703, Usa Tel +1 919 684 6611 Fax +1 919 681 8267 email divakar.gupta@duke.ed u Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Gupta et al Running head recto: Tear film cytokines in glaucoma DOI: http://dx.doi.org/10.2147/OPTH.S125364",Non-OADS,/arxiv_data1/oa_pdf/f6/93/opth-11-411.PMC5328319.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/f6/93/opth-11-411.PMC5328319.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f6/93/opth-11-411.PMC5328319.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/af/aa/opth-11-393.PMC5328320.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2017:11 393–401Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  393Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S12850 9 anti-VegF treatment of diabetic macular edema  in clinical practice: effectiveness and patterns of  use (eChO study report 1) Kevin J Blinder1 Pravin U Dugel2,3 sanford Chen4 J Michael Jumper5 John g Walt6 David a hollander6 lanita C scott6 On behalf of the eChO  study group 1The retina institute, st louis, MO,   2retinal Consultants of arizona,   Phoenix, aZ, 3UsC roski eye institute,   Keck school of Medicine, University  of southern California, los angeles,   4Orange County retina, santa ana,   5West Coast retina Medical group,   san Francisco, 6allergan plc, irvine,   Ca, UsaPurpose:  To evaluate the efficacy, safety, and injection frequency of vascular endothelial  growth factor (VEGF) inhibitors as used in clinical practice for the treatment of diabetic  macular edema.",Non-OADS,/arxiv_data1/oa_pdf/af/aa/opth-11-393.PMC5328320.pdf
"Controlled clinical studies  have shown that treatment with each of these VEGF inhibitors is more effective than Correspondence: Kevin J Blinder The retina institute, 1600 south  Brentwood, 8th Floor, st louis 63144,  MO, Usa Tel +1 314 367 1181 Fax +1 314 968 5117 email kjblinder@gmail.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Blinder et al Running head recto: Anti-VEGF treatment of DME DOI: http://dx.doi.org/10.2147/OPTH.S128509",Non-OADS,/arxiv_data1/oa_pdf/af/aa/opth-11-393.PMC5328320.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/af/aa/opth-11-393.PMC5328320.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/af/aa/opth-11-393.PMC5328320.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/12/42/ott-10-711.PMC5328321.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 711–724OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  711Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11793 3 β-catenin promotes cell proliferation, migration,  and invasion but induces apoptosis in renal cell  carcinoma chun-ming Yang1 shan Ji2 Yan li3 li-ye Fu3 Tao Jiang3 Fan-dong Meng3 1Department of Urology, The  First affiliated hospital, china  Medical University, 2Department of  endocrinology, The Fifth People’s  hospital of shenyang, 3Department of  Biotherapy, cancer research institute,   The First affiliated hospital, china  Medical University, shenyang, chinaAbstract:  β-Catenin ( CTNNB1  gene coding protein) is a component of the Wnt signaling path - way that has been shown to play an important role in the formation of certain cancers.",Non-OADS,/arxiv_data1/oa_pdf/12/42/ott-10-711.PMC5328321.pdf
"The canonical Wnt/ β-catenin signaling pathway plays an important role in the  embryonic development and cellular homeostasis and modulates cell growth and self- renewal in stem cells and progenitor cells.5,6 In the presence of Wnt signaling, β-catenin  is accumulated in the cytosol, translocated into the nucleus, and forms a complex  with transcription factors to activate target genes.7,8 Dysregulated β-catenin signal - ing is a common feature of many malignant tumors, including prostate, melanoma, correspondence: Fan-dong Meng Department of Biotherapy, cancer  research institute, The First  Affiliated Hospital, China Medical  University, no 92 Beier street,  heping District, shenyang 110001,  liaoning Province, china email fandongmm@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Y ang et al Running head recto: CTNNB1 involved in renal cell carcinoma progression DOI: http://dx.doi.org/10.2147/OTT.S117933",Non-OADS,/arxiv_data1/oa_pdf/12/42/ott-10-711.PMC5328321.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/12/42/ott-10-711.PMC5328321.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/12/42/ott-10-711.PMC5328321.pdf
"1, 1270021 http://dx.doi.org/10.1080/19932820.2017.1270021 © 2017 The Author(s).",Non-OADS,/arxiv_data1/oa_pdf/67/45/zljm-12-1270021.PMC5328322.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/67/45/zljm-12-1270021.PMC5328322.pdf
"Available from: http://beslenme.gov.tr/content/ files/diyabet/turkiyediyabetprogrami.pdf [3] McAnulty GR, Robertshaw HJ, Hall GM.",Non-OADS,/arxiv_data1/oa_pdf/67/45/zljm-12-1270021.PMC5328322.pdf
"1, 1272832 http://dx.doi.org/10.1080/20013078.2016.1272832 © 2017 The Author(s).",Non-OADS,/arxiv_data1/oa_pdf/6c/90/zjev-6-1272832.PMC5328325.pdf
"Published by Informa UK Limited, trading as Taylor & Francis Group This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6c/90/zjev-6-1272832.PMC5328325.pdf
"ORCID Kenneth W. Witwer http://orcid.org/0000-0003-1664- 4233 References [1] Raposo G, Stoorvogel W. Extracellular vesicles: exo- somes, microvesicles, and friends.",OADS,/arxiv_data1/oa_pdf/6c/90/zjev-6-1272832.PMC5328325.pdf
"Available from: http://www.ncbi.nlm.nih.gov/pubmed/23420871 [2] Kim D-K, Lee J, Kim SR, et al.",OADS,/arxiv_data1/oa_pdf/6c/90/zjev-6-1272832.PMC5328325.pdf
"Available from: http://www.ncbi.nlm.ni h.gov/pubmed/19011622[6] Pegtel DM, Cosmopoulos K, Thorley-Lawson DA, et al.",OADS,/arxiv_data1/oa_pdf/6c/90/zjev-6-1272832.PMC5328325.pdf
Available from: http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/6c/90/zjev-6-1272832.PMC5328325.pdf
Available from: http://www.ncbi.nlm.nih.gov/ pubmed/26967288 [8] Sverdlov ED.,Non-OADS,/arxiv_data1/oa_pdf/6c/90/zjev-6-1272832.PMC5328325.pdf
Available from: http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/6c/90/zjev-6-1272832.PMC5328325.pdf
Available from: http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/6c/90/zjev-6-1272832.PMC5328325.pdf
Available from: http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/6c/90/zjev-6-1272832.PMC5328325.pdf
"Available from: http://www.ncbi.nlm.nih.gov/pubmed/18228490 [13] Pigati L, Yaddanapudi SCS, Iyengar R, et al.",OADS,/arxiv_data1/oa_pdf/6c/90/zjev-6-1272832.PMC5328325.pdf
"Available from: http://www.ncbi.nlm.nih.gov/pubmed/20976003 [14] Shelke GV, Lässer C, Gho YS, et al.",OADS,/arxiv_data1/oa_pdf/6c/90/zjev-6-1272832.PMC5328325.pdf
Available from: http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/6c/90/zjev-6-1272832.PMC5328325.pdf
Available from: http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/6c/90/zjev-6-1272832.PMC5328325.pdf
Available from: http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/6c/90/zjev-6-1272832.PMC5328325.pdf
"Available from: http://www.ncbi.nlm.nih.gov/ pubmed/21609964 [19] Arroyo JD, Chevillet JR, Kroh EM, et al.",OADS,/arxiv_data1/oa_pdf/6c/90/zjev-6-1272832.PMC5328325.pdf
"Available from: http://www.ncbi.nlm.nih.gov/ pubmed/21383194 [20] Gallo A, Tandon M, Alevizos I, et al.",OADS,/arxiv_data1/oa_pdf/6c/90/zjev-6-1272832.PMC5328325.pdf
Available from: http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/6c/90/zjev-6-1272832.PMC5328325.pdf
"Available from: http://www.ncbi.nlm.nih.gov/pubmed/ 26218736 [22] Zhao K, Liang G, Sun X, et al.",OADS,/arxiv_data1/oa_pdf/6c/90/zjev-6-1272832.PMC5328325.pdf
"Available from: http://www.ncbi.nlm.nih.gov/pubmed/27519500 [23] Landgraf P, Rusu M, Sheridan R, et al.",OADS,/arxiv_data1/oa_pdf/6c/90/zjev-6-1272832.PMC5328325.pdf
"Available from: http://www.ncbi.nlm.nih.gov/pubmed/ 24586876 [25] Pritchard CC, Kroh E, Wood B, et al.",OADS,/arxiv_data1/oa_pdf/6c/90/zjev-6-1272832.PMC5328325.pdf
"Available from: http://www.nature.com/doifinder/10.1038/ nature06607 [27] Zhang C, Wang C, Chen X, et al.",OADS,/arxiv_data1/oa_pdf/6c/90/zjev-6-1272832.PMC5328325.pdf
Available from: http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/6c/90/zjev-6-1272832.PMC5328325.pdf
Available from: https://academic.oup.,Non-OADS,/arxiv_data1/oa_pdf/6c/90/zjev-6-1272832.PMC5328325.pdf
"Available from: http://www.ncbi.nlm.nih.gov/ pubmed/25940616 [31] Baglio SR, Rooijers K, Koppers-Lalic D, et al.",OADS,/arxiv_data1/oa_pdf/6c/90/zjev-6-1272832.PMC5328325.pdf
"Available from: http://www.nature.com/doifinder/ 10.1038/ncb3094 [33] Guduric-Fuchs J, O ’Connor A, Camp B, et al.",OADS,/arxiv_data1/oa_pdf/6c/90/zjev-6-1272832.PMC5328325.pdf
"Available from: http://www.ncbi.nlm.nih.gov/pubmed/ 22849433 [34] Ji H, Chen M, Greening DW, et al.",OADS,/arxiv_data1/oa_pdf/6c/90/zjev-6-1272832.PMC5328325.pdf
Available from: http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/6c/90/zjev-6-1272832.PMC5328325.pdf
"Available from: http://www.ncbi.nlm.nih.gov/pubmed/25242326 [36] Li CCY, Eaton SA, Young PE, et al.",OADS,/arxiv_data1/oa_pdf/6c/90/zjev-6-1272832.PMC5328325.pdf
Available from: http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/6c/90/zjev-6-1272832.PMC5328325.pdf
"Available from: http://www.ncbi.nlm.nih.gov/pubmed/27559612 [38] Villarroya-Beltri C, Gutierrez-Vazquez C, Sanchez-Cabo F, et al.",OADS,/arxiv_data1/oa_pdf/6c/90/zjev-6-1272832.PMC5328325.pdf
"Available from: http://www.ncbi.nlm.nih.gov/pubmed/ 24356509 [39] Holden P, Horton WA.",OADS,/arxiv_data1/oa_pdf/6c/90/zjev-6-1272832.PMC5328325.pdf
"Available from: http://bmcresnotes.biomedcentral.com/ articles/10.1186/1756-0500-2-243 [40] Graham JM, Rickwood D, editors.",Non-OADS,/arxiv_data1/oa_pdf/6c/90/zjev-6-1272832.PMC5328325.pdf
"Oxford University Press; 1997 .A v a i l a b l ef r o m : https://books.google.com/books?hl=en&id= h4hDKHEPTCcC&oi=fnd&pg=PR17&dq=subcellular +fractionation&ots=LfjjSzYFU5&sig=qUU- kYUjobhOipcwmmoIWz0D5qI#v=onepage&q=subcel lularfractionation&f=false [41] Nolte- ’t Hoen EN, Buermans HP, Waasdorp M, et al.",Non-OADS,/arxiv_data1/oa_pdf/6c/90/zjev-6-1272832.PMC5328325.pdf
Available from: http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/6c/90/zjev-6-1272832.PMC5328325.pdf
"Available from: http://www.ncbi.nlm.nih.gov/ pubmed/20615901 [43] Hunter MP, Ismail N, Zhang X, et al.",OADS,/arxiv_data1/oa_pdf/6c/90/zjev-6-1272832.PMC5328325.pdf
"Available from: http://www.ncbi.nlm.nih.gov/ pubmed/19002258 [44] Ouyang Y, Mouillet J-F, Coyne CB, et al.",OADS,/arxiv_data1/oa_pdf/6c/90/zjev-6-1272832.PMC5328325.pdf
"Available from: http://www.ncbi.nlm.nih.gov/pubmed/24280233 [45] Donker RB, Mouillet JF, Chu T, et al.",OADS,/arxiv_data1/oa_pdf/6c/90/zjev-6-1272832.PMC5328325.pdf
"Available from: http://www.ncbi.nlm.nih.gov/pubmed/ 22383544 [46] Liao Z, Muth DC, Eitan E, et al.",OADS,/arxiv_data1/oa_pdf/6c/90/zjev-6-1272832.PMC5328325.pdf
"Available from: http://biorxiv.org/content/early/2016/ 12/08/081687.1 [47] Tosar JP, Rovira C, Naya H, et al.",OADS,/arxiv_data1/oa_pdf/6c/90/zjev-6-1272832.PMC5328325.pdf
Available from: http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/6c/90/zjev-6-1272832.PMC5328325.pdf
Available from: http://www.ncbi.nlm.nih.gov/ pubmed/24027301 [49] Illumina.,OADS,/arxiv_data1/oa_pdf/6c/90/zjev-6-1272832.PMC5328325.pdf
"Available from: https://docs.google.com/file/d/ 0B383TG7oJh2CTWp6MzZkMHBDd28/view [50] Liu X, Barker DF.",Non-OADS,/arxiv_data1/oa_pdf/6c/90/zjev-6-1272832.PMC5328325.pdf
"Available from: http://www.ncbi.nlm.nih.gov/pubmed/10205276 [51] Baraniskin A, Nöpel-Dünnebacke S, Ahrens M, et al.",OADS,/arxiv_data1/oa_pdf/6c/90/zjev-6-1272832.PMC5328325.pdf
"1, 1267896 http://dx.doi.org/10.1080/20013078.2016.1267896 © 2016 The Author(s).",Non-OADS,/arxiv_data1/oa_pdf/66/76/zjev-6-1267896.PMC5328348.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/66/76/zjev-6-1267896.PMC5328348.pdf
"1, 1270602 http://dx.doi.org/10.1080/20002297.2016.1270602 © 2017 The Author(s).",Non-OADS,/arxiv_data1/oa_pdf/c9/5a/zjom-9-1270602.PMC5328363.pdf
"Published by Informa UK Limited, trading as Taylor & Francis Group This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c9/5a/zjom-9-1270602.PMC5328363.pdf
"Data were acquired with a 63× objective on a Leica DMIRB microscope equipped with a Photometrics cascade-cooled EMCCD camera, con- trolled by the open-source software package μManager ( http://www.micromanager.org ).",OADS,/arxiv_data1/oa_pdf/c9/5a/zjom-9-1270602.PMC5328363.pdf
"1, 1270614 http://dx.doi.org/10.1080/20002297.2016.1270614 © 2017 The Author(s).",Non-OADS,/arxiv_data1/oa_pdf/ea/15/zjom-9-1270614.PMC5328370.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ea/15/zjom-9-1270614.PMC5328370.pdf
"1, 1260886 http://dx.doi.org/10.1080/19932820.2017.1260886 © 2016 The Author(s).",Non-OADS,/arxiv_data1/oa_pdf/1a/f5/zljm-12-1260886.PMC5328375.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1a/f5/zljm-12-1260886.PMC5328375.pdf
(The calculation of the sample was made online at: http://marne.u707.jussieu.fr/biostatgv/ ).,OADS,/arxiv_data1/oa_pdf/1a/f5/zljm-12-1260886.PMC5328375.pdf
Available from: http://scholarworks.gvsu.edu/theses .,Non-OADS,/arxiv_data1/oa_pdf/1a/f5/zljm-12-1260886.PMC5328375.pdf
"1, 1267317 http://dx.doi.org/10.1080/17482631.2016.1267317 © 2017 The Author(s).",Non-OADS,/arxiv_data1/oa_pdf/4c/4b/zqhw-12-1267317.PMC5328376.pdf
"Published by Informa UK Limited, trading as Taylor & Francis Group This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4c/4b/zqhw-12-1267317.PMC5328376.pdf
"Retrieved from http://www.arttherapy.org/upload/useofarttherapywithve terans.pdf Andrew, E. H. ( 2014 ).",Non-OADS,/arxiv_data1/oa_pdf/4c/4b/zqhw-12-1267317.PMC5328376.pdf
Retrieved from http://ideas.ted.com /gallery-how-these- powerful-masks-are-helping-combat-veterans-heal/10 M. S. WALKER ET AL.,Non-OADS,/arxiv_data1/oa_pdf/4c/4b/zqhw-12-1267317.PMC5328376.pdf
Retrieved from http://search.pro quest.com/docview/304569092 Defense and Veterans Brain Injury Center.,Non-OADS,/arxiv_data1/oa_pdf/4c/4b/zqhw-12-1267317.PMC5328376.pdf
Retrieved from http://dvbic.dcoe.mil/sites/default/files/DoD-TBI- Worldwide-Totals_2000-2015_Q1-Q4_March-30-2016_v1.,OADS,/arxiv_data1/oa_pdf/4c/4b/zqhw-12-1267317.PMC5328376.pdf
"Retrieved from http://search.proquest.com/ docview/304730772?accountid=10559 Fryrear, J. L., & Stephens, B. C. ( 1988 ).",Non-OADS,/arxiv_data1/oa_pdf/4c/4b/zqhw-12-1267317.PMC5328376.pdf
"Retrieved from https://www.churchilltrust.com.au/media/fellows/2012_ Lawrence_Dena_1.pdf Lobban, J.",Non-OADS,/arxiv_data1/oa_pdf/4c/4b/zqhw-12-1267317.PMC5328376.pdf
"Retrieved from http://www.wcmt.org.uk/ sites/default/files/reportdocuments/Lobban%20J% 20Report%202016%20Final.pdf Malchiodi, C. A.",Non-OADS,/arxiv_data1/oa_pdf/4c/4b/zqhw-12-1267317.PMC5328376.pdf
"Retrieved from http://www.nato.int/cps/en/ natohq/topics_8189.htm Pachalska, M., Pronina, M. V., Manko, G., Chantsoulis, M., Luckos, M., & Kroptov, J. D. ( 2013 ).",OADS,/arxiv_data1/oa_pdf/4c/4b/zqhw-12-1267317.PMC5328376.pdf
"Retrieved from http://www.gao.gov/assets/590/ 585743.pdf Van Der Kolk, B.",OADS,/arxiv_data1/oa_pdf/4c/4b/zqhw-12-1267317.PMC5328376.pdf
"1, 1270613 http://dx.doi.org/10.1080/20002297.2016.1270613 © 2017 The Author(s).",Non-OADS,/arxiv_data1/oa_pdf/35/c4/zjom-9-1270613.PMC5328388.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/35/c4/zjom-9-1270613.PMC5328388.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b6/ce/ndt-12-3237.PMC5328422.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 3237–3241Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  3237OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S11920 8 impact of parental presence during induction of  anesthesia on anxiety level among pediatric   patients and their parents: a randomized clinical   trial afsaneh sadeghi ahmad Khaleghnejad Tabari alireza Mahdavi sara salarian seyed sajjad razavi Department of anesthesiology,   Pediatric surgery research center,   shahid Beheshti University of Medical  sciences, T ehran, iranIntroduction:  Anesthesia induction is a stressful event for children and their parents, and  may have potentially harmful consequences on the patient’s physiological and mental situa - tion.",Non-OADS,/arxiv_data1/oa_pdf/b6/ce/ndt-12-3237.PMC5328422.pdf
"Keywords:  anxiety, anesthesia induction, parents, children Introduction Anesthesia induction is a stressful part of surgery for pediatric patients and their  parents.1 Children may undergo physical, mental, and physiological distress due to  anxiety at the time of induction.2 Stressful anesthesia induction has consequent adverse correspondence: seyed sajjad razavi Department of anesthesiology, Pediatric  surgery research center, shahid  Beheshti University of Medical sciences,  Tehran, iran Tel +98 21 9477 1479 Fax +98 21 3365 4177 email s.razavi@sbmu.ac.i r Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Sadeghi et al Running head recto: Impact of parental presence during induction of anesthesia DOI: http://dx.doi.org/10.2147/NDT.S119208",Non-OADS,/arxiv_data1/oa_pdf/b6/ce/ndt-12-3237.PMC5328422.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/b6/ce/ndt-12-3237.PMC5328422.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b6/ce/ndt-12-3237.PMC5328422.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/3b/3f/mder-10-047.PMC5328423.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/3b/3f/mder-10-047.PMC5328423.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Medical Devices: Evidence and Research 2017:10 47–52Medical Devices: Evidence and Research Dovepress submit your manuscript | www.dovepress.com Dovepress 47 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/MDER.S125425 Low-power system for the acquisition of the  respiratory signal of neonates using diaphragmatic  electromyography Róbinson T orres1,2 Sergio López-Isaza1,2 Elisa Mejía-Mejía1,2 Viviana Paniagua1,2 Víctor González3 1Biomedical Engineering Department,   Universidad EIA, Envigado, 2Biomedical  Engineering Department, Universidad  CES, 3Neonathology Department,   Hospital General de Medellín Luz Castro de Gutiérrez, Medellín,  Antioquia, ColombiaIntroduction: An apnea episode is defined as the cessation of breathing for ≥15 seconds or as  any suspension of breathing accompanied by hypoxia and bradycardia.",Non-OADS,/arxiv_data1/oa_pdf/3b/3f/mder-10-047.PMC5328423.pdf
"5 Differentiation between  these episodes is important to understand the physiopathology of the apnea in neonates, in order to improve its prognosis and treatment.Correspondence: Róbinson Torres Biomedical Engineering Department, Universidad EIA, Calle 25 Sur 42-73, Envigado, Antioquia 055420, Colombia   Tel +57 4 354 9090 ext 1316   Email robinson.torres@eia.edu.coJournal name: Medical Devices: Evidence and Research Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Torres et alRunning head recto: Acquisition of respiratory signal using electromyographyDOI: http://dx.doi.org/10.2147/MDER.S125425",Non-OADS,/arxiv_data1/oa_pdf/3b/3f/mder-10-047.PMC5328423.pdf
"Medical Devices: Evidence and Research 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Medical Devices: Evidence and Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/medical-devices-evidence-and-research-journalMedical Devices: Evidence and Research is an international, peer- reviewed, open access journal that focuses on the evidence, technology, research, and expert opinion supporting the use and application of   medical devices in the diagnosis, monitoring, treatment and management of clinical conditions and physiological processes.",Non-OADS,/arxiv_data1/oa_pdf/3b/3f/mder-10-047.PMC5328423.pdf
Available at: https://biomedical-engineering-online.biomedcentral.com/ articles/10.1186/1475-925X-6-45.,Non-OADS,/arxiv_data1/oa_pdf/3b/3f/mder-10-047.PMC5328423.pdf
Available from: http://www.analog.com/media/en/technical-documentation/application-notes/AN-581.pdf.,Non-OADS,/arxiv_data1/oa_pdf/3b/3f/mder-10-047.PMC5328423.pdf
Available from: http://www.ti.com/lit/an/slyt189/slyt189.pdf.,Non-OADS,/arxiv_data1/oa_pdf/3b/3f/mder-10-047.PMC5328423.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/0b/3e/jbm-8-021.PMC5328424.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/0b/3e/jbm-8-021.PMC5328424.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Blood Medicine 2017:8 21–27Journal of Blood Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress  21 Original research open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JBM.S129111Clinical, hematological, and cytogenetic profile of  adult myelodysplastic syndrome in a tertiary   care center santhosh narayanan Department of Medicine, government  Medical college, Kozhikode, Kerala,   indiaBackground: Myelodysplastic syndrome (MDS), a disorder of clonal hematopoiesis, is an  important clinical entity, but most of the studies available are conducted among the Western  population.",Non-OADS,/arxiv_data1/oa_pdf/0b/3e/jbm-8-021.PMC5328424.pdf
"Clinical variability of MDS, diversity of  histopathological correspondence: santhosh narayanan Department of Medicine, government Medical college, 27/685 Kottooli, Kozhikode 673016, Kerala, indiaTel +91 98 9565 8833email drsanthosh4@gmail.comJournal name: Journal of Blood Medicine Article Designation: Original ResearchY ear: 2017V olume: 8Running head verso: NarayananRunning head recto: Clinical and cytogenetic profile of adult myelodysplastic syndromeDOI: http://dx.doi.org/10.2147/JBM.S129111",Non-OADS,/arxiv_data1/oa_pdf/0b/3e/jbm-8-021.PMC5328424.pdf
"Journal of Blood Medicine 2017:8submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Blood Medicine Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/journal-of-blood-medicine-journalThe Journal of Blood Medicine is an international, peer-reviewed, open  access, online journal publishing laboratory, experimental and clinical aspects   of all aspect pertaining to blood based medicine including but not limited to:   Transfusion Medicine; Blood collection, Donor issues, Transmittable diseases,   and Blood banking logistics; Immunohematology; Artificial and alternative blood based therapeutics; Hematology; Biotechnology/nanotechnology of blood related medicine; Legal aspects of blood medicine; Historical perspec-tives.",Non-OADS,/arxiv_data1/oa_pdf/0b/3e/jbm-8-021.PMC5328424.pdf
Visit http://www.dovepress.com/ testimonials.php to read real quotes from published authors.Dovepress 27 Clinical and cytogenetic profile of adult myelodysplastic syndrome This  observation supports that lenalidomide should be the  first choice of drug for patients with 5q deletion.,Non-OADS,/arxiv_data1/oa_pdf/0b/3e/jbm-8-021.PMC5328424.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/46/09/jpr-10-445.PMC5328425.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/46/09/jpr-10-445.PMC5328425.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2017:10 445–450Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  445 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/.10.2147/JPR.S128992Efficacy of ondansetron for the prevention of  propofol injection pain: a meta-analysis Shenglin Pei1,*  Chengmao Zhou2,*  Yu Zhu2  Bing Huang1 1Department of Anesthesiology,   Affiliated T umor Hospital of Guangxi  Medical University, Nanning,   2Zhaoqing Medical College, Zhaoqing,   People’s Republic of China *These authors contributed equally to  this workAim: This review was performed to investigate the effect of ondansetron on the prevention of  propofol injection pain.",Non-OADS,/arxiv_data1/oa_pdf/46/09/jpr-10-445.PMC5328425.pdf
"In this study, a meta-analysis was performed to study the efficacy of ondansetron for the prevention of propofol injection pain.Correspondence: Bing Huang   Department of Anesthesiology, Affiliated  Tumor Hospital of Guangxi Medical University, 71 River Road, Nanning, Guangxi 532100, People’s Republic of China Fax +86 771 533 0700   Email Huangbing187@126.comJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Pei et alRunning head recto: Efficacy of ondansetron for the prevention of propofol injection painDOI: http://dx.doi.org/.10.2147/JPR.S128992",Non-OADS,/arxiv_data1/oa_pdf/46/09/jpr-10-445.PMC5328425.pdf
"Journal of Pain Research  2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/46/09/jpr-10-445.PMC5328425.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 450 Pei et al Na+ channels and peripheral 5-HT3 receptors that are related  to pain pathways.,Non-OADS,/arxiv_data1/oa_pdf/46/09/jpr-10-445.PMC5328425.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/8a/8f/jpr-10-451.PMC5328426.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/8a/8f/jpr-10-451.PMC5328426.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2017:10 451–460Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  451 CLINICAL TRIAL REPORT open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S127288A famciclovir + celecoxib combination treatment  is safe and efficacious in the treatment of  fibromyalgia William L Pridgen1 Carol Duffy2 Judy F Gendreau3 R Michael Gendreau3 1Innovative Med Concepts, LLC,   2Department of Biological Sciences,   University of Alabama, T uscaloosa, AL,   3Gendreau Consulting, LLC, Poway,   CA, USAObjective: Infections and other stressors have been implicated in the development of fibromy- algia.",Non-OADS,/arxiv_data1/oa_pdf/8a/8f/jpr-10-451.PMC5328426.pdf
"It is generally believed that central sensitization in FM patients does not occur de novo, but is secondary to Correspondence: William L Pridgen Innovative Med Concepts, LLC, 1837 Commons North Drive, Tuscaloosa, AL 35406, USATel +1 205 366 0696Fax +1 205 366 1451Email tsasurgery@gmail.comJournal name: Journal of Pain Research  Article Designation: CLINICAL TRIAL REPORTY ear: 2017V olume: 10Running head verso: Pridgen et alRunning head recto: IMC-1 treatment for fibromyalgiaDOI: http://dx.doi.org/10.2147/JPR.S127288",Non-OADS,/arxiv_data1/oa_pdf/8a/8f/jpr-10-451.PMC5328426.pdf
"Journal of Pain Research  2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/8a/8f/jpr-10-451.PMC5328426.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 460 Pridgen et al  12.,Non-OADS,/arxiv_data1/oa_pdf/8a/8f/jpr-10-451.PMC5328426.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/12/57/ndt-13-535.PMC5328599.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 535–541Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  535OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S12003 8 gene expression-based biological test for major  depressive disorder: an advanced study shin-ya Watanabe1 shusuke Numata1 Jun-ichi iga2 Makoto Kinoshita1 hidehiro Umehara1 Kazuo ishii3 T etsuro Ohmori1 1Department of Psychiatry,   institute of Biomedical sciences,   Tokushima University graduate  school, T okushima, 2Department  of Neuropsychiatry, Molecules  and Function, ehime University  graduate school of Medicine, ehime,   3Department of applied Biological  science, Faculty of agriculture,   Tokyo University of agriculture and  T echnology, T okyo, JapanPurpose:  Recently, we could distinguished patients with major depressive disorder (MDD)  from nonpsychiatric controls with high accuracy using a panel of five gene expression markers  (ARHGAP24, HDAC5, PDGFC, PRNP,  and SLC6A4 ) in leukocyte.",Non-OADS,/arxiv_data1/oa_pdf/12/57/ndt-13-535.PMC5328599.pdf
"Li et al7  have reported that a diagnosis of MDD was changed to bipolar disorder in 7.6%–12% of  patients initially diagnosed with MDD, with a mean time to change of 1.89–2.98 years.7  Ruggero et al8 have reported that 16.4% of participants classified as having MDD correspondence: shusuke Numata Department of Psychiatry, institute of  Biomedical sciences, T okushima University  graduate school, 3-8-15 Kuramoto-cho,  T okushima 770 8503, Japan Tel +81 886 33 7130 Fax +81 886 33 7131 email shu-numata@umin.ac.j p Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Watanabe et al Running head recto: A gene expression test for depression DOI: http://dx.doi.org/10.2147/NDT.S120038",OADS,/arxiv_data1/oa_pdf/12/57/ndt-13-535.PMC5328599.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/12/57/ndt-13-535.PMC5328599.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/12/57/ndt-13-535.PMC5328599.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/7a/84/ndt-13-567.PMC5328600.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 567–576Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  567OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S12248 3 Quality of life, self-stigma, and hope in schizophrenia  spectrum disorders: a cross-sectional study Kristyna Vrbova1 Jan Prasko1 Marie Ociskova1 Dana Kamaradova1 Marketa Marackova1 Michaela holubova1,2 ales grambal1 Milos slepecky3 Klara latalova1 1Department of Psychiatry, Faculty of  Medicine and Dentistry, University  Palacky Olomouc, University hospital  Olomouc, Olomouc, 2Department of  Psychiatry, hospital liberec, liberec,   czech republic; 3Department of  Psychology sciences, Faculty of social  science and health care, constantine  the Philosopher University in Nitra,   Nitra, slovakiaGoals:  The aim of this study was to explore the quality of life, self-stigma, personality traits,  and hope in patients with schizophrenia spectrum disorders.",Non-OADS,/arxiv_data1/oa_pdf/7a/84/ndt-13-567.PMC5328600.pdf
"Keywords:  quality of life, schizophrenia, personality traits, self-stigma, hope, depression,  anxiety Introduction Recently, as a product of an increased emphasis on patients’ experiences and their  needs, the awareness on the quality of life has been taken into account in the explora - tion of psychiatric conditions, such as schizophrenia.1 The dimension of the quality  of life offers additional information that benefits a multidimensional view in research  and treatment of severe mental disorders.2–9 Research data have found that the quality  of life is significantly reduced in schizophrenia.10–12 There are many factors that could  negatively influence the quality of life in psychiatric patients, such as age, the severity of correspondence: Kristyna Vrbova Department of Psychiatry, Faculty  of Medicine and Dentistry, University  Palacky Olomouc, University hospital  Olomouc, i.P.Pavlova 6, 775 20,  Olomouc, czech republic email krist@atlas.c z Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Vrbova et al Running head recto: Quality of life, self-stigma, and hope in schizophrenia spectrum disorders DOI: http://dx.doi.org/10.2147/NDT.S122483",Non-OADS,/arxiv_data1/oa_pdf/7a/84/ndt-13-567.PMC5328600.pdf
Available from: http://www.ema.europa.eu/docs/en_GB/ document_library/Scientific_guideline/2009/09/WC500003526.pdf.,Non-OADS,/arxiv_data1/oa_pdf/7a/84/ndt-13-567.PMC5328600.pdf
Available from: http://www.wma.net/en/30publications /.,Non-OADS,/arxiv_data1/oa_pdf/7a/84/ndt-13-567.PMC5328600.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/7a/84/ndt-13-567.PMC5328600.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/7a/84/ndt-13-567.PMC5328600.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/84/c3/ott-10-1017.PMC5328601.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 1017–1026OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1017Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S12934 3 Overexpression of the long non-coding rna,  linc-UBc1, is associated with poor prognosis and  facilitates cell proliferation, migration, and invasion  in colorectal cancer Xunfeng gao Jianfan Wen Peng gao guowei Zhang gangqing Zhang Department of general surgery,   The second People’s hospital  of guangdong Province, The  Third clinical Medical college  of southern Medical University,   guangzhou, guangdong, People’s  republic of chinaAbstract:  Long non-coding RNAs (lncRNAs) serve comprehensive roles in various diseases,  including cancer.",Non-OADS,/arxiv_data1/oa_pdf/84/c3/ott-10-1017.PMC5328601.pdf
"Therefore, correspondence: gangqing Zhang;   Jianfan Wen Department of general surgery, The  second People’s hospital of guangdong  Province, The Third clinical Medical  college of southern Medical University,  466 Xingang Middle road, guangzhou,  guangdong 510317, People’s republic  of china email z hanggangqing@yahoo.co m;  wenjianfan927@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Gao et al Running head recto: Linc-UBC1 associated with poor prognosis in colorectal cancer DOI: http://dx.doi.org/10.2147/OTT.S129343",Non-OADS,/arxiv_data1/oa_pdf/84/c3/ott-10-1017.PMC5328601.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/84/c3/ott-10-1017.PMC5328601.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/84/c3/ott-10-1017.PMC5328601.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a2/ef/ndt-13-543.PMC5328602.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 543–550Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  543OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S12966 0 analysis concerning nutritional behaviors in the  context of the risk of orthorexia Dominik Olejniczak1 Dorota Bugajec1 Mariusz Panczyk2 anna Brytek-Matera3 Urszula religioni4 aleksandra czerw1 Aleksandra Grąbczewska1 grzegorz Juszczyk1 Karolina Jabłkowska- górecka1 anna staniszewska5 1Department of Public health, Faculty  of health science, Medical University  of Warsaw, 2Division of Teaching  and Outcomes of education, Faculty  of health science, Warsaw Medical  University, 3Faculty of Psychology,   sWPs University of social sciences  and humanities, Katowice, 4collegium  of socio- economics, Warsaw  school of economics, 5Department  of experimental and clinical  Pharmacology, Medical University  of Warsaw, Warsaw, PolandAbstract:  Orthorexia is recognized as an eating disorder, an obsessive–compulsive spectrum  disorder, or a somatoform disorder.",Non-OADS,/arxiv_data1/oa_pdf/a2/ef/ndt-13-543.PMC5328602.pdf
"Banacha 1a, 01-097  Warszawa, Poland email aleksandra.czerw@wum.edu.p l Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Olejniczak et al Running head recto: Analysis of nutritional behaviors for assessing the risk of orthorexia DOI: http://dx.doi.org/10.2147/NDT.S129660",Non-OADS,/arxiv_data1/oa_pdf/a2/ef/ndt-13-543.PMC5328602.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/a2/ef/ndt-13-543.PMC5328602.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a2/ef/ndt-13-543.PMC5328602.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/3a/4a/ndt-13-557.PMC5328603.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 557–558Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  557LeTTeropen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S13258 4 Assessment of poststroke mania and diagnosis Maria Shoaib1 Muhammad Aadil2 1Department of Medicine, DOW  Medical College, Karachi, Pakistan;   2Department of Psychiatry, rush  University Medical Center, Chicago,   IL, USADear editor We would like to applaud the authors of the case report “Post-stroke emotional  incontinence or bipolar disorder?” which highlights a rare yet treatable condition of  mania and emotional incontinence after a cerebrovascular accident.",Non-OADS,/arxiv_data1/oa_pdf/3a/4a/ndt-13-557.PMC5328603.pdf
"5) The symptoms cause clinically significant distress Correspondence: Muhammad Aadil Department of Psychiatry, rush  University Medical Center, 1137 S Taylor,  Oak Park, Chicago 60304, IL, USA email muhammad.aadil9@gmail.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Letter Y ear: 2017 Volume: 13 Running head verso: Shoaib and Aadil Running head recto: Assessment of poststroke mania and diagnosis DOI: http://dx.doi.org/10.2147/NDT.S132584",Non-OADS,/arxiv_data1/oa_pdf/3a/4a/ndt-13-557.PMC5328603.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/3a/4a/ndt-13-557.PMC5328603.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/3a/4a/ndt-13-557.PMC5328603.pdf
Avail - able from: http://dsm.psychiatryonline.org/doi/book/10.1176/app i. books.9780890425596.,Non-OADS,/arxiv_data1/oa_pdf/3a/4a/ndt-13-557.PMC5328603.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/85/55/ott-10-1091.PMC5328604.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 1091–1100OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1091Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S12572 4 Decrease of mir-622 expression suppresses  migration and invasion by targeting regulation  of DYrK2 in colorectal cancer cells Y ong Wang1,* Jie sun2,* Xilin Wei3 lan luan2 Xiandong Zeng4 cuifang Wang2 Wei Zhao1 1The 4th Department of Orthopedic  surgery, central hospital affiliated to  shenyang Medical college, shenyang,   2Department of Pathology, central  hospital affiliated to shenyang  Medical college, shenyang, 3The 3rd  Department of general surgery,   central hospital affiliated to  shenyang Medical college, shenyang,   4Department of surgical Oncology,   central hospital affiliated to shenyang  Medical college, shenyang, People’s  republic of china *These authors contributed equally  to this workBackground:  More and more evidence indicates that microRNAs are present and involved  in many tumor-related diseases.",Non-OADS,/arxiv_data1/oa_pdf/85/55/ott-10-1091.PMC5328604.pdf
"Though a great deal of progress has been made,  including surgery and combined radio and chemotherapy, CRC remains a problematic  disease, with invariable manifestations of tumor recurrence, and the 5-year survival correspondence: Xiandong Zeng Department of surgical Oncology,  Central Hospital affiliated to Shenyang  Medical college, no 5, south seven West  road, Tiexi District, shenyang, liaoning  110024, People’s republic of china Tel +86 24 8571 5888 email zxd _landy1116@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Wang et al Running head recto: Decrease of miR-622 expression suppresses migration and invasion DOI: http://dx.doi.org/10.2147/OTT.S125724",Non-OADS,/arxiv_data1/oa_pdf/85/55/ott-10-1091.PMC5328604.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/85/55/ott-10-1091.PMC5328604.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/85/55/ott-10-1091.PMC5328604.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ac/79/ndt-13-551.PMC5328605.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 551–556Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  551OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S12670 6 Validation of the revised illness Perception  Questionnaire in T urkish epilepsy patients and the  effects of earthquake experience on perception  of disease selda Keskin güler1 sertac güler2 Burcu gökçe Çokal1 Nalan gunes1 Mehmet l∙lker Y on1 Tahir Kurtulus Y oldas1 1Department of Neurology,   2Department of emergency Medicine,   ankara Training and research  hospital, ankara, T urkeyObjective:  The aims of this study were to investigate the reliability of the Revised Illness  Perception Questionnaire (IPQ-R) in Turkish patients with epilepsy (PWE) and to determine  the effects of earthquake experience on the perception of disease in patients.",Non-OADS,/arxiv_data1/oa_pdf/ac/79/ndt-13-551.PMC5328605.pdf
"These cognitive models, created correspondence: selda Keskin güler Department of Neurology, ankara  Training and Research Hospital, Şükriye  District, Ulucanlar avenue, No 89, Postal  Code: 06340, Ankara, Altındag ˘, Turkey Tel +90 312 596 3000 Fax +90 312 363 3396 email keskinselda@gmail.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Keskin Güler et al Running head recto: Validation of IPQ-R in Turkish epilepsy patients DOI: http://dx.doi.org/10.2147/NDT.S12670 6",Non-OADS,/arxiv_data1/oa_pdf/ac/79/ndt-13-551.PMC5328605.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/ac/79/ndt-13-551.PMC5328605.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ac/79/ndt-13-551.PMC5328605.pdf
Available from: https://cansercontrol.canser.gov/brp/research/ constructs/illness_representations.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ac/79/ndt-13-551.PMC5328605.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d4/7d/ndt-13-577.PMC5328606.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 577–583Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  577OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S12775 2 Prefrontal cortex activation during  neuropsychological tasks might predict response  to pharmacotherapy in patients with obsessive– compulsive disorder T omoya Takeda1 satsuki sumitani2 sayo hamatani1 Y osuke Y okose3 Megumi shikata4 T etsuro Ohmori5 1Department of Psychiatry, T okushima  University hospital, 2Department of  support for students with special  Needs, institute of Biomedical  sciences, Tokushima University  graduate school, 3Taoka higashi  hospital, T okushima, 4Department of  Psychiatry, ibogawa hospital, Tatsuno,   5Department of Psychiatry, institute  of Biomedical sciences, T okushima  University graduate school,   T okushima, JapanObjective:  We investigated oxyhemoglobin change in the prefrontal cortex (PFC) of patients  with obsessive–compulsive disorder (OCD) who showed different responses to pharmacotherapy  during neuropsychological tasks with near-infrared spectroscopy.",Non-OADS,/arxiv_data1/oa_pdf/d4/7d/ndt-13-577.PMC5328606.pdf
"However, 40%–60% of OCD  patients treated with SSRIs do not have a satisfactory outcome.5 Atypical antipsy - chotics, such as risperidone, olanzapine, quetiapine, and aripiprazole, are used as an correspondence: satsuki sumitani Department of support for students with  special Needs, institute of Biomedical  sciences, Tokushima University  graduate school, 3-8-15 Kuramoto-cho,  Tokushima 770-8503, Japan Tel +81 886 337 130 Fax +81 886 337 131 email satsuki@tokushima-u.ac.j p Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Takeda et al Running head recto: NIRS during cognitive tasks might predict drug response in OCD DOI: http://dx.doi.org/10.2147/NDT.S127752",Non-OADS,/arxiv_data1/oa_pdf/d4/7d/ndt-13-577.PMC5328606.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/d4/7d/ndt-13-577.PMC5328606.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d4/7d/ndt-13-577.PMC5328606.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/28/54/ndt-13-585.PMC5328607.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 585–596Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  585Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S11478 6 Contemplating stem cell therapy for  epilepsy-induced neuropsychiatric symptoms Gautam Rao Sherwin Mashkouri David Aum Paul Marcet Cesar v Borlongan Department of Neurosurgery and  Brain Repair, Center of excellence  for Aging and Brain Repair, University  of South Florida Morsani College of  Medicine, Tampa, FL, USAAbstract:  Epilepsy is a debilitating disease that impacts millions of people worldwide.",Non-OADS,/arxiv_data1/oa_pdf/28/54/ndt-13-585.PMC5328607.pdf
"Focal seizures originate in one hemi - sphere and can be either localized in that one area or distributed to other areas.12  Correspondence: Cesar v Borlongan Center of excellence for Aging and Brain  Repair, Department of Neurosurgery and  Brain Repair, University of South Florida  Morsani College of Medicine, 12901  Bruce B Downs Blvd, MDC 78, Tampa,  FL 33612, USA Tel +1 813 974 3154 Fax +1 813 974 3078 email cborlong@health.usf.ed u Journal name: Neuropsychiatric Disease and Treatment Article Designation: Review Y ear: 2017 Volume: 13 Running head verso: Rao et al Running head recto: Stem cell therapy for epilepsy-induced neuropsychiatric symptoms DOI: http://dx.doi.org/10.2147/NDT.S114786",Non-OADS,/arxiv_data1/oa_pdf/28/54/ndt-13-585.PMC5328607.pdf
"Availlable  from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6243a2.ht m.  Accessed March 8, 2016.",OADS,/arxiv_data1/oa_pdf/28/54/ndt-13-585.PMC5328607.pdf
Available from: http://www.sciencedirect.com/science/article/pii/ B978044459544700006 8.,Non-OADS,/arxiv_data1/oa_pdf/28/54/ndt-13-585.PMC5328607.pdf
"Available from: http://www.fda.gov/ ForPatients/Approvals/Fast/default.ht m. Accessed March 3, 2016.",Non-OADS,/arxiv_data1/oa_pdf/28/54/ndt-13-585.PMC5328607.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/28/54/ndt-13-585.PMC5328607.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/28/54/ndt-13-585.PMC5328607.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/cb/ca/nss-9-031.PMC5328609.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/cb/ca/nss-9-031.PMC5328609.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Nature and Science of Sleep 2017:9 31–38Nature and Science of Sleep Dovepress submit your manuscript | www.dovepress.com Dovepress  31 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NSS.S125228Sleep-apnea risk and subclinical atherosclerosis  in early-middle-aged retired National Football  League players Faith S Luyster1 Reginald E Dunn2 Diane S Lauderdale3 Mercedes R Carnethon4 Andrew M T ucker5 Robert A Vogel6 Andrew E Lincoln2 Kristen L Knutson7 Elliot J Pellman8–10 Patrick J Strollo Jr11 1School of Nursing, University of  Pittsburgh, Pittsburgh, PA, 2Sports  Medicine Research Center, MedStar  Health Research Institute, Baltimore,  MD,  3Department of Public Health  Sciences, University of Chicago,   4Department of Preventive Medicine,   Northwestern University, Chicago, IL,   5MedStar Sports Medicine, MedStar  Union Memorial Hospital, Baltimore,  MD,  6Cardiology Section, Department  of Veterans Affairs Medical Center,  Denver, CO,  7Department of Medicine,   University of Chicago, Chicago, IL,   8ProHealth Care Associates, Lake  Success, 9Department of Medicine,   10Department of Orthopedics, Mount  Sinai School of Medicine, New Y ork,  NY,  11Department of Pulmonary,   Allergy, and Critical Care Medicine,  University of Pittsburgh Medical Center, Pittsburgh, PA, USAPurpose: Limited data from former National Football League (NFL) players suggest that  obstructive sleep apnea (OSA) may be highly prevalent after retirement.",Non-OADS,/arxiv_data1/oa_pdf/cb/ca/nss-9-031.PMC5328609.pdf
"In the present study, we compared sleep apnea Correspondence: Faith S Luyster School of Nursing, University of Pittsburgh, Room 415, 3500 Victoria Street, Pittsburgh, PA 15261, USATel +1 412 624 7910Fax +1 412 383 7293Email luysterfs@upmc.eduJournal name: Nature and Science of Sleep Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 9Running head verso: Luyster et alRunning head recto: Sleep-apnea risk in retired NFL playersDOI: http://dx.doi.org/10.2147/NSS.S125228",Non-OADS,/arxiv_data1/oa_pdf/cb/ca/nss-9-031.PMC5328609.pdf
"Nature and Science of Sleep 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Nature and Science of Sleep Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/nature-and-science-of-sleep-journalNature and Science of Sleep is an international, peer-reviewed, open  access journal covering all aspects of sleep science and sleep medicine, including the neurophysiology and functions of sleep, the genetics of sleep, sleep and society, biological rhythms, dreaming, sleep disorders and therapy, and strategies to optimize healthy sleep.",Non-OADS,/arxiv_data1/oa_pdf/cb/ca/nss-9-031.PMC5328609.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/47/27/oaem-9-031.PMC5328610.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/47/27/oaem-9-031.PMC5328610.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Open Access Emergency Medicine 2017:9 31–35Open Access Emergency Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress 31 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAEM.S129250 In-flight medical emergencies during airline  operations: a survey of physicians on the incidence,  nature, and available medical equipment Jochen Hinkelbein1,2 Christopher Neuhaus2,3 Lennert Böhm1 Steffen Kalina1 Stefan Braunecker1,2 1Department of Anaesthesiology and  Intensive Care Medicine, University  Hospital of Cologne, Cologne,   2Working group “Emergency Medicine  and Air Rescue”, German Society for Aviation and Space Medicine (DGLRM), Munich,  3Department of  Anesthesiology, Heidelberg University Hospital, Heidelberg, GermanyBackground: Data on the incidence of in-flight medical emergencies on-board civil aircraft  are uncommon and rarely published.",Non-OADS,/arxiv_data1/oa_pdf/47/27/oaem-9-031.PMC5328610.pdf
"Some studies even suggest that the frequency of these emer - gencies is rising.5 Therefore, medical issues during air travel have gained significant  interest over recent years.Correspondence: Jochen Hinkelbein Department of Anaesthesiology and Intensive Care Medicine, University Hospital of Cologne, Kerpener Str 62, D-50937 Cologne, GermanyEmail jochen.hinkelbein@uk-koeln.deTel +49 221 478 97728Journal name: Open Access Emergency Medicine Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 9Running head verso: Hinkelbein et alRunning head recto: Medical emergencies during airline operationsDOI: http://dx.doi.org/10.2147/OAEM.S129250",Non-OADS,/arxiv_data1/oa_pdf/47/27/oaem-9-031.PMC5328610.pdf
Available from: https://de.statista.com/statistik/daten/studie/12552/umfrage/befoerderte-personen-im-luftverkehr/.,OADS,/arxiv_data1/oa_pdf/47/27/oaem-9-031.PMC5328610.pdf
"Open Access Emergency Medicine 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Open Access Emergency Medicine Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/open-access-emergency-medicine-journalThe Open Access Emergency Medicine is an international, peer- reviewed, open access journal publishing original research, reports, editorials, reviews and commentaries on all aspects of emergency medicine.",Non-OADS,/arxiv_data1/oa_pdf/47/27/oaem-9-031.PMC5328610.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 35 Medical emergencies during airline operations  6.,Non-OADS,/arxiv_data1/oa_pdf/47/27/oaem-9-031.PMC5328610.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f7/45/ndt-13-559.PMC5328611.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 559–566Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  559OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S12202 4 gender differences in the association between  HTR2C  gene variants and suicidal behavior in a  Mexican population: a case–control study gabriel Molina-guzman1 Thelma Beatriz  gonzález-castro2 Yazmín hernández Díaz2 carlos alfonso T ovilla- Zárate3 isela e Juárez-rojop3 crystell guadalupe  guzmán-Priego3 alma genis4 sherezada Pool garcía5 María lilia lópez-Narvaez6 José Manuel  rodriguez-Perez7 1División académica de ciencias de la  salud, Universidad Juárez autónoma  de Tabasco, Villahermosa, 2División  académica Multidisciplinaria de  Jalpa de Méndez, Universidad Juárez  autónoma de Tabasco, Jalpa de Méndez,   3División académica Multidisciplinaria  de comalcalco, Universidad Juárez  autónoma de Tabasco, comalcalco,   Tabasco, México; 4instituto Nacional  de Medicina genómica (iNM egeN),   servicios de atención Psiquiátrica  (saP), secretaría de salud, ciudad de  México, México; 5hospital general  de comalcalco, secretaria de salud,   comalcalco, Tabasco, México; 6hospital  general de Yajalón, secretaría de salud,   Yajalón, chiapas, México; 7Departamento  de Biología Molecular, instituto Nacional  de cardiología ignacio chávez, ciudad  de México, MéxicoBackground:  The aim of this case–control study was to explore the association by gender  between the HTR2C  gene variants and suicidal behavior in a Mexican population.",Non-OADS,/arxiv_data1/oa_pdf/f7/45/ndt-13-559.PMC5328611.pdf
"Keywords:  suicide, serotonin receptor, HTR2C  gene, Mexican population, polymorphism Introduction Suicide is one of the leading causes of death throughout the world; it ranks among the  top 10 causes of death for individuals of all ages and is the leading cause of death in  males under 35 years old.1,2 A decrease in the concentrations of serotonin metabolites (in particular the sero - tonin 5-hydroxyindoleacetic) in patients with suicide behavior (suicide attempt and  suicide) suggests that the serotonergic system is associated with suicide behavior.3,4  Studies have consistently proposed that genes of the serotonergic system could play  an important role in suicide.5,6 For example, in SH-SY5Y cells, the administration  of human interferon-alpha modifies the HTR2C mRNA editing, and this could be a  mechanism of drug-induced depression or suicidal side effects in humans.7,8 It has  also been proposed that the serotonin receptor 2C ( HTR2C ) gene9,10 contributes to  suicide behavior.11 The HTR2C belongs to the family of 5-HT2 receptors, which has three members:  5-HT2A, 5-HT2B, and 5-HT2C.1 The gene that encodes the HTR2C is located on  the long arm of the X chromosome at position 24; and it contains six exons and five  introns, spanning at least 230 kb.12 One of the most common variants of the HTR2C is correspondence: carlos alfonso  Tovilla-Zárate División académica Multidisciplinaria de  comalcalco, Universidad Juárez autónoma  de Tabasco, ranchería sur, cuarta sección,  cP 86650, comalcalco, Tabasco, México email alfonso_tovillaz@yahoo.com.m x Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Molina-Guzman et al Running head recto: HTR2C  gene in a Mexican population DOI: http://dx.doi.org/10.2147/NDT.S122024",Non-OADS,/arxiv_data1/oa_pdf/f7/45/ndt-13-559.PMC5328611.pdf
Available from  http://snpper.chip.org/.,Non-OADS,/arxiv_data1/oa_pdf/f7/45/ndt-13-559.PMC5328611.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/f7/45/ndt-13-559.PMC5328611.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f7/45/ndt-13-559.PMC5328611.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d6/01/ott-10-1131.PMC5328612.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 1131–1142OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1131Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S9362 9 intrahepatic cholangiocarcinoma: current  perspectives Stefan Buettner Jeroen LA van vugt Jan NM iJzermans Bas Groot Koerkamp Department of Surgery, erasmus MC  University Medical Center, Rotterdam,   the NetherlandsAbstract:  Intrahepatic cholangiocarcinoma (ICC) is the second most common malignancy  arising from the liver.",Non-OADS,/arxiv_data1/oa_pdf/d6/01/ott-10-1131.PMC5328612.pdf
"A correlation with diseases  causing biliary inflammation and fibrosis, such as primary sclerosing cholangitis and  primary biliary cirrhosis, has been noted.13,14 Other risk factors for ICC are congenital Correspondence: Bas Groot Koerkamp Department of Surgery, erasmus  MC University Medical Center,  ’s-Gravendijkwal 230, Room H-809,  3015 Ce Rotterdam, the Netherlands Tel +31 10 703 1810 email b.grootkoerkamp@erasmusmc.n l Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2017 Volume: 10 Running head verso: Buettner et al Running head recto: Intrahepatic cholangiocarcinoma DOI: http://dx.doi.org/10.2147/OTT.S93629",Non-OADS,/arxiv_data1/oa_pdf/d6/01/ott-10-1131.PMC5328612.pdf
Available from: http://www.oncoline.nl /.,Non-OADS,/arxiv_data1/oa_pdf/d6/01/ott-10-1131.PMC5328612.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/d6/01/ott-10-1131.PMC5328612.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d6/01/ott-10-1131.PMC5328612.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/99/12/ott-10-1123.PMC5328613.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 1123–1129OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1123Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S12413 4 Diagnostic and prognostic values of contrast- enhanced ultrasound in breast cancer:  a retrospective study Yi-Xuan Zhao shuang liu Yan-Bing hu Yan-Yan ge Dong-Mei lv Department of Ultrasound, second  hospital, Jilin University, changchun,   People’s republic of chinaAbstract:  This study aimed to explore the diagnostic and prognostic values of contrast-enhanced  ultrasound (CEUS) in breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/99/12/ott-10-1123.PMC5328613.pdf
"Keywords:  contrast-enhanced ultrasound, breast cancer, diagnosis, prognosis Introduction Breast cancer is a heterogeneous disorder and currently is the most common malignancy in  females.1 Systemic symptoms of breast cancer generally include hot flashes, insomnia, and  mood changes, while its local symptoms include urogenital atrophy and vaginal dryness.2  So far, the etiology of breast cancer has not been fully understood, but it was discovered  that the development of breast cancer is associated with genetic and environmental factors  as well as obesity, while hormone replacement therapy may also lead to breast cancer.3–5  At present, traditional methods, such as sentinel lymph node biopsy, are typically used to  determine the staging of breast cancer, but they are associated with high cost and technical  complexity.6 A new technology named contrast-enhanced ultrasound (CEUS) provides  an earlier assessment of intrahepatic cholangiocarcinoma and hepatocellular carcinoma,  as well as providing a prediction of neoadjuvant chemotherapy efficiency.7correspondence: Dong-Mei lv Department of Ultrasound, second  hospital, Jilin University, 218 Ziqiang  street, nanguan District, changchun,  Jilin 130041, People’s republic of china Tel +86 0431 8897 5634 email dongmei_lvv@126.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Zhao et al Running head recto: CEUS and breast cancer DOI: http://dx.doi.org/10.2147/OTT.S124134",Non-OADS,/arxiv_data1/oa_pdf/99/12/ott-10-1123.PMC5328613.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/99/12/ott-10-1123.PMC5328613.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/99/12/ott-10-1123.PMC5328613.pdf
Available at: https://openarchive.ki.se/ xmlui/handle/10616/4177 7.,Non-OADS,/arxiv_data1/oa_pdf/99/12/ott-10-1123.PMC5328613.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/36/f5/567.PMC5328616.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/32/f4/576.PMC5328617.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/35/05/587.PMC5328618.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License(http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/d9/a8/600.PMC5328619.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Cre - ative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/a9/ee/613.PMC5328620.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/be/fc/624.PMC5328621.pdf
Two months after publication it is available to  the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Creative  Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/29/95/634.PMC5328622.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/ab/e5/645.PMC5328623.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/c0/ca/661.PMC5328624.pdf
Two months after publication it is  available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/de/70/673.PMC5328625.pdf
https://github.com/EarnshawLab/NanoRF  (accessed 20 January 2017).,Non-OADS,/arxiv_data1/oa_pdf/de/70/673.PMC5328625.pdf
Two months after publication it is  available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/fc/9c/681.PMC5328626.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f3/7f/ijn-12-1475.PMC5328660.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 1475–1483International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1475OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12504 1 enhancing the oral bioavailability of biochanin a  by encapsulation in mixed micelles containing  Pluronic F127 and Plasdone s630 Xiaoyan Wu1 Weihong ge1 T engfei shao1 Weijun Wu1 Jian hou2 li cui2 Jing Wang2 Zhenghai Zhang2 1Department of Pharmacy, The  affiliated Nanjing Drum Tower  hospital of Nanjing University Medical  school, 2Key laboratory of New Drug  Delivery system of chinese Materia  Medica, Jiangsu Provincial academy  of chinese Medicine, Nanjing, Jiangsu,   People’s republic of chinaAbstract:  Biochanin A (BCA), a natural dietary isoflavone, has been reported to show  anticancer activities.",Non-OADS,/arxiv_data1/oa_pdf/f3/7f/ijn-12-1475.PMC5328660.pdf
"Nonetheless,  they possess some limitations, such as manufacturing complexities and diseconomy in correspondence: Jing Wang Key laboratory of New Drug Delivery  system of chinese Materia Medica,  Jiangsu Provincial academy of chinese  Medicine, 100 shizi road, Nanjing, Jiangsu  210028, People’s republic of china Tel +86 25 136 7512 3890 Fax +86 25 5236 2115 email wangjing3968@126.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Wu et al Running head recto: Biochanin A micelles containing Pluronic F127 and Plasdone S630 DOI: http://dx.doi.org/10.2147/IJN.S125041",Non-OADS,/arxiv_data1/oa_pdf/f3/7f/ijn-12-1475.PMC5328660.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/f3/7f/ijn-12-1475.PMC5328660.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f3/7f/ijn-12-1475.PMC5328660.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ff/37/ijn-12-1485.PMC5328661.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 1485–1497International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1485OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12621 0 effects of nanoparticles with hydrotropic  nicotinamide on tacrolimus: permeability  through psoriatic skin and antipsoriatic and  antiproliferative activities Tao Wan* Wenhui Pan* Yueming long Kaiyue Yu sibo liu Wenyi ruan Jingtong Pan Mengyao Qin chuanbin Wu Yuehong Xu Department of Pharmaceutics,   school of Pharmaceutical sciences,   sun Yat-sen University, guangzhou,   People’s republic of china *These authors contributed equally  to this workAbstract:  The hybrid system based on nanoparticles (NPs) self-assembled by the conjugations  of hyaluronic acid with cholesterol (HA–Chol NPs) combined with nicotinamide (NIC) for  tacrolimus (FK506), ie, FK506 NPs–NIC, has been confirmed to exhibit a significant synergistic  effect on FK506 permeation through and into intact skin; thus, it may be a promising approach  for FK506 to effectively treat skin diseases.",Non-OADS,/arxiv_data1/oa_pdf/ff/37/ijn-12-1485.PMC5328661.pdf
"Keywords:  tacrolimus, nanoparticles, nicotinamide, percutaneous delivery, psoriasis,  antiproliferation Abbreviations ANOVA, analysis of variance; C6, coumarin 6; Chol, cholesterol; CLSM, confocal  laser scanning microscope; CP, clobetasol propionate; CCTCC, China Center for  Type Culture Collection; DAPI, 4 ′,6-diamidino-2-phenylindole; DMEM, Dulbecco’s  Modified Eagle’s Medium; DMSO, dimethyl sulfoxide; EDC, ethylcarbodiimide  hydrochloride; FBS, fetal bovine serum; FDA, Food and Drug Administration;  FK506, tacrolimus; HA, hyaluronic acid; HaCaT, immortalized human keratinocytes;  IL-2, interleukin-2; HE, hematoxylin and eosin; HPLC, high-performance liquid  chromatography; IMQ, imiquimod; MTT, 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl- 2-H-tetrazolium bromide; LSD, least significant difference; NF- κB, nuclear factor- κB; correspondence: Yuehong Xu Department of Pharmaceutics, school  of Pharmaceutical sciences, sun Yat-sen  University, No 132, east Out-ring road,  University Town, guangzhou 510006,  People’s republic of china Tel/fax +86 20 3994 3119 email lssxyh@mail.sysu.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Wan et al Running head recto: NPs with hydrotrope for percutaneous delivery to treat psoriasis DOI: http://dx.doi.org/10.2147/IJN.S126210",Non-OADS,/arxiv_data1/oa_pdf/ff/37/ijn-12-1485.PMC5328661.pdf
"Available from: https://www.aad.org/practice-tools/quality-care/ clinical-guidelines/psoriasis/topical-therapy/recommendations-for- topical-tacrolimus-and-pimecrolimu s. Accessed January 5, 2017.",Non-OADS,/arxiv_data1/oa_pdf/ff/37/ijn-12-1485.PMC5328661.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/ff/37/ijn-12-1485.PMC5328661.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ff/37/ijn-12-1485.PMC5328661.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e0/0e/ijn-12-1453.PMC5328662.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 1453–1464International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1453OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12203 6 superparamagnetic reconstituted high-density  lipoprotein nanocarriers for magnetically guided  drug delivery sarika sabnis1 Nirupama a sabnis1 sangram raut2 andras g lacko1,3 1Institute of cardiovascular and  Metabolic Diseases, University of  North T exas health science center,   2Department of Physics, T exas  christian University, 3Department of  Pediatrics, University of North T exas  health science center, Fort Worth,   TX, UsaAbstract:  Current cancer chemotherapy is frequently associated with short- and long-term side  effects, affecting the quality of life of cancer survivors.",Non-OADS,/arxiv_data1/oa_pdf/e0/0e/ijn-12-1453.PMC5328662.pdf
"Keywords:  drug delivery, nanoparticles, rHDL, magnetic nanoparticles, SPION Background Despite many new approaches involving gene and immunotherapy, surgery and  subsequent adjuvant chemotherapy remain the standard clinical approaches for the  management of most malignancies, the second highest cause of mortality worldwide.1–5  The efficacy of cancer chemotherapy is often limited by physical and biological barriers.6–9  These include solubility, bioavailability, pharmacokinetics and biological barriers such  as tumor microenvironment, hypoxic core and extracellular tumor pH, interstitial fluid  pressure and many other factors.9–15 Nanotechnology has been invoked as a means of  overcoming several of these difficulties.16 More specifically, cancer chemotherapy is  frequently associated with short- and long-term side effects,17–20 affecting the quality  of life of cancer survivors.21,22 To advance the state of the art in cancer therapeutics,  numerous new approaches have been developed, including active or passive targeting of  the drug to the desired site via nanocarrier drug delivery platform designed as transport - ers of anti-cancer drugs with the potential application for enhanced chemotherapy.23–26  Other localized treatment options include magnetically guided drug delivery utilizing  iron particles that can subsequently be directed to the site of the tumor.27,28 The current study involves a novel targeting approach utilizing encapsulation of the  anti-cancer drug into reconstituted high-density lipoprotein (rHDL) nanoparticles with correspondence: andras g lacko Institute of cardiovascular and metabolic  Diseases, University of North Texas  health science center, 3500 camp  Bowie Blvd, Fort Worth, TX 76107, Usa email andras.lacko@unthsc.ed u Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Sabnis et al Running head recto: Superparamagnetic rHDL nanocarriers for drug delivery DOI: http://dx.doi.org/10.2147/IJN.S122036",Non-OADS,/arxiv_data1/oa_pdf/e0/0e/ijn-12-1453.PMC5328662.pdf
"Available from: http://www.cdc.gov/nchs/data/nvsr/nvsr65/ nvsr65_02.pd f. Accessed June 10, 2016.",OADS,/arxiv_data1/oa_pdf/e0/0e/ijn-12-1453.PMC5328662.pdf
Available from: https://www.cdc.gov/nchs/data/hus/hus15.pdf#01 9.,OADS,/arxiv_data1/oa_pdf/e0/0e/ijn-12-1453.PMC5328662.pdf
"Available from: http://ww5.komen.org/BreastCancer/Short - TermSideEffectsofChemotherapy.htm l. Accessed February 8, 2016.",Non-OADS,/arxiv_data1/oa_pdf/e0/0e/ijn-12-1453.PMC5328662.pdf
"Available  from: http://www.chem.uky.edu/courses/che226/labs/050-fe_absorp - tion.pd f. Accessed September 27, 2014.",Non-OADS,/arxiv_data1/oa_pdf/e0/0e/ijn-12-1453.PMC5328662.pdf
"Available from: http://www.ihcworld.com/_protocols/ special_stains /prussian_blue.ht m. Accessed December 15, 2014.",Non-OADS,/arxiv_data1/oa_pdf/e0/0e/ijn-12-1453.PMC5328662.pdf
Malvern Instru - ments Ltd.; n. d. Available from: http://www.malvern.com/en/products/ measurement-type/zeta-potential /.,Non-OADS,/arxiv_data1/oa_pdf/e0/0e/ijn-12-1453.PMC5328662.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/e0/0e/ijn-12-1453.PMC5328662.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e0/0e/ijn-12-1453.PMC5328662.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/46/61/ijn-12-1465.PMC5328663.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 1465–1474International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1465OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11911 5 strategy for chemotherapeutic delivery using  a nanosized porous metal-organic framework  with a central composite design Yingpeng li1 Xiuyan li2 Qingxia guan2 chunjing Zhang2 Ting Xu2 Yujing Dong2 Xinyu Bai2 Weiping Zhang3 1college of Pharmacy, Tianjin  University of Traditional chinese  Medicine, Tianjin, 2college of  Pharmacy, heilongjiang University of  Traditional chinese Medicine, harbin,   People’s republic of china; 3Pope John  XXIII high school, everett, M a, UsaBackground:  Enhancing drug delivery is an ongoing endeavor in pharmaceutics, especially  when the efficacy of chemotherapy for cancer is concerned.",Non-OADS,/arxiv_data1/oa_pdf/46/61/ijn-12-1465.PMC5328663.pdf
"A considerable number of NP formulations for drug delivery have been explored, correspondence: Xiuyan li college of Pharmacy, heilongjiang  University of Traditional chinese  Medicine, heping road 24, harbin,  heilongjiang Province, People’s republic  of china Tel/fax +86 451 8726 6893 email lixiuyan211486@163.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Li et al Running head recto: NMOF strategy for chemotherapy delivery DOI: http://dx.doi.org/10.2147/IJN.S119115",Non-OADS,/arxiv_data1/oa_pdf/46/61/ijn-12-1465.PMC5328663.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/46/61/ijn-12-1465.PMC5328663.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/46/61/ijn-12-1465.PMC5328663.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/78/30/main.PMC5328681.pdf
E-mail address: jmﬁtzgerald@irelandmail.com http://dx.doi.org/10.1016/j.dadm.2016.12.013 2352-8729/ /C2112017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/78/30/main.PMC5328681.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/30/main.PMC5328681.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/69/90/main.PMC5328682.pdf
E-mail address: w.swardfager@utoronto.ca http://dx.doi.org/10.1016/j.dadm.2016.12.011 2352-8729/ /C2112017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/69/90/main.PMC5328682.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/69/90/main.PMC5328682.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ad/a7/main.PMC5328683.pdf
E-mail address: jessica.alber@lifespan.org http://dx.doi.org/10.1016/j.dadm.2017.01.005 2352-8729/ /C2112017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ad/a7/main.PMC5328683.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ad/a7/main.PMC5328683.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7e/fc/dmj-41-1.PMC5328690.pdf
"Copyright © 2017 Korean Diabetes Association http://e-dmj.orgMy Sweetheart Is Broken: Role of Glucose in Diabetic  Cardiomyopathy Manoja K. Brahma1, Mark E. Pepin1,2, Adam R. Wende1 1Division of Molecular and Cellular Pathology, Department of Pathology, 2Department of Biomedical Engineering, The University of Alabama at Birmingham,  Birmingham, AL, USA Despite overall reductions in heart disease prevalence, the risk of developing heart failure has remained 2-fold greater among  people with diabetes.",Non-OADS,/arxiv_data1/oa_pdf/7e/fc/dmj-41-1.PMC5328690.pdf
"Keywords:  Cardiomyopathies; Diabetes; Glucose; Metabolism Corresponding author: Adam R. Wende    http://orcid.org/0000-0002-5536-4675   Division of Molecular and Cellular Pathology, Department of Pathology, The University  of Alabama at Birmingham, BMR2, Office 506, 901 19th Street South, Birmingham, AL  35294-2180 USA   E-mail: adamwende@uabmc.edu Received: Sep. 23, 2016; Accepted: Oct. 11, 2016INTRODUCTION Of the numerous complications associated with diabetes, car - diovascular diseases (CVD) remain the major cause of death  [1].",Non-OADS,/arxiv_data1/oa_pdf/7e/fc/dmj-41-1.PMC5328690.pdf
Candidate  mechanisms of diabetes-induced dysfunction include: (1) in - creased reactive oxygen species (ROS); (2) increased advanced Review Complications https://doi.org/10.4093/dmj.2017.41.1.1 pISSN 2233-6079 · eISSN 2233-6087Diabetes Metab J 2017;41:1-9,Non-OADS,/arxiv_data1/oa_pdf/7e/fc/dmj-41-1.PMC5328690.pdf
"Brahma MK, et al.2 Diabetes Metab J 2017;41:1-9 http://e-dmj.orgglycation end products (AGEs); (3) increased polyol flux; (4)  increased protein kinase C (PKC) activation; (5) increased  protein O-linked N-acetylglucosamine ( O-GlcNAc); and (6)  altered gene expression [11,12].",Non-OADS,/arxiv_data1/oa_pdf/7e/fc/dmj-41-1.PMC5328690.pdf
"Glucose and heart disease3 Diabetes Metab J 2017;41:1-9 http://e-dmj.orging diabetes that appears to take place at multiple levels, in - cluding reduced glucose transport, suppressed glycolysis and  reduced PDH activity by the PDKs.",Non-OADS,/arxiv_data1/oa_pdf/7e/fc/dmj-41-1.PMC5328690.pdf
"Brahma MK, et al.4 Diabetes Metab J 2017;41:1-9 http://e-dmj.orglieved to be a major contributor of mitochondrial dysfunction  in diabetic heart.",Non-OADS,/arxiv_data1/oa_pdf/7e/fc/dmj-41-1.PMC5328690.pdf
"Glucose and heart disease5 Diabetes Metab J 2017;41:1-9 http://e-dmj.orgcrucial mediator of cardiac function in various etiologies of  cardiac dysfunction, since its activity is required for the re-se - questering of Ca2+ during diastolic relaxation [42,43].",Non-OADS,/arxiv_data1/oa_pdf/7e/fc/dmj-41-1.PMC5328690.pdf
"Brahma MK, et al.6 Diabetes Metab J 2017;41:1-9 http://e-dmj.orgsion, and altered contractile machinery and sensitivity to calci - um (Fig.",Non-OADS,/arxiv_data1/oa_pdf/7e/fc/dmj-41-1.PMC5328690.pdf
Glucose and heart disease7 Diabetes Metab J 2017;41:1-9 http://e-dmj.orgthe broken diabetic heart.,Non-OADS,/arxiv_data1/oa_pdf/7e/fc/dmj-41-1.PMC5328690.pdf
"Brahma MK, et al.8 Diabetes Metab J 2017;41:1-9 http://e-dmj.org22.",Non-OADS,/arxiv_data1/oa_pdf/7e/fc/dmj-41-1.PMC5328690.pdf
Glucose and heart disease9 Diabetes Metab J 2017;41:1-9 http://e-dmj.org43.,Non-OADS,/arxiv_data1/oa_pdf/7e/fc/dmj-41-1.PMC5328690.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/33/26/dmj-41-10.PMC5328691.pdf
"Copyright © 2017 Korean Diabetes Association http://e-dmj.orgNuclear Receptors Resolve Endoplasmic Reticulum  Stress to Improve Hepatic Insulin Resistance Jae Man Lee1,2 1Department of Biochemistry and Cell Biology, Cell and Matrix Research Institute, 2BK21 Plus KNU Biomedical Convergence Program, Department of  Biomedical Science, Kyungpook National University School of Medicine, Daegu, Korea Chronic endoplasmic reticulum (ER) stress culminating in proteotoxicity contributes to the development of insulin resistance  and progression to type 2 diabetes mellitus.",Non-OADS,/arxiv_data1/oa_pdf/33/26/dmj-41-10.PMC5328691.pdf
"Keywords:  Diabetes mellitus, type 2; Endoplasmic reticulum stress; Hepatic steatosis; Insulin resistance; Receptors, cytoplasmic  and nuclear; Unfolded protein response Corresponding author: Jae Man Lee    http://orcid.org/0000-0003-2707-5136   Department of Biochemistry and Cell Biology, Kyungpook National University School of  Medicine, 680 Gukchaebosang-ro, Jung-gu, Daegu 41944, Korea   E-mail: jaemanlee@knu.ac.kr Received: Nov. 5, 2016; Accepted: Dec. 2, 2016INTRODUCTION The endoplasmic reticulum (ER) has diverse biological func - tions associated with cellular homeostasis and whole organism  physiology.",Non-OADS,/arxiv_data1/oa_pdf/33/26/dmj-41-10.PMC5328691.pdf
For the longer-Review Pathophysiology https://doi.org/10.4093/dmj.2017.41.1.10 pISSN 2233-6079 · eISSN 2233-6087Diabetes Metab J 2017;41:10-19,Non-OADS,/arxiv_data1/oa_pdf/33/26/dmj-41-10.PMC5328691.pdf
"Nuclear receptor, endoplasmic reticulum stress, and insulin resistance11 Diabetes Metab J 2017;41:10-19 http://e-dmj.org Fig.",Non-OADS,/arxiv_data1/oa_pdf/33/26/dmj-41-10.PMC5328691.pdf
"Lee JM12 Diabetes Metab J 2017;41:10-19 http://e-dmj.orgterm response, UPR pathways rely on transcriptional mecha - nisms, typically inducing the expression of target genes encod - ing chaperones that increase ER protein-folding fidelity, and  proteins that are essential for the ERAD machinery.",Non-OADS,/arxiv_data1/oa_pdf/33/26/dmj-41-10.PMC5328691.pdf
"Nuclear receptor, endoplasmic reticulum stress, and insulin resistance13 Diabetes Metab J 2017;41:10-19 http://e-dmj.orgat Ser 51, which inhibits the activity of the guanine nucleotide  exchange factor eIF2B.",Non-OADS,/arxiv_data1/oa_pdf/33/26/dmj-41-10.PMC5328691.pdf
Lee JM14 Diabetes Metab J 2017;41:10-19 http://e-dmj.orgsulin action and systemic glucose tolerance.,Non-OADS,/arxiv_data1/oa_pdf/33/26/dmj-41-10.PMC5328691.pdf
"Nuclear receptor, endoplasmic reticulum stress, and insulin resistance15 Diabetes Metab J 2017;41:10-19 http://e-dmj.orgnovel pathway in which ER stress-dependent LRH-1 activation  induces expression of polo-like kinase 3 (Plk3) gene, which  leads to increased phosphorylation of ATF2.",Non-OADS,/arxiv_data1/oa_pdf/33/26/dmj-41-10.PMC5328691.pdf
Lee JM16 Diabetes Metab J 2017;41:10-19 http://e-dmj.orgcreased ER stress.,Non-OADS,/arxiv_data1/oa_pdf/33/26/dmj-41-10.PMC5328691.pdf
"Nuclear receptor, endoplasmic reticulum stress, and insulin resistance17 Diabetes Metab J 2017;41:10-19 http://e-dmj.org15.",Non-OADS,/arxiv_data1/oa_pdf/33/26/dmj-41-10.PMC5328691.pdf
Lee JM18 Diabetes Metab J 2017;41:10-19 http://e-dmj.orgcreased adiposity but no glucose intolerance.,Non-OADS,/arxiv_data1/oa_pdf/33/26/dmj-41-10.PMC5328691.pdf
"Nuclear receptor, endoplasmic reticulum stress, and insulin resistance19 Diabetes Metab J 2017;41:10-19 http://e-dmj.org59.",Non-OADS,/arxiv_data1/oa_pdf/33/26/dmj-41-10.PMC5328691.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/78/d2/dmj-41-20.PMC5328692.pdf
"Copyright © 2017 Korean Diabetes Association http://e-dmj.orgRe-Evaluation of Efficacy of Moderate-Intensity Statins  in Korean Patients with Type 2 Diabetes Mellitus Soo Kyoung Kim Department of Internal Medicine and Institute of Health Sciences, Gyeongsang National University Hospital, Gyeongsang National University School of  Medicine, Jinju, Korea Corresponding author: Soo Kyoung Kim    http://orcid.org/0000-0002-7230-4033 Department of Internal Medicine, Gyeongsang National University Hospital,  Gyeongsang National University School of Medicine, 79 Gangnam-ro, Jinju  52727, Korea E-mail: sookyoungendo@gnuh.co.krStatins are competitive inhibitors of 3-hydroxy-3-methylgluta - ryl-coenzyme A reductase, a rate-limiting enzyme in the cho - lesterol biosynthesis pathway [1].",Non-OADS,/arxiv_data1/oa_pdf/78/d2/dmj-41-20.PMC5328692.pdf
A genetic differ -Editorial Clinical Care/Education https://doi.org/10.4093/dmj.2017.41.1.20 pISSN 2233-6079 · eISSN 2233-6087Diabetes Metab J 2017;41:20-22,Non-OADS,/arxiv_data1/oa_pdf/78/d2/dmj-41-20.PMC5328692.pdf
Efficacy of moderate-intensity statins in Koreans 21 Diabetes Metab J 2017;41:20-22 http://e-dmj.orgence in statin metabolism could explain this ethnic difference  in LDL-lowering efficacy of statins [14].,Non-OADS,/arxiv_data1/oa_pdf/78/d2/dmj-41-20.PMC5328692.pdf
22Kim SK Diabetes Metab J 2017;41:20-22 http://e-dmj.orgatherosclerotic cardiovascular risk in adults: a report of the  American College of Cardiology/American Heart Association  Task Force on Practice Guidelines.,Non-OADS,/arxiv_data1/oa_pdf/78/d2/dmj-41-20.PMC5328692.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b9/25/dmj-41-23.PMC5328693.pdf
"Copyright © 2017 Korean Diabetes Association http://e-dmj.orgEfficacy of Moderate Intensity Statins in the Treatment  of Dyslipidemia in Korean Patients with Type 2  Diabetes Mellitus Sung Hye Kong1, Bo Kyung Koo1,2, Min Kyong Moon1,2 1Department of Internal Medicine, Seoul National University College of Medicine, Seoul,  2 Department of Internal Medicine, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul National University College of  Medicine, Seoul, Korea Background:  There has been evidences of ethnic differences in the low density lipoprotein cholesterol (LDL-C) lowering effect of  statin.",Non-OADS,/arxiv_data1/oa_pdf/b9/25/dmj-41-23.PMC5328693.pdf
"Keywords:  Diabetes mellitus, type 2; Dyslipidemia; Efficacy; Statin   Corresponding author: Min Kyong Moon    http://orcid.org/0000-0002-5460-2846   Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul  Metropolitan Government Seoul National University Boramae Medical Center, Seoul  National University College of Medicine, 20 Boramae-ro 5-gil, Dongjak-gu, Seoul 07061,  Korea   E-mail: mkmoon@snu.ac.kr Received: Apr.",Non-OADS,/arxiv_data1/oa_pdf/b9/25/dmj-41-23.PMC5328693.pdf
"In contrast, the current Original Article Clinical Care/Education https://doi.org/10.4093/dmj.2017.41.1.23 pISSN 2233-6079 · eISSN 2233-6087Diabetes Metab J 2017;41:23-30",Non-OADS,/arxiv_data1/oa_pdf/b9/25/dmj-41-23.PMC5328693.pdf
"Kong SH, et al.24 Diabetes Metab J 2017;41:23-30 http://e-dmj.orgtreatment guidelines for dyslipidemia recommended by the  Korean Society of Lipidology and Atherosclerosis, the Korean  Academy of Medical Sciences, or the Korean Diabetes Associa - tion, provide actual LDL-C target levels [8-10].",Non-OADS,/arxiv_data1/oa_pdf/b9/25/dmj-41-23.PMC5328693.pdf
Statin efficacy in Korean patients with diabetes 25 Diabetes Metab J 2017;41:23-30 http://e-dmj.orgStatistics The continuous parameters were presented as mean±standard  deviation.,OADS,/arxiv_data1/oa_pdf/b9/25/dmj-41-23.PMC5328693.pdf
"Kong SH, et al.26 Diabetes Metab J 2017;41:23-30 http://e-dmj.orgment groups (Table 2).",Non-OADS,/arxiv_data1/oa_pdf/b9/25/dmj-41-23.PMC5328693.pdf
"Statin efficacy in Korean patients with diabetes 27 Diabetes Metab J 2017;41:23-30 http://e-dmj.orgtatin 5, 10 mg, pitavastatin 2 mg, and pravastatin 40 mg  groups, respectively.",Non-OADS,/arxiv_data1/oa_pdf/b9/25/dmj-41-23.PMC5328693.pdf
"Kong SH, et al.28 Diabetes Metab J 2017;41:23-30 http://e-dmj.orgDISCUSSION In this study, treatment with a moderate-intensity statin in Ko - rean patients with T2DM achieved the LDL-C target goal  (<100 mg/dL) in 92.1% of the participants, and the LDL-C  levels were reduced by 63.0 mg/dL (−47.4% from baseline).",Non-OADS,/arxiv_data1/oa_pdf/b9/25/dmj-41-23.PMC5328693.pdf
"Statin efficacy in Korean patients with diabetes 29 Diabetes Metab J 2017;41:23-30 http://e-dmj.orgrecommended by the Korean Society of Lipidology and Ath - erosclerosis, the Korean Academy of Medical Sciences, or the  Korean Diabetes Association.",Non-OADS,/arxiv_data1/oa_pdf/b9/25/dmj-41-23.PMC5328693.pdf
"Kong SH, et al.30 Diabetes Metab J 2017;41:23-30 http://e-dmj.orgdouble-blind, 52-week trial.",Non-OADS,/arxiv_data1/oa_pdf/b9/25/dmj-41-23.PMC5328693.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/72/e4/dmj-41-31.PMC5328694.pdf
"Copyright © 2017 Korean Diabetes Association http://e-dmj.orgPractical Focus on American Diabetes Association/ European Association for the Study of Diabetes  Consensus Algorithm in Patients with Type 2 Diabetes  Mellitus: Timely Insulin Initiation and Titration (Iran- AFECT) Mohammad Ebrahim Khamseh1, Gholamreza Y ousefzadeh2, Zahra Banazadeh3, Sahar Ghareh4 1Endocrine Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Tehran,  2 Endocrinology and Metabolism Research Center, Institute of Basic and Clinic Physiology Science and Department of Internal Medicine, Kerman University  of Medical Sciences, Kerman,  3Department of Internal Medicine, Lolagar Hospital, Iran University of Medical Sciences, Tehran,  4Division of Endocrinology, Department of Internal Medicine, Faculty of Medicine, Islamic Azad University, Mashhad Medical Branch, Mashhad, Iran Background:  The aim of this study was to evaluate the safety and effectiveness of insulin glargine in a large population from a va - riety of clinical care in Iranian people with type 2 diabetes mellitus (T2DM) and to measure the percentage of patients achieving  glycosylated hemoglobin (HbA1c) <7% by the end of 24 weeks of treatment in routine clinical practice.",Non-OADS,/arxiv_data1/oa_pdf/72/e4/dmj-41-31.PMC5328694.pdf
"Keywords:  Diabetes mellitus, type 2; Hemoglobin A, glycosylated; Insulin glargine Corresponding author: Mohammad Ebrahim Khamseh    http://orcid.org/0000-0003-4313-8440   Endocrine Research Center, Institute of Endocrinology and Metabolism, Iran  University of Medical Sciences, Firouzeh St, South Vali-Asr Ave, Tehran, Iran   E-mail: khamseh.m@iums.ac.ir Received: Apr.",Non-OADS,/arxiv_data1/oa_pdf/72/e4/dmj-41-31.PMC5328694.pdf
"However, tight glycemic control is  associated with an increased risk of hypoglycemia [8,9] that  often results in poor compliance with treatment and subse - quent failure to achieve targeted glycosylated hemoglobin Original Article Clinical Care/Education https://doi.org/10.4093/dmj.2017.41.1.31 pISSN 2233-6079 · eISSN 2233-6087Diabetes Metab J 2017;41:31-37",Non-OADS,/arxiv_data1/oa_pdf/72/e4/dmj-41-31.PMC5328694.pdf
"Khamseh ME, et al.32 Diabetes Metab J 2017;41:31-37 http://e-dmj.org(HbA1c) levels [10].",Non-OADS,/arxiv_data1/oa_pdf/72/e4/dmj-41-31.PMC5328694.pdf
"Timely insulin initiation and titration33 Diabetes Metab J 2017;41:31-37 http://e-dmj.orgment, and during the study, the changes in the number of noc - turnal hypoglycemic events and the number of adverse drug  reactions (ADRs) from baseline to final visit.",Non-OADS,/arxiv_data1/oa_pdf/72/e4/dmj-41-31.PMC5328694.pdf
"Khamseh ME, et al.34 Diabetes Metab J 2017;41:31-37 http://e-dmj.orgof insulin naïve, prior insulin users, and entire participants.",Non-OADS,/arxiv_data1/oa_pdf/72/e4/dmj-41-31.PMC5328694.pdf
Timely insulin initiation and titration35 Diabetes Metab J 2017;41:31-37 http://e-dmj.orgTable 2.,Non-OADS,/arxiv_data1/oa_pdf/72/e4/dmj-41-31.PMC5328694.pdf
"Khamseh ME, et al.36 Diabetes Metab J 2017;41:31-37 http://e-dmj.orgTreatment with insulin glargine leads to a reduction of  HbA1c to 7.62% after 24 weeks of treatment.",Non-OADS,/arxiv_data1/oa_pdf/72/e4/dmj-41-31.PMC5328694.pdf
Timely insulin initiation and titration37 Diabetes Metab J 2017;41:31-37 http://e-dmj.org13.,Non-OADS,/arxiv_data1/oa_pdf/72/e4/dmj-41-31.PMC5328694.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bb/9f/dmj-41-38.PMC5328695.pdf
"Copyright © 2017 Korean Diabetes Association http://e-dmj.orgApplication of the 2013 American College of  Cardiology/American Heart Association Cholesterol  Guideline to the Korean National Health and Nutrition  Examination Surveys from 1998 to 2012 Y oung Shin Song1,2, Tae Jung Oh1,2, Kyoung Min Kim1,2, Jae Hoon Moon1,2, Sung Hee Choi1,2, Hak Chul Jang1,2,   Kyong Soo Park2, Soo Lim1,2 1Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam,  2Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea  Background:  The 2013 American College of Cardiology/American Heart Association (ACC/AHA) guideline for the treatment of  blood cholesterol recommends statin therapy for individuals at high risk of atherosclerotic cardiovascular disease (ASCVD).",Non-OADS,/arxiv_data1/oa_pdf/bb/9f/dmj-41-38.PMC5328695.pdf
"Keywords:  American Heart Association; Atherosclerosis; Cardiovascular disease; Guideline; Korea Corresponding author: Soo Lim    http://orcid.org/0000-0002-4137-1671   Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul  National University College of Medicine, 82 Gumi-ro 173beon-gil, Bundang-gu,  Seongnam 13620, Korea   E-mail: limsoo@snu.ac.kr  Received: Jun.",Non-OADS,/arxiv_data1/oa_pdf/bb/9f/dmj-41-38.PMC5328695.pdf
"Instead, the main  focus of the new guideline is identification of individuals at risk Original Article Epidemiology https://doi.org/10.4093/dmj.2017.41.1.38 pISSN 2233-6079 · eISSN 2233-6087Diabetes Metab J 2017;41:38-50",Non-OADS,/arxiv_data1/oa_pdf/bb/9f/dmj-41-38.PMC5328695.pdf
2013 ACC/AHA cholesterol guideline in Korean39 Diabetes Metab J 2017;41:38-50 http://e-dmj.orgof ASCVD for whom statin therapy may be beneficial.,Non-OADS,/arxiv_data1/oa_pdf/bb/9f/dmj-41-38.PMC5328695.pdf
The  sampling method was certified as producing representative sta -tistics by Statistics Korea (http://kostat.go.kr/portal/english/in - dex.action).,OADS,/arxiv_data1/oa_pdf/bb/9f/dmj-41-38.PMC5328695.pdf
"Song YS, et al.40 Diabetes Metab J 2017;41:38-50 http://e-dmj.orgagents was not assessed in the health interview survey because  it was considered to be very low in Korea at that time.",Non-OADS,/arxiv_data1/oa_pdf/bb/9f/dmj-41-38.PMC5328695.pdf
2013 ACC/AHA cholesterol guideline in Korean41 Diabetes Metab J 2017;41:38-50 http://e-dmj.orgTable 1.,Non-OADS,/arxiv_data1/oa_pdf/bb/9f/dmj-41-38.PMC5328695.pdf
"Song YS, et al.42 Diabetes Metab J 2017;41:38-50 http://e-dmj.orgpeople with LDL-C ≥190 mg/dL changed little (1.1% to 1.7%)  over the survey period ( P=0.922).",OADS,/arxiv_data1/oa_pdf/bb/9f/dmj-41-38.PMC5328695.pdf
2013 ACC/AHA cholesterol guideline in Korean43 Diabetes Metab J 2017;41:38-50 http://e-dmj.orgDistribution of adults eligible for statin therapy according  to sex and age groups We investigated the distribution of adults eligible for statin thera - py according to sex and age (Table 3).,Non-OADS,/arxiv_data1/oa_pdf/bb/9f/dmj-41-38.PMC5328695.pdf
"Song YS, et al.44 Diabetes Metab J 2017;41:38-50 http://e-dmj.orging agents among those with dyslipidemia was only 3.0% in  2007.",Non-OADS,/arxiv_data1/oa_pdf/bb/9f/dmj-41-38.PMC5328695.pdf
2013 ACC/AHA cholesterol guideline in Korean45 Diabetes Metab J 2017;41:38-50 http://e-dmj.orgty sampling design and give representative estimates of the Ko - rean population covering all adult ages.,Non-OADS,/arxiv_data1/oa_pdf/bb/9f/dmj-41-38.PMC5328695.pdf
Available from: http://www.who.int/gho/publications/world_ health_statistics/2015/en/index.html (updated 2015 May 14).,Non-OADS,/arxiv_data1/oa_pdf/bb/9f/dmj-41-38.PMC5328695.pdf
Available from:  http://ghdx.healthdata.org (updated 2015 Mar 10).,Non-OADS,/arxiv_data1/oa_pdf/bb/9f/dmj-41-38.PMC5328695.pdf
Available from: http://www.kostat.go.kr (updated 2015  Sep 23).,Non-OADS,/arxiv_data1/oa_pdf/bb/9f/dmj-41-38.PMC5328695.pdf
"Song YS, et al.46 Diabetes Metab J 2017;41:38-50 http://e-dmj.orgDiabetes Fact Sheet of the Korean Diabetes Association.",Non-OADS,/arxiv_data1/oa_pdf/bb/9f/dmj-41-38.PMC5328695.pdf
Available from: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bb/9f/dmj-41-38.PMC5328695.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f8/15/dmj-41-51.PMC5328696.pdf
"Copyright © 2017 Korean Diabetes Association http://e-dmj.orgRelationship between Regional Body Fat Distribution  and Diabetes Mellitus: 2008 to 2010 Korean National  Health and Nutrition Examination Surveys Soo In Choi1,*, Dawn Chung2,*, Jung Soo Lim1, Mi Y oung Lee1, Jang Y el Shin1, Choon Hee Chung1, Ji Hye Huh1 Departments of 1Internal Medicine, 2Obstetrics and Gynecology, Y onsei University Wonju College of Medicine, Wonju, Korea Background:  The aim of this study was to investigate the association between regional body fat distribution, especially leg fat  mass, and the prevalence of diabetes mellitus (DM) in adult populations.",Non-OADS,/arxiv_data1/oa_pdf/f8/15/dmj-41-51.PMC5328696.pdf
"Keywords:  Absorptiometry, photon; Body composition; Body fat distribution; Diabetes mellitus Corresponding author: Ji Hye Huh    http://orcid.org/0000-0001-5445-8007   Department of Internal Medicine, Y onsei University Wonju College of Medicine,   20 Ilsan-ro, Wonju 26426, Korea   E-mail: png1212@yonsei.ac.kr *Soo In Choi and Dawn Chung contributed equally to this study as first authors.",Non-OADS,/arxiv_data1/oa_pdf/f8/15/dmj-41-51.PMC5328696.pdf
[6] reported adverse risk for metabolic dis -Original Article Obesity and Metabolic Syndrome https://doi.org/10.4093/dmj.2017.41.1.51 pISSN 2233-6079 · eISSN 2233-6087Diabetes Metab J 2017;41:51-59,Non-OADS,/arxiv_data1/oa_pdf/f8/15/dmj-41-51.PMC5328696.pdf
"Choi SI, et al.52 Diabetes Metab J 2017;41:51-59 http://e-dmj.orgorder with high trunk adiposity, but high leg adiposity was as - sociated with a decreased risk of having two or more cardio - metabolic risk factors in both African American and white  adults.",Non-OADS,/arxiv_data1/oa_pdf/f8/15/dmj-41-51.PMC5328696.pdf
"Association between body fat distribution and DM53 Diabetes Metab J 2017;41:51-59 http://e-dmj.orgMN, USA) using a γ-counter (1470 Wizard; PerkinElmer,  Turku, Finland).",Non-OADS,/arxiv_data1/oa_pdf/f8/15/dmj-41-51.PMC5328696.pdf
"Choi SI, et al.54 Diabetes Metab J 2017;41:51-59 http://e-dmj.orgue of leg fat mass and leg muscle mass: HF-LM, HF-HM, LF- LM, and LF-HM.",Non-OADS,/arxiv_data1/oa_pdf/f8/15/dmj-41-51.PMC5328696.pdf
Association between body fat distribution and DM55 Diabetes Metab J 2017;41:51-59 http://e-dmj.orgcle mass; but subjects with lower leg fat mass have a higher risk  of DM even though they have large leg muscle mass.,Non-OADS,/arxiv_data1/oa_pdf/f8/15/dmj-41-51.PMC5328696.pdf
"Choi SI, et al.56 Diabetes Metab J 2017;41:51-59 http://e-dmj.orging that leg fat mass was inversely associated with glucose lev - els and homeostatic model assessment of insulin resistance  from an oral glucose tolerance test [7].",Non-OADS,/arxiv_data1/oa_pdf/f8/15/dmj-41-51.PMC5328696.pdf
Association between body fat distribution and DM57 Diabetes Metab J 2017;41:51-59 http://e-dmj.orgtissue has lower gene expression of total adiponectin than sub - cutaneous depots.,Non-OADS,/arxiv_data1/oa_pdf/f8/15/dmj-41-51.PMC5328696.pdf
"Choi SI, et al.58 Diabetes Metab J 2017;41:51-59 http://e-dmj.orgBales VS, Marks JS.",Non-OADS,/arxiv_data1/oa_pdf/f8/15/dmj-41-51.PMC5328696.pdf
"Association between body fat distribution and DM59 Diabetes Metab J 2017;41:51-59 http://e-dmj.orgY amashita S, Noda M, Kita S, Ueki K, Eto K, Akanuma Y ,  Froguel P , Foufelle F, Ferre P , Carling D, Kimura S, Nagai R,  Kahn BB, Kadowaki T. Adiponectin stimulates glucose utiliza - tion and fatty-acid oxidation by activating AMP-activated pro - tein kinase.",Non-OADS,/arxiv_data1/oa_pdf/f8/15/dmj-41-51.PMC5328696.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/00/f9/dmj-41-60.PMC5328697.pdf
"Copyright © 2017 Korean Diabetes Association http://e-dmj.orgSerum Calcium and the Risk of Incident Metabolic  Syndrome: A 4.3-Y ear Retrospective Longitudinal  Study  Jong Ha Baek1,2,*, Sang-Man Jin1,*, Ji Cheol Bae3, Jae Hwan Jee4, Tae Y ang Yu1, Soo Kyoung Kim5, Kyu Y eon Hur1,   Moon-Kyu Lee1, Jae Hyeon Kim1 1Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul,  2 Division of Endocrinology and Metabolism, Department of Internal Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National  University School of Medicine, Changwon,  3 Division of Endocrinology and Metabolism, Department of Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine,  Changwon,  4Department of Health Promotion Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, 5Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University School of Medicine, Jinju, Korea Background:  An association between serum calcium level and risk of metabolic syndrome (MetS) has been suggested in cross- sectional studies.",Non-OADS,/arxiv_data1/oa_pdf/00/f9/dmj-41-60.PMC5328697.pdf
"Keywords:  Calcium; Longitudinal studies; Metabolic syndrome; Obesity, abdominal Corresponding author: Jae Hyeon Kim    http://orcid.org/0000-0001-5001-963X   Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of  Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 06351, Korea   E-mail: jaehyeon@skku.edu *Jong Ha Baek and Sang-Man Jin contributed equally to this study as first authors.",Non-OADS,/arxiv_data1/oa_pdf/00/f9/dmj-41-60.PMC5328697.pdf
Abdominal obesity is the most prevalent Original Article Obesity and Metabolic Syndrome https://doi.org/10.4093/dmj.2017.41.1.60 pISSN 2233-6079 · eISSN 2233-6087Diabetes Metab J 2017;41:60-68,Non-OADS,/arxiv_data1/oa_pdf/00/f9/dmj-41-60.PMC5328697.pdf
"Serum calcium and the risk of metabolic syndrome61 Diabetes Metab J 2017;41:60-68 http://e-dmj.orgmanifestation of MetS [7], and obese patients with MetS are at  higher risk of cardiovascular disease than non-obese patients  with MetS [8].",Non-OADS,/arxiv_data1/oa_pdf/00/f9/dmj-41-60.PMC5328697.pdf
"Baek JH, et al.62 Diabetes Metab J 2017;41:60-68 http://e-dmj.orgor more of the following criteria were classified as having MetS:  (1) WC ≥90 cm in men or ≥80 cm in women; (2) triglycerides  (TG) ≥150 mg/dL; (3) high density lipoprotein cholesterol  (HDL-C) <40 mg/dL in men or <50 mg/dL in women; (4) ele - vated blood pressure (systolic blood pressure [SBP] ≥130 mm  Hg and/or diastolic blood pressure [DBP] ≥85 mm Hg) or be - ing on anti-hypertensive medications; or (5) fasting serum glu - cose (FPG) ≥100 mg/dL or being treated for diabetes [19].",Non-OADS,/arxiv_data1/oa_pdf/00/f9/dmj-41-60.PMC5328697.pdf
"The homeo - stasis model assessment 2 of insulin resistance (HOMA2-IR) calculation was based on model-derived estimates (rather than  linear approximations) using the HOMA2 calculator version  2.2.3 (Diabetes Trials Unit, University of Oxford, Oxford, UK;  http://www.dtu.ox.ac.uk/homacalculator/download.php) [21].",OADS,/arxiv_data1/oa_pdf/00/f9/dmj-41-60.PMC5328697.pdf
"Serum calcium and the risk of metabolic syndrome63 Diabetes Metab J 2017;41:60-68 http://e-dmj.orgRESULTS Albumin-corrected serum calcium levels and metabolic  conditions at baseline Of all subjects ( n=12,706), the mean age was 51 years and  6,873 (54.1%) were men.",Non-OADS,/arxiv_data1/oa_pdf/00/f9/dmj-41-60.PMC5328697.pdf
"Baek JH, et al.64 Diabetes Metab J 2017;41:60-68 http://e-dmj.orgmodel ( P for trend=0.001) (Table 3).",OADS,/arxiv_data1/oa_pdf/00/f9/dmj-41-60.PMC5328697.pdf
Serum calcium and the risk of metabolic syndrome65 Diabetes Metab J 2017;41:60-68 http://e-dmj.orgTable 4.,Non-OADS,/arxiv_data1/oa_pdf/00/f9/dmj-41-60.PMC5328697.pdf
"Baek JH, et al.66 Diabetes Metab J 2017;41:60-68 http://e-dmj.orgDISCUSSION In this retrospective longitudinal cohort study, the positive  correlation between serum calcium and MetS observed in pre - vious cross-sectional studies was not found.",OADS,/arxiv_data1/oa_pdf/00/f9/dmj-41-60.PMC5328697.pdf
Serum calcium and the risk of metabolic syndrome67 Diabetes Metab J 2017;41:60-68 http://e-dmj.org2.,Non-OADS,/arxiv_data1/oa_pdf/00/f9/dmj-41-60.PMC5328697.pdf
"Baek JH, et al.68 Diabetes Metab J 2017;41:60-68 http://e-dmj.org23.",Non-OADS,/arxiv_data1/oa_pdf/00/f9/dmj-41-60.PMC5328697.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f9/24/dmj-41-69.PMC5328698.pdf
"Copyright © 2017 Korean Diabetes Association http://e-dmj.orgExenatide versus Insulin Lispro Added to Basal Insulin  in a Subgroup of Korean Patients with Type 2 Diabetes  Mellitus Kun-Ho Y oon1, Elise Hardy2, Jenny Han3 1 Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of  Korea, Seoul, Korea,  2AstraZeneca, Gaithersburg, MD,  3Pharmapace, San Diego, CA, USA Background:  The prevalence of type 2 diabetes mellitus (T2DM) and obesity is increasing in Korea.",Non-OADS,/arxiv_data1/oa_pdf/f9/24/dmj-41-69.PMC5328698.pdf
"Keywords:  Diabetes mellitus, type 2; Exenatide; Insulin lispro Corresponding author: Kun-Ho Y oon    http://orcid.org/0000-0002-9109-2208   Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St.  Mary’s Hospital, College of Medicine, The Catholic University of Korea, 222 Banpo- daero, Seocho-gu, Seoul 06591, Korea   E-mail: yoonk@catholic.ac.kr Received: Apr.",Non-OADS,/arxiv_data1/oa_pdf/f9/24/dmj-41-69.PMC5328698.pdf
One such option includes the combination of basal Original Article Others https://doi.org/10.4093/dmj.2017.41.1.69 pISSN 2233-6079 · eISSN 2233-6087Diabetes Metab J 2017;41:69-74,Non-OADS,/arxiv_data1/oa_pdf/f9/24/dmj-41-69.PMC5328698.pdf
"Y oon KH, et al.70 Diabetes Metab J 2017;41:69-74 http://e-dmj.orginsulin and a glucagon-like peptide-1 receptor agonist (GLP- 1RA).",Non-OADS,/arxiv_data1/oa_pdf/f9/24/dmj-41-69.PMC5328698.pdf
Exenatide versus insulin lispro in Korean patients71 Diabetes Metab J 2017;41:69-74 http://e-dmj.orgdaily and 13 received three times daily mealtime insulin lispro.,Non-OADS,/arxiv_data1/oa_pdf/f9/24/dmj-41-69.PMC5328698.pdf
"Y oon KH, et al.72 Diabetes Metab J 2017;41:69-74 http://e-dmj.orgcurred most often with insulin lispro.",Non-OADS,/arxiv_data1/oa_pdf/f9/24/dmj-41-69.PMC5328698.pdf
Exenatide versus insulin lispro in Korean patients73 Diabetes Metab J 2017;41:69-74 http://e-dmj.orgtreatment with insulin lispro resulted in weight gain (2.1 kg)  [12].,Non-OADS,/arxiv_data1/oa_pdf/f9/24/dmj-41-69.PMC5328698.pdf
"Y oon KH, et al.74 Diabetes Metab J 2017;41:69-74 http://e-dmj.orgfees from Boehringer Ingelheim, Eli Lilly, Merck, Novartis,  Novo Nordisk, and Takeda.",Non-OADS,/arxiv_data1/oa_pdf/f9/24/dmj-41-69.PMC5328698.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/37/4b/dmj-41-75.PMC5328699.pdf
"Copyright © 2017 Korean Diabetes Association http://e-dmj.orgClinical Course and Risk Factors of Diabetic  Retinopathy in Patients with Type 2 Diabetes Mellitus  in Korea ( Diabetes Metab J  2016;40:482-93) Nam Hoon Kim  Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea  Corresponding author: Nam Hoon Kim    http://orcid.org/0000-0002-9926-1344 Division of Endocrinology and Metabolism, Department of Internal  Medicine, Korea University Anam Hospital, Korea University College of  Medicine, 73 Inchon-ro, Seongbuk-gu, Seoul 02841, Korea E-mail: pourlife@naver.comDiabetic retinopathy (DR) is a common and important micro - vascular complication that occurs in patients with either type 1  or type 2 diabetes mellitus, and remains the leading cause of  visual loss in the general population.",Non-OADS,/arxiv_data1/oa_pdf/37/4b/dmj-41-75.PMC5328699.pdf
Blood pressure control is known to be Letter https://doi.org/10.4093/dmj.2017.41.1.75 pISSN 2233-6079 · eISSN 2233-6087Diabetes Metab J 2017;41:75-76,Non-OADS,/arxiv_data1/oa_pdf/37/4b/dmj-41-75.PMC5328699.pdf
76Kim NH Diabetes Metab J 2017;41:75-76 http://e-dmj.orgclosely associated with DR development or progression; 10  mm Hg decrease in systolic blood pressure roughly decreased  the risk of DR progression by 35% [8].,Non-OADS,/arxiv_data1/oa_pdf/37/4b/dmj-41-75.PMC5328699.pdf
http://doi.org/10.1056/NEJMoa1607141.,Non-OADS,/arxiv_data1/oa_pdf/37/4b/dmj-41-75.PMC5328699.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9c/18/dmj-41-77.PMC5328700.pdf
"Copyright © 2017 Korean Diabetes Association http://e-dmj.orgClinical Course and Risk Factors of Diabetic  Retinopathy in Patients with Type 2 Diabetes Mellitus  in Korea ( Diabetes Metab J  2016;40:482-93)  Jae-Seung Yun, Seung-Hyun Ko Division of Endocrinology and Metabolism, Department of Internal Medicine, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea,  Seoul, Korea Corresponding author: Seung-Hyun Ko     http://orcid.org/0000-0003-3703-1479   Division of Endocrinology and Metabolism, Department of Internal  Medicine, St. Vincent's Hospital, College of Medicine, The Catholic University  of Korea, 93 Jungbu-daero, Paldal-gu, Suwon 16247, Korea  E-mail: wgato@georgiasouthern.edu We sincerely appreciate the interests and comments on our  study, “Clinical course and risk factors of diabetic retinopathy in  patients with type 2 diabetes mellitus in Korea” which was pub - lished in Diabetes & Metabolism Journal .",Non-OADS,/arxiv_data1/oa_pdf/9c/18/dmj-41-77.PMC5328700.pdf
Response https://doi.org/10.4093/dmj.2017.41.1.77 pISSN 2233-6079 · eISSN 2233-6087Diabetes Metab J 2017;41:77-78,Non-OADS,/arxiv_data1/oa_pdf/9c/18/dmj-41-77.PMC5328700.pdf
Diabetes Metab J 2017;41:77-78 http://e-dmj.orgCONFLICTS OF INTEREST  No potential conflict of interest relevant to this article was re - ported.,Non-OADS,/arxiv_data1/oa_pdf/9c/18/dmj-41-77.PMC5328700.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/38/5d/dmj-41-79.PMC5328701.pdf
"Copyright © 2017 Korean Diabetes Association http://e-dmj.orgCorrigendum https://doi.org/10.4093/dmj.2017.41.1.79 pISSN 2233-6079 · eISSN 2233-6087Diabetes Metab J 2017;41:79 Corrigendum: Author ORCID Number Correction Dietary Sodium Intake in Patients with Type 2  Diabetes Mellitus Mi-Kyung Kim Division of Endocrinology and Metabolism, Department of Internal Medicine, Keimyung University School of Medicine, Daegu, Korea Diabetes Metab J 2016;40:280-282. https://doi.org/10.4093/dmj.2016.40.4.280 Author ORCID number was misprinted.",Non-OADS,/arxiv_data1/oa_pdf/38/5d/dmj-41-79.PMC5328701.pdf
The author ORCID number should be corrected as follows:  http://orcid.org/0000-0001-5750-3598 .,Non-OADS,/arxiv_data1/oa_pdf/38/5d/dmj-41-79.PMC5328701.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.11.018,Non-OADS,/arxiv_data1/oa_pdf/95/ec/main.PMC5328702.pdf
MALDI-TOF MS spectrum The MALDI-TOF MS spectrum of ‘Colibacter massiliensis ’strain Marseille-P2911Tis available online ( http://www.mediterranee- infection.com/article.php?laref=256&titre=urms-database ).,OADS,/arxiv_data1/oa_pdf/95/ec/main.PMC5328702.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,17,2 3 –24 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/95/ec/main.PMC5328702.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4b/09/main.PMC5328703.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.c om/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2017.02.006 2213-0071/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/4b/09/main.PMC5328703.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 20 (2017) 164 e167,Non-OADS,/arxiv_data1/oa_pdf/4b/09/main.PMC5328703.pdf
"33 (7) (2013) 1655 e1667, http://dx.doi.org/ 10.1007/s00296-012-2659-y .",Non-OADS,/arxiv_data1/oa_pdf/4b/09/main.PMC5328703.pdf
"Lynch, Raised pulmonary artery pressures measured with Doppler echocardiography in rheumatoid arthritispatients, Rheumatology 39 (12) (2000) 1320 e1325, http://dx.doi.org/10.1093/ rheumatology/39.12.1320 .",Non-OADS,/arxiv_data1/oa_pdf/4b/09/main.PMC5328703.pdf
"24 (135) (2015) 1 e16,http://dx.doi.org/10.1183/ 09059180.00008014 .",Non-OADS,/arxiv_data1/oa_pdf/4b/09/main.PMC5328703.pdf
"363 (2010) 620 e628, http://dx.doi.org/10.1056/NEJMoa1002110 .",Non-OADS,/arxiv_data1/oa_pdf/4b/09/main.PMC5328703.pdf
"31 (6) (2008) 1357 e1367, http://dx.doi.org/10.1183/ 09031936.00171307 .",Non-OADS,/arxiv_data1/oa_pdf/4b/09/main.PMC5328703.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.12.010,Non-OADS,/arxiv_data1/oa_pdf/99/1d/main.PMC5328704.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,17,2 1 –22 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/99/1d/main.PMC5328704.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.12.009,Non-OADS,/arxiv_data1/oa_pdf/17/3e/main.PMC5328705.pdf
MALDI-TOF MS spectrum The MALDI-TOF MS spectrum of ‘Traorella massiliensis ’strain Marseille-P3110Tis available online ( http://www.mediterranee- infection.com/article.php?laref=256&titre=urms-database ).,OADS,/arxiv_data1/oa_pdf/17/3e/main.PMC5328705.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,17,1 3 –14 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/17/3e/main.PMC5328705.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious DiseasesThis is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.11.002,Non-OADS,/arxiv_data1/oa_pdf/c0/f0/main.PMC5328706.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,17,3 6 –38 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/c0/f0/main.PMC5328706.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,17,3 6 –38 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/c0/f0/main.PMC5328706.pdf
"In addition to astrogliosis, the activation of microglia, the innate http://dx.doi.org/10.1016/j.redox.2017.02.016 Received 13 January 2017; Received in revised form 12 February 2017; Accepted 21 February 2017⁎Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/c2/f1/main.PMC5328707.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c2/f1/main.PMC5328707.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.11.015,Non-OADS,/arxiv_data1/oa_pdf/8a/02/main.PMC5328708.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,17,3 3 –35 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/8a/02/main.PMC5328708.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,17,3 3 –35 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/8a/02/main.PMC5328708.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.11.023,Non-OADS,/arxiv_data1/oa_pdf/a0/76/main.PMC5328710.pdf
MALDI-TOF MS spectrum The MALDI-TOF MS spectrum of ‘Colidextribacter massiliensis ’ strain Marseille-P23083Tis available online ( http://www.mediterranee-infection.com/article.php?laref=256&titre=urms- database ).,OADS,/arxiv_data1/oa_pdf/a0/76/main.PMC5328710.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,17,2 7 –29 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/a0/76/main.PMC5328710.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,17,2 7 –29 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/a0/76/main.PMC5328710.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious DiseasesThis is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.11.021,Non-OADS,/arxiv_data1/oa_pdf/54/ac/main.PMC5328711.pdf
MALDI-TOF MS spectrum The MALDI-TOF MS spectrum of ‘Caecibacter massiliensis ’ strain Marseille-P2974Tis available online ( http://www.Megasphaera paucivorans  (NR 043657) Megasphaera sueciensis  ( NR 043656) Megasphaera cerevisiae  (LC037207) Anaeroglobus geminatus  (NR 028812) Megasphaera massiliensis  (NR 133027) Megasphaera indica  (NR 134080) Megasphaera elsdenii  (NR 102980) Caecibacter massiliensis (LT576402)  Veillonella ratti  (NR 113377) Veillonella criceti  (NR 113376)  Veillonella magna  ( NR 044400) Veillonella atypica  (NR 119170) Veillonella parvula  (NR 074980)  Veillonella tobetsuensis  (NR 113570)  Veillonella denticariosi   (NR 044153)  Veillonella dispar  ( NR 115355)  Sporomusa malonica  (NR 117652) Selenomonas bovis  (NR 044111) Mitsuokella multacida  ( LC036321) Dialister micraerophilus  (NR 113356) Dialister succinatiphilus  (NR 041666) Dialister invisus  (NR 113355) Dialister pneumosintes  (LC037225) Allisonella histaminiformans  (NR 028862)100 9994100 100 100 10093 100100  98 100  100 0.02  FIG.,Non-OADS,/arxiv_data1/oa_pdf/54/ac/main.PMC5328711.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,17,3 0 –32 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/54/ac/main.PMC5328711.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,17,3 0 –32 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/54/ac/main.PMC5328711.pdf
"1 , A), di ﬀuse in ﬁltrate of the http://dx.doi.org/10.1016/j.lrr.2017.01.001 Received 23 October 2016; Accepted 15 January 2017⁎Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/5e/10/main.PMC5328712.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/5e/10/main.PMC5328712.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.11.016,Non-OADS,/arxiv_data1/oa_pdf/03/bb/main.PMC5328713.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,17,1 1 –12 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/03/bb/main.PMC5328713.pdf
http://dx.doi.org/10.1016/j.pmedr.2017.02.015 2211-3355/© 2017 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/70/28/main.PMC5328714.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/70/28/main.PMC5328714.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/70/28/main.PMC5328714.pdf
New Microbe and New Infect 2017; 17:18–20 © 2016 Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious DiseasesThis is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.12.008,Non-OADS,/arxiv_data1/oa_pdf/a2/47/main.PMC5328715.pdf
"‘Intestinibacillus massiliensis ’ 19 © 2016 Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,17,1 8 –20 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/a2/47/main.PMC5328715.pdf
"Int J Syst Evol Microbiol 2014;64:346 –51.20 New Microbes and New Infections , Volume 17 Number C, May 2017 NMNI © 2016 Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,17,1 8 –20 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/a2/47/main.PMC5328715.pdf
Most notably there was an increase in http://dx.doi.org/10.1016/j.redox.2017.01.025 Received 22 November 2016; Received in revised form 17 January 2017; Accepted 19 January 2017⁎Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/1e/6a/main.PMC5328717.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1e/6a/main.PMC5328717.pdf
Supplementary material Supplementary data associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.redox.2017.01.025 .,OADS,/arxiv_data1/oa_pdf/1e/6a/main.PMC5328717.pdf
Available from: 〈http://www.who.int/medicines/publications/essentialmedicines/ en/ 〉.,Non-OADS,/arxiv_data1/oa_pdf/1e/6a/main.PMC5328717.pdf
http://dx.doi.org/ 10.1021/ac401559v .,Non-OADS,/arxiv_data1/oa_pdf/1e/6a/main.PMC5328717.pdf
http://dx.doi.org/10.1016/j.pmedr.2017.02.001 2211-3355/Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/d1/0b/main.PMC5328718.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d1/0b/main.PMC5328718.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/d1/0b/main.PMC5328718.pdf
"Available from: https://wwwn.cdc.gov/hivrisk/decreased_risk/communication/same_status.html S m i t h ,B .",OADS,/arxiv_data1/oa_pdf/d1/0b/main.PMC5328718.pdf
http://www.census.gov/newsroom/press-releases/2014/ cb14-17.html .,OADS,/arxiv_data1/oa_pdf/d1/0b/main.PMC5328718.pdf
http://www.cdc.gov/hepatitis/HCV/HCVfaq.htm .U.S.,Non-OADS,/arxiv_data1/oa_pdf/d1/0b/main.PMC5328718.pdf
http://dx.doi.org/10.1016/j.lrr.2017.01.003 Received 4 August 2015; Accepted 15 January 2017⁎Corresponding author.,OADS,/arxiv_data1/oa_pdf/d0/e8/main.PMC5328719.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d0/e8/main.PMC5328719.pdf
"Under the constraints of increased and/or external stress factors, however, elevated accumulation of autophagicvacuoles and organelle elimination renders the cell incapable of normal http://dx.doi.org/10.1016/j.redox.2017.01.024 Received 18 October 2016; Received in revised form 7 January 2017; Accepted 11 January 2017⁎Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/05/84/main.PMC5328722.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/05/84/main.PMC5328722.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.12.012,Non-OADS,/arxiv_data1/oa_pdf/f1/45/main.PMC5328723.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,17,1 5 –17 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/f1/45/main.PMC5328723.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,17,1 5 –17 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/f1/45/main.PMC5328723.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.11.022,Non-OADS,/arxiv_data1/oa_pdf/16/01/main.PMC5328724.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,17,2 5 –26 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/16/01/main.PMC5328724.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/ licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/82/da/je-27-049.PMC5328726.pdf
Contents lists available at ScienceDirect Journal of Epidemiology journal homepage: http://www.journals.e lsevier.com/journal- of-epidemiology/ http://dx.doi.org/10.1016/j.je.2016.09.003 0917-5040/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/82/da/je-27-049.PMC5328726.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Journal of Epidemiology 27 (2017) 49 e55,Non-OADS,/arxiv_data1/oa_pdf/82/da/je-27-049.PMC5328726.pdf
2012 Aug;1(1):55 e82 [cited 2012 Aug 29] Available from: http://www.degruyter.com/view/j/em.2012.1.issue-1/2161-962X.1004/ 2161-962X.1004.xml?format ¼INT.,OADS,/arxiv_data1/oa_pdf/82/da/je-27-049.PMC5328726.pdf
6 [4 p.] [cited 2009 Sep 4] Available from: http://archive.biomedcentral.com/1742-5573/6/4.,OADS,/arxiv_data1/oa_pdf/82/da/je-27-049.PMC5328726.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/ licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/fa/ff/je-27-056.PMC5328727.pdf
Contents lists available at ScienceDirect Journal of Epidemiology journal homepage: http://w ww.journals.elsevier.com/j ournal-of-epidemiology/ http://dx.doi.org/10.1016/j.je.2016.09.004 0917-5040/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/fa/ff/je-27-056.PMC5328727.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Journal of Epidemiology 27 (2017) 56 e62,Non-OADS,/arxiv_data1/oa_pdf/fa/ff/je-27-056.PMC5328727.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a9/d7/je-27-063.PMC5328728.pdf
Contents lists available at ScienceDirect Journal of Epidemiology journal homepage: http://www.journals.e lsevier.com/journal- of-epidemiology/ http://dx.doi.org/10.1016/j.je.2016.09.006 0917-5040/ ©2016 Publishing services by Elsevier B.V. on behalf of The Japan Epidemiological Association.,Non-OADS,/arxiv_data1/oa_pdf/a9/d7/je-27-063.PMC5328728.pdf
This is an open access article under the CC BY-NC-ND lic ense (http://creativecommons.org/licenses/by-nc-nd/4.0/).Journal of Epidemiology 27 (2017) 63 e68,Non-OADS,/arxiv_data1/oa_pdf/a9/d7/je-27-063.PMC5328728.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/ licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2d/c5/je-27-069.PMC5328729.pdf
Contents lists available at ScienceDirect Journal of Epidemiology journal homepage: http://www.journals.e lsevier.com/journal- of-epidemiology/ http://dx.doi.org/10.1016/j.je.2016.09.002 0917-5040/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2d/c5/je-27-069.PMC5328729.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Journal of Epidemiology 27 (2017) 69 e74,Non-OADS,/arxiv_data1/oa_pdf/2d/c5/je-27-069.PMC5328729.pdf
International Standard Classi ﬁcation of Occu- pations (ISCO-88) ; 2008. http://laborsta.ilo.org/applv8/data/isco88e.html.,OADS,/arxiv_data1/oa_pdf/2d/c5/je-27-069.PMC5328729.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/ licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/e5/e7/je-27-075.PMC5328730.pdf
Contents lists available at ScienceDirect Journal of Epidemiology journal homepage: http://www.journals.e lsevier.com/journal- of-epidemiology/ http://dx.doi.org/10.1016/j.je.2016.09.007 0917-5040/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e5/e7/je-27-075.PMC5328730.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Journal of Epidemiology 27 (2017) 75 e79,Non-OADS,/arxiv_data1/oa_pdf/e5/e7/je-27-075.PMC5328730.pdf
"Available at: http://www.mhlw.go.jp/english/database/db-hss/cslc.html (accessed on Nov 6, 2015).",OADS,/arxiv_data1/oa_pdf/e5/e7/je-27-075.PMC5328730.pdf
"Available at: http://www.mhlw.go.jp/ toukei/list/20-19-1.html (accessed on Nov 6, 2015) (in Japanese).",Non-OADS,/arxiv_data1/oa_pdf/e5/e7/je-27-075.PMC5328730.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/ licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ac/12/je-27-080.PMC5328731.pdf
Contents lists available at ScienceDirect Journal of Epidemiology journal homepage: http://w ww.journals.elsevier.com/j ournal-of-epidemiology/ http://dx.doi.org/10.1016/j.je.2016.09.005 0917-5040/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ac/12/je-27-080.PMC5328731.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Journal of Epidemiology 27 (2017) 80 e86,Non-OADS,/arxiv_data1/oa_pdf/ac/12/je-27-080.PMC5328731.pdf
Retrieved from http://www.maastrichtuniversity.nl/web/ ﬁle?uuid¼d101b63c-dbbe-472d-971f-7a4eae14ba47 &owner ¼d5b3681e-fc4a- 476e-b9ff-a807c26760b9.,Non-OADS,/arxiv_data1/oa_pdf/ac/12/je-27-080.PMC5328731.pdf
http://dx.doi.org/10.1093/eurpub/ckv043.,Non-OADS,/arxiv_data1/oa_pdf/ac/12/je-27-080.PMC5328731.pdf
Retrieved from http://unstats.un.org/unsd/demographic/ sources/census/2010_phc/Myanmar/MMR-2015-05.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ac/12/je-27-080.PMC5328731.pdf
20 September 2016 Available online 21 December 2016 Contents lists available at ScienceDirect Journal of Epidemiology journal homepage: http://www.journals.e lsevier.com/journal- of-epidemiology/ Journal of Epidemiology 27 (2017) 1 http://dx.doi.org/10.1016/j.je.2016.10.001 0917-5040/ ©2016 Publishing services by Elsevier B.V. on behalf of The Japan Epidemiological Association.,Non-OADS,/arxiv_data1/oa_pdf/dc/aa/je-27-001.PMC5328732.pdf
This is an open access article under the CC BY-NC-ND lic ense (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/dc/aa/je-27-001.PMC5328732.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/ licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/be/45/je-27-002.PMC5328733.pdf
Contents lists available at ScienceDirect Journal of Epidemiology journal homepage: http://w ww.journals.elsevier.com/j ournal-of-epidemiology/ http://dx.doi.org/10.1016/j.je.2016.09.001 0917-5040/ ©2016 The Author.,Non-OADS,/arxiv_data1/oa_pdf/be/45/je-27-002.PMC5328733.pdf
This is an open access article under the CC B Y-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Journal of Epidemiology 27 (2017) 2 e7,Non-OADS,/arxiv_data1/oa_pdf/be/45/je-27-002.PMC5328733.pdf
"[Internet,http://www.wcrf.org/int/research-we-fund/continuous-update-project- ﬁndings-reports/prostate-cancer].",Non-OADS,/arxiv_data1/oa_pdf/be/45/je-27-002.PMC5328733.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/ licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/27/a1/je-27-008.PMC5328734.pdf
Contents lists available at ScienceDirect Journal of Epidemiology journal homepage: http://w ww.journals.elsevier.com/j ournal-of-epidemiology/ http://dx.doi.org/10.1016/j.je.2016.08.001 0917-5040/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/27/a1/je-27-008.PMC5328734.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Journal of Epidemiology 27 (2017) 8 e13,Non-OADS,/arxiv_data1/oa_pdf/27/a1/je-27-008.PMC5328734.pdf
Contents lists available at ScienceDirect Journal of Epidemiology journal homepage: http://w ww.journals.elsevier.com/j ournal-of-epidemiology/ http://dx.doi.org/10.1016/j.je.2016.08.002 0917-5040/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ca/09/je-27-014.PMC5328735.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Journal of Epidemiology 27 (2017) 14 e23,Non-OADS,/arxiv_data1/oa_pdf/ca/09/je-27-014.PMC5328735.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/ licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ca/09/je-27-014.PMC5328735.pdf
The National Health and Nutrition Survey of 2012. http://www.mhlw.go.jp/ bunya/kenkou/kenkou_eiyou_chousa.html.W.,Non-OADS,/arxiv_data1/oa_pdf/ca/09/je-27-014.PMC5328735.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/ licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2f/ba/je-27-024.PMC5328736.pdf
Contents lists available at ScienceDirect Journal of Epidemiology journal homepage: http://w ww.journals.elsevier.com/j ournal-of-epidemiology/ http://dx.doi.org/10.1016/j.je.2016.08.003 0917-5040/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2f/ba/je-27-024.PMC5328736.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Journal of Epidemiology 27 (2017) 24 e29,Non-OADS,/arxiv_data1/oa_pdf/2f/ba/je-27-024.PMC5328736.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/ licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ed/23/je-27-030.PMC5328737.pdf
Contents lists available at ScienceDirect Journal of Epidemiology journal homepage: http://w ww.journals.elsevier.com/j ournal-of-epidemiology/ http://dx.doi.org/10.1016/j.je.2016.07.001 0917-5040/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ed/23/je-27-030.PMC5328737.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Journal of Epidemiology 27 (2017) 30 e35,Non-OADS,/arxiv_data1/oa_pdf/ed/23/je-27-030.PMC5328737.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/ licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/25/dc/je-27-036.PMC5328738.pdf
Contents lists available at ScienceDirect Journal of Epidemiology journal homepage: http://w ww.journals.elsevier.com/j ournal-of-epidemiology/ http://dx.doi.org/10.1016/j.je.2016.08.004 0917-5040/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/25/dc/je-27-036.PMC5328738.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Journal of Epidemiology 27 (2017) 36 e41,Non-OADS,/arxiv_data1/oa_pdf/25/dc/je-27-036.PMC5328738.pdf
Available from: http://www.ico.org/news/ icc-112-4e-consumption-asia.pdf.L.-G. Zhao et al.,Non-OADS,/arxiv_data1/oa_pdf/25/dc/je-27-036.PMC5328738.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d3/be/je-27-042.PMC5328739.pdf
Contents lists available at ScienceDirect Journal of Epidemiology journal homepage: http://w ww.journals.elsevier.com/j ournal-of-epidemiology/ http://dx.doi.org/10.1016/j.je.2016.08.005 0917-5040/ ©2016 Publishing services by Elsevier B.V. on behalf of The Japan Epidemiological Association.,Non-OADS,/arxiv_data1/oa_pdf/d3/be/je-27-042.PMC5328739.pdf
This is an open access article under the CC BY-NC-ND lic ense (http://creativecommons.org/licenses/by-nc-nd/4.0/).Journal of Epidemiology 27 (2017) 42 e47,Non-OADS,/arxiv_data1/oa_pdf/d3/be/je-27-042.PMC5328739.pdf
Japan: AMDA International Medical Information Center; 2008. http://amda-imic.com/oldpage/amdact/PDF/eng/spe-he-ex-e.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d3/be/je-27-042.PMC5328739.pdf
http://www.mhlw.go.,Non-OADS,/arxiv_data1/oa_pdf/d3/be/je-27-042.PMC5328739.pdf
These results indicate that random forest approach can achieve accurate segmentation of ICH in a population of patientsfromavarietyofimagingcenters.WeprovideanRpackage(https://github.com/muschellij2/ichseg) and a Shiny R application online ( http://johnmuschelli.com/ich_segment_all.html ) for implementing and testingthe proposed approach.,OADS,/arxiv_data1/oa_pdf/54/9b/main.PMC5328741.pdf
This is an openaccess article underthe CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ) *Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/54/9b/main.PMC5328741.pdf
Introduction Intracerebral hemorrhage (ICH) is a neurological condition that results from a blood vessel rupturing into the tissue and possibly extendingintotheventriclesofthebrain.TheuseofX-raycomputed http://dx.doi.org/10.1016/j.nicl.2017.02.007 2213-1582/©2017 TheAuthors.,Non-OADS,/arxiv_data1/oa_pdf/54/9b/main.PMC5328741.pdf
This is an open access articleunder the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ),Non-OADS,/arxiv_data1/oa_pdf/54/9b/main.PMC5328741.pdf
"Images with gantry tilt were corrected using a customized MATLAB (The Mathworks, Natick, Massachusetts, USA) user-written script (http://bit.ly/1ltIM8c ).",OADS,/arxiv_data1/oa_pdf/54/9b/main.PMC5328741.pdf
"We have released an open source package that can per- formICHsegmentation(https://github.com/muschellij2/ichseg ).Our software includes the models for prediction, the CT template from Rorden et al.",OADS,/arxiv_data1/oa_pdf/54/9b/main.PMC5328741.pdf
"Therefore, we have also released a Shiny(Chang et al., 2015) R application online (http://johnmuschelli.com/ich_segment_all.html ) that takes an input CT scan and outputs ICH segmentationmaskandprovidesarepresentationofeachprocessing step.",OADS,/arxiv_data1/oa_pdf/54/9b/main.PMC5328741.pdf
http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/FLIRT/FAQ .,Non-OADS,/arxiv_data1/oa_pdf/54/9b/main.PMC5328741.pdf
Decrement in the value of dielectric constant and increment in dielectric loss was observed for silicaReceived: 30 November 2016 Revised: 2 February 2017 Accepted: 13 February 2017 Heliyon 3 (2017) e00253 http://dx.doi.org/10.1016/j.heliyon.2017.e00253 2405-8440/© 2017 The Authors.,OADS,/arxiv_data1/oa_pdf/ff/1a/main.PMC5328743.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/1a/main.PMC5328743.pdf
Article No~e00253 2 http://dx.doi.org/10.1016/j.heliyon.2017.e00253 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ff/1a/main.PMC5328743.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/1a/main.PMC5328743.pdf
Article No~e00253 3 http://dx.doi.org/10.1016/j.heliyon.2017.e00253 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ff/1a/main.PMC5328743.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/1a/main.PMC5328743.pdf
Article No~e00253 4 http://dx.doi.org/10.1016/j.heliyon.2017.e00253 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ff/1a/main.PMC5328743.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/1a/main.PMC5328743.pdf
Sample Lattice parameters (Å) Crystallite size (nm) Shape abc α-Fe2O3 5.0351 5.0351 13.7483 20 Hexagonal Article No~e00253 5 http://dx.doi.org/10.1016/j.heliyon.2017.e00253 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ff/1a/main.PMC5328743.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/1a/main.PMC5328743.pdf
Article No~e00253 6 http://dx.doi.org/10.1016/j.heliyon.2017.e00253 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ff/1a/main.PMC5328743.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/1a/main.PMC5328743.pdf
"The result shows that thesaturation magnetization decreases from 0.25 to 0.127, 0.0801 and 0.076 emu g −1 Article No~e00253 7 http://dx.doi.org/10.1016/j.heliyon.2017.e00253 2405-8440/© 2017 The Authors.",OADS,/arxiv_data1/oa_pdf/ff/1a/main.PMC5328743.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/1a/main.PMC5328743.pdf
NPs Saturation magnetization (M s) Remanent magnetizations (M r) Coercivity (H c) α-Fe2O3 0.25 emu g−10.048 emu g−154.08 Oe α-Fe2O3@ SiO 2(methanol) 0.127 emu g−10.029 emu g−175.45 Oe α-Fe2O3@ SiO 2(ethanol) 0.0801 emu g−10.0088 emu g−185.83 Oe α-Fe2O3@ SiO 2(isopropanol) 0.076 emu g−10.0079 emu g−191.313 Oe Article No~e00253 8 http://dx.doi.org/10.1016/j.heliyon.2017.e00253 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ff/1a/main.PMC5328743.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/1a/main.PMC5328743.pdf
Article No~e00253 9 http://dx.doi.org/10.1016/j.heliyon.2017.e00253 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ff/1a/main.PMC5328743.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/1a/main.PMC5328743.pdf
Article No~e00253 10 http://dx.doi.org/10.1016/j.heliyon.2017.e00253 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ff/1a/main.PMC5328743.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/1a/main.PMC5328743.pdf
Article No~e00253 11 http://dx.doi.org/10.1016/j.heliyon.2017.e00253 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ff/1a/main.PMC5328743.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/1a/main.PMC5328743.pdf
Article No~e00253 12 http://dx.doi.org/10.1016/j.heliyon.2017.e00253 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ff/1a/main.PMC5328743.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/1a/main.PMC5328743.pdf
Article No~e00253 13 http://dx.doi.org/10.1016/j.heliyon.2017.e00253 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ff/1a/main.PMC5328743.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/1a/main.PMC5328743.pdf
Article No~e00253 14 http://dx.doi.org/10.1016/j.heliyon.2017.e00253 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ff/1a/main.PMC5328743.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/1a/main.PMC5328743.pdf
Article No~e00253 15 http://dx.doi.org/10.1016/j.heliyon.2017.e00253 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ff/1a/main.PMC5328743.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/1a/main.PMC5328743.pdf
Article No~e00253 16 http://dx.doi.org/10.1016/j.heliyon.2017.e00253 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ff/1a/main.PMC5328743.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/1a/main.PMC5328743.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/75/62/main.PMC5328744.pdf
Contents lists available at ScienceDirect Molecular Genetics and Metabolism Reports journal homepage: www.elsevier.com/locate/ymgmr http://dx.doi.org/10.1016/j.ymgmr.2017.01.008 2214-4269/© 2017 The Author.,Non-OADS,/arxiv_data1/oa_pdf/75/62/main.PMC5328744.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/75/62/main.PMC5328744.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ae/9c/main.PMC5328745.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.com/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2017.02.008 2213-0071/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ae/9c/main.PMC5328745.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 20 (2017) 171 e175,Non-OADS,/arxiv_data1/oa_pdf/ae/9c/main.PMC5328745.pdf
"33 (3) (2016 Mar) 29,http://dx.doi.org/10.1007/s12032-016-0744-x .",Non-OADS,/arxiv_data1/oa_pdf/ae/9c/main.PMC5328745.pdf
"46 (11) (2016) 1145 e1151, http://dx.doi.org/10.1111/hepr.12663 .",Non-OADS,/arxiv_data1/oa_pdf/ae/9c/main.PMC5328745.pdf
"[12] H. Nakagomi, I. Sakamoto, Y. Hirotsu, et al., Willingness of Japanese patients with breast cancer to have genetic testing of BRCA without burden of ex- penses, Breast Cancer 23 (4) (2016) 649 e653, http://dx.doi.org/10.1007/ s12282-015-0618-7 .Table 4 Detection of somatic mutations in primary lung tumor, bronchial washing samples, sputum and plasma.",OADS,/arxiv_data1/oa_pdf/ae/9c/main.PMC5328745.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/bf/main.PMC5328746.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2017.02.006 2049-0801/ ©2017 The Author(s).,Non-OADS,/arxiv_data1/oa_pdf/78/bf/main.PMC5328746.pdf
"(2017 Feb 8), http://dx.doi.org/10.2174/ 1389201018666170208125131 ([Epub ahead of print]).",Non-OADS,/arxiv_data1/oa_pdf/78/bf/main.PMC5328746.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.c om/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2017.02.007 2213-0071/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/5c/35/main.PMC5328747.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 20 (2017) 156 e159,Non-OADS,/arxiv_data1/oa_pdf/5c/35/main.PMC5328747.pdf
"Thus, the role of IgA early in the human immune response should be further investigated.Received: 13 February 2017 Accepted: 16 February 2017 Heliyon 3 (2017) e00255 http://dx.doi.org/10.1016/j.heliyon.2017.e00255 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/16/ff/main.PMC5328748.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/16/ff/main.PMC5328748.pdf
Both vaccines were Article No~e00255 2 http://dx.doi.org/10.1016/j.heliyon.2017.e00255 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/16/ff/main.PMC5328748.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/16/ff/main.PMC5328748.pdf
"Kinetics of antibody response ELISAs for serotypes 2, 8, 9N, 10A, and 12F (present only in PSV); 6A (present only in PCV); 1, 3, 6B, 9 V, 14, 19A, 19F, and 23F (present in both vaccines) were Article No~e00255 3 http://dx.doi.org/10.1016/j.heliyon.2017.e00255 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/16/ff/main.PMC5328748.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/16/ff/main.PMC5328748.pdf
Article No~e00255 4 http://dx.doi.org/10.1016/j.heliyon.2017.e00255 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/16/ff/main.PMC5328748.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/16/ff/main.PMC5328748.pdf
Article No~e00255 5 http://dx.doi.org/10.1016/j.heliyon.2017.e00255 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/16/ff/main.PMC5328748.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/16/ff/main.PMC5328748.pdf
Article No~e00255 6 http://dx.doi.org/10.1016/j.heliyon.2017.e00255 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/16/ff/main.PMC5328748.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/16/ff/main.PMC5328748.pdf
Article No~e00255 7 http://dx.doi.org/10.1016/j.heliyon.2017.e00255 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/16/ff/main.PMC5328748.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/16/ff/main.PMC5328748.pdf
Article No~e00255 8 http://dx.doi.org/10.1016/j.heliyon.2017.e00255 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/16/ff/main.PMC5328748.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/16/ff/main.PMC5328748.pdf
Article No~e00255 9 http://dx.doi.org/10.1016/j.heliyon.2017.e00255 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/16/ff/main.PMC5328748.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/16/ff/main.PMC5328748.pdf
Article No~e00255 10 http://dx.doi.org/10.1016/j.heliyon.2017.e00255 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/16/ff/main.PMC5328748.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/16/ff/main.PMC5328748.pdf
http://dx.doi.org/10.1016/j.nicl.2017.02.009 2213-1582/© 2017 The Author(s).,Non-OADS,/arxiv_data1/oa_pdf/a0/a0/main.PMC5328749.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a0/a0/main.PMC5328749.pdf
This i s an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a0/a0/main.PMC5328749.pdf
S1 can be found online at http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a0/a0/main.PMC5328749.pdf
"the computation, should then be packed in a Docker container ( https://www.docker.com ) which can be installed on the server.",OADS,/arxiv_data1/oa_pdf/a0/a0/main.PMC5328749.pdf
Supplementary information Supplementary information to this article can be found online at http://dx.doi.org/10.1016/j.nicl.2017.02.009 .,Non-OADS,/arxiv_data1/oa_pdf/a0/a0/main.PMC5328749.pdf
"R Founda- tion for Statistical Computing, Vienna, Austria https://www.r-project.org/ .",Non-OADS,/arxiv_data1/oa_pdf/a0/a0/main.PMC5328749.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ae/68/main.PMC5328750.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.c om/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2017.02.010 2213-0071/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ae/68/main.PMC5328750.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 20 (2017) 168 e170,Non-OADS,/arxiv_data1/oa_pdf/ae/68/main.PMC5328750.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Polygenic risk scoreNeural connectivityCross-disorderDisorder-speci ﬁc fMRI 1.,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC5328751.pdf
http://dx.doi.org/10.1016/j.nicl.2017.02.011 2213-1582/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC5328751.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC5328751.pdf
Imputation and PGRS generation The genome coordinates were converted from hg19 to hg18 assem- bly using liftOver ( https://genome.ucsc.edu/cgi-bin/hgLiftOver )t ob e Table 1 Demographic characteristics of the participants.,OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC5328751.pdf
"The same preprocessing procedures were applied to each dataset, and DPARSFA (Data Processing Assistant for Resting State fMRI Advanced Edition, http://www.restfmri.net/forum/DPARSF ) was used to preprocess the images.",OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC5328751.pdf
"We searched the meta-analysis results from Neurosynth ( Yarkoni et al., n.d. )(http://neurosynth.org /) for the 5 major psychiatric disorders, separately using ADHD, autism, bipolar, de- pression, and schizophrenia as search terms.",OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC5328751.pdf
"The meta-analysis results from Neurosynth ( Yarkoni et al., n.d. )(http://neurosynth.org /) showed that the bilateral anterior insula are related to all ﬁve major psy- chiatric disorders, so it is a reasonable ROI to ﬁnd functional connectiv- ity alterations related to cross-disorder PGRS.",OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC5328751.pdf
This is an open access article under the CCBY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ed/8f/main.PMC5328755.pdf
1936-5233/17http://dx.doi.org/10.1016/j.tranon.2016.12.006,OADS,/arxiv_data1/oa_pdf/ed/8f/main.PMC5328755.pdf
"The parent linear mRNAs of differentially expressed circRNAs were studied with Gene Ontology (GO)(http://www.geneontology.org ) and Kyoto Encyclopedia of Genes and Genomes (KEGG) ( http://www.genome ,jp/kegg) databases.",OADS,/arxiv_data1/oa_pdf/ed/8f/main.PMC5328755.pdf
"Acta Neuropathol 114,9 7–109.http://dx.doi.org/10.1007/s00401-007-0243-4 .",Non-OADS,/arxiv_data1/oa_pdf/ed/8f/main.PMC5328755.pdf
http://dx.doi.org/10.3322/caac.20069 .,Non-OADS,/arxiv_data1/oa_pdf/ed/8f/main.PMC5328755.pdf
"Transl Oncol 8, 279 –287.http://dx.doi.org/10.1016/j.tranon.2015.05.003 .",OADS,/arxiv_data1/oa_pdf/ed/8f/main.PMC5328755.pdf
http://dx.doi.org/10.1016/j.tranon.2014.10.004 .,OADS,/arxiv_data1/oa_pdf/ed/8f/main.PMC5328755.pdf
http://dx.doi.org/10.1016/j.tranon.2014.10.002 .,OADS,/arxiv_data1/oa_pdf/ed/8f/main.PMC5328755.pdf
http://dx.doi.org/10.1038/nbt.2890 .,Non-OADS,/arxiv_data1/oa_pdf/ed/8f/main.PMC5328755.pdf
http://dx.doi.org/10.1261/rna.035667.112 .,Non-OADS,/arxiv_data1/oa_pdf/ed/8f/main.PMC5328755.pdf
http://dx.doi.org/10.1038/nature11928 .,Non-OADS,/arxiv_data1/oa_pdf/ed/8f/main.PMC5328755.pdf
http://dx.doi.org/10.1186/s13059-014-0409-z .,Non-OADS,/arxiv_data1/oa_pdf/ed/8f/main.PMC5328755.pdf
"Nat Commun 7, 11215. http://dx.doi.org/10.1038/ncomms11215 .",Non-OADS,/arxiv_data1/oa_pdf/ed/8f/main.PMC5328755.pdf
http://dx.doi.org/10.1016/j.molcel.2015.03.027 .,OADS,/arxiv_data1/oa_pdf/ed/8f/main.PMC5328755.pdf
http://dx.doi.org/10.1371/journal.pgen.1003777 .,Non-OADS,/arxiv_data1/oa_pdf/ed/8f/main.PMC5328755.pdf
http://dx.doi.org/10.18632/oncotarget.9706 .,OADS,/arxiv_data1/oa_pdf/ed/8f/main.PMC5328755.pdf
http://dx.doi.org/10.18632/oncotarget.8589 .,OADS,/arxiv_data1/oa_pdf/ed/8f/main.PMC5328755.pdf
Oncotarget .http://dx.doi.org/10.18632/oncotarget.11523 .,OADS,/arxiv_data1/oa_pdf/ed/8f/main.PMC5328755.pdf
"Bioinformatics 29,1 5–21.http://dx.doi.org/10.1093/bioinformatics/bts635 .",Non-OADS,/arxiv_data1/oa_pdf/ed/8f/main.PMC5328755.pdf
http://dx.doi.org/10.1093/bioinformatics/btv656 .,Non-OADS,/arxiv_data1/oa_pdf/ed/8f/main.PMC5328755.pdf
http://dx.doi.org/10.1016/j.molcel.2015.03.027 .,OADS,/arxiv_data1/oa_pdf/ed/8f/main.PMC5328755.pdf
"Expert Opin Drug Metab Toxicol ,1–9.http://dx.doi.org/10.1080/17425255.2016.1214710 .",Non-OADS,/arxiv_data1/oa_pdf/ed/8f/main.PMC5328755.pdf
http://dx.doi.org/10.1016/j.molcel.2014.08.019 .,OADS,/arxiv_data1/oa_pdf/ed/8f/main.PMC5328755.pdf
http://dx.doi.org/10.1126/science.1238522 .,Non-OADS,/arxiv_data1/oa_pdf/ed/8f/main.PMC5328755.pdf
http://dx.doi.org/10.1093/nar/gkw027 .,Non-OADS,/arxiv_data1/oa_pdf/ed/8f/main.PMC5328755.pdf
http://dx.doi.org/10.3892/ijo.2015.3270 .,Non-OADS,/arxiv_data1/oa_pdf/ed/8f/main.PMC5328755.pdf
http://dx.doi.org/10.1016/j.jid.2015.11.006 .,OADS,/arxiv_data1/oa_pdf/ed/8f/main.PMC5328755.pdf
http://dx.doi.org/10.1074/jbc.M113.513762 .,Non-OADS,/arxiv_data1/oa_pdf/ed/8f/main.PMC5328755.pdf
http://dx.doi.org/10.1038/nature11993 .,Non-OADS,/arxiv_data1/oa_pdf/ed/8f/main.PMC5328755.pdf
http://dx.doi.org/10.1016/j.eplepsyres.2016.08.028 .Table 6.,OADS,/arxiv_data1/oa_pdf/ed/8f/main.PMC5328755.pdf
Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gynor http://dx.doi.org/10.1016/j.gore.2017.02.008 2352-5789/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/15/71/main.PMC5328756.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/15/71/main.PMC5328756.pdf
This i s an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Quorum sensingN-acyl- L-homoserine lactone Activated sludge Acylase Speciﬁcations Organism/cell line/tissueRoseomonas sp.,Non-OADS,/arxiv_data1/oa_pdf/2e/ef/main.PMC5328757.pdf
Direct link to deposited data https://www.ncbi.nlm.nih.gov/nuccore/BDLP00000000.1 .,OADS,/arxiv_data1/oa_pdf/2e/ef/main.PMC5328757.pdf
"[8], and 25 species with 2 subspecies have been isolated ( http://www.bacterio.",Non-OADS,/arxiv_data1/oa_pdf/2e/ef/main.PMC5328757.pdf
http://dx.doi.org/10.1016/j.gdata.2017.02.001 2213-5960/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2e/ef/main.PMC5328757.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2e/ef/main.PMC5328757.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c6/c9/main.PMC5328758.pdf
E-mail address: Jones.david@mayo.edu http://dx.doi.org/10.1016/j.dadm.2017.01.004 2352-8729/ /C2112017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c6/c9/main.PMC5328758.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c6/c9/main.PMC5328758.pdf
The ﬁrst three volumes were removed and the time series within each voxel were despiked using AFNI’s3dDespike program ( http://afni.nimh.nih.gov ).,Non-OADS,/arxiv_data1/oa_pdf/c6/c9/main.PMC5328758.pdf
"Statistical procedures A combination of MATLAB-based (Mathworks Inc, Na- tick, MA) and R-based ( http://www.R-project.org ) software packages was used to perform all statistical analysis.",OADS,/arxiv_data1/oa_pdf/c6/c9/main.PMC5328758.pdf
The surface renderings of the four independent components from the high- dimensional independent component analysis (ICA) Mayo Clinic Studyof Aging Functional Connectivity Atlas [19]were created using the CARET software package http://www.nitrc.org/projects/caret/ .,OADS,/arxiv_data1/oa_pdf/c6/c9/main.PMC5328758.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/8d/08/main.PMC5328759.pdf
E-mail address: j.denhaan1@vumc.nl http://dx.doi.org/10.1016/j.dadm.2016.12.014 2352-8729/ /C2112017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/8d/08/main.PMC5328759.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8d/08/main.PMC5328759.pdf
Supplementary data Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.dadm.2016.12.014 .,OADS,/arxiv_data1/oa_pdf/8d/08/main.PMC5328759.pdf
"Multidimensional scaling (MDS) plots for each cell type, before and after background subtraction and normaliza-tion, were examined to assess for the presence of batch effects.The batch effects were found to be minimal, and were reducedfollowing data normalization (for examples, see Supplemen-tary Figures 4 and 5, available on the Arthritis & Rheumatology web site at http://onlinelibrary.wiley.com/doi/10.1002/art.39952/abstract).",OADS,/arxiv_data1/oa_pdf/f2/ed/ART-69-550.PMC5328845.pdf
"CD41naive T cells were found to have a q value of ,0.05 (see Supplementary Table 1, available on the Arthritis & Rheumatology web site at http://onlinelibrary.wiley.com/ doi/10.1002/art.39952/abstract).",OADS,/arxiv_data1/oa_pdf/f2/ed/ART-69-550.PMC5328845.pdf
Results are summarized in Supplementary Table 2 (available on the Arthritis & Rheu- matology web site at http://onlinelibrary.wiley.com/doi/10.,OADS,/arxiv_data1/oa_pdf/f2/ed/ART-69-550.PMC5328845.pdf
Results of the genome- wide tests of differences in methylation are summarized inSupplementary Table 6 (available on the Arthritis & Rheu- matology web site at http://onlinelibrary.wiley.com/doi/10.,OADS,/arxiv_data1/oa_pdf/f2/ed/ART-69-550.PMC5328845.pdf
bouchesdurhonensis ”is available online ( http://www.mediterranee-infection.com/ article.php?laref=256&titre=urms-database ).,OADS,/arxiv_data1/oa_pdf/7f/ee/main.PMC5328908.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.11.004,Non-OADS,/arxiv_data1/oa_pdf/7f/ee/main.PMC5328908.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,17,3 9 –40 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/7f/ee/main.PMC5328908.pdf
” MALDI-TOF MS spectrum The MALDI-TOF MS spectrum of “Eggerthella timonensis ”is available online ( http://www.mediterranee-infection.com/ article.php?laref=256&titre=urms-database ).,Non-OADS,/arxiv_data1/oa_pdf/a4/31/main.PMC5328910.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.11.001,Non-OADS,/arxiv_data1/oa_pdf/a4/31/main.PMC5328910.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,17,4 1 –42 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/a4/31/main.PMC5328910.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1d/c3/main.PMC5328911.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1d/c3/main.PMC5328911.pdf
http://dx.doi.org/10.1016/j.eucr.2017.01.010Urology Case Reports 12 (2017) 14 e16,Non-OADS,/arxiv_data1/oa_pdf/1d/c3/main.PMC5328911.pdf
http://dx.doi.org/10.1016/j.idcr.2017.02.002 2214-2509/©  2017  Published  by  Elsevier  Ltd.,Non-OADS,/arxiv_data1/oa_pdf/28/df/main.PMC5328912.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).IDCases  8  (2017)  9–11 Contents  lists  available  at  ScienceDirect IDCases journal  homepage:  www.elsevier.com/locate/idcr,Non-OADS,/arxiv_data1/oa_pdf/28/df/main.PMC5328912.pdf
"1.11.1.11) activity to remove the hydrogen peroxide, either as an individual reaction but also as the ﬁrst stage of the ascorbate-glutathione cycle in plants (Foyer-Halliwell-Asada path- http://dx.doi.org/10.1016/j.redox.2017.02.009 Received 5 December 2016; Received in revised form 15 January 2017; Accepted 12 February 2017☆Note: Sequence data from this article have been deposited in the EMBL/GenBank data libraries under accession number AY547352 and AY572427 for the Capsicum annuum L GalLDH complete cDNA and actin mRNA, partial cDNA, respectively.",Non-OADS,/arxiv_data1/oa_pdf/7f/5b/main.PMC5328913.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/7f/5b/main.PMC5328913.pdf
The full-length cDNA for the GalLDH in Capsicum annuum L. were deposited in the databank with accession number AY547352 ( https://www.ncbi.nlm.nih.gov ).2.4.,OADS,/arxiv_data1/oa_pdf/7f/5b/main.PMC5328913.pdf
Alignments were performed using OMIGA (2.0) and CLUSTALW ( http://www.ebi.,OADS,/arxiv_data1/oa_pdf/7f/5b/main.PMC5328913.pdf
Localization predictions were achieved with PSORT Prediction and iPSORT Prediction ( http://psort.hgc.jp/form.html ) programs.,OADS,/arxiv_data1/oa_pdf/7f/5b/main.PMC5328913.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2c/48/main.PMC5328914.pdf
The  444  pb  fragment  obtained and  compared  with  GeneBank  sequences  using  the  BLAST algorithm  (http://www.ncbi.nlm.nih.gov/BLAST )  showed  100% identity  with  M.  nonliquefaciens  strain  V0542163  (GeneBank accession  n/C14KC866286.1).,OADS,/arxiv_data1/oa_pdf/2c/48/main.PMC5328914.pdf
http://dx.doi.org/10.1016/j.idcr.2017.02.006 2214-2509/©  2017  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/2c/48/main.PMC5328914.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).IDCases  8  (2017)  12–13 Contents  lists  available  at  ScienceDirect IDCases journal  homepage:  www.elsevier.com/locat  e/idcr,Non-OADS,/arxiv_data1/oa_pdf/2c/48/main.PMC5328914.pdf
"As  recommended  by  CA-SFM  2016  (Comité de  l'Antibiogramme  de  la  Société  Française  de  Microbiologie; http://www.sfm-microbiologie.org ),  the  breakpoints  described  for Moraxella  catarrhalis  were  used  to  determine  the  susceptibility  of this  bacterium.",OADS,/arxiv_data1/oa_pdf/2c/48/main.PMC5328914.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Readability Health literacy Inﬂuenza vaccination Anti-vaccinationInternetProcessing ﬂuency 1.,Non-OADS,/arxiv_data1/oa_pdf/37/36/main.PMC5328916.pdf
http://dx.doi.org/10.1016/j.pmedr.2017.02.013 2211-3355/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/37/36/main.PMC5328916.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/37/36/main.PMC5328916.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/37/36/main.PMC5328916.pdf
"http://dx.doi.org/10.1016/S0897-1897(96)80254-0 .Alter, A.M., Oppenheimer, D.M., 2009.",Non-OADS,/arxiv_data1/oa_pdf/37/36/main.PMC5328916.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/37/36/main.PMC5328916.pdf
http://dx.doi.org/10.1016/j.pec.2016.08.028 .,OADS,/arxiv_data1/oa_pdf/37/36/main.PMC5328916.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/37/36/main.PMC5328916.pdf
http://dx.doi.org/10.1016/j.socscimed.2005.06.020 .,OADS,/arxiv_data1/oa_pdf/37/36/main.PMC5328916.pdf
http://dx.doi.org/10.1097/00006199-198405000-00012 .,Non-OADS,/arxiv_data1/oa_pdf/37/36/main.PMC5328916.pdf
http://dx.doi.org/10.5993/AJHB.31.s1.11 .,Non-OADS,/arxiv_data1/oa_pdf/37/36/main.PMC5328916.pdf
http://dx.doi.org/10.1111/spc3.12179 .,Non-OADS,/arxiv_data1/oa_pdf/37/36/main.PMC5328916.pdf
http://dx.doi.org/10.1586/14760584.2015.964212 .,Non-OADS,/arxiv_data1/oa_pdf/37/36/main.PMC5328916.pdf
http://dx.doi.org/10.1037/ 0003-066X.34.10.906.,Non-OADS,/arxiv_data1/oa_pdf/37/36/main.PMC5328916.pdf
http://www.pewinternet.org/ ﬁles/ old-media/Files/Reports/2000/PIP_Health_Report.pdf.pdf (accessed 16.09.05).,Non-OADS,/arxiv_data1/oa_pdf/37/36/main.PMC5328916.pdf
http://dx.doi.org/10.1001/archinte.165.22.2618 .,Non-OADS,/arxiv_data1/oa_pdf/37/36/main.PMC5328916.pdf
http://dx.doi.org/10.1016/j.vaccine.2008.06.042 .,OADS,/arxiv_data1/oa_pdf/37/36/main.PMC5328916.pdf
"Internet World Stats, 2001. http://www.internetworldstats.com (accessed 16.09.05).",OADS,/arxiv_data1/oa_pdf/37/36/main.PMC5328916.pdf
2012:1 –8.http://dx.doi.org/10.1155/2012/ 932741 .,Non-OADS,/arxiv_data1/oa_pdf/37/36/main.PMC5328916.pdf
http://jreadability.net/ (accessed 16.09.06).,OADS,/arxiv_data1/oa_pdf/37/36/main.PMC5328916.pdf
http://dx.doi.org/10.1080/ 13548509808400589 .,Non-OADS,/arxiv_data1/oa_pdf/37/36/main.PMC5328916.pdf
1:7–28.http://dx.doi.org/10.1080/13548509608400003 .,Non-OADS,/arxiv_data1/oa_pdf/37/36/main.PMC5328916.pdf
http://dx.doi.org/10.1002/asi.20557 .,Non-OADS,/arxiv_data1/oa_pdf/37/36/main.PMC5328916.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/37/36/main.PMC5328916.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/37/36/main.PMC5328916.pdf
Comparing the quality of pro- and anti-vac- cination online information: a content analysis of vaccination-related webpages.BMC Public Health 16:1 –12.http://dx.doi.org/10.1186/s12889-016-2722-9 .,Non-OADS,/arxiv_data1/oa_pdf/37/36/main.PMC5328916.pdf
http://dx.doi.org/10.1207/s15327663jcp1404_2 .,Non-OADS,/arxiv_data1/oa_pdf/37/36/main.PMC5328916.pdf
"StatCounter Global Stats, 1999. http://gs.statcounter.com/#all-search_engine-JP- monthly-201608-201608-bar (accessed 16.09.06).",OADS,/arxiv_data1/oa_pdf/37/36/main.PMC5328916.pdf
http://dx.doi.org/10.1016/0010-0285(73)90033-9 .U.S.,OADS,/arxiv_data1/oa_pdf/37/36/main.PMC5328916.pdf
http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/37/36/main.PMC5328916.pdf
http://dx.doi.org/10.1016/j.ymgmr.2017.02.001 2214-4269/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/db/db/main.PMC5328917.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/db/db/main.PMC5328917.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Isovaleric acidemiaProtein restricted diet Leucine Leucine free L-amino acids Natural protein 1.,Non-OADS,/arxiv_data1/oa_pdf/db/db/main.PMC5328917.pdf
"[36] European Registry and network for introduction type metabolic diseases (E-IMD), Isovaleric Acidemia: Quick Reference Guide, 2014 http://www.e-imd.org/rc/e-imd/ htm/Article/2014/e-imd-20140716-085102-695/src/htm_fullText/en/IVA%20guide- line_Quick%20reference%20guide_Ensenauer_201408.pdf (accessed 27.01.17).",Non-OADS,/arxiv_data1/oa_pdf/db/db/main.PMC5328917.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bd/28/main.PMC5328931.pdf
http://dx.doi.org/10.1016/j.idcr.2017.02.005 2214-2509/Crown  Copyright  ©  2017  Published  by  Elsevier  Ltd.,Non-OADS,/arxiv_data1/oa_pdf/bd/28/main.PMC5328931.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/ 4.0/).IDCases  8  (2017)  14–16 Contents  lists  available  at  ScienceDirect IDCases journal  homepage:  www.elsevier.com/locat  e/idcr,Non-OADS,/arxiv_data1/oa_pdf/bd/28/main.PMC5328931.pdf
http://dx.doi.org/10.1016/j.pmedr.2017.02.004 2211-3355/© 2017 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/f2/05/main.PMC5328933.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f2/05/main.PMC5328933.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/f2/05/main.PMC5328933.pdf
(Available from: http://2006.confex.com/ uicc/wctoh/techprogram/P8729.HTM ).,Non-OADS,/arxiv_data1/oa_pdf/f2/05/main.PMC5328933.pdf
(Available from: http://thelstop.org/2012/11/its-a-bitch-to- quit-interview-with-dr-phoenix-matthews/ ).,Non-OADS,/arxiv_data1/oa_pdf/f2/05/main.PMC5328933.pdf
(Available from: http://www.cdc.gov/tobacco/stateandcommunity/ best_practices/ ).,Non-OADS,/arxiv_data1/oa_pdf/f2/05/main.PMC5328933.pdf
"n.d. (Available from: http://www.lgbttobacco.org/ ﬁles/Chicago%20LGBT%20Tobacco%202008% 20Creating%20Change.pdf ) Huber, M., Ledergerber, B., Sauter, R., et al., 2012 Aug.",Non-OADS,/arxiv_data1/oa_pdf/f2/05/main.PMC5328933.pdf
"Program Train-ing and Consultation Centre, Ottawa, ON (Available from: https://www.ptcc-cfc.on.",Non-OADS,/arxiv_data1/oa_pdf/f2/05/main.PMC5328933.pdf
(Available from: http://www.lgbttobacco.org/ ﬁles/ QueerTIPsrevManual.pdf ).,Non-OADS,/arxiv_data1/oa_pdf/f2/05/main.PMC5328933.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fc/19/main.PMC5328934.pdf
The  diagnosis  of  sarcoma  (and  given  the  age  of  the  patient http://dx.doi.org/10.1016/j.ejro.2017.01.003 2352-0477/© 2017  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/fc/19/main.PMC5328934.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/ 4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fc/19/main.PMC5328934.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/21/0e/main.PMC5328935.pdf
His  blood pressure  was  149/107  mm  Hg  and  his  heart  frequency  122  beats http://dx.doi.org/10.1016/j.ijscr.2017.02.015 2210-2612/© 2017  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/21/0e/main.PMC5328935.pdf
This is a n open access article under the CC BY-NC-ND license (http://creativecommons.org /licenses/by-nc-nd/4.0/ ).Keywords: ParksTrailsOpen spaceHealthcare systemDemographics 1.,Non-OADS,/arxiv_data1/oa_pdf/5a/3b/main.PMC5328936.pdf
"3500 University Drive, Penn State Hershey Internal Medicine, The Pennsylvania State University, Hershey, PA 17033. http://dx.doi.org/10.1016/j.pmedr.2017.02.0062211-3355/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/5a/3b/main.PMC5328936.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5a/3b/main.PMC5328936.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/5a/3b/main.PMC5328936.pdf
http://dx.doi.org/10.1016/j.amepre.2004.10.024 .,OADS,/arxiv_data1/oa_pdf/5a/3b/main.PMC5328936.pdf
http://dx.doi.org/10.1089/chi.2012.0085.blan .,Non-OADS,/arxiv_data1/oa_pdf/5a/3b/main.PMC5328936.pdf
"Ashburn, VA, National Recreation and Park As- sociation ( http://www.nrpa.org/uploadedFiles/nrpa.org/ Publications_and_Research/ Research/Papers/Godbey-Mowen-Research-Paper.pdf.",Non-OADS,/arxiv_data1/oa_pdf/5a/3b/main.PMC5328936.pdf
http://dirt.asla.org/2012/08/01/parks-are-part-of-our-healthcare-sys- tem/.,Non-OADS,/arxiv_data1/oa_pdf/5a/3b/main.PMC5328936.pdf
http://dx.doi.org/10.2105/AJPH.2013.,Non-OADS,/arxiv_data1/oa_pdf/5a/3b/main.PMC5328936.pdf
Health 5 (4):619 –632 ( http://www.ncbi.nlm.nih.gov/pubmed/18648125 ).,Non-OADS,/arxiv_data1/oa_pdf/5a/3b/main.PMC5328936.pdf
( http://www.forbes.com/sites/danmunro/2015/01/04/u-s- healthcare-spending-on-track-to-hit-10000-per-person-this-year/#494a7622294c .,Non-OADS,/arxiv_data1/oa_pdf/5a/3b/main.PMC5328936.pdf
http://dx.doi.org/10.1289/ehp.,Non-OADS,/arxiv_data1/oa_pdf/5a/3b/main.PMC5328936.pdf
Seismic data also revealed buried pockmark fields that had repeatedlyReceived: 31 August 2016 Revised: 17 February 2017 Accepted: 17 February 2017 Heliyon 3 (2017) e00257 http://dx.doi.org/10.1016/j.heliyon.2017.e00257 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/65/e0/main.PMC5328937.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/65/e0/main.PMC5328937.pdf
"Pockmarks may also become “resealed ”, Article No~e00257 2 http://dx.doi.org/10.1016/j.heliyon.2017.e00257 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/65/e0/main.PMC5328937.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/65/e0/main.PMC5328937.pdf
Article No~e00257 3 http://dx.doi.org/10.1016/j.heliyon.2017.e00257 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/65/e0/main.PMC5328937.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/65/e0/main.PMC5328937.pdf
Article No~e00257 4 http://dx.doi.org/10.1016/j.heliyon.2017.e00257 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/65/e0/main.PMC5328937.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/65/e0/main.PMC5328937.pdf
These pockmarks had variable diameters that ranged up to 230 m. Correlations between Article No~e00257 5 http://dx.doi.org/10.1016/j.heliyon.2017.e00257 2405-8440/© 2017 The Authors.,OADS,/arxiv_data1/oa_pdf/65/e0/main.PMC5328937.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/65/e0/main.PMC5328937.pdf
Article No~e00257 6 http://dx.doi.org/10.1016/j.heliyon.2017.e00257 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/65/e0/main.PMC5328937.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/65/e0/main.PMC5328937.pdf
Article No~e00257 7 http://dx.doi.org/10.1016/j.heliyon.2017.e00257 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/65/e0/main.PMC5328937.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/65/e0/main.PMC5328937.pdf
Article No~e00257 8 http://dx.doi.org/10.1016/j.heliyon.2017.e00257 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/65/e0/main.PMC5328937.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/65/e0/main.PMC5328937.pdf
Article No~e00257 9 http://dx.doi.org/10.1016/j.heliyon.2017.e00257 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/65/e0/main.PMC5328937.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/65/e0/main.PMC5328937.pdf
Article No~e00257 10 http://dx.doi.org/10.1016/j.heliyon.2017.e00257 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/65/e0/main.PMC5328937.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/65/e0/main.PMC5328937.pdf
Gas may also migrate laterally until it is released via Article No~e00257 11 http://dx.doi.org/10.1016/j.heliyon.2017.e00257 2405-8440/© 2017 The Authors.,OADS,/arxiv_data1/oa_pdf/65/e0/main.PMC5328937.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/65/e0/main.PMC5328937.pdf
Modelling of pockmark formation has shown that liquefaction of overlying sediments occurs when a gas chimney reaches the Article No~e00257 12 http://dx.doi.org/10.1016/j.heliyon.2017.e00257 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/65/e0/main.PMC5328937.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/65/e0/main.PMC5328937.pdf
Article No~e00257 13 http://dx.doi.org/10.1016/j.heliyon.2017.e00257 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/65/e0/main.PMC5328937.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/65/e0/main.PMC5328937.pdf
Article No~e00257 14 http://dx.doi.org/10.1016/j.heliyon.2017.e00257 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/65/e0/main.PMC5328937.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/65/e0/main.PMC5328937.pdf
Article No~e00257 15 http://dx.doi.org/10.1016/j.heliyon.2017.e00257 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/65/e0/main.PMC5328937.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/65/e0/main.PMC5328937.pdf
Article No~e00257 16 http://dx.doi.org/10.1016/j.heliyon.2017.e00257 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/65/e0/main.PMC5328937.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/65/e0/main.PMC5328937.pdf
"Giongo, A., Haag, T., Simão, T.L.L., Medina-Silva, R., Utz, L.R.P., Bogo, M.R., Bonatto, S.L., Zamberlan, P.M., Augustin, A.H., Lourega, R.V., Rodrigues, L.F.,Sbrissa, G.F., Kowsmann, R.O., Freire, A.F.M., Miller, D.J., Viana, A.R., Ketzer, Article No~e00257 17 http://dx.doi.org/10.1016/j.heliyon.2017.e00257 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/65/e0/main.PMC5328937.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/65/e0/main.PMC5328937.pdf
Article No~e00257 18 http://dx.doi.org/10.1016/j.heliyon.2017.e00257 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/65/e0/main.PMC5328937.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/65/e0/main.PMC5328937.pdf
Article No~e00257 19 http://dx.doi.org/10.1016/j.heliyon.2017.e00257 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/65/e0/main.PMC5328937.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/65/e0/main.PMC5328937.pdf
Article No~e00257 20 http://dx.doi.org/10.1016/j.heliyon.2017.e00257 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/65/e0/main.PMC5328937.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/65/e0/main.PMC5328937.pdf
Article No~e00257 21 http://dx.doi.org/10.1016/j.heliyon.2017.e00257 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/65/e0/main.PMC5328937.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/65/e0/main.PMC5328937.pdf
This  is  an  open  access  article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a1/2d/main.PMC5328938.pdf
"A  CT  scan  of  the  abdomen  showed  free  air  in  peritoneal  cav- ity  surrounding  the  liver  and  spleen,  especially  in  the  epigastrium http://dx.doi.org/10.1016/j.ijscr.2017.02.010 2210-2612/© 2017  Published  by  Elsevier  Ltd  on  behalf  of  IJS  Publishing  Group  Ltd.",Non-OADS,/arxiv_data1/oa_pdf/a1/2d/main.PMC5328938.pdf
"9  (2007)  266–268, http://dx.doi.org/10.1111/j.1463-1318.2006.01154.x .",Non-OADS,/arxiv_data1/oa_pdf/a1/2d/main.PMC5328938.pdf
"34  (2016)  180–186,  http://dx.doi.org/10.1016/j.ijsu.2016.08.014 ,  Epub 2016  Sep  7.",Non-OADS,/arxiv_data1/oa_pdf/a1/2d/main.PMC5328938.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.11.024,Non-OADS,/arxiv_data1/oa_pdf/60/1d/main.PMC5328939.pdf
MALDI-TOF MS spectrum The MALDI-TOF MS spectrum of ‘Duodenibacillus massiliensis ’ strain Marseille-P2968Tis available online ( http://www.mediterr anee-infection.com/article.php?laref=256&titre=urms-database ).,OADS,/arxiv_data1/oa_pdf/60/1d/main.PMC5328939.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,17,4 3 –44 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/60/1d/main.PMC5328939.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/25/98/main.PMC5328960.pdf
E-mail address: lapostol@iu.edu http://dx.doi.org/10.1016/j.dadm.2016.10.002 2352-8729/ /C2112016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/25/98/main.PMC5328960.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/25/98/main.PMC5328960.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/thoraxjnl-2016-208357).,Non-OADS,/arxiv_data1/oa_pdf/19/bf/thoraxjnl-2016-208357.PMC5329047.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Barber D, Brown B.",Non-OADS,/arxiv_data1/oa_pdf/19/bf/thoraxjnl-2016-208357.PMC5329047.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ thoraxjnl-2016-208514).,Non-OADS,/arxiv_data1/oa_pdf/42/6b/thoraxjnl-2016-208514.PMC5329049.pdf
"Correspondence to Dr Anne E Holland, La Trobe University Clinical School,Alfred Health, 99 CommercialRd, Melbourne, VIC 3004, Australia; a.holland@alfred.org.au Received 19 February 2016 Revised 30 July 2016Accepted 15 August 2016 Published Online First 26 September 2016 ▸http://dx.doi.org/10.1136/ thoraxjnl-2016-209345 To cite: Holland AE, Mahal A, Hill CJ, et al.",Non-OADS,/arxiv_data1/oa_pdf/42/6b/thoraxjnl-2016-208514.PMC5329049.pdf
2014. http://www.goldcopd.,Non-OADS,/arxiv_data1/oa_pdf/42/6b/thoraxjnl-2016-208514.PMC5329049.pdf
2008. http://www.lungfoundation.com.au/lung-information/patient-educational-material/ better-living-with-copd-a-patient-guide (accessed 22 Nov 2012).,Non-OADS,/arxiv_data1/oa_pdf/42/6b/thoraxjnl-2016-208514.PMC5329049.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ thoraxjnl-2016-208599).,Non-OADS,/arxiv_data1/oa_pdf/e1/84/thoraxjnl-2016-208599.PMC5329050.pdf
"Correspondence to Dr Leopoldo N Segal, Division of Pulmonary and Critical CareMedicine, Department ofMedicine, Bellevue Hospital Center/New York University School of Medicine, 462 FirstAve 7W54, New York, NY10016, USA; Leopoldo.Segal@ nyumc.org; Dr Michael D Weiden,Michael.Weiden@nyumc.org Received 7 March 2016 Revised 22 June 2016 Accepted 6 July 2016 Published Online First2 August 2016 ▸http://dx.doi.org/10.1136/ thoraxjnl-2016-209180 To cite: Segal LN, Clemente JC, Wu BG, et al.",Non-OADS,/arxiv_data1/oa_pdf/e1/84/thoraxjnl-2016-208599.PMC5329050.pdf
"comparing AZM treatment with placebo for 8 weeks in 20 sub- jects with CT-de ﬁned emphysema who had not been treated with antibiotics or corticosteroids ( ﬁgure 1 , NCT02557958; http://www.clinicaltrials.gov).",Non-OADS,/arxiv_data1/oa_pdf/e1/84/thoraxjnl-2016-208599.PMC5329050.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits anynoncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.CYBERPSYCHOLOGY ,BEHAVIOR ,ANDSOCIAL NETWORKING Volume 20, Number 1, 2017 Mary Ann Liebert, Inc.DOI: 10.1089/cyber.2016.0402 37",Non-OADS,/arxiv_data1/oa_pdf/19/5b/cyber.2016.0402.PMC5329052.pdf
"13,14These strategies were developed inside the interdisciplinary ﬁeld known as ‘‘natural language pro- cessing’’ or ‘‘computer linguistics’’ that aims to get com- puters to perform useful tasks with human language, likeimproving human-to-human communication.15In fact, such strategies have served as the basis for developing recent software that have been rewarded by the Society for PoliticalMethodology (http://polmeth.wustl.edu/) to enhance the way of doing research in political and social sciences.",Non-OADS,/arxiv_data1/oa_pdf/19/5b/cyber.2016.0402.PMC5329052.pdf
Ad hoc queries were designed and used with the software ‘‘Import.io’’ (https://import.io/) for retrieving the ofﬁcial results from the elections web page (http://colombia.com/elecciones/2015/regionales/).,OADS,/arxiv_data1/oa_pdf/19/5b/cyber.2016.0402.PMC5329052.pdf
http://dx.doi.org/10.1016/j.pmedr.2017.02.0052211-3355/© 2017 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/30/0b/main.PMC5329065.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/30/0b/main.PMC5329065.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/30/0b/main.PMC5329065.pdf
"California Department of Public Health, Sacramento (CA) https://www.cdph.ca.gov/ programs/Pages/cdic.aspx (Accessed February 7, 2017).",Non-OADS,/arxiv_data1/oa_pdf/30/0b/main.PMC5329065.pdf
"Centers for Disease Control and Prevention, Atlanta (GA) http://www.cdc.gov/obesity/downloads/community_strategies_guide.pdf (Accessed June 11, 2015).",Non-OADS,/arxiv_data1/oa_pdf/30/0b/main.PMC5329065.pdf
"Centers for Disease Control and Prevention, Atlanta (GA) http://www.cdc.gov/nccdphp/dnpao/ state-local-programs/ (Accessed November 23, 2016).",Non-OADS,/arxiv_data1/oa_pdf/30/0b/main.PMC5329065.pdf
"http://www.cdc.gov/pcd/issues/2008/jan/06_0153.htm (Accessed Septem- ber 4, 2015).",OADS,/arxiv_data1/oa_pdf/30/0b/main.PMC5329065.pdf
"U.S. Department of Health and Human Services, Washington DC https://www.healthypeople.gov/2020/ data-search/Search-the-Data#objid=5052 , (Accessed February 16, 2017).",Non-OADS,/arxiv_data1/oa_pdf/30/0b/main.PMC5329065.pdf
"The National Academies Press, Washington DC 2009. http://www.nap.edu/read/12674/chapter/1 (Accessed June 11, 2015).Khan, L.K., Sobush, K., Keener, D., et al., 2009.",Non-OADS,/arxiv_data1/oa_pdf/30/0b/main.PMC5329065.pdf
"Minnesota Department of Health, St. Paul (MN) http://www.health.state.mn.us/ divs/hpcd/index.html (Accessed February 7, 2017).",Non-OADS,/arxiv_data1/oa_pdf/30/0b/main.PMC5329065.pdf
"National Cancer Institute, Division of Cancer Control and Population Sciences, Ap- plied Research Program, Bethesda (MD) http://appliedresearch.cancer.gov/diet/ usualintakes/pop/2007-10/ (Accessed October 8, 2014).",Non-OADS,/arxiv_data1/oa_pdf/30/0b/main.PMC5329065.pdf
"U.S. Census Bureau, Suitland (MD) https://www.census.gov/geo/reference/ua/uafacts.html (Accessed June 11, 2015).",OADS,/arxiv_data1/oa_pdf/30/0b/main.PMC5329065.pdf
"U.S. Census Bureau, Suitland (MD) https://www.census.gov/govs/cog/historical_data_2007.html (Accessed June 11, 2015).",OADS,/arxiv_data1/oa_pdf/30/0b/main.PMC5329065.pdf
"U.S. Census Bureau, Suitland (MD) https://www.census.",OADS,/arxiv_data1/oa_pdf/30/0b/main.PMC5329065.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8f/a8/main.PMC5329067.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2017.02.008 2049-0801/ ©2017 The Author(s).,Non-OADS,/arxiv_data1/oa_pdf/8f/a8/main.PMC5329067.pdf
"Elsevier Ltd. 34 (1) (2012) 276 e280, http://dx.doi.org/10.1016/j.child- youth.2011.10.026 .",Non-OADS,/arxiv_data1/oa_pdf/8f/a8/main.PMC5329067.pdf
"2 (1) (2012) 33 e37,http://dx.doi.org/10.1016/j.ejfs.2012.01.001 .",OADS,/arxiv_data1/oa_pdf/8f/a8/main.PMC5329067.pdf
"Medi-cal records of 68 patients with BD and 70 age- and sex- matched healthy controls were examined retrospectively.The effect of vitamin D on clinical manifestations   and activity of Behçet’s disease Nurşad Aslan1, Kamile Demirci2, Tuba Güler3, Fulya Dörtbaş4, Ebru Kale5 1Department of Dermatology, Kocaeli Derince Training and Research Hospital, Kocaeli, Turkey 2Department of Dermatology, Gölcük Necati Çelik State Hospital, Kocaeli, Turkey 3Department of Physical Therapy and Rehabilitation, Kocaeli Derince Training and Research Hospital, Kocaeli, Turkey 4Department of Rheumatology, Kocaeli Derince Training and Research Hospital, Kocaeli, Turkey 5Department of Biochemistry, Kocaeli Derince Training and Research Hospital, Kocaeli, Turkey Adv Dermatol Allergol 2017; XXXIV (1): 15–20 DOI: https://doi.org/10.5114/pdia.2016.57222 Abstract Introduction: Immune mechanisms have been implemented to have a role in the pathogenesis of Behçet’s disease  (BD) and vitamin D has been shown to have a regulatory role in the immune system function.",Non-OADS,/arxiv_data1/oa_pdf/aa/7d/PDIA-34-26716.PMC5329099.pdf
"Advances in Dermatology and Allergology 1, February / 201770Original paper Address for correspondence: Dr. Papatya Bayrak Degirmenci MD, Fatih Sultan Mehmet Caddesi, Seyhan Sitesi No: 29/1, Cblok D: 10,  Bornova, Izmir, Turkey, phone: +90 05416549994, e-mail: papatyabayrak@yahoo.com Received: 3.08.2015, accepted: 26.01.2016.Analysis of the association of chronic spontaneous  urticaria with interlekin-4, -10, transforming growth factor-b1, interferon-γ, interleukin-17A and -23  by autologous serum skin test Papatya Bayrak Degirmenci1, Cengiz Kırmaz2, Seda Vatansever3, Ece Onur4, Emine Nal3, Soner Erdin4, Beyhan Ozyurt5 1Allergy Immunology Department, Tepecik Training and Research Hospital, Izmir, Turkey 2Division of Allergy Immunology, Department of Internal Medicine, Celal Bayar University, Manisa, Turkey 3Department of Histology and Embryology, Faculty of Medicine, Celal Bayar University, Manisa, Turkey 4Department of Biochemistry, Faculty of Medicine, Celal Bayar University, Manisa, Turkey 5Department of Public Health, Faculty of Medicine, Celal Bayar University, Manisa, Turkey Adv Dermatol Allergol 2016; XXXIV (1): 70–76 DOI: https://doi.org/10.5114/pdia.2016.57679 Abstract Aim: To contribute to the understanding of the pathogenesis of chronic spontaneous urticaria (CSU) by identifying  its relationship with autoimmunity and cytokines using the autologous serum skin test (ASST) and peripheral blood  mononuclear cell culture (PBMC) method.",Non-OADS,/arxiv_data1/oa_pdf/55/70/PDIA-34-26878.PMC5329100.pdf
"Patryk Łakuta1, Kamil Marcinkiewicz2, Beata Bergler-Czop3, Ligia Brzezińska-Wcisło3 1SWPS University of Social Sciences and Humanities, Warsaw, Poland 2Institute of Cardiology, Warsaw, Poland 3Departament of Dermatology, Medical University of Silesia, Katowice, Poland Adv Dermatol Allergol 2017; XXXIV (1): 36–41 DOI: https://doi.org/10.5114/pdia.2016.62286 Abstract Introduction: Psoriasis is associated with a major additional psychological burden.",Non-OADS,/arxiv_data1/oa_pdf/8f/40/PDIA-34-28311.PMC5329101.pdf
"6, 90-647 Lodz, Poland, phone: +48 604 437 151, e-mail: jolanta.torzecka@umed.lodz.pl Received: 21.12.2015, accepted: 26.02.2016.The use of isotretinoin in low doses and unconventional  treatment regimens in different types of acne: a literature  review Jolanta D. Torzecka1, Bożena Dziankowska-Bartkowiak1, Zofia Gerlicz-Kowalczuk2,3, Anna Wozniacka1 1Department of Dermatology and Venereology, Medical University of Lodz, Lodz, Poland 2Psychodermatology Department, Medical University of Lodz, Lodz, Poland 3Department of Dermatology, Pediatric Dermatology and Oncology, Medical University of Lodz, Lodz, Poland Adv Dermatol Allergol 2017; XXXIV (1): 1–5 DOI: https://doi.org/10.5114/ada.2017.65614 Abstract High effectiveness of isotretinoin treatment for severe types of acne resistant to antibiotics has been widely recog- nized.",Non-OADS,/arxiv_data1/oa_pdf/13/15/PDIA-34-29327.PMC5329102.pdf
"Barbara Zegarska1, Katarzyna Pietkun1,2, Wojciech Zegarski3, Paulina Bolibok4, Marek Wiśniewski4, Katarzyna Roszek5,   Joanna Czarnecka5, Maciej Nowacki3 1Chair of Cosmetology and Aesthetic Dermatology, Ludwik Rydygier’s Collegium Medicum in Bydgoszcz, Nicolaus Copernicus   University in Torun, Poland 2Chair and Department of Rehabilitation, Ludwik Rydygier’s Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun,    Poland 3Chair and Department of Surgical Oncology, Ludwik Rydygier’s Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University   in Torun, Oncology Centre – Professor Franciszek Łukaszczyk Memorial Hospital in Bydgoszcz, Poland 4Physicochemistry of Carbon Materials Research Group, Faculty of Chemistry, Nicolaus Copernicus University, Torun, Poland 5Department of Biochemistry, Faculty of Biology and Environment Protection, Nicolaus Copernicus University, Torun, Poland Adv Dermatol Allergol 2017; XXXIV (1): 6–14 DOI: https://doi.org/10.5114/ada.2017.65616 Abstract The link between air pollution, UV irradiation and skin carcinogenesis has been demonstrated within a large number of epidemiological studies.",Non-OADS,/arxiv_data1/oa_pdf/8d/a1/PDIA-34-29328.PMC5329103.pdf
"Advances in Dermatology and Allergology 1, February / 2017 21Original paper  Address for correspondence: Justyna Gornowicz-Porowska PhD, MSc, Autoimmune Blistering Dermatoses Section, Department   of Dermatology, Poznan University of Medical Sciences, 49 Przybyszewskiego St, 60-355 Poznan, Poland, phone: +48 603 222 280,  e-mail: justynagornowicz1@poczta.onet.pl Received: 16.09.2015, accepted: 29.11.2015.Accuracy of molecular diagnostics in pemphigus and  bullous pemphigoid: comparison of commercial and modified mosaic indirect immunofluorescence tests   as well as enzyme-linked immunosorbent assays Justyna Gornowicz-Porowska1, Agnieszka Seraszek-Jaros2, Monika Bowszyc-Dmochowska3, Elżbieta Kaczmarek2,  Paweł Pietkiewicz1, Paweł Bartkiewicz1, Marian Dmochowski1 1Autoimmune Blistering Dermatoses Section, Department of Dermatology, Poznan University of Medical Sciences, Poznan, Poland 2Department of Bioinformatics and Computational Biology, Poznan University of Medical Sciences, Poznan, Poland 3Cutaneous Histopathology and Immunopathology Section, Department of Dermatology, Poznan University of Medical Sciences,   Poznan, Poland Adv Dermatol Allergol 2017; XXXIV (1): 21–27 DOI: https://doi.org/10.5114/ada.2017.65617 Abstract Introduction:  Pemphigus and bullous pemphigoid (BP) are identified by autoantibodies (abs) against desmoglein 1,  3 (DSG1/3) and BP180/BP230, respectively.",Non-OADS,/arxiv_data1/oa_pdf/da/d4/PDIA-34-29329.PMC5329104.pdf
"Pietkiewicz1, Anna Świrkowicz1,   Monika Bowszyc-Dmochowska2, Marian Dmochowski1 1Autoimmune Blistering Dermatoses Section, Department of Dermatology, Poznan University of Medical Sciences, Poznan, Poland 2Cutaneous Histopathology and Immunopathology Section, Department of Dermatology, Poznan University of Medical Sciences,   Poznan, Poland Adv Dermatol Allergol 2017; XXIV (1): 42–46 DOI: https://doi.org/10.5114/ada.2017.65619 Abstract Introduction: Bullous pemphigoid (BP) is an autoimmune blistering dermatosis of the elderly with autoimmunity  to hemidesmosomal proteins, BP180 and BP230, which are expressed also in neuronal tissue.",Non-OADS,/arxiv_data1/oa_pdf/82/62/PDIA-34-29331.PMC5329105.pdf
"Aim In this study we focus on the possible relations be- tween the expression of chosen HERV sequences and factors influencing the pathomechanism of the disease, Human endogenous retroviruses and chosen disease  parameters in morphea Michał J. Kowalczyk1, Aleksandra Dańczak-Pazdrowska2, Beata Szramka-Pawlak3, Ryszard Żaba1,   Agnieszka Osmola-Mańkowska4, Wojciech Silny 3 1Department of Dermatology and Venereology, Poznan University of Medical Sciences, Poznan, Poland 2Unit of Noninvasive Diagnostics of Skin Diseases, Department of Dermatology, Poznan University of Medical Sciences, Poznan, Poland 3Department of Dermatology, Poznan University of Medical Sciences, Poznan, Poland  4Psoriasis and Novel Therapies Unit, Department of Dermatology, Poznan University of Medical Sciences, Poznan, Poland Adv Dermatol Allergol 2017; XXXIV (1): 47–51 DOI: https://doi.org/10.5114/ada.2017.65621 Abstract Introduction: Morphea (localized scleroderma) is a  relatively rare disease characterized by excessive skin fibro- sis.",Non-OADS,/arxiv_data1/oa_pdf/dd/04/PDIA-34-29332.PMC5329106.pdf
"Advances in Dermatology and Allergology 1, February / 201752Original paper Address for correspondence: Urszula Grzybowska-Chlebowczyk MD, PhD, Department of Pediatrics, Medical University of Silesia,   16 Medykow St, 40-752 Katowice, Poland, phone: +48 322 071 700, e-mail: urszulachlebowczyk@wp.pl Received: 28.09.2015, accepted: 28.12.2015.Eosinophilic colitis in children Urszula Grzybowska-Chlebowczyk1, Sabina Horowska-Ziaja2, Maciej Kajor3, Sabina Więcek1, Wojciech Chlebowczyk4,  Halina Woś1 1Department of Pediatrics, School of Medicine, Medical University of Silesia, Katowice, Poland 2Gastroenterology Unit, Upper-Silesian Child Health Care Centre, Katowice, Poland 3Department of Pathomorphology, School of Medicine, Medical University of Silesia, Katowice, Poland 4Department of Nursing and Social Medical Problems, School of Medicine, Medical University of Silesia, Katowice, Poland Adv Dermatol Allergol 2017; XXXIV (1): 52–59 DOI: https://doi.org/10.5114/ada.2017.65622 Abstract Introduction: Eosinophilic colitis, which is a rare form of eosinophilic gastrointestinal diseases, occurs as primary  and secondary allergic eosinophilic colitis of the gastrointestinal tract infection, inflammatory bowel disease, celiac  disease, and vasculitis.",Non-OADS,/arxiv_data1/oa_pdf/24/51/PDIA-34-29333.PMC5329107.pdf
"Advances in Dermatology and Allergology 1, February / 201760Original paper Address for correspondence: Luís Miguel Lourenço Martins, Department of Veterinary Medicine, School of Sciences and Technology,  University of Évora, Núcleo da Mitra, 7000-093 Évora, Portugal, phone: +351 919498570, fax: +351 266760944, e-mail: lmlm@uevora.pt Received: 12.10.2015, accepted: 25.12.2015.Allergy to grass pollen: mapping of Dactylis glomerata   and Phleum pratense allergens for dogs by two-dimensional  immunoblotting Luís Miguel Lourenço Martins1,2, Andreia Grilo Marques1, Luísa Maria Dotti Silva Pereira2,3, Saul José Semião-Santos4,  Ofélia Pereira Bento2,5  1Department of Veterinary Medicine, School of Sciences and Technology, University of Évora, Évora, Portugal 2Institute of Mediterranean Agricultural and Environmental Science (ICAAM), University of Évora, Évora, Portugal 3Escola Superior Agrária de Elvas, Polytechnique Institute of Portalegre, Elvas, Portugal 4Department of Nursing, GEE, Universidade Tiradentes, Aracaju, Brazil 5Department of Animal Science, School of Sciences and Technology, University of Évora, Évora, Portugal Adv Dermatol Allergol 2017; XXXIV (1): 60–69 DOI: https://doi.org/10.5114/ada.2017.65623 Abstract Introduction: Much less is known about grass-pollen allergens to dogs, when compared with humans.",Non-OADS,/arxiv_data1/oa_pdf/04/6f/PDIA-34-29334.PMC5329108.pdf
2009. http://www.ivis.org/proceedings/NAVC/2006/SAE/139.asp?LA=1.,OADS,/arxiv_data1/oa_pdf/04/6f/PDIA-34-29334.PMC5329108.pdf
"Advances in Dermatology and Allergology 1, February / 201777Original paper Address for correspondence: Katarzyna Dońka, Chair and Department of Pediatric Nursing, Medical University of Lublin,   6 Prof. A. Gębali St, 20-093 Lublin, Poland, phone: +48 81 718 53 75, e-mail: katarzyna.donka@umlub.pl Received: 1.12.2015, accepted: 27.01.2016.Validation of the Polish version of Satisfaction with  Asthma Treatment Questionnaire (SATQ)  Katarzyna Dońka1, Krzysztof J. Czarnocki², Andrzej Emeryk3 1Chair and Department of Pediatric Nursing, Medical University of Lublin, Lublin, Poland ²Chair of Ergonomics, Lublin Polytechnic School, Lublin, Poland 3Chair of Lung Diseases and Rheumatology, Medical University of Lublin, Lublin, Poland Adv Dermatol Allergol 2017; XXXIV (1): 77–81 DOI: https://doi.org/10.5114/ada.2017.65625 Abstract Introduction: Among the chronically ill there is a tendency for non-compliance with medical recommendations, which is often due to low satisfaction with the offered treatment.",Non-OADS,/arxiv_data1/oa_pdf/da/f0/PDIA-34-29335.PMC5329109.pdf
http://www.mapi-insti-tute.com (01.06.2009).,Non-OADS,/arxiv_data1/oa_pdf/da/f0/PDIA-34-29335.PMC5329109.pdf
"Advances in Dermatology and Allergology 1, February / 201782Letter to the Editor Address for correspondence: Xinfeng Wu, Jiangsu Key Laboratory of Molecular Biology for Skin Diseases and STIs, Jiangsu, China,  phone: 86-13675109778, fax: 86-25-85478035, e-mail: wuxinfengdr@163.com; Baoxi Wang, Jiangsu Key Laboratory of Molecular Biology for Skin Diseases and STIs, Jiangsu, China, phone: 86-13815441336, fax: 86-10-88771611, e-mail: wangbx@ncstdlc.org Received: 23.11.2015, accepted: 11.04.2016.Increased serum interleukin-6 levels in patients with  hidradenitis suppurativa Haoxiang Xu1,2, Xuemin Xiao3, Yanyan He1,2, Xiaofeng Zhang1,2, Chengrang Li1,2, Qiuxia Mao1,2, Xinfeng Wu1,2,   Baoxi Wang2,4 1Institute of Dermatology, Chinese Academy of Medical Sciences, Jiangsu, China 2Jiangsu Key Laboratory of Molecular Biology for Skin Diseases and STIs, Jiangsu, China 3Department of Dermatology, Union Hospital, Fujian Medical University, Fujian, China 4Department of Dermatology, Institute of Plastic Surgery, Chinese Academy of Medical Sciences, Beijing, China Adv Dermatol Allergol 2017; XXXIV (1): 82–84 DOI: https://doi.org/10.5114/ada.2017.65626 Hidradenitis suppurativa (HS), also known as acne  inversa, is a chronic, recurrent, and inflammatory skin  disease.",Non-OADS,/arxiv_data1/oa_pdf/b8/e9/PDIA-34-29336.PMC5329110.pdf
"The presence of allele T   in –1237 T/C TLR9 polymorphism was more common in the group of early onset psoriasis (86.3% vs. 73.8%;   p = 0.0086) and their presence increases more than twice  the risk of the development of this type of the disease The significance of Toll-like receptor (TLR) 2 and 9 gene  polymorphisms in psoriasis Monika Zabłotna, Michał Sobjanek, Dorota Purzycka-Bohdan, Aneta Szczerkowska-Dobosz, Bogusław Nedoszytko, Roman J. Nowicki Department of Dermatology, Venereology and Allergology, Medical University of Gdansk, Gdansk, Poland Adv Dermatol Allergol 2017; XXXIV (1): 85–86 DOI: https://doi.org/10.5114/ada.2017.65628 Table 1.",Non-OADS,/arxiv_data1/oa_pdf/b2/cf/PDIA-34-29337.PMC5329111.pdf
"Advances in Dermatology and Allergology 1, February / 201787Letter to the Editor Address for correspondence: Krzysztof Gomułka MD, PhD, Department of Internal Diseases and Allergology, Medical University  of Wroclaw, 66 Marii Curie-Skłodowskiej St, 50-369 Wroclaw, Poland, phone: +48 71 784 25 28, e-mail: kgomulka@wp.pl Received: 11.12.2015, accepted: 22.04.2016.Food-dependent, exercise-induced anaphylaxis triggered  by co-incidence of culprit food, physical effort and a very high dose of ibuprofen or menstruation: a case report Krzysztof Gomułka1, Anna Wolańczyk-Mędrala1, Wojciech Barg2, Wojciech Mędrala1 1Department of Internal Diseases and Allergology, Medical University of Wroclaw, Wroclaw, Poland 2Department of Physiology, Medical University of Wroclaw, Wroclaw, Poland Adv Dermatol Allergol 2017; XXXIV (1): 87–88 DOI: https://doi.org/10.5114/ada.2017.65629 Food-dependent exercise-induced anaphylaxis (FDEIA)   is defined as anaphylaxis resulting from co-incidence of  ingestion of sensitizing food and physical activity, while  any of those factors alone does not cause any adverse reactions [1–4].",Non-OADS,/arxiv_data1/oa_pdf/fd/bf/PDIA-34-29338.PMC5329112.pdf
Abbreviations 5-FU 5-ﬂuorouracilCRC colorectal cancerDCCH designated cancer care hospitalFAP familial adenomatous polyposis JSCCR Japan Society of Colorectal Cancer Research LS Lynch syndromeMMR mismatch repairMSI-H high-frequency microsatellite instabilityNSAID nonsteroidal anti-inﬂammatory drugPD-1 programmed death-1 References 1 http://ganjoho.jp/reg_stat/statistics/stat/summary.html.,Non-OADS,/arxiv_data1/oa_pdf/95/84/CAS-108-243.PMC5329156.pdf
"(25) We ﬁltered the above reported variants according to the fol-lowing items: (i) only one variant was selected as multiple one were in LD at r2>0.2 (1000 Genomes Project data of Chinese population, http://browser.1000genomes.org/index.html); (ii)those variants with a minor allele frequency <5% in the Chi- nese population were excluded.",Non-OADS,/arxiv_data1/oa_pdf/69/07/CAS-108-250.PMC5329157.pdf
"Analysis of the Encyclopedia of DNA Elements data, as imple-mented in the online tool HaploReg (http://broadinstitute.org/mammals/haploreg/haploreg.php), indicated that rs1679013 was located in a transcription regulatory region and may inﬂu- ence the chromatin structure and histone modiﬁcations byaltering the transcription factor binding sites of OTX2 , which may serve as a regulatory variant in the expression of CDKN2B , suggesting that modulation of CDKN2B expression may mediate ESCC susceptibility.",OADS,/arxiv_data1/oa_pdf/69/07/CAS-108-250.PMC5329157.pdf
The relative densities of bands were quantiﬁed using ImageJ(https://imagej.nih.gov/ij/) software.,OADS,/arxiv_data1/oa_pdf/9f/05/CAS-108-178.PMC5329158.pdf
The relative density of bands was quanti- ﬁed using ImageJ (http://rsb.info.nih.gov/ij/) software.,OADS,/arxiv_data1/oa_pdf/9f/05/CAS-108-178.PMC5329158.pdf
"1b), which is consistent with the analysis of ONCOMINE dataset (https://www.oncomine.org) (Fig.",OADS,/arxiv_data1/oa_pdf/9f/05/CAS-108-178.PMC5329158.pdf
(19)The RNA read count at each mutation site was obtained by bam-readcount (https://github.com/genome/ba m-readcount).,OADS,/arxiv_data1/oa_pdf/2b/25/CAS-108-170.PMC5329159.pdf
Primer3Plus (http://primer3plus.com/) was used to design the primer pairs to amplify the region ranging from 200 to 600 bp in size containing each mutation (Table S1).,OADS,/arxiv_data1/oa_pdf/2b/25/CAS-108-170.PMC5329159.pdf
"(20)In brief, four-digit-typed HLA class I alleles of each patient wereidentiﬁed from WES data of their normal lung tissue using Omixon Target HLA Typing (http://www.omixon.com).",Non-OADS,/arxiv_data1/oa_pdf/2b/25/CAS-108-170.PMC5329159.pdf
All statistical analyses were carried out using R 3.3.0 (http://www.r-project.org).,OADS,/arxiv_data1/oa_pdf/2b/25/CAS-108-170.PMC5329159.pdf
"Further, we ﬁltered out possible germline mutations using the databases of the 1000 genomes project (http://www.internationalgenome.org/) and 5000 exomes project (http://evs.gs.washington.edu/EVS/), asmatched normal tissue samples were not analyzed in thisstudy.",OADS,/arxiv_data1/oa_pdf/23/5a/CAS-108-256.PMC5329163.pdf
"(7)On the other hand, the mutation frequencies of TP53 in HNSCC and OSCC in COSMIC data (v78, released 05-SEP-16) were 32% and 42%,respectively (http://cancer.sanger.ac.uk/cancergenome/projects/cosmic/).",Non-OADS,/arxiv_data1/oa_pdf/23/5a/CAS-108-256.PMC5329163.pdf
E-mail: liuhl75@163.com ORCID: http://orcid.org/0000-0002-9743-1039,Non-OADS,/arxiv_data1/oa_pdf/a7/58/SaudiMedJ-38-123.PMC5329622.pdf
Available from: http://monographs.iarc.fr/ENG/Monographs/ vol60/index.php   5.,Non-OADS,/arxiv_data1/oa_pdf/7d/d4/SaudiMedJ-38-132.PMC5329623.pdf
E-mail: jkari@doctors.org.uk / jkari@kau.edu.sa ORCID: http://orcid.org/0000-0001-7628-8926 OPEN ACCESS 138 Saudi Med J 2017; Vol.,Non-OADS,/arxiv_data1/oa_pdf/b1/c0/SaudiMedJ-38-138.PMC5329624.pdf
E-mail: dr_fmucar@hotmail.com ORCID: http://orcid.org/0000-0001-8123-4121 143  www.smj.org.sa    Saudi Med J 2017; Vol.,Non-OADS,/arxiv_data1/oa_pdf/37/c8/SaudiMedJ-38-143.PMC5329625.pdf
Sample references are available from:   http://www.nlm.nih.gov/bsd/uniform_requirements.html,Non-OADS,/arxiv_data1/oa_pdf/a5/c7/SaudiMedJ-38-156.PMC5329627.pdf
Email: lneitan@just.edu.jo ORCID :http://orcid.org/0000-0003-0064-0190.,Non-OADS,/arxiv_data1/oa_pdf/02/2c/SaudiMedJ-38-163.PMC5329628.pdf
E-mail: mahmoud_juh@hotmail.com ORCID: http://orcid.org/0000-0003-2835-0777 OPEN ACCESS 170 Saudi Med J 2017; Vol.,Non-OADS,/arxiv_data1/oa_pdf/7b/d6/SaudiMedJ-38-170.PMC5329629.pdf
E-mail: akmermutlu@yahoo.com / akmer@hacettepe.edu.tr ORCID: http://orcid.org/0000-0001-6346-1750 OPEN ACCESS 176 Saudi Med J 2017; Vol.,Non-OADS,/arxiv_data1/oa_pdf/ed/e0/SaudiMedJ-38-176.PMC5329630.pdf
Available From: http://www.who.int/mediacentre/factsheets/ fs311/en/   2.,Non-OADS,/arxiv_data1/oa_pdf/b0/98/SaudiMedJ-38-186.PMC5329631.pdf
Body mass index - BMI [June   2016] Available From:  http://www.euro.who.int/en/health- topics/disease-prevention/nutrition/a-healthy-lifestyle/body- mass-index-bmi,Non-OADS,/arxiv_data1/oa_pdf/b0/98/SaudiMedJ-38-186.PMC5329631.pdf
Available From: http://www.health.gov.au/ internet/main/publishing.nsf/content/health-pubhlth-strateg- phys-act-guidelines#apa1317 14.,Non-OADS,/arxiv_data1/oa_pdf/b0/98/SaudiMedJ-38-186.PMC5329631.pdf
E-mail: : aalthobity@uod.edu.sa ORCID: http://orcid.org/0000-0001-7402-9242 OPEN ACCESSDisclosure .,Non-OADS,/arxiv_data1/oa_pdf/43/08/SaudiMedJ-38-192.PMC5329632.pdf
3. http://www.ehuman.com.,Non-OADS,/arxiv_data1/oa_pdf/43/08/SaudiMedJ-38-192.PMC5329632.pdf
Available from: http://www.ehuman.com/   4.,Non-OADS,/arxiv_data1/oa_pdf/43/08/SaudiMedJ-38-192.PMC5329632.pdf
[Accessed  2016 March 15] Available from: http://www.net.educause.edu/ ir/library/pdf/pub7101.pdf   7.,Non-OADS,/arxiv_data1/oa_pdf/43/08/SaudiMedJ-38-192.PMC5329632.pdf
"E-mail: fahadalhameed@hotmail.com ORCID: http://orcid.org/0000-0003-0231-871X The Middle East respiratory syndrome corona  virus (MERS-CoV) is a novel positive sense single  stranded ribonucleic acid virus of the genus Beta corona  virus.1 The virus was first isolated from a patient who  died from severe respiratory illness in June 2012 in  King Abdul-Aziz Medical City,  Jeddah, Kingdom of  Saudi Arabia.2 As of May 25, 2016, the World Health  Organization reported 1733 laboratory-confirmed cases  of the Middle East respiratory syndrome (MERS) in  27 countries (almost 80% arising from the Kingdom  of Saudi Arabia [KSA]), with an overall mortality rate  of 36%.3 The spectrum of the clinical presentation  of MERS-CoV patients is wide, and it ranges from  asymptomatic infection, mild to severe pneumonia that  leads to respiratory failure, septic shock, multiorgan  failure, and death.",Non-OADS,/arxiv_data1/oa_pdf/ee/20/SaudiMedJ-38-196.PMC5329633.pdf
Geneva (CH); 2015  Avaliable from:  http://www.who.int/emergencies/mers-cov/en/   4.,Non-OADS,/arxiv_data1/oa_pdf/ee/20/SaudiMedJ-38-196.PMC5329633.pdf
E-mail: shangxiao6776@sina.com ORCID: http://orcid.org/0000-0002-9733-2874 References   1.,Non-OADS,/arxiv_data1/oa_pdf/c4/33/SaudiMedJ-38-204.PMC5329635.pdf
Available from: http://www.who.int/gho/publications/ world_health_statistics/2014/en/   3.,Non-OADS,/arxiv_data1/oa_pdf/53/83/SaudiMedJ-38-209.PMC5329636.pdf
2012 Available at: http://www.bbc.com/ news/magazine-18793842   4.,Non-OADS,/arxiv_data1/oa_pdf/35/75/SaudiMedJ-38-213.PMC5329637.pdf
Available at:  https://islamqa.info/ en/9412Non-therapeutic infant male circumcision ...  Berhanu Student Corner We invite students from a variety of medical disciplines to submit original contributions based  on their supervised research.,Non-OADS,/arxiv_data1/oa_pdf/35/75/SaudiMedJ-38-213.PMC5329637.pdf
Available from:  http://www.who.int/mediacentre/news/releases/2017/tobacco-control-lives/en/,Non-OADS,/arxiv_data1/oa_pdf/6a/d5/SaudiMedJ-38-216.PMC5329639.pdf
"See: http://creativecommons.org/licenses/by ­nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Juan R Tejedo, PhD,  Andalusian Center  for Molecular Biology and Regenerative Medicine ­University Pablo  de Olavide, Parque Científico y Tecnológico Cartuja 93, 41092  Seville, Spain.",Non-OADS,/arxiv_data1/oa_pdf/63/9d/WJSC-9-26.PMC5329687.pdf
"Nevertheless, many studies have demonstrated Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4252/wjsc.v9.i2.26World J Stem Cells  2017 February 26; 9(2): 26-36 ISSN 1948-0210 (online)",Non-OADS,/arxiv_data1/oa_pdf/63/9d/WJSC-9-26.PMC5329687.pdf
World J Stem Cells  2017; 9(2): 26­36   Available from: URL: http://www.wjgnet.com/1948 ­0210/full/v9/ i2/26.htm  DOI: http://dx.doi.org/10.4252/wjsc.v9.i2.,OADS,/arxiv_data1/oa_pdf/63/9d/WJSC-9-26.PMC5329687.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/63/9d/WJSC-9-26.PMC5329687.pdf
"Core tip:  T cells act as a double-edged sword upon  allogeneic hematopoietic stem and progenitor cells (HSPC)  transplantation, as they support engraftment of HSPCs  and provide anti-tumor activity, but are also the cause  Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4252/wjsc.v9.i2.37World J Stem Cells  2017 February 26; 9(2): 37-44 ISSN 1948-0210 (online)",Non-OADS,/arxiv_data1/oa_pdf/16/c8/WJSC-9-37.PMC5329688.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/16/c8/WJSC-9-37.PMC5329688.pdf
"Production and hosting by ElsevierArab Journal of Urology (2017) 15, 30–35 Arab Journal of Urology (Ofﬁcial Journal of the Arab Association of Urology) www.sciencedirect.com http://dx.doi.org/10.1016/j.aju.2016.11.002 2090-598X /C2112016 Arab Association of Urology.",Non-OADS,/arxiv_data1/oa_pdf/9a/40/main.PMC5329696.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9a/40/main.PMC5329696.pdf
"Production and hosting by ElsevierArab Journal of Urology (2017) 15, 17–23 Arab Journal of Urology (Ofﬁcial Journal of the Arab Association of Urology) www.sciencedirect.com http://dx.doi.org/10.1016/j.aju.2016.11.003 2090-598X /C2112016 Arab Association of Urology.",Non-OADS,/arxiv_data1/oa_pdf/e3/e3/main.PMC5329697.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e3/e3/main.PMC5329697.pdf
"Production and hosting by ElsevierArab Journal of Urology (2017) 15, 60–63 Arab Journal of Urology (Ofﬁcial Journal of the Arab Association of Urology) www.sciencedirect.com http://dx.doi.org/10.1016/j.aju.2016.10.003 2090-598X /C2112016 Arab Association of Urology.",Non-OADS,/arxiv_data1/oa_pdf/ba/9b/main.PMC5329698.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ba/9b/main.PMC5329698.pdf
Available at: < http://www.can- cer.gov/cancertopics/pdq/treatment/bladder/HealthProfes-sional/page6 >.,Non-OADS,/arxiv_data1/oa_pdf/ba/9b/main.PMC5329698.pdf
"Production and hosting by ElsevierArab Journal of Urology (2017) 15, 42–47 Arab Journal of Urology (Ofﬁcial Journal of the Arab Association of Urology) www.sciencedirect.com http://dx.doi.org/10.1016/j.aju.2016.10.001 2090-598X /C2112016 Arab Association of Urology.",Non-OADS,/arxiv_data1/oa_pdf/04/e2/main.PMC5329699.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/04/e2/main.PMC5329699.pdf
"Production and hosting by ElsevierArab Journal of Urology (2017) 15, 24–29 Arab Journal of Urology (Ofﬁcial Journal of the Arab Association of Urology) www.sciencedirect.com http://dx.doi.org/10.1016/j.aju.2016.12.001 2090-598X /C2112016 Arab Association of Urology.",Non-OADS,/arxiv_data1/oa_pdf/1a/79/main.PMC5329700.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1a/79/main.PMC5329700.pdf
"Production and hosting by ElsevierArab Journal of Urology (2017) 15, 53–59 Arab Journal of Urology (Ofﬁcial Journal of the Arab Association of Urology) www.sciencedirect.com http://dx.doi.org/10.1016/j.aju.2016.11.001 2090-598X /C2112016 Arab Association of Urology.",Non-OADS,/arxiv_data1/oa_pdf/eb/f3/main.PMC5329701.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/eb/f3/main.PMC5329701.pdf
"Aliza Abeles, Richard Mark Kwasnicki, Ara DarziMINIREVIEWS 37 February 27, 2017 |Volume 9 |Issue 2| WJGS|www.wjgnet.comEnhanced recovery after surgery: Current research insights  and future directionSubmit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4240/wjgs.v9.i2.37World J Gastrointest Surg   2017  February 27; 9(2): 37-45 ISSN 1948-9366 (online) Aliza Abeles, Richard Mark Kwasnicki, Ara Darzi, Department  of Surgery and Cancer, St Mary’s Hospital, Imperial College  London, London W2 1NY , United Kingdom Author contributions:  Abeles A and Kwasnicki RM analysed  the literature and wrote the manuscript; Darzi A reviewed and  edited the manuscript.",Non-OADS,/arxiv_data1/oa_pdf/2e/29/WJGS-9-37.PMC5329702.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Dr. Richard Mark Kwasnicki, Department  of Surgery and Cancer, St Mary’s Hospital, Imperial College  London, 10th Floor QEQM Building, Praed Street, London W2  1NY , United Kingdom.",Non-OADS,/arxiv_data1/oa_pdf/2e/29/WJGS-9-37.PMC5329702.pdf
World  J Gastrointest Surg  2017; 9(2): 37-45  Available from: URL:   http://www.wjgnet.com/ 1948-9366 /full/v9/i2/37.htm  DOI:  http://dx.doi.org/10.4240/wjgs.v9.i2.37 INTRODUCTION The concept of enhanced recovery after surgery (ERAS)  was initially proposed by Kehlet[1] who explored the  possible determinants of post-operative morbidity in  the late 1990s.,Non-OADS,/arxiv_data1/oa_pdf/2e/29/WJGS-9-37.PMC5329702.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/2e/29/WJGS-9-37.PMC5329702.pdf
"Sandra Prgomet, Boris Lukšić, Zenon Pogorelić, Ivo Jurić, Vesna Čapkun, Adela Arapović, Nataša BobanORIGINAL ARTICLE 46 February 27, 2017 |Volume 9 |Issue 2| WJGS|www.wjgnet.comPerinatal risk factors in newborns with gastrointestinal  perforationSubmit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4240/wjgs.v9.i2.46World J Gastrointest Surg   2017  February 27; 9(2): 46-52 ISSN 1948-9366 (online) Sandra Prgomet, Adela Arapović, Department of Pediatrics,  University Hospital of Split and University of Split, School of  Medicine, 21000 Split, Croatia Boris Lukšić, Department of Infectious diseases, University  Hospital of Split and University of Split, School of Medicine,  21000 Split, Croatia Zenon Pogorelić, Ivo Jurić,  Department of Pediatric Surgery,  University Hospital of Split and University of Split, School of  Medicine, 21000 Split, Croatia Vesna Čapkun,  Department of Nuclear Medicine, University  Hospital of Split and University of Split, School of Medicine,  21000 Split, Croatia Nataša Boban, Department of Clinical Epidemiology,  University Hospital of Split and University of Split, School of  Medicine, 21000 S plit, Croatia Author contributions:  All the authors completely contributed to  this paper.",Non-OADS,/arxiv_data1/oa_pdf/35/e2/WJGS-9-46.PMC5329703.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Zenon Pogorelić, MD, PhD, Associate  Professor, Department of Pediatric Surgery, University Hospital  of Split and University of Split, School of Medicine , Spinčićeva 1,  21000 Split, Croatia.",Non-OADS,/arxiv_data1/oa_pdf/35/e2/WJGS-9-46.PMC5329703.pdf
World J Gastrointest Surg  2017; 9(2): 46-52   Available from: URL:  http://www.wjgnet.com/ 1948-9366 /full/ v9/i2/46.htm  DOI: http://dx.doi.org/10.4240/wjgs.v9.i2.46 INTRODUCTION Gastrointestinal perforation (GIP) in newborns is a  severe and life threatening condition associated with  high mortality of 17%-60%[1-4].,Non-OADS,/arxiv_data1/oa_pdf/35/e2/WJGS-9-46.PMC5329703.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/35/e2/WJGS-9-46.PMC5329703.pdf
"Andrew M Blakely, Saad Ajmal, Rachel E Sargent, Thomas T Ng, Thomas J MinerORIGINAL ARTICLE 53 February 27, 2017 |Volume 9 |Issue 2| WJGS|www.wjgnet.comCritical analysis of feeding jejunostomy following resection  of upper gastrointestinal malignanciesSubmit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4240/wjgs.v9.i2.53World J Gastrointest Surg   2017  February 27; 9(2): 53-60 ISSN 1948-9366 (online) Andrew M Blakely, Saad Ajmal, Thomas T Ng, Thomas  J Miner, Department of Surgery, Rhode Island Hospital,  Providence, RI 02903, United States Andrew M Blakely, Rachel E Sargent, Thomas T Ng,  Thomas J Miner, Warren Alpert Medical School of Brown  University, Providence, RI 02903, United States Author contributions:  Blakely AM, Ajmal S, Ng TT and Miner  TJ designed the study; Blakely AM, Ajmal S and Sargent RE  conducted the study; Blakely AM, Ajmal S, Sargent RE, Ng TT  and Miner TJ interpreted the data; Blakely AM, Ajmal S and  Sargent RE drafted the manuscript; Blakely AM, Ajmal S, Sargent  RE, Ng TT and Miner TJ edited and approved the final manuscript.",Non-OADS,/arxiv_data1/oa_pdf/bb/4e/WJGS-9-53.PMC5329704.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source: Invited manuscript Correspondence to:  Thomas J Miner, MD, FACS, Department  of Surgery, Rhode Island Hospital, 593 Eddy Street, APC 443,  Providence, RI 02903,  United States.",Non-OADS,/arxiv_data1/oa_pdf/bb/4e/WJGS-9-53.PMC5329704.pdf
"World J Gastrointest Surg  2017; 9(2):  53-60  Available from: URL:  http://www.wjgnet.com/ 1948-9366 / full/v9/i2/53.htm  DOI: http://dx.doi.org/10.4240/wjgs.v9.i2.53 INTRODUCTION Upper gastrointestinal malignancy, comprised of es­ ophageal and gastric cancer , represents nearly 42000  new diagnoses per year in the United States.",Non-OADS,/arxiv_data1/oa_pdf/bb/4e/WJGS-9-53.PMC5329704.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/bb/4e/WJGS-9-53.PMC5329704.pdf
"Mohamed Abdel Wahab, Ehab El Hanafy, Ayman El Nakeeb, Mahmoud Abdelwahab Ali ORIGINAL ARTICLE 61 February 27, 2017 |Volume 9 |Issue 2| WJGS|www.wjgnet.comClinicopathological features and surgical outcome of  patients with fibrolamellar hepatocellular carcinoma  (experience with 22 patients over a 15-year period)Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4240/wjgs.v9.i2.61World J Gastrointest Surg   2017  February 27; 9(2): 61-67 ISSN 1948-9366 (online) Mohamed Abdel Wahab, Ehab El Hanafy, Ayman El Nakeeb,  Mahmoud Abdelwahab Ali, Gastroenterology Surgical Center,  Mansoura University, Mansoura 35516, Egypt Author contributions:  Wahab MA and El Hanafy E contributed  to study concept; Wahab MA, El Hanafy E and El Nakeeb A  contributed to data collection; El Hanafy E and El Nakeeb A  contributed to data analysis; Wahab MA and Ali MA contributed  to writing the draft; all authors have approved the manuscript in  its fina l form and approving the manuscript in its final form.",Non-OADS,/arxiv_data1/oa_pdf/d7/a6/WJGS-9-61.PMC5329705.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ Manuscript source: Unsolicited manuscript Correspondence to:  Ehab El Hanafy, MD, Assistant Pro - fessor, Gastroenterology Surgical Center, Mansoura Unive rsity,  Elgomhouria St., Mansoura 35516,  Egypt.",Non-OADS,/arxiv_data1/oa_pdf/d7/a6/WJGS-9-61.PMC5329705.pdf
"World J Gastrointest Surg  2017; 9(2):  61-67  Available from: URL:  http://www.wjgnet.com/ 1948-9366 / full/v9/i2/61.htm  DOI: http://dx.doi.org/10.4240/wjgs.v9.i2.61 INTRODUCTION Fibrolamellar hepatocellular carcinoma (FL-HCC) has  conventionally been considered to be a histologic  variant of hepatocellular carcinoma (HCC), with distinct  clinicopathologic features.",Non-OADS,/arxiv_data1/oa_pdf/d7/a6/WJGS-9-61.PMC5329705.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/d7/a6/WJGS-9-61.PMC5329705.pdf
"Alexandros Diamantis, Grigorios Christodoulidis, Dionysia Vasdeki, Foteini Karasavvidou, Evangelos Margonis,  Konstantinos TepetesCASE REPORT 68 February 27, 2017 |Volume 9 |Issue 2| WJGS|www.wjgnet.comGiant abdominal osteosarcoma causing intestinal  obstruction treated with resection and adjuvant  chemotherapySubmit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4240/wjgs.v9.i2.68World J Gastrointest Surg   2017  February 27; 9(2): 68-72 ISSN 1948-9366 (online) Alexandros Diama ntis, Grigorios Christodoulidis, Dionysia  Vasdeki, Evangelos Margonis, Konstantinos Tepetes, Depart­ ment of General Surgery, University Hospital of Larisa, Mezourlo,  Larisa, 41110 Thessaly, Greece Foteini Karasavvidou, Division of Anatomic Pathology, Univer­ sity Hospital of Larisa, Mezourlo, Larisa, 41110 Thessaly, Greece Author contributions:  All authors contributed to the acquisition  of data, writing and revision of this manuscript.",Non-OADS,/arxiv_data1/oa_pdf/95/23/WJGS-9-68.PMC5329706.pdf
"See: http://creativecommons.org/ licenses/by ­nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to:  Konstantinos Tepetes, MD, ScD, FACS,  FEBS (Surgical Oncology ), Professor and Head of General  Surgery, Department of General Surgery, University Hospital of  Larisa, Mezourlo, Larisa, 41110 Thessaly,  Greece.",Non-OADS,/arxiv_data1/oa_pdf/95/23/WJGS-9-68.PMC5329706.pdf
World J Gastrointest Surg  2017; 9(2): 68 ­72  Available  from: URL:  http://www.wjgnet.com/ 1948 ­9366 /full/v9/i2/68.htm   DOI: http://dx.doi.org/10.4240/wjgs.v9.i2.68 INTRODUCTION Extraskeletal osteosarcoma (ESOS) is a rare mesen­ chymal malignant soft tissue neoplasm.,Non-OADS,/arxiv_data1/oa_pdf/95/23/WJGS-9-68.PMC5329706.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/95/23/WJGS-9-68.PMC5329706.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Feng Tao, MD, PhD, Associate Pro - fessor,  Department of Biomedical Sciences, Texas A&M  University College of Dentistry, 3302 Gaston Avenue, Dallas, TX  75246, United States.",Non-OADS,/arxiv_data1/oa_pdf/91/5a/WJBC-8-1.PMC5329709.pdf
"World J Biol Chem  2017; 8(1): 1-3  Available  from: URL: http://www.wjgnet.com/ 1949-8454 /full/v8/i1/1.htm    DOI: http://dx.doi.org/ 10.4331 /wjbc .v8.i1.1 PAIN CHRONIFICATION AFTER SURGERY After surgery, patients experience either short-term or  long-lasting pain.",Non-OADS,/arxiv_data1/oa_pdf/91/5a/WJBC-8-1.PMC5329709.pdf
As we World J Biol Chem  207 February 26; 8(): -3  ISSN 949-8454 (online)World Journal of Biological Chemistry WJBC Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 0.433/wjbc.v8.i.,Non-OADS,/arxiv_data1/oa_pdf/91/5a/WJBC-8-1.PMC5329709.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/91/5a/WJBC-8-1.PMC5329709.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Ferdinando Febbraio, PhD, Researcher,   Institute of Protein Biochemistry, National Research Council, via  P. Castellino 111, 80131 Naples, Italy.",Non-OADS,/arxiv_data1/oa_pdf/4b/1f/WJBC-8-13.PMC5329710.pdf
Such World J Biol Chem  2017 February 26; 8(1): 13-20  ISSN 1949-8454 (online)World Journal of Biological Chemistry WJBC Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4331/wjbc.v8.i1.13,Non-OADS,/arxiv_data1/oa_pdf/4b/1f/WJBC-8-13.PMC5329710.pdf
wjgnet.com/ 1949-8454 /full/v8/i1/13.htm   DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4b/1f/WJBC-8-13.PMC5329710.pdf
"The fact that five of the nine  new persistent organic pollutants (POPs)[23­25], which  bioaccumulate in humans and animals, are pesticides  (https://www.environment.gov.au/protection /chemicals ­ management/pops/new ­pops), highlights the importance  that must be attached to the presence of these sub­ stances in the environment.",Non-OADS,/arxiv_data1/oa_pdf/4b/1f/WJBC-8-13.PMC5329710.pdf
"Available from: URL: http://www.epa.gov/ncct/ Tox21/ 2 Judson R , Richard A, Dix DJ, Houck K, Martin M, Kavlock R,  Dellarco V , Henry T, Holderman T, Sayre P, Tan S, Carpenter T,  Smith E. The toxicity data landscape for environmental chemicals.",OADS,/arxiv_data1/oa_pdf/4b/1f/WJBC-8-13.PMC5329710.pdf
Available from:  URL: http://www.cdc.gov/exposurereport/fourthreport.pdf 5 Updated Tables to the Fourth National Report on Human Exposure to  Environmental Chemicals.,OADS,/arxiv_data1/oa_pdf/4b/1f/WJBC-8-13.PMC5329710.pdf
Available from: URL: http://www.cdc.,Non-OADS,/arxiv_data1/oa_pdf/4b/1f/WJBC-8-13.PMC5329710.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/4b/1f/WJBC-8-13.PMC5329710.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Dr. Deb Sanjay Nag,  Department of  Anaesthesia and Critical Care, Tata Main Hospital, C Road West,  Northern Town, Bistupur, Jamshedpur 831011,  India.",Non-OADS,/arxiv_data1/oa_pdf/d1/5e/WJBC-8-21.PMC5329711.pdf
"In addition,  small non-coding RNAs have presented themselves as  potential markers of brain injury for future research.World J Biol Chem  2017 February 26; 8(1): 21-31  ISSN 1949-8454 (online)World Journal of Biological Chemistry WJBC Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4331/wjbc.v8.i1.21",Non-OADS,/arxiv_data1/oa_pdf/d1/5e/WJBC-8-21.PMC5329711.pdf
"World J Biol Chem  2017; 8(1): 21-31  Available  from: URL: http://www.wjgnet.com/ 1949-8454 /full/v8/i1/21.htm    DOI: http://dx.doi.org/ 10.4331 /wjbc .v8.i1.21 INTRODUCTION The brain is one of the most energy intensive organs of  the body, utilizing around 60% of the available energy  for the fulfillment of electrophysiological function, and the  remaining 40% is expended in the homeostasis of the  internal milieu of the brain cells[1].",Non-OADS,/arxiv_data1/oa_pdf/d1/5e/WJBC-8-21.PMC5329711.pdf
Available from: URL: http://www.acnp.org/g4/GN401000004/ CH004.html 3 Schoenemann PT .,Non-OADS,/arxiv_data1/oa_pdf/d1/5e/WJBC-8-21.PMC5329711.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/d1/5e/WJBC-8-21.PMC5329711.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Alan N Engelman, PhD, Professor  of  Medicine, Department of Cancer Immunology and Virology, Dana- Farber Cancer Institute, 450 Brookline Avenue, CLS-1010, Boston,  MA 02215, United States.",Non-OADS,/arxiv_data1/oa_pdf/65/08/WJBC-8-32.PMC5329712.pdf
Published by Baishideng Publishing  Group Inc. All rights reserved.World J Biol Chem  2017 February 26; 8(1): 32-44  ISSN 1949-8454 (online)World Journal of Biological Chemistry WJBC Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4331/wjbc.v8.i1.32,Non-OADS,/arxiv_data1/oa_pdf/65/08/WJBC-8-32.PMC5329712.pdf
World J Biol Chem   2017; 8(1): 32-44  Available from: URL: http://www.wjgnet.,OADS,/arxiv_data1/oa_pdf/65/08/WJBC-8-32.PMC5329712.pdf
"com/ 1949-8454 /full/v8/i1/32.htm   DOI: http://dx.doi.org/ 10.4331 / wjbc.v8.i1.32 INTRODUCTION Retroviral replication requires the incorporation of the viral  genetic information into the host cellular genome, which  occurs  via two main steps: (1) the reverse tra nscription  of single-stranded viral RNA into linear double-stranded  DNA; and (2) the integration of this DNA into a host  chromosome.",Non-OADS,/arxiv_data1/oa_pdf/65/08/WJBC-8-32.PMC5329712.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/65/08/WJBC-8-32.PMC5329712.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Dr. Yuri N Utkin, PhD, Professor,  Labo - ratory of Molecular Toxinology, Shemyakin-Ovchinnikov Institute  of Bioorganic Chemistry, Miklukho-Maklaya 16/10, V-437, 117997  Moscow, Russia.",Non-OADS,/arxiv_data1/oa_pdf/17/e6/WJBC-8-4.PMC5329713.pdf
The data on application  of omics and nanotechnologies in venom research are  systematized concisely in this paper.World J Biol Chem  2017 February 26; 8(1): -12  ISSN 199-85 (online)World Journal of Biological Chemistry WJBC Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.331/wjbc.v8.i1.,Non-OADS,/arxiv_data1/oa_pdf/17/e6/WJBC-8-4.PMC5329713.pdf
"World J Biol Chem  2017; 8(1): 4-12  Available  from: URL: http://www.wjgnet.com/ 1949-8454 /full/v8/i1/4.htm    DOI: http://dx.doi.org/ 10.4331 /wjbc .v8.i1.4 INTRODUCTION Animal venoms are complex mixtures of toxic sub­ stances, which are used to defend against predators and/ or to hunt.",Non-OADS,/arxiv_data1/oa_pdf/17/e6/WJBC-8-4.PMC5329713.pdf
"Available from: URL:  http://en.wikipedia.org/wiki/Omics 2 Pimenta AM , Stöcklin R, Favreau P, Bougis PE, Martin-Eauclaire  MF.",Non-OADS,/arxiv_data1/oa_pdf/17/e6/WJBC-8-4.PMC5329713.pdf
Available from: URL: http://en.wikipedia.org/wiki/Genomics 16 The Honeybee Genome Sequencing Consortium .,Non-OADS,/arxiv_data1/oa_pdf/17/e6/WJBC-8-4.PMC5329713.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/17/e6/WJBC-8-4.PMC5329713.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Stefano Biffo, PhD, Program Leader  of  INGM, Professor  of Cell Biology and Comparative Anatomy,   Department of Biosciences, University of Milan, Piazza dell’ Ateneo Nuovo 1, 20133 Milano, Italy.",Non-OADS,/arxiv_data1/oa_pdf/84/8a/WJBC-8-45.PMC5329714.pdf
"In this review we critically analyze the  mechanism of action of miRNAs and their potential role  in cancer, opening a window on future perspectives for  their use as novel therapeutic targets.World J Biol Chem  2017 February 26; 8(1): 45-56  ISSN 1949-8454 (online)World Journal of Biological Chemistry WJBC Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4331/wjbc.v8.i1.45",Non-OADS,/arxiv_data1/oa_pdf/84/8a/WJBC-8-45.PMC5329714.pdf
World J Biol Chem  2017; 8(1):  45-56  Available from: URL: http://www.wjgnet.com/ 1949-8454 / full/v8/i1/45.htm   DOI: http://dx.doi.org/ 10.4331 /wjbc.v8.i1.45 INTRODUCTION Recent advances in transcriptome analysis and high- throughput technologies highlighted an impressive com - plexity in the RNA world.,Non-OADS,/arxiv_data1/oa_pdf/84/8a/WJBC-8-45.PMC5329714.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/84/8a/WJBC-8-45.PMC5329714.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Dr. Marco Edilson Freire Lima, Univer - sidade Federal Rural do Rio de Janeiro, Instituto de Ciências  Exatas, Departamento de Química, Rodovia BR 465, Km 7,  Seropédica, CEP 23890-000, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/08/85/WJBC-8-57.PMC5329715.pdf
"Here, we note that detailed  knowledge of both the differences and similarities  between the Trypanosoma cruzi  parasite and the human  host’s biochemical targets may be the key to developing  novel effective drugs to treat patients who are suffering  with this severe and debilitating sickness.World J Biol Chem  2017 February 26; 8(1): 57-80  ISSN 1949-8454 (online)World Journal of Biological Chemistry WJBC Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4331/wjbc.v8.i1.57",Non-OADS,/arxiv_data1/oa_pdf/08/85/WJBC-8-57.PMC5329715.pdf
World J Biol Chem   2017; 8(1): 57-80  Available from: URL: http://www.wjgnet.,OADS,/arxiv_data1/oa_pdf/08/85/WJBC-8-57.PMC5329715.pdf
com/ 1949-8454 /full/v8/i1/57.htm   DOI: http://dx.doi.org/ 10.4331 / wjbc.v8.i1.57 INTRODUCTION American trypanosomiasis (or Chagas disease) is a  parasitic illness that results from infection by the hemofla­ gellate protozoan Trypanosoma cruzi (T. cruzi ).,Non-OADS,/arxiv_data1/oa_pdf/08/85/WJBC-8-57.PMC5329715.pdf
"The numbers of published papers available  on the Scopus database (https://www.scopus.com/)  were compared, resulting in the graph shown in Figure 4.",OADS,/arxiv_data1/oa_pdf/08/85/WJBC-8-57.PMC5329715.pdf
"Available from: URL:  http://www.who.int/healthinfo/global_burden_disease/GBD_report _2004update_full.pdf 19 Reithinger R , Tarleton RL, Urbina JA, Kitron U, Gürtler RE.",OADS,/arxiv_data1/oa_pdf/08/85/WJBC-8-57.PMC5329715.pdf
Available from: URL:  http://apps.who.int/iris/bitstream/10665/93142/1/EML_18_eng.,OADS,/arxiv_data1/oa_pdf/08/85/WJBC-8-57.PMC5329715.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/08/85/WJBC-8-57.PMC5329715.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Buddhike Sri Harsha Indrasena, MBBS  (Hons), MS (Surgery), MSc (Statistics), MRCS(Ed),  Consultant  General and Endocrine Surgeon, Kandy General Hospital  (Teaching), William Gopallawa Mawatha, Kandy 20000,  Sri Lanka.",Non-OADS,/arxiv_data1/oa_pdf/94/12/WJBC-8-81.PMC5329716.pdf
"Apart from that, there is hardly World J Biol Chem  2017 February 26; 8(1): 81-85  ISSN 1949-8454 (online)World Journal of Biological Chemistry WJBC Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4331/wjbc.v8.i1.81",Non-OADS,/arxiv_data1/oa_pdf/94/12/WJBC-8-81.PMC5329716.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/94/12/WJBC-8-81.PMC5329716.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Jean Demarquoy, PhD,  Faculté des  Science Gabriel, 6 Bd Gabriel, 21000 Dijon,  France.",Non-OADS,/arxiv_data1/oa_pdf/0a/e8/WJBC-8-86.PMC5329717.pdf
"Key words:  Superoxide anions; Mitochondria; Reactive  Autophagy; Muscle; Carnitine; Oxygen species; Cell death World J Biol Chem  2017 February 26; 8(1): 86-94  ISSN 1949-8454 (online)World Journal of Biological Chemistry WJBC Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4331/wjbc.v8.i1.86 Françoise Le Borgne, Gaétan Ravaut, Arnaud Bernard, Jean DemarquoyORIGINAL ARTICLE L-carnitine protects C2C12 cells against mitochondrial  superoxide overproduction and cell deathBasic Study",Non-OADS,/arxiv_data1/oa_pdf/0a/e8/WJBC-8-86.PMC5329717.pdf
"World J Biol Chem  2017; 8(1): 86-94   Available from: URL: http://www.wjgnet.com/ 1949-8454 /full/v8/ i1/86.htm   DOI: http://dx.doi.org/ 10.4331 /wjbc.v8.i1.86 INTRODUCTION During oxidative stress, a massive production of reactive  oxygen species (ROS) induces alterations in cell structure.",Non-OADS,/arxiv_data1/oa_pdf/0a/e8/WJBC-8-86.PMC5329717.pdf
"Data were  acquired with the Cellquest software (BD Biosciences,  Le Pont De Claix, France) and analyzed with the Cyflogic  Software (http://www.cyflogic.com).",OADS,/arxiv_data1/oa_pdf/0a/e8/WJBC-8-86.PMC5329717.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/0a/e8/WJBC-8-86.PMC5329717.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Victor D Rosenthal, MD, Chairman,  International Nosocomial Infection Control Consortium, 11 de  Septiembre 4567, Floor 12, Apt 1201, Buenos Aires 1429,  Argentina.",Non-OADS,/arxiv_data1/oa_pdf/69/f9/WJBC-8-95.PMC5329718.pdf
"METHODS A device-associated healthcare-acquired infection (DA-World J Biol Chem  2017 February 26; 8(1): 95-101  ISSN 1949-8454 (online)World Journal of Biological Chemistry WJBC Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4331/wjbc.v8.i1.95 Estuardo Salgado Yepez, Maria M Bovera, Victor D Rosenthal, Hugo A González Flores, Leonardo Pazmiño,  Francisco Valencia, Nelly Alquinga, Vanessa Ramirez, Edgar Jara, Miguel Lascano, Veronica Delgado, Cristian  Cevallos, Gasdali Santacruz, Cristian Pelaéz, Celso Zaruma, Diego Barahona PintoORIGINAL ARTICLE Device-associated infection rates, mortality, length of stay  and bacterial resistance in intensive care units in Ecuador:  International Nosocomial Infection Control Consortium’s  findingsCase Control Study",Non-OADS,/arxiv_data1/oa_pdf/69/f9/WJBC-8-95.PMC5329718.pdf
"World J Biol Chem  2017; 8(1): 95-101   Available from: URL: http://www.wjgnet.com/ 1949-8454 /full/v8/ i1/95.htm   DOI: http://dx.doi.org/ 10.4331 /wjbc.v8.i1.95 INTRODUCTION Device-associated healthcare-acquired infections (DA- HAIs) are one of the main threats to the safety of patients,  causing patient morbidity, mortality, excess costs and  prolonged length of hospital stay (LOS), particularly in  intensive care settings of limited-resource countries[1-3].",Non-OADS,/arxiv_data1/oa_pdf/69/f9/WJBC-8-95.PMC5329718.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/69/f9/WJBC-8-95.PMC5329718.pdf
"Production and hosting by ElsevierArab Journal of Urology (2017) 15, 74–77 Arab Journal of Urology (Ofﬁcial Journal of the Arab Association of Urology) www.sciencedirect.com http://dx.doi.org/10.1016/j.aju.2016.12.002 2090-598X /C2112017 Arab Association of Urology.",Non-OADS,/arxiv_data1/oa_pdf/99/eb/main.PMC5329719.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/99/eb/main.PMC5329719.pdf
"Production and hosting by ElsevierArab Journal of Urology (2017) 15, 7–16 Arab Journal of Urology (Ofﬁcial Journal of the Arab Association of Urology) www.sciencedirect.com http://dx.doi.org/10.1016/j.aju.2016.11.005 2090-598X /C2112017 Arab Association of Urology.",Non-OADS,/arxiv_data1/oa_pdf/ee/0c/main.PMC5329720.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ee/0c/main.PMC5329720.pdf
"Production and hosting by ElsevierArab Journal of Urology (2017) 15, 68–73 Arab Journal of Urology (Ofﬁcial Journal of the Arab Association of Urology) www.sciencedirect.com http://dx.doi.org/10.1016/j.aju.2017.01.001 2090-598X /C2112017 Arab Association of Urology.",Non-OADS,/arxiv_data1/oa_pdf/ad/a8/main.PMC5329721.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ad/a8/main.PMC5329721.pdf
"Production and hosting by ElsevierArab Journal of Urology (2017) 15, 78–81 Arab Journal of Urology (Ofﬁcial Journal of the Arab Association of Urology) www.sciencedirect.com http://dx.doi.org/10.1016/j.aju.2016.11.007 2090-598X /C2112017 Arab Association of Urology.",Non-OADS,/arxiv_data1/oa_pdf/05/12/main.PMC5329722.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/05/12/main.PMC5329722.pdf
"Production and hosting by ElsevierArab Journal of Urology (2017) 15, 64–67 Arab Journal of Urology (Ofﬁcial Journal of the Arab Association of Urology) www.sciencedirect.com http://dx.doi.org/10.1016/j.aju.2016.12.003 2090-598X /C2112017 Arab Association of Urology.",Non-OADS,/arxiv_data1/oa_pdf/86/b3/main.PMC5329723.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/86/b3/main.PMC5329723.pdf
"Production and hosting by ElsevierArab Journal of Urology (2017) 15, 48–52 Arab Journal of Urology (Ofﬁcial Journal of the Arab Association of Urology) www.sciencedirect.com http://dx.doi.org/10.1016/j.aju.2016.11.004 2090-598X /C2112016 Arab Association of Urology.",Non-OADS,/arxiv_data1/oa_pdf/96/51/main.PMC5329724.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/96/51/main.PMC5329724.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/96/51/main.PMC5329724.pdf
J Pediatr Urol 2016. http://dx.doi.org/10.1016/j.jpurol.2016.06.016 .52 Badawy et al.,OADS,/arxiv_data1/oa_pdf/96/51/main.PMC5329724.pdf
"Production and hosting by ElsevierArab Journal of Urology (2017) 15, 1–6 Arab Journal of Urology (Ofﬁcial Journal of the Arab Association of Urology) www.sciencedirect.com http://dx.doi.org/10.1016/j.aju.2016.11.006 2090-598X /C2112017 Arab Association of Urology.",Non-OADS,/arxiv_data1/oa_pdf/55/93/main.PMC5329725.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/55/93/main.PMC5329725.pdf
See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript  source:  Invited  manuscript Correspondence to: Dr .,Non-OADS,/arxiv_data1/oa_pdf/8f/0c/WJC-9-109.PMC5329738.pdf
"World J  Cardiol  2017; 9(2): 109-133  Available from: URL:  http://www.REVIEWSubmit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4330/wjc.v9.i2.109 109 February  26, 2017 |Volume 9 |Issue 2| WJC|www.wjgnet.comWorld J Cardiol  2017 February 26; 9(2): 109-133 ISSN 1949-8462 (online)World Journal of  Cardiology WJC",Non-OADS,/arxiv_data1/oa_pdf/8f/0c/WJC-9-109.PMC5329738.pdf
wjgnet.com/ 1949-8462 /full/v9/i2/ 109.htm  DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8f/0c/WJC-9-109.PMC5329738.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/8f/0c/WJC-9-109.PMC5329738.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/8f/0c/WJC-9-109.PMC5329738.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript  source:  Invited  manuscript Correspondence to:  Timothy J Vittorio, MS, MD,  St. Francis  Hospital - the Heart Center®, Center for Advanced Cardiac  Therapeutics, 100 Port Washington Blvd., Roslyn, NY 11576,  United States.",Non-OADS,/arxiv_data1/oa_pdf/b8/25/WJC-9-134.PMC5329739.pdf
World J Cardiol  2017; 9(2): 134-138   Available from: URL:  http://www.wjgnet.com/ 1949-8462 /full/ v9/i2/ 134.htm  DOI : http://dx.doi.org/ 10.4330 /wjc.v9.i2.,Non-OADS,/arxiv_data1/oa_pdf/b8/25/WJC-9-134.PMC5329739.pdf
"134 INTRODUCTION More than 250000 yearly deaths in the United States are MINIREVIEWSSubmit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4330/wjc.v9.i2.134 134 February  26, 2017 |Volume 9 |Issue 2| WJC|www.wjgnet.comWorld J Cardiol  2017 February 26; 9(2): 134-138 ISSN 1949-8462 (online)World Journal of  Cardiology WJC",Non-OADS,/arxiv_data1/oa_pdf/b8/25/WJC-9-134.PMC5329739.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/b8/25/WJC-9-134.PMC5329739.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source: Invited manuscript Correspondence to: Dr. Ibrahim Akin, Professor, Medical  Faculty Mannheim, University Heidelberg, Theodor-Kutzer Ufer  1-3, 68167 Mannheim, Germany.",Non-OADS,/arxiv_data1/oa_pdf/52/3b/WJC-9-139.PMC5329740.pdf
World J Cardiol  2017; 9(2): 139-146   Available from: URL:  http://www.wjgnet.com/ 1949-8462 /full/v9/ i2/139.htm  DOI: http://dx.doi.org/ 10.4330 /wjc.v9.i2.,Non-OADS,/arxiv_data1/oa_pdf/52/3b/WJC-9-139.PMC5329740.pdf
"Compelling evidence points to the LAA as the primary  origin of thrombus formation particular in the presence  of non-valvular atrial fibrillation (AF); since the major  risk of non-valvular AF to suffer from ischemic stroke, MINIREVIEWSSubmit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4330/wjc.v9.i2.139 139 February  26, 2017 |Volume 9 |Issue 2| WJC|www.wjgnet.comWorld J Cardiol  2017 February 26; 9(2): 139-146 ISSN 1949-8462 (online)World Journal of  Cardiology WJC",Non-OADS,/arxiv_data1/oa_pdf/52/3b/WJC-9-139.PMC5329740.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/52/3b/WJC-9-139.PMC5329740.pdf
"See: http://creativecommons.org/ licenses/by ­nc/4.0/ Manuscript source: Unsolicited manuscript Correspondence to: Imre J Pavo, MD, Division of Pediatric  Cardiology, Department of Pediatrics and Adolescent Medicine, Medical University of Vienna,  Waehringer Guertel 18 ­20, A ­1909  Vienna, Austria.",Non-OADS,/arxiv_data1/oa_pdf/6e/79/WJC-9-147.PMC5329741.pdf
"MINIREVIEWSSubmit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4330/wjc.v9.i2.147 147 February  26, 2017 |Volume 9 |Issue 2| WJC|www.wjgnet.comWorld J Cardiol  2017 February 26; 9(2): 147-153 ISSN 1949-8462 (online)World Journal of  Cardiology WJC",Non-OADS,/arxiv_data1/oa_pdf/6e/79/WJC-9-147.PMC5329741.pdf
World J Cardiol  2017; 9(2): 147 ­153  Available from:  URL:  http://www.wjgnet.com/ 1949 ­8462 /full/v9/i2/ 147.htm   DOI: http://dx.doi.org/ 10.4330 /wjc.v9.i2.,Non-OADS,/arxiv_data1/oa_pdf/6e/79/WJC-9-147.PMC5329741.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/6e/79/WJC-9-147.PMC5329741.pdf
"See: http://creativecommons.org/ licenses/by ­nc/4.0/ Manuscript  source:  Invited  manuscriptCorrespondence to:  Dipanjan Banerjee, MD, MS, Department  of Medicine, Stanford University School of Medicine, 300 Pasteur  Dr MC 5319, Rm A260, Stanford, CA 94305,  United States.",Non-OADS,/arxiv_data1/oa_pdf/71/01/WJC-9-154.PMC5329742.pdf
"One hundred and  sixty-four (7.5%) patients also underwent OHT during ORIGINAL ARTICLESubmit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4330/wjc.v9.i2.154 154 February  26, 2017 |Volume 9 |Issue 2 | WJC|www.wjgnet.comWorld J Cardiol  2017 February 26; 9(2): 154-161 ISSN 1949-8462 (online)World Journal of  Cardiology WJC Retrospective Cohort Study",Non-OADS,/arxiv_data1/oa_pdf/71/01/WJC-9-154.PMC5329742.pdf
World J Cardiol  2017; 9(2): 154 ­161   Available from: URL:  http://www.wjgnet.com/ 1949 ­8462 /full/ v9/i2/ 154.htm  DOI: http://dx.doi.org/ 10.4330 /wjc.v9.i2.,Non-OADS,/arxiv_data1/oa_pdf/71/01/WJC-9-154.PMC5329742.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/71/01/WJC-9-154.PMC5329742.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript  source:  Invited  manuscript Correspondence to: John P Higgins, MD, MBA, MPhil, FACC,  FACP, FAHA, FACSM, FSGC, FASNC, Associate Professor  of  Medicine, Department of Internal Medicine, McGovern Medical  School, The University of Texas Health Science Center at Houston,  LBJ General Hospital, 5656 Kelley St, UT Annex-Room 104,  Houston, TX 77030, United States.",Non-OADS,/arxiv_data1/oa_pdf/c5/b8/WJC-9-162.PMC5329743.pdf
"After fasting and not smoking for at least  8 h prior , eleven medical students (9 males) received an  electrocardiogram, blood pressure and pulse check, and  underwent baseline testing (BL) of endothelial function  using the technique of endothelium-dependent flow  mediated dilatation (FMD) with high-resolution ultrasound ORIGINAL ARTICLESubmit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4330/wjc.v9.i2.162 162 February  26, 2017 |Volume 9 |Issue 2| WJC|www.wjgnet.comWorld J Cardiol  2017 February 26; 9(2): 162-166 ISSN 1949-8462 (online)World Journal of  Cardiology WJC Clinical Trials Study",Non-OADS,/arxiv_data1/oa_pdf/c5/b8/WJC-9-162.PMC5329743.pdf
World J Cardiol  2017; 9(2): 162-166  Available from:  URL:  http://www.wjgnet.com/ 1949-8462 /full/v9/i2/ 162.htm   DOI: http://dx.doi.org/ 10.4330 /wjc.v9.i2.,Non-OADS,/arxiv_data1/oa_pdf/c5/b8/WJC-9-162.PMC5329743.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/c5/b8/WJC-9-162.PMC5329743.pdf
"See: http://creativecommons.org/ licenses/by ­nc/4.0/ Manuscript source: Invited manuscript Correspondence to: Markus Roos, MSc, MD, Heart Center,  Salzburger Leite, 97616 Bad Neustadt a.d. Saale,  Germany.",Non-OADS,/arxiv_data1/oa_pdf/3b/84/WJC-9-167.PMC5329744.pdf
"An ineffective  SMT occurred in 4% and two third of those needed  implantation of a subcutaneous electrode array to pass ORIGINAL ARTICLESubmit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4330/wjc.v9.i2.167 167 February  26, 2017 |Volume 9 |Issue 2| WJC|www.wjgnet.comWorld J Cardiol  2017 February 26; 9(2): 167-173 ISSN 1949-8462 (online)World Journal of  Cardiology WJC Observational Study",Non-OADS,/arxiv_data1/oa_pdf/3b/84/WJC-9-167.PMC5329744.pdf
World J Cardiol  2017; 9(2): 167 ­173  Available from: URL:   http://www.wjgnet.com/ 1949 ­8462 /full/v9/i2/ 167.htm  DOI:  http://dx.doi.org/ 10.4330 /wjc.v9.i2.,Non-OADS,/arxiv_data1/oa_pdf/3b/84/WJC-9-167.PMC5329744.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/3b/84/WJC-9-167.PMC5329744.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript  source:  Unsolicited  manuscript Correspondence to:  Toshiyuki Kobayashi, MD,  Department  of General Medicine, Zama General Hospital, 1-50-1, Sobudai,  Zama City, Kanagawa 252-0011,  Japan.",Non-OADS,/arxiv_data1/oa_pdf/7a/2b/WJC-9-174.PMC5329745.pdf
"We screened ORIGINAL ARTICLESubmit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4330/wjc.v9.i2.174 174 February  26, 2017 |Volume 9 |Issue 2| WJC|www.wjgnet.comWorld J Cardiol  2017 February 26; 9(2): 174-181 ISSN 1949-8462 (online)World Journal of  Cardiology WJC Observational Study",Non-OADS,/arxiv_data1/oa_pdf/7a/2b/WJC-9-174.PMC5329745.pdf
World J Cardiol  2017; 9(2): 174-181   Available from: URL:  http://www.wjgnet.com/ 1949-8462 /full/ v9/i2/ 174.htm  DOI: http://dx.doi.org/ 10.4330 /wjc.v9.i2.,Non-OADS,/arxiv_data1/oa_pdf/7a/2b/WJC-9-174.PMC5329745.pdf
"Available from: URL: http://www.world-heart-federation.org/fileadmin/ user_upload/images/CVD_Health/Global_CVD_Atlas.pdf 4 Hirsch AT , Haskal ZJ, Hertzer NR, Bakal CW, Creager MA,  Halperin JL, Hiratzka LF, Murphy WR, Olin JW, Puschett JB,  Rosenfield KA, Sacks D, Stanley JC, Taylor LM, White CJ, White  J, White RA, Antman EM, Smith SC, Adams CD, Anderson JL,  Faxon DP , Fuster V , Gibbons RJ, Hunt SA, Jacobs AK, Nishimura R,  Ornato JP , Page RL, Riegel B. ACC/AHA 2005 Practice Guidelines  for the management of patients with peripheral arterial disease (lower  extremity, renal, mesenteric, and abdominal aortic): a collaborative  report from the American Association for Vascular Surgery/Society  for Vascular Surgery, Society for Cardiovascular Angiography and  Interventions, Society for V ascular Medicine and Biology, Society of  Interventional Radiology, and the ACC/AHA Task Force on Practice  Guidelines (Writing Committee to Develop Guidelines for the  Management of Patients With Peripheral Arterial Disease): endorsed  by the American Association of Cardiovascular and Pulmonary  Rehabilitation; National Heart, Lung, and Blood Institute; Society  for Vascular Nursing; TransAtlantic Inter-Society Consensus; and  Vascu lar Disease Foundation.",Non-OADS,/arxiv_data1/oa_pdf/7a/2b/WJC-9-174.PMC5329745.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/7a/2b/WJC-9-174.PMC5329745.pdf
"See: http://creativecommons.org/ licenses/by ­ nc/4.0/ Manuscript   source:   Invited   manuscript Correspondence to: Mahesh Anantha Narayanan, MD,   Division of Cardiovascular Diseases, University of Minnesota  Medical Center, 500 SE Harvard Street, Minneapolis, MN 55455,  United States.",Non-OADS,/arxiv_data1/oa_pdf/81/41/WJC-9-182.PMC5329746.pdf
"CONCLUSION From the available clinical trials, ivabradine + beta- blocker resulted in a significantly greater reduction in HR META-ANALYSISSubmit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4330/wjc.v9.i2.182 182 February  26, 2017 |Volume 9 |Issue 2| WJC|www.wjgnet.comWorld J Cardiol  2017 February 26; 9(2): 182-190 ISSN 1949-8462 (online)World Journal of  Cardiology WJC",Non-OADS,/arxiv_data1/oa_pdf/81/41/WJC-9-182.PMC5329746.pdf
wjgnet.com/ 1949 ­ 8462 /full/v9/i2/ 182.htm  DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/81/41/WJC-9-182.PMC5329746.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/81/41/WJC-9-182.PMC5329746.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Jochen Grohmann, MD, Department of Congenital Heart Disease and Pediatric Cardiology, Heart Center,  Freiburg University, Mathildenstrasse 1, 79106 Freiburg,  Germany.",Non-OADS,/arxiv_data1/oa_pdf/23/35/WJC-9-191.PMC5329747.pdf
"In  this case report we discuss the potential relevance of a  persisting li gamentum arteriosum for patients with left CASE REPORTSubmit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4330/wjc.v9.i2.191 191 February  26, 2017 |Volume 9 |Issue 2| WJC|www.wjgnet.comWorld J Cardiol  2017 February 26; 9(2): 191-195 ISSN 1949-8462 (online)World Journal of  Cardiology WJC",Non-OADS,/arxiv_data1/oa_pdf/23/35/WJC-9-191.PMC5329747.pdf
wjgnet.com/ 1949-8462 /full/v9/i2/ 191.htm  DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/23/35/WJC-9-191.PMC5329747.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/23/35/WJC-9-191.PMC5329747.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Benoit Daneault, MD, Division of  Cardiology, Centre Hospitalier Universitaire de Sherbrooke, 12e  avenue nord, Sherbrooke J1H 5N4,  Canada.",Non-OADS,/arxiv_data1/oa_pdf/d0/61/WJC-9-196.PMC5329748.pdf
World J Cardiol  2017;  9(2): 196-199  Available from: URL:  http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/d0/61/WJC-9-196.PMC5329748.pdf
com/ 1949-8462 /full/v9/i2/ 196.htm  DOI: http://dx.doi.org/ 10.4330 / wjc.v9.i2.,Non-OADS,/arxiv_data1/oa_pdf/d0/61/WJC-9-196.PMC5329748.pdf
"196 INTRODUCTION We describe a case of very late transcatheter heart  valve (THV) thrombosis of a first-generation SAPIEN  prosthesis (Edwards Lifesciences, Irvine, CA) implanted  in a 64-year-old woman with severe symptomatic CASE REPORTSubmit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4330/wjc.v9.i2.196 196 February  26, 2017 |Volume 9 |Issue 2| WJC|www.wjgnet.comWorld J Cardiol  2017 February 26; 9(2): 196-199 ISSN 1949-8462 (online)World Journal of  Cardiology WJC",Non-OADS,/arxiv_data1/oa_pdf/d0/61/WJC-9-196.PMC5329748.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/d0/61/WJC-9-196.PMC5329748.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source: Invited manuscript Correspondence to: Jalaj Garg, MD, FESC, Division of  Cardiology, Lehigh Valley Health Network, 1250 S Cedar Crest  Blvd, Allentown, PA 18103,  United States.",Non-OADS,/arxiv_data1/oa_pdf/d9/53/WJC-9-76.PMC5329749.pdf
"PCSK9 inhibitors are REVIEWSubmit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4330/wjc.v9.i2.76 76 February  26, 2017 |Volume 9 |Issue 2 | WJC|www.wjgnet.comWorld J Cardiol  2017 February 26; 9(2): 76-91 ISSN 1949-8462 (online)World Journal of  Cardiology WJC",Non-OADS,/arxiv_data1/oa_pdf/d9/53/WJC-9-76.PMC5329749.pdf
World J Cardiol  2017; 9(2): 76-91   Available from: URL:  http://www.wjgnet.com/ 1949-8462 /full/v9/ i2/76.htm  DOI: http://dx.doi.org/ 10.4330 /wjc.v9.i2.,Non-OADS,/arxiv_data1/oa_pdf/d9/53/WJC-9-76.PMC5329749.pdf
"Available from: URL: http://www.pfizer.com/news/press-release/ press-release-detail/pfizer_announces_positive_topline_results_from_ second_phase_3_lipid_lowering_study_evaluating_bococizumab 51  Stein EA , Kasichayanula S, Turner T, Kranz T, Arumugam U,  Biernat L, Lee J. LDL cholesterol reduction with bms-962476, an  adnectin inhibitor of PCSK9: results of a single ascending dose  study.",Non-OADS,/arxiv_data1/oa_pdf/d9/53/WJC-9-76.PMC5329749.pdf
"Available from: URL: http://www.prnewswire.com/news-releases/ regeneron-and-sanofi-announce-positive-topline-results-from-first- phase-3-trials-evaluating-monthly-dosing-of-alirocumab-in-patients- with-hypercholesterolemia-300017492.html 60  Colhoun HM , Robinson JG, Farnier M, Cariou B, Blom D,  Kereiakes DJ, Lorenzato C, Pordy R, Chaudhari U. Efficacy  and safety of alirocumab, a fully human PCSK9 monoclonal  antibody, in high cardiovascular risk patients with poorly controlled  hypercholesterolemia on maximally tolerated doses of statins:  rationale and design of the ODYSSEY COMBO I and II trials.",Non-OADS,/arxiv_data1/oa_pdf/d9/53/WJC-9-76.PMC5329749.pdf
"Available from: URL: http://www.acc.org/latest- in-cardiology/clinical-trials/2014/11/18/15/23/odyssey-high-fh 68  Robinson JG , Farnier M, Krempf M, Bergeron J, Luc G, Averna M,  Stroes ES, Langslet G, Raal FJ, El Shahawy M, Koren MJ, Lepor  NE, Lorenzato C, Pordy R, Chaudhari U, Kastelein JJ.",Non-OADS,/arxiv_data1/oa_pdf/d9/53/WJC-9-76.PMC5329749.pdf
"Available from: URL: http://www.acc.org/latest-in-cardiology/ articles/2015/06/01/12/36/early-evidence-linking-pcsk9-inhibitors-to- neurocognitive-adverse-events 89  Catapano AL , Papadopoulos N. The safety of therapeutic monoclonal  antibodies: implications for cardiovascular disease and targeting the  PCSK9 pathway.",Non-OADS,/arxiv_data1/oa_pdf/d9/53/WJC-9-76.PMC5329749.pdf
"Available  from: URL: http://cepac.icer-review.org/adaptations/cholesterol/ P- Reviewer : Aronow WS, Hohenegger M, Kasai T, Labonte P, Sun CK     S- Editor : Ji FF    L- Editor : A    E- Editor : Lu YJ   Ezetimibe in Patients With Muscle-Related Statin Intolerance: The  GAUSS-3 Randomized Clinical Trial.",Non-OADS,/arxiv_data1/oa_pdf/d9/53/WJC-9-76.PMC5329749.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/d9/53/WJC-9-76.PMC5329749.pdf
"See: http://creativecommons.org/ licenses/by ­ nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: John P Greenwood, Professor, Multidi­ sciplinary Cardiovascular Research Centre and Leeds Institute  of Cardiovascular and Metabolic Medicine, University of  Leeds, Leeds LS2 9JT,  United Kingdom.",Non-OADS,/arxiv_data1/oa_pdf/6b/6a/WJC-9-92.PMC5329750.pdf
"Assessment of stable coronary REVIEWSubmit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4330/wjc.v9.i2.92 92 February  26, 2017 |Volume 9 |Issue 2| WJC|www.wjgnet.comWorld J Cardiol  2017 February 26; 9(2): 92-108 ISSN 1949-8462 (online)World Journal of  Cardiology WJC",Non-OADS,/arxiv_data1/oa_pdf/6b/6a/WJC-9-92.PMC5329750.pdf
World J Cardiol  2017; 9(2):  92 ­ 108  Available from: URL:  http://www.wjgnet.com/ 1949 ­ 8462 / full/v9/i2/ 92.htm  DOI: http://dx.doi.org/ 10.4330 /wjc.v9.i2.,Non-OADS,/arxiv_data1/oa_pdf/6b/6a/WJC-9-92.PMC5329750.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/6b/6a/WJC-9-92.PMC5329750.pdf
"Production and hosting by ElsevierArab Journal of Urology (2017) 15, 36–41 Arab Journal of Urology (Ofﬁcial Journal of the Arab Association of Urology) www.sciencedirect.com http://dx.doi.org/10.1016/j.aju.2016.10.002 2090-598X /C2112016 Arab Association of Urology.",Non-OADS,/arxiv_data1/oa_pdf/48/f5/main.PMC5329753.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/48/f5/main.PMC5329753.pdf
"Available December 4, 2015 from: http://nccd.cdc.gov/gtssdata/Ancillary/DataReports.aspx?CAID=2.",OADS,/arxiv_data1/oa_pdf/93/10/sjph-2017-0010.PMC5329770.pdf
"Available October 15, 2013 from: http://www.renal.org/docs/default-source/what-we do/Improvement_Science_Fellowships.pdf?sfvrsn=0  9.",Non-OADS,/arxiv_data1/oa_pdf/02/7a/sjph-2017-0011.PMC5329771.pdf
"Available March 29, 2015 from: http://www.zzzs.si/zzzs/internet/zzzs.nsf/o/6F2CAD56EE119706C125770B00390171 15.",Non-OADS,/arxiv_data1/oa_pdf/6d/f6/sjph-2017-0012.PMC5329772.pdf
"Available April 20, 2014 from: http://www.euro.who.int/document/Nut/instanbul_conf_%20ebd02.pdf.",Non-OADS,/arxiv_data1/oa_pdf/10/5c/sjph-2017-0015.PMC5329775.pdf
"Available April 20, 2014 from:  http://www.euro.who.int/Document/E72199.pdf.",Non-OADS,/arxiv_data1/oa_pdf/10/5c/sjph-2017-0015.PMC5329775.pdf
"Available April 20, 2014 from: http://www.who.int/gb/ebwha/pdf_files/WHA57/A57_9-en.pdf.",OADS,/arxiv_data1/oa_pdf/10/5c/sjph-2017-0015.PMC5329775.pdf
"Available April 20, 2014 from: http://www.euro.who.int/Document/ E89567.pdf.",Non-OADS,/arxiv_data1/oa_pdf/10/5c/sjph-2017-0015.PMC5329775.pdf
"Available May 21, 2014 from: http://www.euro.who.int/__data/assets/pdf_file/0017/74402/E91153.pdf.",OADS,/arxiv_data1/oa_pdf/10/5c/sjph-2017-0015.PMC5329775.pdf
"Available August 15, 2016 from: http://www.nijz.",Non-OADS,/arxiv_data1/oa_pdf/10/5c/sjph-2017-0015.PMC5329775.pdf
"Available April 20, 2014 from: http://www.measuredhs.com/pubs/ pdf/FR230/FR230.pdf 11.",Non-OADS,/arxiv_data1/oa_pdf/10/5c/sjph-2017-0015.PMC5329775.pdf
"Available April 20, 2014 from: http://www.who.int/nmh/countries/alb_en.pdf.",OADS,/arxiv_data1/oa_pdf/10/5c/sjph-2017-0015.PMC5329775.pdf
"Available April  20, 2014 from: http://www.euro.who.int/document/E90711.pdf 13.",Non-OADS,/arxiv_data1/oa_pdf/10/5c/sjph-2017-0015.PMC5329775.pdf
"Available 5 April 2016, from: http://ec.europa.eu/Eurostat/data/database (Database by themes – Population and social conditions – Demography and migration – Mortality)  14.",Non-OADS,/arxiv_data1/oa_pdf/15/0d/sjph-2017-0016.PMC5329776.pdf
"Available 8 June 2016, from: http://ec.europa.eu/Eurostat/data/database?node_code=proj  15.",OADS,/arxiv_data1/oa_pdf/15/0d/sjph-2017-0016.PMC5329776.pdf
"Available 4 November 2015, from: http://ec.europa.eu/Eurostat/data/database (Database by themes – Population and social conditions – Demography and migration – Population) 21.",Non-OADS,/arxiv_data1/oa_pdf/15/0d/sjph-2017-0016.PMC5329776.pdf
"Available 12 April 2016, from: http://www.ine.es/dynt3/inebase/index.htm?type=pcaxis&path=/t15/p417/a2014&file=pcaxis&L=1 25.",OADS,/arxiv_data1/oa_pdf/15/0d/sjph-2017-0016.PMC5329776.pdf
"Available 13 January 2016, from: http://www.actuaries.org/EVENTS/Congresses/Cape_Town/Presentations/Life%20Insurance%20(IAALS)/183_PPT_Ridsdale.pdf 34.",Non-OADS,/arxiv_data1/oa_pdf/15/0d/sjph-2017-0016.PMC5329776.pdf
"Available Apr 8, 2015 from: http://www.who.int/mental_health/media/68.pdf 9.",Non-OADS,/arxiv_data1/oa_pdf/a7/8e/sjph-2017-0017.PMC5329777.pdf
"Available Jan 10, 2016 from: https://www.cda-adc.ca/_files/position_statements/fluoride.pdf.",OADS,/arxiv_data1/oa_pdf/02/7b/sjph-2017-0018.PMC5329778.pdf
"Available Nov 10, 2015 from: http://www.mpv.si/rezultati [in Slovene].",Non-OADS,/arxiv_data1/oa_pdf/02/7b/sjph-2017-0018.PMC5329778.pdf
"Available March, 2012 from: http://www.paragraf.rs/propisi/.",Non-OADS,/arxiv_data1/oa_pdf/fd/ab/sjph-2017-0002.PMC5329780.pdf
"Available April 6, 2013 from:  http://www.who.int/substanceabuse/researchtools/ translation/.",Non-OADS,/arxiv_data1/oa_pdf/fd/ab/sjph-2017-0002.PMC5329780.pdf
"Available 1st January, 2014 from: http://www.psychometrica.de/effect_size.html.",OADS,/arxiv_data1/oa_pdf/09/85/sjph-2017-0003.PMC5329781.pdf
"Available 22nd April, 2010 from: http://www.wilderdom.",Non-OADS,/arxiv_data1/oa_pdf/09/85/sjph-2017-0003.PMC5329781.pdf
"Available May 16, 2016 from: http://www.eucast.org/.",Non-OADS,/arxiv_data1/oa_pdf/7f/05/sjph-2017-0004.PMC5329782.pdf
"Available September 19, 2015 from: 7. http://ecdc.europa.eu/en/healthtopics/antimicrobial_resistance/ database/Pages/table_reports.aspx.",Non-OADS,/arxiv_data1/oa_pdf/7f/05/sjph-2017-0004.PMC5329782.pdf
"Available  May 10, 2016 from: http://www.mz.gov.si/si/delovna_podrocja/kakovost_in_varnost/nacionalna_komisija_za_ obvladovanje_bolnisnicnih_okuzb/strokovnjaki/.",Non-OADS,/arxiv_data1/oa_pdf/7f/05/sjph-2017-0004.PMC5329782.pdf
"Available Nov 18, 2015 from: http://www.who.int/mental_health/resources/suicide/en/index.html.",Non-OADS,/arxiv_data1/oa_pdf/3e/e0/sjph-2017-0005.PMC5329783.pdf
"Available Feb 15, 2016 from: 5. http://www.mkgp.gov.si/fileadmin/mkgp.gov.si/pageuploads/podrocja/Kmetijstvo/Promocija_SI_kmetijstva/priporocila_JN_zivil.pdf.",OADS,/arxiv_data1/oa_pdf/b0/4a/sjph-2017-0006.PMC5329784.pdf
"Available Apr 11, 2016 from: http://www.stat.si/StatWeb/glavnanavigacija/podatki/ prikazistaronovico?IdNovice=5386.",OADS,/arxiv_data1/oa_pdf/b0/4a/sjph-2017-0006.PMC5329784.pdf
"Available December 16,  2014 from: http://books.google.hr/books?id=s8_AAAAMAAJ&print - sec=frontcover&dq=inauthor:%22Heinrich+Moritz+Gottlieb+Grell- mann%22&hl=hr&sa=X&ei=wU7YUvBej8yPumYHoAw&ved=0CC0Q6A - EwAA#v=onepage&q&f=false 3.",Non-OADS,/arxiv_data1/oa_pdf/48/8b/sjph-2017-0007.PMC5329785.pdf
"Available April 24, 2016 from: http://www.dzs.hr/Hrv_Eng/publication/2012/SI-1469.pdf 5.",Non-OADS,/arxiv_data1/oa_pdf/48/8b/sjph-2017-0007.PMC5329785.pdf
"Available April 24, 2016 from: http://fra.europa.eu/sites/default/ files/situation-of-roma-2012-hr.",Non-OADS,/arxiv_data1/oa_pdf/48/8b/sjph-2017-0007.PMC5329785.pdf
"Available April 24, 2016 from:  https://bs.wikipedia.org/wiki/Popis_stanovni%C5%A1tva_u_Hrvat - skoj_1991 7.",Non-OADS,/arxiv_data1/oa_pdf/48/8b/sjph-2017-0007.PMC5329785.pdf
"Available April 24, 2016 from: http://www.dzs.",Non-OADS,/arxiv_data1/oa_pdf/48/8b/sjph-2017-0007.PMC5329785.pdf
"Available December 16, 2014 from: http://www.unicef.org/ceecis/070305-Subregional_Study_Roma_Children.pdf 41.",Non-OADS,/arxiv_data1/oa_pdf/48/8b/sjph-2017-0007.PMC5329785.pdf
"Available Feb 01, 2016 from: http://www.idf.org/diabetesatlas  2.",Non-OADS,/arxiv_data1/oa_pdf/46/e0/sjph-2017-0009.PMC5329787.pdf
"Available Feb 01, 2016 from: http://medical-dictionary.thefreedictionary.com/screening  15.",Non-OADS,/arxiv_data1/oa_pdf/46/e0/sjph-2017-0009.PMC5329787.pdf
"Available Feb 01, 2016  from: http://www.nijz.si/sites/www.nijz.si/files/uploaded/jelka_ zaletel_sladkorna_bolezen_v_letu_2015.pdf   16.",OADS,/arxiv_data1/oa_pdf/46/e0/sjph-2017-0009.PMC5329787.pdf
"All the data was analyzed by stata11.0 soft-ware (http://www.stata.com; Stata Corporation, College Station, TX).",OADS,/arxiv_data1/oa_pdf/f2/c0/med-2016-0006.PMC5329793.pdf
"2.4  Statistical analysis STATA/SE 11.0 （Stata Corp LP , http://www.stata.com ） was used to perform the statistical analysis.",OADS,/arxiv_data1/oa_pdf/f2/c0/med-2016-0006.PMC5329793.pdf
"3.3  miR-218 targets survivin to increase  cisplatin sensitivity To investigate whether miR-218-induced cisplatin sensitiv- ity was mediated by its downstream targets, we first exam-ined in silico predicted targets using miRDB (http://mirdb.org/miRDB/).",OADS,/arxiv_data1/oa_pdf/69/f1/med-2016-0007.PMC5329794.pdf
2.9  miR-29 target prediction Candidate targets of miR-29 were predicted by miRBase  (http://www.mirbase.org/) and TargetScan (http://www.Targetscan.org/).,OADS,/arxiv_data1/oa_pdf/47/50/med-2016-0015.PMC5329802.pdf
"3.3  miR-29a targets CDC42 To probe the potential mechanisms of miR-29 in the BC cell growth, we searched the literature and miRNA database, TargetScan (http://www.targetscan.org/) for potential targets of miR-29.",OADS,/arxiv_data1/oa_pdf/47/50/med-2016-0015.PMC5329802.pdf
"2.3  Statistical analysis All the analyses were performed by the STATA/SE 11.0（StataCorp LP , http://www.stata.com）software.",OADS,/arxiv_data1/oa_pdf/ab/cf/med-2016-0020.PMC5329807.pdf
"If disagreements were encountered, the discussion was  made and a third reviewer was consulted.2.4  Statistical analysis Stata/SE 11.0 （StataCorp LP , http://www.stata.com ） were used for statistical analysis.",OADS,/arxiv_data1/oa_pdf/33/17/med-2016-0052.PMC5329839.pdf
"The  number of patient controls, the distribution of GSTM1 null  and positive expression subjects were further carefully  extracted, which was important for calculation of the  odds ratio.1.4  Statistical analysis  The data was analyzed by stata11.0 software (StataCorp  LP , http://www.stata.com).",OADS,/arxiv_data1/oa_pdf/54/8e/med-2016-0094.PMC5329881.pdf
"2.4  Statistical analysis We use Stata 11.0 (http://www.stata.com; Stata Corpo - ration, College Station, TX) to do all statistical analyses.",OADS,/arxiv_data1/oa_pdf/67/83/med-2016-0099.PMC5329886.pdf
Available from: https://www.youtube.,Non-OADS,/arxiv_data1/oa_pdf/5a/ff/IJPsyM-39-1.PMC5329982.pdf
Available from: http://www.ncbi.nlm.nih.gov/books/ NBK384616/.,Non-OADS,/arxiv_data1/oa_pdf/5a/ff/IJPsyM-39-1.PMC5329982.pdf
Available from:  https://www.youtube.com/watch?v=2n5BYKID9hk.,Non-OADS,/arxiv_data1/oa_pdf/5a/ff/IJPsyM-39-1.PMC5329982.pdf
"Since the sample size was small, the  computer package for analysis http://www.caqdas.soc.",OADS,/arxiv_data1/oa_pdf/85/52/IJPsyM-39-12.PMC5329985.pdf
"Since the sample size was small, the  computer package for analysis http://www.caqdas.soc.survey.ac.uk was not purchased.",OADS,/arxiv_data1/oa_pdf/85/52/IJPsyM-39-12.PMC5329985.pdf
Available from: http://www.childtrafficking.com;  www.rayofhope.org.,Non-OADS,/arxiv_data1/oa_pdf/85/52/IJPsyM-39-12.PMC5329985.pdf
Available from: http://www.alnap.,Non-OADS,/arxiv_data1/oa_pdf/85/52/IJPsyM-39-12.PMC5329985.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/ yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/85/52/IJPsyM-39-12.PMC5329985.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free  applications.,Non-OADS,/arxiv_data1/oa_pdf/85/52/IJPsyM-39-12.PMC5329985.pdf
Available from: http://www.psychcentral.com/ blog/archives/2005/08/21/beard‑and‑wolfs‑2001‑criteria‑ for‑maladaptive‑internet‑use/.,Non-OADS,/arxiv_data1/oa_pdf/35/1e/IJPsyM-39-21.PMC5329986.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/35/1e/IJPsyM-39-21.PMC5329986.pdf
Available from:  http://www.mekelleadministration.gov.et.,Non-OADS,/arxiv_data1/oa_pdf/db/ec/IJPsyM-39-52.PMC5329992.pdf
Available from: http://www.who.int/mental_health/ management/depression/en/.,Non-OADS,/arxiv_data1/oa_pdf/5c/19/IJPsyM-39-69.PMC5329995.pdf
We  adhered to the ethical principles for medical research  involving human subjects as per the World Medical  Association Declaration of Helsinki (http://www.wma.,Non-OADS,/arxiv_data1/oa_pdf/74/d6/IJPsyM-39-92.PMC5330000.pdf
"[10] T wo online tACS sessions  (first session  with theta frequency and second session with gamma  frequency) were administered with an inter‑session  interval of 48  h using standard equipment  (Neuroconn  DC Stimulator Plus, http://www.neuroconn.de/ dc‑stimulator_plus_en/) [Figure  1a].",Non-OADS,/arxiv_data1/oa_pdf/74/d6/IJPsyM-39-92.PMC5330000.pdf
Available  form: http://www.psikofarmakoloji.org.,Non-OADS,/arxiv_data1/oa_pdf/33/38/IJPsyM-39-96.PMC5330001.pdf
Available from:  https://www.cdc.gov/dengue/clinicallab/index.html.,Non-OADS,/arxiv_data1/oa_pdf/12/98/JGID-9-1.PMC5330037.pdf
Available from: http://www.nvbdcp.gov.in/DENGU1.html.,Non-OADS,/arxiv_data1/oa_pdf/12/98/JGID-9-1.PMC5330037.pdf
Available from: http://www.aafp.org/afp/2011/0901/p566.,Non-OADS,/arxiv_data1/oa_pdf/3f/d1/IJA-61-103.PMC5330066.pdf
Available from: http://www.webarchive.nationalarchives.gov.,Non-OADS,/arxiv_data1/oa_pdf/3f/d1/IJA-61-103.PMC5330066.pdf
Available  from: http://www.banglajol.info/index.php/JAFMC/article/ view/16342.,Non-OADS,/arxiv_data1/oa_pdf/3f/d1/IJA-61-103.PMC5330066.pdf
Available from: http://www.iaas-med.com/files/ historical/DaySurgery.,Non-OADS,/arxiv_data1/oa_pdf/59/43/IJA-61-110.PMC5330067.pdf
Available from: http://www.apps.who.int/ iris/bitstream/10665/107831/1/E90295.pdf.,Non-OADS,/arxiv_data1/oa_pdf/59/43/IJA-61-110.PMC5330067.pdf
Available from:  http://www.archivehealthcare.expressbpd.com/201101/ anniversaryspecial12.shtml.,Non-OADS,/arxiv_data1/oa_pdf/59/43/IJA-61-110.PMC5330067.pdf
Available  from: http://www.trai.gov.in/sites/default/files/ PR-32-TSD-May -15_10072015.pdf.,Non-OADS,/arxiv_data1/oa_pdf/59/43/IJA-61-110.PMC5330067.pdf
Available from:  http://www.iars.org/assets/1/7/RCL-01.pdf.,OADS,/arxiv_data1/oa_pdf/59/43/IJA-61-110.PMC5330067.pdf
Visit http://www.cjisa.org for details.,Non-OADS,/arxiv_data1/oa_pdf/3e/e0/IJA-61-144.PMC5330071.pdf
Visit http://www.njisa.org for details.,Non-OADS,/arxiv_data1/oa_pdf/45/43/IJA-61-157.PMC5330073.pdf
Available from: https://www.anzca.edu.au/ documesnts/Slater.pdf.,Non-OADS,/arxiv_data1/oa_pdf/cf/11/IJA-61-163.PMC5330074.pdf
Available  from: http://www.idf.org/diabetesatlas/5e/Update2012.,Non-OADS,/arxiv_data1/oa_pdf/ec/5b/PR-9-1.PMC5330092.pdf
Available from: http://www.who.org.,Non-OADS,/arxiv_data1/oa_pdf/ec/5b/PR-9-1.PMC5330092.pdf
Available from: http://www.ssa.gob.mx.,Non-OADS,/arxiv_data1/oa_pdf/ec/5b/PR-9-1.PMC5330092.pdf
Available from: https://ntp.niehs.nih.,Non-OADS,/arxiv_data1/oa_pdf/ec/5b/PR-9-1.PMC5330092.pdf
Available from: http://www.diabetes.org.br/sala-de- noticias/2364-sao-134-milhoes-de-pessoas-portadoras-de-diabetes-no-brasilbet es-no-Brasil.,Non-OADS,/arxiv_data1/oa_pdf/0e/63/PR-9-101.PMC5330093.pdf
Available from: http://www.google.com/patents/ US8242178.,Non-OADS,/arxiv_data1/oa_pdf/21/72/PR-9-116.PMC5330095.pdf
Available from: http://www.who.int/healthinfo/global_burden_disease/ GlobalHealthRisks_report_part 2.pdf.,Non-OADS,/arxiv_data1/oa_pdf/45/5a/PR-9-21.PMC5330098.pdf
Available from: https://www.s.cribd.com/doc/111589775/ Isolation-and-Characterization-of-Galactomannan-From-Sugar -Palm.,Non-OADS,/arxiv_data1/oa_pdf/05/3d/PR-9-39.PMC5330101.pdf
"All the  analyses were carried out using PRISM 5 software ( Graph Pad Software,  San Diego, CA, USA,  [http://www.graphpad.com]).",OADS,/arxiv_data1/oa_pdf/3e/fb/PR-9-51.PMC5330103.pdf
Available from: http://www.ich.,Non-OADS,/arxiv_data1/oa_pdf/4c/75/PR-9-60.PMC5330104.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/ae/1e/idr-10-061.PMC5330186.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/ae/1e/idr-10-061.PMC5330186.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Infection and Drug Resistance  2017:10 61–67Infection and Drug Resistance Dovepress submit your manuscript | www.dovepress.com Dovepress 61 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IDR.S122390Post-influenza aspergillosis, do not underestimate  influenza B Eric FL Nulens1 Marc JC Bourgeois2 Marijke BML Reynders1 1Laboratory Medicine, Medical  Microbiology, 2Department of  Intensive Care, Algemeen Ziekenhuis  Sint-Jan Brugge-Oostende AV, Brugge,  BelgiumAbstract:  Our objective is to highlight and focus on post-influenza aspergillosis, triggered by  influenza B virus.",Non-OADS,/arxiv_data1/oa_pdf/ae/1e/idr-10-061.PMC5330186.pdf
"Correspondence: Marijke BML Reynders Laboratory Medicine, Medical Microbiology, Algemeen Ziekenhuis Sint-Jan Brugge-Oostende AV, Ruddershove 10, B-8000 Brugge, BelgiumTel +32 5045 2603Fax +32 5045 2619Email marijke.reynders@azsintjan.beJournal name: Infection and Drug Resistance  Article Designation: REVIEWY ear: 2017V olume: 10Running head verso: Nulens et alRunning head recto: Post-influenza aspergillosisDOI: http://dx.doi.org/10.2147/IDR.S122390",Non-OADS,/arxiv_data1/oa_pdf/ae/1e/idr-10-061.PMC5330186.pdf
"Infection and Drug Resistance  2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Infection and Drug Resistance  Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/infection-and-drug-resistance-journalInfection and Drug Resistance is an international, peer-reviewed open- access journal that focuses on the optimal treatment of infection (bacte-rial, fungal and viral) and the development and institution of preventive strategies to minimize the development and spread of resistance.",Non-OADS,/arxiv_data1/oa_pdf/ae/1e/idr-10-061.PMC5330186.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 67 Post-influenza aspergillosis  34.,Non-OADS,/arxiv_data1/oa_pdf/ae/1e/idr-10-061.PMC5330186.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/a2/2d/mder-10-053.PMC5330187.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/a2/2d/mder-10-053.PMC5330187.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Medical Devices: Evidence and Research 2017:10 53–59Medical Devices: Evidence and Research Dovepress submit your manuscript | www.dovepress.com Dovepress 53 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/MDER.S115632 Peroral endoscopic myotomy: procedural  complications and pain management for the  perioperative clinician Lopa Misra1 Norio Fukami2 Katarina Nikolic1 T errence L Trentman1 1Department of Anesthesiology,   2Division of Gastroenterology and  Hepatology, Mayo Clinic Arizona,   Phoenix,  AZ, USAAbstract:  Achalasia refers to the lack of smooth muscle relaxation of the distal esophagus.",Non-OADS,/arxiv_data1/oa_pdf/a2/2d/mder-10-053.PMC5330187.pdf
"2 A growing body of literature supports POEM as a therapy for achalasia that Correspondence: Terrence L Trentman Department of Anesthesiology, Mayo Clinic in Arizona, 5777 E Mayo Blvd, Phoenix, AZ 85054, USATel +1 480 342 1800Mobile +1 602 619 2534Fax +1 480 342 2319Email trentman.terrence@mayo.eduJournal name: Medical Devices: Evidence and Research Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Misra et alRunning head recto: POEM pain managementDOI: http://dx.doi.org/10.2147/MDER.S115632 Video abstract Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/a2/2d/mder-10-053.PMC5330187.pdf
Or use: http://youtu.be/HNcb4ijQ7VY,Non-OADS,/arxiv_data1/oa_pdf/a2/2d/mder-10-053.PMC5330187.pdf
"Medical Devices: Evidence and Research 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Medical Devices: Evidence and Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/medical-devices-evidence-and-research-journalMedical Devices: Evidence and Research is an international, peer- reviewed, open access journal that focuses on the evidence, technology, research, and expert opinion supporting the use and application of   medical devices in the diagnosis, monitoring, treatment and management of clinical conditions and physiological processes.",Non-OADS,/arxiv_data1/oa_pdf/a2/2d/mder-10-053.PMC5330187.pdf
Available from http://www.ctsnet.org/article/peroral-endoscopic-myotomy-poem.,Non-OADS,/arxiv_data1/oa_pdf/a2/2d/mder-10-053.PMC5330187.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/5c/0c/dddt-11-497.PMC5330188.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2017:11 497–502Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  497Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S13094 5 Sofosbuvir/velpatasvir regimen promises an  effective pan-genotypic hepatitis C virus cure Fazia Mir Alp S Kahveci  Jamal A ibdah veysel Tahan Division of Gastroenterology and  Hepatology, University of Missouri,   Columbia, MO, USAAbstract:  Hepatitis C virus (HCV) is a global pandemic, with nearly 200 million infected  patients worldwide.",Non-OADS,/arxiv_data1/oa_pdf/5c/0c/dddt-11-497.PMC5330188.pdf
"Extrahepatic manifestations are often associated with chronic HCV infec - tion and include cryoglobulinemia, porphyria cutanea tarda, membranoproliferative  glomerulonephritis, Sjogren’s syndrome, idiopathic thrombocytopenic purpura, and Correspondence: veysel Tahan Division of Gastroenterology and  Hepatology, University of Missouri  Columbia, DC043.00, 1 Hospital Drive,  Columbia, MO 65201, USA Tel +1 573 884 6044 Fax +1 573 884 4595 email tahanv@health.missouri.ed u Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2017 Volume: 11 Running head verso: Mir et al Running head recto: Sofosbuvir/velpatasvir for HCV treatment DOI: http://dx.doi.org/10.2147/DDDT.S130945 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/5c/0c/dddt-11-497.PMC5330188.pdf
Or use: http://youtu.be/NgQWXXtUvO 0video abstract,Non-OADS,/arxiv_data1/oa_pdf/5c/0c/dddt-11-497.PMC5330188.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/5c/0c/dddt-11-497.PMC5330188.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/5c/0c/dddt-11-497.PMC5330188.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/fd/e5/dddt-11-503.PMC5330189.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2017:11 503–512Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  503Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S12958 6 Pharmacokinetic interactions between glimepiride  and rosuvastatin in healthy Korean subjects: does  the SLCO1B1  or CYP2C9  genetic polymorphism  affect these drug interactions?",Non-OADS,/arxiv_data1/oa_pdf/fd/e5/dddt-11-503.PMC5330189.pdf
"For type 2 diabetic patients, sulfonylureas usually are the second-line therapy for  increasing insulin secretion.5 Among them, glimepiride is a widely used third-generation correspondence: Min soo Park Department of clinical Pharmacology,  severance hospital, Yonsei University  college of Medicine, 50-1 Yonsei-ro,  seodaemun-gu, seoul, 03722, Korea Tel +82 2 2228 0270 Fax +82 2 2227 7890 email minspark@yuhs.a c Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Kim et al Running head recto: PK interactions between glimepiride and rosuvastatin DOI: http://dx.doi.org/10.2147/DDDT.S129586",Non-OADS,/arxiv_data1/oa_pdf/fd/e5/dddt-11-503.PMC5330189.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/fd/e5/dddt-11-503.PMC5330189.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/fd/e5/dddt-11-503.PMC5330189.pdf
"Available from: http://www.idf.org/guideline-type-2-diabete s.  Accessed January 17, 2017.",Non-OADS,/arxiv_data1/oa_pdf/fd/e5/dddt-11-503.PMC5330189.pdf
"Available from: http://www.fda.gov/down - loads/Drugs/GuidanceComplianceRegulatoryInformation/ Guidances / UCM292362.pd f. Accessed January 30, 2015.",Non-OADS,/arxiv_data1/oa_pdf/fd/e5/dddt-11-503.PMC5330189.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/21/14/ccide-9-001.PMC5330190.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/21/14/ccide-9-001.PMC5330190.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).",Non-OADS,/arxiv_data1/oa_pdf/21/14/ccide-9-001.PMC5330190.pdf
"1 However, the use of photo- polymerizable composite restorative materials requires the performance of sensitive technical procedures, such as complete isolation, multiple methodical layering, and Correspondence: Fahad I Alkhudhairy   Restorative Dental Sciences Department,  College of Dentistry, King Saud University, PO Box 60169, Riyadh 11545, Kingdom of Saudi Arabia   Email Dr_fahad9@outlook.comJournal name:  Clinical, Cosmetic and Investigational Dentistry Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 9Running head verso: AlkhudhairyRunning head recto: Light intensity on bulk-fill composite resinsDOI: http://dx.doi.org/10.2147/CCIDE.S130085",Non-OADS,/arxiv_data1/oa_pdf/21/14/ccide-9-001.PMC5330190.pdf
" Clinical, Cosmetic and Investigational Dentistry 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress  Clinical, Cosmetic and Investigational Dentistry Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinical-cosmetic-and-investigational-dentistry-journalClinical, Cosmetic and Investigational Dentistry is an international,   peer-reviewed, open access, online journal focusing on the latest clini- cal and experimental research in dentistry with specific emphasis on cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/21/14/ccide-9-001.PMC5330190.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/21/14/ccide-9-001.PMC5330190.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/67/52/dddt-11-513.PMC5330191.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2017:11 513–519Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  513Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S12656 9 combined application of dexamethasone and  hyperbaric oxygen therapy yields better efficacy  for patients with delayed encephalopathy after  acute carbon monoxide poisoning Wenping Xiang1 hui Xue2 Baojun Wang2 Yuechun li2 Jun Zhang2 changchun Jiang2 Furu liang2 Jiangxia Pang2 lehua Yu1 1Department of rehabilitation  Medicine, The second affiliated  hospital of chongqing Medical  University, chongqing, 2Department  of neurology, Baotou central  hospital, Baotou, inner Mongolia,   People’s republic of chinaBackground:  Delayed encephalopathy after acute carbon monoxide (CO) poisoning  (DEACMP) commonly occurs after recovering from acute CO poisoning.",Non-OADS,/arxiv_data1/oa_pdf/67/52/dddt-11-513.PMC5330191.pdf
"This complica - tion in clinical practice is viewed as delayed encephalopathy after acute CO poison - ing (DEACMP).3,4 DEACMP is a disease with poor prognosis and could cause huge  economic burden for individuals, families and society.5correspondence: lehua Yu Department of rehabilitation Medicine,  The Second Affiliated Hospital of  chongqing Medical University, 76 linjiang  road, 400010 chongqing, People’s  republic of china Tel/fax +86 23 6309 3543 email yulehuaa@yeah.ne t Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Xiang et al Running head recto: Combined application of dexamethasone and HBO therapy DOI: http://dx.doi.org/10.2147/DDDT.S126569",Non-OADS,/arxiv_data1/oa_pdf/67/52/dddt-11-513.PMC5330191.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/67/52/dddt-11-513.PMC5330191.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/67/52/dddt-11-513.PMC5330191.pdf
"Keywords: Antibodies; Estrogens; Immunohistochemistry; Prostate This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Original Article - Lower Urinary Tract Dysfunction Received: 20 October, 2016  •  Accepted: 27 December, 2016 Corresponding Author: Rohit Bhattar Department of Urology and Renal Transplantation, SMS Medical College & Attached Hospitals, Jaipur, Rajasthan 302004, IndiaTEL: +91-7597402895, FAX: +91-0141-5110496, E-mail: bhattarrohit@gmail.com ⓒ The Korean Urological Association, 2017by specific intracellular estrogen receptors (ERs) and their  activation, which can occur independent of the serum  estrogen level [4].",Non-OADS,/arxiv_data1/oa_pdf/62/b7/icu-58-117.PMC5330371.pdf
Many studies have  demonstrated increased ER expression and differential  www.icurology.orgInvestig Clin Urol 2017;58:117-126.https://doi.org/10.4111/icu.2017.58.2.117pISSN 2466-0493  •  eISSN 2466-054X,Non-OADS,/arxiv_data1/oa_pdf/62/b7/icu-58-117.PMC5330371.pdf
"118 www.icurology.orgGangkak et al https://doi.org/10.4111/icu.2017.58.2.117 expression of receptor subtypes in BPH specimens as well as  cel l  cul tures  [8,10,15-17].",OADS,/arxiv_data1/oa_pdf/62/b7/icu-58-117.PMC5330371.pdf
120 www.icurology.orgGangkak et al https://doi.org/10.4111/icu.2017.58.2.117 epithelium.,Non-OADS,/arxiv_data1/oa_pdf/62/b7/icu-58-117.PMC5330371.pdf
"122 www.icurology.orgGangkak et al https://doi.org/10.4111/icu.2017.58.2.117 epithelial as well as stromal cells [8, 15,24] .",OADS,/arxiv_data1/oa_pdf/62/b7/icu-58-117.PMC5330371.pdf
124 www.icurology.orgGangkak et al https://doi.org/10.4111/icu.2017.58.2.117 act peripherally independent of serum estradiol levels [4].,Non-OADS,/arxiv_data1/oa_pdf/62/b7/icu-58-117.PMC5330371.pdf
126 www.icurology.orgGangkak et al https://doi.org/10.4111/icu.2017.58.2.117 XR.,Non-OADS,/arxiv_data1/oa_pdf/62/b7/icu-58-117.PMC5330371.pdf
"Keywords: Compliance; Frail elderly; Muscarinic antagonists; Overactive urinary bladder  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Original Article - Lower Urinary Tract Dysfunction Received: 18 October, 2016  •  Accepted: 12 December, 2016 Corresponding Author: Kirill Vladimirovich Kosilov Department of Social Sciences, School of Humanities, Far Eastern Federal University, Ayax 10, F733, DVFU, Vladivostok, Russian FederationTEL: +7-914-717-3915, FAX: +7-423-231-2169, E-mail: oton2000@mail.ru ⓒ The Korean Urological Association, 2017less than 46.9% in men, and no less than 61.0% in women  older than 65 years [1] .",Non-OADS,/arxiv_data1/oa_pdf/ac/da/icu-58-109.PMC5330372.pdf
"Intrusive and annoying OAB  symptoms reduce the health-related quality of life, suppress  www.icurology.orgInvestig Clin Urol 2017;58:109-116.https://doi.org/10.4111/icu.2017.58.2.109pISSN 2466-0493  •  eISSN 2466-054X",Non-OADS,/arxiv_data1/oa_pdf/ac/da/icu-58-109.PMC5330372.pdf
"110 www.icurology.orgKosilov et al https://doi.org/10.4111/icu.2017.58.2.109 social activity, often lead to depression and psychological  discomfort [2,3] .",Non-OADS,/arxiv_data1/oa_pdf/ac/da/icu-58-109.PMC5330372.pdf
112 www.icurology.orgKosilov et al https://doi.org/10.4111/icu.2017.58.2.109 treatment at the moment of discontinuing the AM drugs  administration.,Non-OADS,/arxiv_data1/oa_pdf/ac/da/icu-58-109.PMC5330372.pdf
"114 www.icurology.orgKosilov et al https://doi.org/10.4111/icu.2017.58.2.109 Table 4  provides objective characteristics of health,  economic and socio-psychological status of patients indicated  different reasons for the refusal of treatment.",OADS,/arxiv_data1/oa_pdf/ac/da/icu-58-109.PMC5330372.pdf
116 www.icurology.orgKosilov et al https://doi.org/10.4111/icu.2017.58.2.109 United States: results from EpiLUTS.,Non-OADS,/arxiv_data1/oa_pdf/ac/da/icu-58-109.PMC5330372.pdf
"Keywords: Neoplasm grading; Transforming growth factor beta2; Urinary bladder neoplasms; ZEB1 protein This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Original Article - Basic and Translational Research Received: 14 November, 2016  •  Accepted: 22 December, 2016 Corresponding Author: Massoud Saidijam Research Center for Molecular Medicine, Department of Genetics and Molecular Medicine, Hamadan University of Medical Sciences, Hamadan, IranTEL: +98-912-132-4616, FAX: +98-81-38380-208, E-mail: sjam110@yahoo.com ⓒ The Korean Urological Association, 2017 www.icurology.orgInvestig Clin Urol 2017;58:140-145.https://doi.org/10.4111/icu.2017.58.2.140pISSN 2466-0493  •  eISSN 2466-054X",Non-OADS,/arxiv_data1/oa_pdf/6b/94/icu-58-140.PMC5330373.pdf
"142 www.icurology.orgMahdavinezhad et al https://doi.org/10.4111/icu.2017.58.2.140 against Cancer, World Health Organization/International  Society of Urological Pathology criteria of 2004 was applied  to assess tumor staging and histological grading, respectively.",Non-OADS,/arxiv_data1/oa_pdf/6b/94/icu-58-140.PMC5330373.pdf
"144 www.icurology.orgMahdavinezhad et al https://doi.org/10.4111/icu.2017.58.2.140 cm2, we did not obtain statistically significant relationship  between tumor size and TGF ­β2 up­regulation (p=0.431) (Table  6).",OADS,/arxiv_data1/oa_pdf/6b/94/icu-58-140.PMC5330373.pdf
"The authors reply: Phosphorus as predictive factor  for erectile dysfunction in middle aged men: A cross sectional study in Korea Seung Ki Min1, Kwi Bok Choi1, Soon Ki Kim1, Gyeong In Lee2, In-Chang Cho1 Departments of 1Urology and 2Laboratory Medicine, National Police Hospital, Seoul, Korea This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Letter Received: 18 January, 2017  •  Accepted: 25 January, 2017 Corresponding Author: In-Chang Cho Department of Urology, National Police Hospital, 123 Songi-ro, Songpa-gu, Seoul 05715, KoreaTEL: +82-2-3400-1205, FAX: +82-2-431-3192, E-mail: uroiccho@gmail.com ⓒ The Korean Urological Association, 2017We promise readers that if we find target groups later, we  will continue to do further research including validation.",Non-OADS,/arxiv_data1/oa_pdf/d1/84/icu-58-148.PMC5330374.pdf
Ann Intern Med 1999;130:515- 24. www.icurology.orgInvestig Clin Urol 2017;58:148. https://doi.org/10.4111/icu.2017.58.2.148pISSN 2466-0493  •  eISSN 2466-054X,Non-OADS,/arxiv_data1/oa_pdf/d1/84/icu-58-148.PMC5330374.pdf
"Keywords: Meta-analysis; Phosphodiesterase 5 inhibitors; Review; Ureteral calculi This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Special Article - Endourology/Urolithiasis Received: 1 November, 2016  •  Accepted: 23 December, 2016 Corresponding Author: Carlos Eduardo Montes Cardona Department of Urology, Universidad del Valle, Calle 4B #36-00, Cali - ColombiaTEL: +57-31-3776-4785, FAX: +57-2-5572208, E-mail: medihelp65@gmail.com ⓒ The Korean Urological Association, 2017in economically developed countries [1,2] .",Non-OADS,/arxiv_data1/oa_pdf/0f/1d/icu-58-82.PMC5330375.pdf
"Because ureterolithiasis is a high-incidence pathology,  www.icurology.orgInvestig Clin Urol 2017;58:82-89.https://doi.org/10.4111/icu.2017.58.2.82pISSN 2466-0493  •  eISSN 2466-054X",Non-OADS,/arxiv_data1/oa_pdf/0f/1d/icu-58-82.PMC5330375.pdf
The protocol was registered in  the international prospective register of systematic reviews (PROSPERO; https://www.crd.york.ac.uk/PROSPERO/) under  number CDR42016038858.,Non-OADS,/arxiv_data1/oa_pdf/0f/1d/icu-58-82.PMC5330375.pdf
84 www.icurology.orgMontes Cardona and García-Perdomo https://doi.org/10.4111/icu.2017.58.2.82 or publication statuses of the articles were considered.,Non-OADS,/arxiv_data1/oa_pdf/0f/1d/icu-58-82.PMC5330375.pdf
86 www.icurology.orgMontes Cardona and García-Perdomo https://doi.org/10.4111/icu.2017.58.2.82 Random sequence generation (selection bias) Allocation concealment (selection bias) Blinding ofparticipants andpersonnel (performance bias) Blinding ofoutcome assessment (detection bias) Incomplete outcome data (attrition bias) Selective reporting (reporting bias) Other biasA Low riskofbias Unclear riskofbias High riskofbias0 100 %25 50 75Abhishek 2015 Hasan 2011 Kumar 2015 Shokeir 2016Randomsequencegeneration(selectionbias) Allocationconcealment(selectionbias) Blindingofparticipantsandpersonnel(performancebias) Blindingofoutcomeassessment(detectionbias) Incompleteoutcomedata(attritionbias) Selectivereporting(reportingbias) Otherbias ?,Non-OADS,/arxiv_data1/oa_pdf/0f/1d/icu-58-82.PMC5330375.pdf
"88 www.icurology.orgMontes Cardona and García-Perdomo https://doi.org/10.4111/icu.2017.58.2.82 the same principle and on the in vitro  effects on ureteral  smooth muscle [6,7], PDE5i have been proposed as an option  for MET.",Non-OADS,/arxiv_data1/oa_pdf/0f/1d/icu-58-82.PMC5330375.pdf
"SUPPLEMENTARY MATERIAL Scan this QR code to see the supplementary material, or  visit http://www.icurology.org/src/sm/icurology-58- 82-s001 .pdf.",Non-OADS,/arxiv_data1/oa_pdf/0f/1d/icu-58-82.PMC5330375.pdf
Available from: http://handbook.cochrane.org.,OADS,/arxiv_data1/oa_pdf/0f/1d/icu-58-82.PMC5330375.pdf
March 2017. https://doi.org/10.4111/icu.2017.58.2.82,Non-OADS,/arxiv_data1/oa_pdf/0f/1d/icu-58-82.PMC5330375.pdf
"Keywords: Botox; Myofascial pain; Pelvic pain; Therapy This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Original Article - Female Urology Received: 25 July, 2016  •  Accepted: 6 January, 2017 Corresponding Author: Gabriela E. Halder Department of Obstetrics and Gynecology, University of South Florida, 2 Tampa General Circle, 6th floor, Tampa, FL 33606, USATEL: +1-813-259-8500, FAX: +1-813-259-8582, E-mail: ghalder@health.usf.edu ⓒ The Korean Urological Association, 2017bands of muscle, in addition to regional pelvic pain [1,2] .",Non-OADS,/arxiv_data1/oa_pdf/47/eb/icu-58-134.PMC5330376.pdf
These  www.icurology.orgInvestig Clin Urol 2017;58:134-139.https://doi.org/10.4111/icu.2017.58.2.134pISSN 2466-0493  •  eISSN 2466-054X,Non-OADS,/arxiv_data1/oa_pdf/47/eb/icu-58-134.PMC5330376.pdf
136 www.icurology.orgHalder et al https://doi.org/10.4111/icu.2017.58.2.134 f ollowed by 10–20 mL of  0.25% Marcaine into the identif ied  trigger points.,Non-OADS,/arxiv_data1/oa_pdf/47/eb/icu-58-134.PMC5330376.pdf
138 www.icurology.orgHalder et al https://doi.org/10.4111/icu.2017.58.2.134 muscles.,Non-OADS,/arxiv_data1/oa_pdf/47/eb/icu-58-134.PMC5330376.pdf
"Keywords: Dutasteride; Prostate neoplasms; Recurrence This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Original Article - Urological Oncology Received: 21 December, 2016  •  Accepted: 5 January, 2017 Corresponding Author: Seung Chol Park Department of Urology, Wonkwang University School of Medicine and Hospital, 895 Muwang-ro, Iksan 54538, KoreaTEL: +82-63-859-1334, FAX: +82-63-842-1455, E-mail: sc.park@wonkwang.ac.kr ⓒ The Korean Urological Association, 2017men worldwide [1].",Non-OADS,/arxiv_data1/oa_pdf/70/4f/icu-58-98.PMC5330377.pdf
"The presence  of prostate-specific antigen (PSA) in the circulation  immediately after RP indicates a failure to eliminate  the PCa completely, and the reappearance of PSA at a  www.icurology.orgInvestig Clin Urol 2017;58:98-102.https://doi.org/10.4111/icu.2017.58.2.98pISSN 2466-0493  •  eISSN 2466-054X",Non-OADS,/arxiv_data1/oa_pdf/70/4f/icu-58-98.PMC5330377.pdf
100 www.icurology.orgShin et al https://doi.org/10.4111/icu.2017.58.2.98 3.,Non-OADS,/arxiv_data1/oa_pdf/70/4f/icu-58-98.PMC5330377.pdf
"102 www.icurology.orgShin et al https://doi.org/10.4111/icu.2017.58.2.98 RP, and in patients with PSA progression having resistance  to androgen deprivation therapy.",Non-OADS,/arxiv_data1/oa_pdf/70/4f/icu-58-98.PMC5330377.pdf
There are numerous applications  where CXCL12 and VEGF are used as regenerative  pharmacologic tools on a variety of tissues and which  highlight the importance of  understanding interactive  www.icurology.orgInvestig Clin Urol 2017;58:79-81. https://doi.org/10.4111/icu.2017.58.2.79pISSN 2466-0493  •  eISSN 2466-054X,Non-OADS,/arxiv_data1/oa_pdf/9d/8e/icu-58-79.PMC5330378.pdf
80 www.icurology.orgAndersson and Williams https://doi.org/10.4111/icu.2017.58.2.79 pathways in tissue regeneration.,Non-OADS,/arxiv_data1/oa_pdf/9d/8e/icu-58-79.PMC5330378.pdf
"Keywords: Prognosis; Prostate-specific antigen; Prostatic neoplasms; Radical prostatectomy This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Original Article - Urological Oncology Received: 15 November, 2016  •  Accepted: 22 December, 2016 Corresponding Author: Koon Ho Rha Department of Urology and Urological Science Institute, Severance Hospital, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul 03722, KoreaTEL: +82-2-2228-2310, FAX: +82-2-312-2538, E-mail: khrha@yuhs.ac ⓒ The Korean Urological Association, 2017with life expectancy of more than 10 years.",Non-OADS,/arxiv_data1/oa_pdf/49/b8/icu-58-90.PMC5330379.pdf
"Based on  patient’s risk stratification, patients may be offered with  www.icurology.orgInvestig Clin Urol 2017;58:90-97.https://doi.org/10.4111/icu.2017.58.2.90pISSN 2466-0493  •  eISSN 2466-054X",Non-OADS,/arxiv_data1/oa_pdf/49/b8/icu-58-90.PMC5330379.pdf
"92 www.icurology.orgSantok et al https://doi.org/10.4111/icu.2017.58.2.90 Patients in the upgraded group were older (p=0.007) and had  higher PSA and smaller prostate in volume; 7.7 ng/mL (IQR,  5.2–12.4 ng/mL) and 36.4±16.4 mL, respectively.",Non-OADS,/arxiv_data1/oa_pdf/49/b8/icu-58-90.PMC5330379.pdf
94 www.icurology.orgSantok et al https://doi.org/10.4111/icu.2017.58.2.90 potency and continent rate postoperatively.,OADS,/arxiv_data1/oa_pdf/49/b8/icu-58-90.PMC5330379.pdf
"96 www.icurology.orgSantok et al https://doi.org/10.4111/icu.2017.58.2.90 ham JA, et al.",Non-OADS,/arxiv_data1/oa_pdf/49/b8/icu-58-90.PMC5330379.pdf
"Keywords: Adult; Kidney calculi; Lithotripsy; Stents This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Original Article - Endourology/Urolithiasis Received: 5 December, 2016  •  Accepted: 28 December, 2016 Corresponding Author: Arpan Choudhary Department of Urology, R G Kar Medical College and Hospital, Room 36, KB hostel, Kolkata 700004, IndiaTEL: +91-9229042276, FAX: +91-33-2555-8618, E-mail: jn_rpn@yahoo.co.in ⓒ The Korean Urological Association, 2017stone varying according to age, gender, race, and geographic  location [1] .",Non-OADS,/arxiv_data1/oa_pdf/71/d3/icu-58-103.PMC5330380.pdf
The lower ef f icacy of  ESWL  www.icurology.orgInvestig Clin Urol 2017;58:103-108.https://doi.org/10.4111/icu.2017.58.2.103pISSN 2466-0493  •  eISSN 2466-054X,Non-OADS,/arxiv_data1/oa_pdf/71/d3/icu-58-103.PMC5330380.pdf
"104 www.icurology.orgSharma et al https://doi.org/10.4111/icu.2017.58.2.103 with increasing stone size, however, and the promising role  of retrograde intrarenal surgery and mini-percutaneous  nephrolithotomy have made ESWL a less popular choice  for stones sized 1 to 2 cm.",Non-OADS,/arxiv_data1/oa_pdf/71/d3/icu-58-103.PMC5330380.pdf
Sample  size was calculated by using G*Power version 3.1.9.2 (Heinrich  Heine Universität Düsseldorf; http://www.gpower.hhu.,OADS,/arxiv_data1/oa_pdf/71/d3/icu-58-103.PMC5330380.pdf
106 www.icurology.orgSharma et al https://doi.org/10.4111/icu.2017.58.2.103 (11.1% and 72.2%) or group 2 (10.0% and 65.0%) (p=0.02).,OADS,/arxiv_data1/oa_pdf/71/d3/icu-58-103.PMC5330380.pdf
108 www.icurology.orgSharma et al https://doi.org/10.4111/icu.2017.58.2.103 lithotripsy in impacted upper ureteral stones: a prospective  randomized comparison between stented and non-stented techniques.,OADS,/arxiv_data1/oa_pdf/71/d3/icu-58-103.PMC5330380.pdf
"Keywords: Female; Midurethral sling; Stress urinary incontinence This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Original Article - Female Urology Received: 21 October, 2016  •  Accepted: 13 December, 2016 Corresponding Author: Eun Sang Yoo Department of Urology, Kyungpook National University School of Medicine, 130 Dongdeok-ro, Jung-gu, Daegu 41944, KoreaTEL: +82-53-420-5843, FAX: +82-53-421-9618, E-mail: uroyoo@knu.ac.kr ⓒ The Korean Urological Association, 2017To treat SUI, several forms of  retropubic colposuspension,  pubovaginal slings, injectable bulking agents, and needle  suspensions have been developed [2].",Non-OADS,/arxiv_data1/oa_pdf/74/62/icu-58-127.PMC5330381.pdf
"Owing to the evolution of midurethral slings and their  high efficacy and safety, retropubic midurethral slings and  transobturator midurethral slings have been introduced  www.icurology.orgInvestig Clin Urol 2017;58:127-133.https://doi.org/10.4111/icu.2017.58.2.127pISSN 2466-0493  •  eISSN 2466-054X",Non-OADS,/arxiv_data1/oa_pdf/74/62/icu-58-127.PMC5330381.pdf
128 www.icurology.orgChung and Yoo https://doi.org/10.4111/icu.2017.58.2.127 into numerous urologic fields [3] .,Non-OADS,/arxiv_data1/oa_pdf/74/62/icu-58-127.PMC5330381.pdf
"130 www.icurology.orgChung and Yoo https://doi.org/10.4111/icu.2017.58.2.127 “improved,” and 4 (3.9%) reported “failure.” Twenty patients  (19.6%) were “very satisfied”, 54 (52.9%) were “satisfied,” 24  (23.5%) were “neither satisfied nor dissatisfied,” 3 (2.9%) were  “dissatisfied,” and 1 (1.0%) was “very dissatisfied.” There were  no significant differences in subjective surgical outcomes  and patient satisfaction between the 2 groups ( Table 4 ).",Non-OADS,/arxiv_data1/oa_pdf/74/62/icu-58-127.PMC5330381.pdf
"132 www.icurology.orgChung and Yoo https://doi.org/10.4111/icu.2017.58.2.127 Thus, patients with low bladder compliance could be good  candidates for the Remeex operation.",Non-OADS,/arxiv_data1/oa_pdf/74/62/icu-58-127.PMC5330381.pdf
"The internal and external validation of the Letter to the editor: Phosphorus as predictive  factor for erectile dysfunction in middle aged men: A cross sectional study in Korea; Methodological issues to avoid prediction fallacy Reza Pakzad1, Saeid Safiri2,3 1Department of Epidemiology, Faculty of Health, Ilam University of Medical Sciences, Ilam, 2Managerial Epidemiology Research Center, Department of Public Health,  School of Nursing and Midwifery, Maragheh University of Medical Sciences, Maragheh, 3Department of Epidemiology and Biostatistics, School of Public Health, Tehran  University of Medical Sciences, Tehran, Iran This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Letter Received: 20 December, 2016  •  Accepted: 23 January, 2017 Corresponding Author: Saeid Safiri Managerial Epidemiology Research Center, Department of Public Health, School of Nursing and Midwifery, Maragheh University of Medical Sciences, Maragheh, IranTEL: +98-4137276365, FAX: +98-4137276365, E-mail: saeidsafiri@gmail.com ⓒ The Korean Urological Association, 2017prediction model must be done through bootstrapping and  split-validation, respectively [2,4] .",Non-OADS,/arxiv_data1/oa_pdf/dc/cc/icu-58-146.PMC5330382.pdf
www.icurology.orgInvestig Clin Urol 2017;58:146-147.https://doi.org/10.4111/icu.2017.58.2.146pISSN 2466-0493  •  eISSN 2466-054X,Non-OADS,/arxiv_data1/oa_pdf/dc/cc/icu-58-146.PMC5330382.pdf
https://doi.org/10.1016/j.urology.2016.10.052.,Non-OADS,/arxiv_data1/oa_pdf/dc/cc/icu-58-146.PMC5330382.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).",Non-OADS,/arxiv_data1/oa_pdf/6d/72/10.1177_2058460116686392.PMC5330413.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).",Non-OADS,/arxiv_data1/oa_pdf/f1/4e/10.1177_2058460116678708.PMC5330414.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).",Non-OADS,/arxiv_data1/oa_pdf/93/6c/10.1177_2058460116684371.PMC5330415.pdf
"2, 123 –138 http://dx.doi.org/10.1080/15592294.2016.1265713",Non-OADS,/arxiv_data1/oa_pdf/32/d8/kepi-12-02-1265713.PMC5330441.pdf
Science 2009; 324:929-30; PMID:19372393; http://dx.doi.org/10.1126/science.1169786 2.,Non-OADS,/arxiv_data1/oa_pdf/32/d8/kepi-12-02-1265713.PMC5330441.pdf
Science 2013; 341:1237905; PMID:23828890; http://dx.doi.org/10.1126/science.1237905 3.,Non-OADS,/arxiv_data1/oa_pdf/32/d8/kepi-12-02-1265713.PMC5330441.pdf
Faseb J 2016; 30:2874-84; PMID:27118675; http://dx.doi.org/10.1096/ fj.201600310R 4.,Non-OADS,/arxiv_data1/oa_pdf/32/d8/kepi-12-02-1265713.PMC5330441.pdf
Genes Dev 2016; 30:733-50; PMID:27036965; http://dx.doi.org/10.1101/gad.276568.115 6.,Non-OADS,/arxiv_data1/oa_pdf/32/d8/kepi-12-02-1265713.PMC5330441.pdf
PloS one2011; 5:e15367; PMID:21203455; http://dx.doi.org/10.1371/journal.pone.0015367 7.,Non-OADS,/arxiv_data1/oa_pdf/32/d8/kepi-12-02-1265713.PMC5330441.pdf
Gen Res 2012; 22:467-77; PMID:22106369; http://dx.doi.org/ 10.1101/gr.126417.111 8.,Non-OADS,/arxiv_data1/oa_pdf/32/d8/kepi-12-02-1265713.PMC5330441.pdf
Nucleic Acids Res 1982; 10:2709-21; PMID:7079182; http://dx.doi.org/10.1093/nar/ 10.8.2709 9.,OADS,/arxiv_data1/oa_pdf/32/d8/kepi-12-02-1265713.PMC5330441.pdf
Biomol Concepts 2016; 7:169-78; PMID:27356236; http://dx.doi.org/10.1515/bmc-2016-0011 10.,OADS,/arxiv_data1/oa_pdf/32/d8/kepi-12-02-1265713.PMC5330441.pdf
Genome Biol 2014; 15:R49; PMID:24594098; http://dx.doi.org/10.1186/gb-2014-15-3-r49 12.,Non-OADS,/arxiv_data1/oa_pdf/32/d8/kepi-12-02-1265713.PMC5330441.pdf
Genome Biol 2013; 14:R91; PMID:23987249; http://dx.doi.org/10.1186/gb-2013-14-8-r91 13.,OADS,/arxiv_data1/oa_pdf/32/d8/kepi-12-02-1265713.PMC5330441.pdf
Trend Gen: TIG 2015; 31:274-80;PMID:25837375; http://dx.doi.org/10.1016/j.tig.2015.03.002 14.,OADS,/arxiv_data1/oa_pdf/32/d8/kepi-12-02-1265713.PMC5330441.pdf
Gen Res 2011; 21:1074-86; PMID:21628449; http://dx.doi.org/10.1101/gr.118703.110 15.,OADS,/arxiv_data1/oa_pdf/32/d8/kepi-12-02-1265713.PMC5330441.pdf
Oncotarget 2012;3:462-74; PMID:22577155; http://dx.doi.org/10.18632/oncotarget.497 16.,OADS,/arxiv_data1/oa_pdf/32/d8/kepi-12-02-1265713.PMC5330441.pdf
Science 2012; 336:934-7;PMID:22539555; http://dx.doi.org/10.1126/science.1220671136 V. K. C. PONNALURI ET AL.,OADS,/arxiv_data1/oa_pdf/32/d8/kepi-12-02-1265713.PMC5330441.pdf
Epigenomics 2014; 6:563-6; PMID:25531248;http://dx.doi.org/10.2217/epi.14.48 18.,Non-OADS,/arxiv_data1/oa_pdf/32/d8/kepi-12-02-1265713.PMC5330441.pdf
Molecular cell 2014; 56:286-97; PMID:25263596; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/32/d8/kepi-12-02-1265713.PMC5330441.pdf
Genome Biol 2014; 15:469; PMID:25239471; http://dx.doi.org/10.1186/s13059-014-0469-0 20.,OADS,/arxiv_data1/oa_pdf/32/d8/kepi-12-02-1265713.PMC5330441.pdf
Mol Cell Biol 2012; 32:36-49; PMID:22006022; http://dx.doi.org/ 10.1128/MCB.05857-11 22.,Non-OADS,/arxiv_data1/oa_pdf/32/d8/kepi-12-02-1265713.PMC5330441.pdf
Nature 2016; 537:63-8; PMID:27533040; http://dx.doi.org/10.1038/nature19081 23.,Non-OADS,/arxiv_data1/oa_pdf/32/d8/kepi-12-02-1265713.PMC5330441.pdf
Early de novoDNA methylation and prolonged demethylation in the muscle lineage.Epigenetics 2013; 8:317-32; PMID:23417056; http://dx.doi.org/ 10.4161/epi.23989 24.,Non-OADS,/arxiv_data1/oa_pdf/32/d8/kepi-12-02-1265713.PMC5330441.pdf
Stat Appl Genet Mol Biol 2013; 12:723-42; PMID:24163200; http://dx.doi.org/10.1515/sagmb-2013-0027 25.,OADS,/arxiv_data1/oa_pdf/32/d8/kepi-12-02-1265713.PMC5330441.pdf
Epigen Chromatin 2013; 6:25; PMID:23916067; http://dx.doi.org/10.1186/1756-8935-6-25 26.,Non-OADS,/arxiv_data1/oa_pdf/32/d8/kepi-12-02-1265713.PMC5330441.pdf
Cell Res 2016; 26:103-18; PMID:26680004; http://dx.doi.org/10.1038/cr.2015.150 27.,OADS,/arxiv_data1/oa_pdf/32/d8/kepi-12-02-1265713.PMC5330441.pdf
Nucleic Acids Res 2015; 43:732-44;PMID:25572316; http://dx.doi.org/10.1093/nar/gku1305 28.,Non-OADS,/arxiv_data1/oa_pdf/32/d8/kepi-12-02-1265713.PMC5330441.pdf
PloSOne 2013; 8:e81148; PMID:24324667; http://dx.doi.org/10.1371/ journal.pone.0081148 29.,Non-OADS,/arxiv_data1/oa_pdf/32/d8/kepi-12-02-1265713.PMC5330441.pdf
Mol Genet Metabol 2005; 86:84-90;PMID:16165387; http://dx.doi.org/10.1016/j.ymgme.2005.07.028 30.,OADS,/arxiv_data1/oa_pdf/32/d8/kepi-12-02-1265713.PMC5330441.pdf
Science 2015; 348:648-60; PMID:25954001; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/32/d8/kepi-12-02-1265713.PMC5330441.pdf
Nucleic Acids Res 1983; 11:6883-94; PMID:6314264; http://dx.doi.org/10.1093/nar/11.19.688333.,OADS,/arxiv_data1/oa_pdf/32/d8/kepi-12-02-1265713.PMC5330441.pdf
Cell2014; 158:673-88; PMID:25083876; http://dx.doi.org/10.1016/j.cell.,OADS,/arxiv_data1/oa_pdf/32/d8/kepi-12-02-1265713.PMC5330441.pdf
Free Radic Biol Med 2014; 75 Suppl 1:S37; PMID:26461356; http://dx.doi.org/10.1016/j.freeradbiomed.2014.10.781 35.,OADS,/arxiv_data1/oa_pdf/32/d8/kepi-12-02-1265713.PMC5330441.pdf
Placenta 2006; 27:119-26; PMID:16338457; http://dx.doi.org/10.1016/j.placenta.2004.12.003 36.,OADS,/arxiv_data1/oa_pdf/32/d8/kepi-12-02-1265713.PMC5330441.pdf
J Biol Chem 2008; 283:7027-35; PMID:18175804; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/32/d8/kepi-12-02-1265713.PMC5330441.pdf
Dev Biol 2013; 377:293- 304; PMID:23438814; http://dx.doi.org/10.1016/j.ydbio.2013.02.011 40.,OADS,/arxiv_data1/oa_pdf/32/d8/kepi-12-02-1265713.PMC5330441.pdf
Nucleic Acids Res 2014; 42:6956-71; PMID:24875481; http://dx.doi.org/10.1093/nar/gku372 41.,OADS,/arxiv_data1/oa_pdf/32/d8/kepi-12-02-1265713.PMC5330441.pdf
Mol Cell Biol 2016; 36:452-61; PMID:26598602;http://dx.doi.org/10.1128/MCB.00587-15 42.,Non-OADS,/arxiv_data1/oa_pdf/32/d8/kepi-12-02-1265713.PMC5330441.pdf
Epigenetics2012; 7:421-8; PMID:22415013; http://dx.doi.org/10.4161/epi.19565 43.,Non-OADS,/arxiv_data1/oa_pdf/32/d8/kepi-12-02-1265713.PMC5330441.pdf
Nucleic Acids Res 2007; 35:406-13;PMID:17169996; http://dx.doi.org/10.1093/nar/gkl1057 44.,OADS,/arxiv_data1/oa_pdf/32/d8/kepi-12-02-1265713.PMC5330441.pdf
Nucleic AcidsRes 2006; 34:W676-82; PMID:16845096; http://dx.doi.org/10.1093/nar/gkl253 45.,OADS,/arxiv_data1/oa_pdf/32/d8/kepi-12-02-1265713.PMC5330441.pdf
NucleicAcids Res 2014; 42:9612-22; PMID:25081205; http://dx.doi.org/ 10.1093/nar/gku648 46.,OADS,/arxiv_data1/oa_pdf/32/d8/kepi-12-02-1265713.PMC5330441.pdf
Nature 2011; 473:43-9; PMID:21441907; http://dx.doi.org/10.1038/nature09906 47.,Non-OADS,/arxiv_data1/oa_pdf/32/d8/kepi-12-02-1265713.PMC5330441.pdf
Hum Mol Genet 2015; 24:4660-73; PMID:26041816; http://dx.doi.org/10.1093/hmg/ddv198 48.,OADS,/arxiv_data1/oa_pdf/32/d8/kepi-12-02-1265713.PMC5330441.pdf
Nature 2010; 466:253-7; PMID:20613842; http://dx.doi.org/10.1038/nature09165 49.,Non-OADS,/arxiv_data1/oa_pdf/32/d8/kepi-12-02-1265713.PMC5330441.pdf
Epigenetics 2014; 9:842-50; PMID:24670287; http://dx.doi.org/10.4161/epi.28597 50.,Non-OADS,/arxiv_data1/oa_pdf/32/d8/kepi-12-02-1265713.PMC5330441.pdf
Exp Gerontol 2014; 55:80-91; PMID:24685641; http://dx.doi.org/10.1016/j.exger.2014.03.015 51.,OADS,/arxiv_data1/oa_pdf/32/d8/kepi-12-02-1265713.PMC5330441.pdf
PLoS Comput Biol 2016; 12:e1004905;PMID:27224554; http://dx.doi.org/10.1371/journal.pcbi.1004905 52.,Non-OADS,/arxiv_data1/oa_pdf/32/d8/kepi-12-02-1265713.PMC5330441.pdf
Behav Neurosci2015; 129:765-76; PMID:26595880; http://dx.doi.org/10.1037/bne0000108 53.,Non-OADS,/arxiv_data1/oa_pdf/32/d8/kepi-12-02-1265713.PMC5330441.pdf
PloS One 2013; 8:e66254; PMID:23785489; http://dx.doi.org/10.1371/journal.pone.0066254 54.,OADS,/arxiv_data1/oa_pdf/32/d8/kepi-12-02-1265713.PMC5330441.pdf
Cell reports 2016; 11:283-94; PMID:25843715; http://dx.doi.org/10.1016/j.celrep.2015.03.020 55.,OADS,/arxiv_data1/oa_pdf/32/d8/kepi-12-02-1265713.PMC5330441.pdf
